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ABSTRACT 
The regenerative potential of adult skeletal muscle is primarily attributed to satellite 
cells. Normally quiescent, satellite cells are activated on demand" to proliferate and 
differentiate, facilitating growth or repair. Maintenance of the regenerative capacity 
requires satellite cell replenishment. It has been shown in vitro that activated satellite 
cells can adopt divergent fates., with most undergoing terminal differentiation, whilst a 
minority return to quiescence, mediating self-renewal. This occurs in cell clusters. 
suggesting that cell-cell signalling may direct fate decisions. Notch signalling relies on 
cell-cell interaction to specify alternate fates in several systems and has been previously 
implicated in myogenesis. The aim of this project was to investigate the role of Notch 
signalling in satellite cell regulation and maintenance. Studies were carried out using 
C2C 12 cultures as a model of satellite cell specification. When induced to differentiate, 
most C2C12 myoblasts contribute to differentiated myotubes, but some are retained as 
undifferentiated reserve cells with a quiescent, satellite cell-like phenotype. This thesis 
shows that Notch signalling maintains proliferation in myoblasts and inhibits myogenic 
differentiation in reserve cells via distinct ligand/receptor interactions. Specifically, 
interaction between Notch l and Jagged l appears to maintain proliferation. ý, vhereas 
interaction of Notch3 with Delta-like4 on nascent myotubes specifies a reserve cell 
phenotype. Evidence consistent with this model was obtained using satellite cells 
activated on the surface of isolated myofibres and satellite cell-derived primary cultures. 
Together, the results show that Notch signalling is involved in satellite cell regulation 
and suggest a mechanism that may specify alternate fates to facilitate stem cell self- 
renewal. 
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CHAPTER 1: Introduction 
1.1 Adult skeletal muscle characteristics and satellite cell function 
Skeletal muscle is the most abundant tissue in mammals, constituting approximately 10- 
40% of total body mass in humans (reviewed in Collins and Partridge. 2005; Sloper et 
al., 1978; reviewed in Zierath and Hawley, 2004). It plays vital roles in locomotion. 
heat production and overall metabolism (reviewed in Zierath and Hawley, 2004) and is 
a highly specialised contractile tissue composed of bundles of syncytial mvofibres, 
which each contain hundreds of post-mitotic myonuclei (Moss and Leblond, 1971, 
Stockdale and Holtzer, 1961; reviewed in Zammit and Beauchamp, 2001; revie\ved in 
Zammit et al., 2002). Individual adult skeletal muscles have different metabolic and 
contractile properties, determined by the proportions of slow-twitch fibres (slow- 
contracting/fatigue-resistant) and fast-twitch fibres (fast-contracting/fatigue-susceptible) 
that they contain (Engel, 1998; reviewed in Zierath and Hawley, 2004). The 
contractility of both fibre-types is mediated via a sliding mechanism of myosin-rich 
thick filaments over actin-rich thin filaments, following activation by motor neurons 
(Huxley, 1957; Huxley, 2000). Connective tissue is abundant in adult skeletal muscle, 
combining the myofibres into functional units; myotendinous junctions attach myofibres 
to the skeleton, transforming fibre contraction into movement. There is also vascular 
tissue within skeletal muscle, which facilitates the delivery of nutrients to the myofibres 
to mediate muscle function (reviewed in Charge and Rudnicki, 2004). 
Adult skeletal muscle is a stable tissue. Normally there is little turnover of the post- 
mitotic myonuclei within each fibre (Decary et al., 1997; Spalding et al.. 2005) and 
minor lesions inflicted by daily wear and tear elicit only a slow turnover of myotibres 
(reviewed in Charge and Rudnicki, 2004). In adult rodent muscle. for example. only 
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1-2% of myonuclei are replaced weekly (Schmalbruch and Lewis. 2000). Howw ever. 
skeletal muscle is one of several adult tissues that retains the ability throughout life to 
rapidly repair and regenerate if necessary, due to the presence of a population of adult 
stem cells (Akashi et al., 1999; Beauchamp et al., 2000: Booth and Potten. 2000; Watt. 
1998), and does so in response to disease (e. g. Duchenne muscular dystrophy). 
physiological demands (such as growth or exercise) or following direct injury (which 
can be induced experimentally by freezing, crushing or toxin-injection)(Appell et al.. 
1988; Blaveri et al., 1999; Grounds, 1998; reviewed in Hawke and Garr`, 2001; 
reviewed in Negroni et al., 2006; Rosenblatt et al., 1994; Schultz et al., 1985). Muscle 
damage is characterised by an initial degenerative phase, involving necrosis and 
infiltration of inflammatory cells, which is followed by regeneration (re% ieww-cd in 
Charge and Rudnicki, 2004). 
The regenerative potential of adult skeletal muscle is primarily attributed to a small 
population of mononucleated stem cells known as satellite cells, discovered in frogs in 
1961 (Katz, 1961; Mauro, 1961), which reside in indentations between the sarcolemma 
and the surrounding basal lamina of the myofibres (reviewed in Bischoff, 1994; 
reviewed in Hawke and Garry, 2001). Normally, satellite cells remain quiescent 
(Schultz et al., 1978), but in response to growth signals or myotrauma they become 
activated and proliferate to produce myoblasts. Myoblasts move to the site of injury 
(Bischoff, 1997) and ultimately undergo terminal myogenic differentiation by fusing to 
existing myofibres or forming new fibres (Grounds and McGeachie, 1987: Rantanen et 
al., 1995), facilitating the growth or repair of damaged skeletal muscle (Figure 
1.1)(reviewed in Hawke and Garry, 2001). Satellite cells are the main, if not only, cell- 
type that contribute to muscle regeneration (Bischoff, 1994). 
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Resting Myofibre 
Quiescent satellite cell 
Myonuclei 
t Regenerated Myofibre 
Chemotaxis to site of injury 
Fusion to damaged fibre - repair 
AM 
or 
Myoblasts fuse to each other - form new myofibre 
Figure 1.1: The satellite cell response to myotrauma (reviewed in Hawke and 
Garry, 2001) 
Resting myofibres contain hundreds of post-mitotic myonuclei and have relatively tcýww 
quiescent satellite cells associated with them. Quiescent satellite cells, which reside 
under the basal lamina of the fibre, are activated in response to myotrauma or growth 
signals. Skeletal muscle trauma may be minor (e. g. exercise) or more extensive (e. g. 
toxin-injection, Duchenne muscular dystrophy). Once activated, satellite cells 
proliferate to generate myoblasts that move to the site of injury, and either fuse to the 
damaged region to repair it or fuse to each other to create new myofibres. Newly 
regenerated fibres can be identified by their centrally-located myonuclei (Sloper and 
Partridge, 1980). 
1.1.1 Studying satellite cells 
Traditionally, satellite cells were isolated from whole muscle by a process that involved 
mincing, enzymatic digestion and centrifugation (Bischoff, 1974; Rosenblatt et A. 
1995). The released cells consisted mainly of satellite cells and fibroblasts, which were 
cultured while the muscular tissue was discarded, but the process was inefficient and 
irreproducible (Rosenblatt et al., 1995). In more recent studies, it «gas shown that, by 
Satellite cell acti%ation and 
proliferation to produce mvoblasts 
1111aml MIIIII-IPW mb, all 
1 
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enzymatic digestion, viable myofibres could be isolated from muscle. complete %t ith 
their cohort of satellite cells still resident beneath the basal lamina (Beauchamp et al.. 
2000; Bischoff, 1975; Bischoff, 1986; Konigsberg et al.. 1975. Rosenblatt et al., 1995; 
Yablonka-Reuveni and Rivera, 1994). When these isolated fibres are cultured. the 
satellite cells proliferate, giving rise to satellite cell-derived myoblasts. which migrate 
off the fibre onto their substrate, and differentiate to produce multinucleated myotubes 
(Zammit et al., 2006a). Alternatively, if isolated fibres are maintained in suspension 
culture (Zammit et al., 2004), the associated satellite cells become activated, proliferate 
and differentiate while still exposed to signals from the myofibre (Beauchamp et al., 
2000). This allows the fate of an entire cohort of satellite cells to be studied without 
any bias of selection (Zammit et al., 2006a), and ensures that the myofibre is isolated 
from potential exogenous sources of myogenic cells such as connective tissue and the 
vasculature (Ferrari et al., 1998; LaBarge and Blau, 2002; Tamaki et al., 2002). 
Myogenic cell lines (there are several, but C2C12 cells were used in this project so are 
focused upon) can be used to investigate myogenic differentiation. The myogenic C2 
cell line was originally derived from the crush-injured thigh muscle of an adult female 
C3H mouse (Yaffe and Saxel, 1977). C2C12, a subclone of the C2 line, was isolated 
and karyotyped by Blau et al. (1983) and selected for its ability to differentiate rapidly 
(within 3-4 days) and produce extensive contracting myotubes, expressing characteristic 
muscle proteins. C2C 12 cells are well-characterised and have been used extensively for 
studies of muscle cell differentiation (Cossins et al., 2002; Nofziger et al., 1999; 
Shawber et al., 1996) because they are much more easily manipulable in tissue culture 
than primary muscle cells (Morgan et al., 1992). In the presence of a high concentration 
of serum, C2C12 cells proliferate as undifferentiated myoblasts (Yoshida et al., l 99ý ). 
Serum depletion induces differentiation in 40-60% of cells: cells withdraw from the cell 
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cycle, fusion occurs and myotubes are formed. However, a proportion remain 
undifferentiated and mononucleated and are known as reserve cell. which have 
characteristics that are similar to quiescent satellite cells (Yoshida et al., 1998)(ýce 
section 1.11). Therefore, reserve cells may be considered as a model of quit'cent 
satellite cells. Furthermore, divergent differentiated and undifferentiated cell fates are 
not only seen in C2C 12 cultures (Yoshida et al., 1998), but are also observed in primary 
cultures (Baroffio et al., 1996; Kitzmann et al., 1998) and in satellite cell progen 
associated with isolated myofibres in suspension culture (Zammit et al., 2004), 
highlighting the value of C2C12 cultures as a satellite cell model. 
There are some possible disadvantages to using C2C12 cells as a satellite cell model. 
C2C12 cells are a transformed, immortal, aneuploid cell line (Anastasia et al., 2006) 
that may not actually be satellite cell-derived, as mononucleated myogenic cells were 
originally isolated from digested whole muscle (Yaffe and Saxel, 1977), which also 
contains other sources of myogenic cells (e. g. in the interstitium and vasculature 
(Ferrari et al., 1998; LaBarge and Blau, 2002; Tamaki et al., 2002)). Therefore, 
although C2C 12 cells are a myogenic cell line, they may not express all of the same 
myogenic transcription factors as satellite cells. 
1.1.2 The classification of satellite cells as stem cells 
Stem cells are defined as single cells that are the clonal precursors of both more stem 
cells of the same type and of a specific set of differentiated progeny (Weissman et al., 
2001). It is well-established that satellite cells can generate differentiated muscle (`lo,,, 
and Leblond, 1971; Zammit et al., 2002), and there is growing evidence to suggest that 
satellite cells are capable of self-renewal (Collins et al., 200-5: Olguin and 01% in, 2004, 
Zammit et al., 2004). Therefore, satellite cells appear to fulfil the defined 'stem cell' 
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criteria. An additional `stem cell' characteristic of satellite cells are their proposed 
plasticity (Verfaillie, 2002). Satellite cells ma,,, - be multipotent. since they are able to 
give rise to adipogenic and osteogenic cells in vitro as well as myouenic cells (. -\,, akura 
et al., 2001). Multipotency in vivo has yet to be demonstrated. although the 
accumulation of adipose tissue and ectopic bone formation within skeletal muscle in 
some human diseases suggests that satellite cells may indeed be capable of non- 
myogenic commitment (reviewed in Charge and Rudnicki, 2004). 
1.2 Adult skeletal muscle development and satellite cell origin 
In the embryo, all vertebrate skeletal muscles (apart from those of the head) are derived 
from mesodermal precursors originating from the somites (reviewed in Charge and 
Rudnicki, 2004). The somites are formed via segmentation of the paraxial mesoderm 
and are situated on either side of the neural tube and notochord (Christ and Ordahl, 
1995). Mesodermal somitic cells located in the dermomyotome, the dorsal part of each 
somite (Buckingham et al., 2003), receive signals from surrounding tissues, which 
induce (Writs, Sonic hedgehog, Noggin) or inhibit (BMP4) the expression of Myf5 and 
MyoD, which are basic helix-loop-helix (bHLH) transcription factors that belong to the 
myogenic regulatory factor (MRF) family (reviewed in Charge and Rudnicki, 2004). 
NO, a paired-box transcription factor, acts with Myf5 upstream of MyoD (Tajbakhsh 
et al., 1997). After MyoD and Myf5 (primary MRFs) are upregulated, mesodermal 
somitic cells become committed to the myogenic lineage (Kablar et al., 1998; Rudnicki 
et al., 1993; Tajbakhsh et al., 1996), forming myoblasts, and Pax3 contributes to 
myogenic cell expansion (reviewed in Charge and Rudnicki, 2004). The committed 
myoblasts migrate laterally to create the myotome, which eventually forms the skeletal 
musculature. Pax3 promotes myogenesis in the myotome, and upregulation otthe 
secondary MRFs, myogenin and MRF4, induces terminal differentiation of my-ohlast' 
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into mononucleated myocytes, which ultimately fuse to form multinucleated ni otibres 
(reviewed in Charge and Rudnicki, 2004). 
Satellite cells, which are undifferentiated mononuclear myogenic cells. appear in the 
limbs of mouse embryos around 17.5 days post-coitum, subsequent to the appearance of 
embryonic and foetal myoblasts and primary muscle fibre formation (Bischoff. 1994: 
Cossu et al., 1985; De Angelis et al., 1999; reviewed in Morgan and Partridge, 2003; 
reviewed in Seale and Rudnicki, 2000). Their origin has not been fully elucidated. One 
model suggests that multipotent cells of non-somitic origin may be the precursors of 
satellite cells (De Angelis et al., 1999; Ordahl, 1999). It was demonstrated that cells 
derived from the embryonic dorsal aorta express endothelial cell markers yet also have a 
similar morphological appearance and gene expression profile to that of satellite cells, 
in addition to the ability to participate in postnatal muscle growth, regeneration and 
fusion with resident satellite cells following their transplantation into neonatal mice (De 
Angelis et al., 1999). These results implied that satellite cells may be derived from 
multipotent endothelial precursors or a mesodermal progenitor common to both 
endothelial cells and satellite cells, thus supporting a model for satellite cell 
development that occurs independent of embryonic myogenesis (De Angelis et al., 
1999; reviewed in Seale and Rudnicki, 2000). 
However, an alternative paradigm proposes that satellite cells are derived from the 
somite, either migrating from the somite as a distinct lineage or originating from a pre- 
existing lineage (i. e. embryonic or foetal myoblasts) in the developing limb (reviewed 
in Hawke and Garry, 2001). Recent evidence suggests that the majority of satellite cell, 
are indeed derived from the somites. Satellite cells may be derived from progenitors 
expressing Pax3 and another paired-box transcription factor. Pax- i. that arise 
from the 
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central dermomyotome, with retention of Pax7 expression by the ýatJ11te cell 
population into adulthood (Gros et al.. 2005; Kassar-Duchossoy et al.. 2(iU-5. Rehfix et 
al., 2005; Seale et al., 2000). Derivation of satellite cells from the -omite or a non- 
somitic source may not be mutually exclusive. however. and it is conceivable that both 
lineages may contribute to the satellite cell pool, to form a heterogeneous population 
(reviewed in Hawke and Garry, 2001; reviewed in Holterman and Rudnicki, 2005). 
Several lines of evidence support this hypothesis. For example. quiescent satellite cells 
show differences in molecular markers, with some expressing NI-cadherin and CD 34, 
while others do not (Beauchamp et al., 2000; Cornelison and \V old, 1997). In addition, 
although the majority of satellite cells enter a proliferative phase and eventually fuse to 
form myotubes, a small proportion proliferate at a slower rate and eventually return to a 
quiescent state (Schultz, 1996; Zammit et al., 2004). This observed heterogeneity 
within the satellite cell compartment might perhaps be explained by the satellite cells 
arising from two or more distinct developmental origins (reviewed in Holterman and 
Rudnicki, 2005). 
1.3 Satellite cell numbers 
Satellite cell numbers vary dependent on species and fibre-type (Gibson and Schultz, 
1982; reviewed in Hawke and Garry, 2001; Schmalbruch and Hellhammer. 1976). In 
murine neonates, satellite cells account for 20-30% of sublaminar nuclei associated with 
myofibres (reviewed in Charge and Rudnicki, 2004; reviewed in Hawke and Garry. 
2001). During postnatal growth, satellite cells proliferate and their progeny fuse with 
growing muscle fibres, dramatically increasing the number of myonuclei associated 
with each fibre (Bischoff, 1994); some also form new satellite cells (re\ 
iewed in 
Morgan and Partridge, 2003). Despite this replenishment of the satellite cell population, 
the number of satellite cells rapidly declines with age to approximately 
5°o two month,, 
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postnatally (Bischoff, 1994). After sexual maturity is reached, it has been ýuý. º_e"ted 
that satellite cell numbers continue to decrease. albeit not as dramatically (rev ie« cd in 
Charge and Rudnicki, 2004; reviewed in Hawke and Garry. 2001). and in adult mice the 
percentage of satellite cell nuclei per extensor digitorum longus myofibre average, 
between 2.5-6% (Zammit et al., 2004). 
1.3.1 The age-related decline in the regenerative abilit`, of skeletal muscle 
With age, there is a gradual deterioration in the regenerative properties of most tissues, 
but the cause of this decline remains uncertain (Conboy et al., 2003). Indeed, there is a 
loss in muscle bulk and regenerative ability with age (Collins et al., 2007), termed 
sarcopenia. It has been proposed that this is due to a decrease in satellite cell numbers 
caused by intrinsic age-dependent changes that result in downregulated self-reiic\\ al 
capability (Conboy and Rando, 2005). Previous evidence of this has been 
contradictory, suggesting a decline, no change or even a relative increase in satellite cell 
numbers with age (Gibson and Schultz, 1983; Nnodim, 2000; Roth et al., 2000; Schultz 
and Lipton, 1982). 
Recently, it was shown that the number of satellite cells expressing Pax7 decline with 
age (Collins et al., 2007; Shefer et al., 2006). Although a subset of satellite cells from 
aged muscles remain capable of generating large clusters of progeny, containing both 
differentiated cells and quiescent satellite cell-like cells, the majority of aged satellite 
cells generate few progeny, of which a minority reacquire the satellite cell-like 
phenotype (Pax7+) associated with self-renewal (Collins et al., 2007). However, when 
grafted into a young host muscle environment, the aged satellite cell population can 
regenerate muscle and self-renew as effectively as the larger population of satellite cells 
associated with younger myofibres (Collins et al., 2007). This suggests that a minority 
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of satellite cells must be responsible for adult muscle regeneration and these stern cell. 
retain their intrinsic potential throughout life. and are present in approximately similar 
frequencies in young and aged muscles (Collins et al.. 21007). Therefore. the 
effectiveness of stem cell-mediated muscle regeneration appears to be determined by 
both diversity in the intrinsic potential of the stem cells (Collins et al., 2007; Shefer et 
al., 2006) and the extrinsic micro environment surrounding the satellite cells (Collins et 
al., 2007; Conboy et al., 2003; Conboy and Rando, 2005; Grounds, 1998, Sadeh. 1988, )- 
There is indeed evidence to suggest that the age of the host environment affects muscle 
regeneration, since transplants of young or aged muscle tissue regenerate well in VOL- 
hosts but poorly in aged hosts (Carlson and Faulkner, 1989). In addition, in parabiotic 
pairs of young and aged mice sharing a common circulation, the aged partner shows 
improved muscle regeneration in comparison to control pairs of aged mice only 
(Conboy et al., 2005). 
1.4 Satellite cell identification 
1.4.1 Satellite cell morphology 
Since their initial description in frogs (Mauro, 1961), satellite cells have been observed 
in mammalian (Campion et al., 1981; Gamble et al., 1978), avian (Hartley et al., 1992), 
amphibian (Morrison et al., 2006) and reptilian (Kahn and Simpson, 1974) skeletal 
muscle. Originally, satellite cells were primarily identified in situ by their 
morphological characteristics, using electron microscopy (reviewed in Charge and 
Rudnicki, 2004; reviewed in Morgan and Partridge, 2003). They are classically defined 
by their location under the basal lamina of individual myofibres (reviewed in Bischoff. 
1994; reviewed in Holterman and Rudnicki, 2005). In addition, when compared ww ith 
myonuclei, quiescent satellite cells are identifiable by their increased nuclear-to- 
cytoplasmic ratio, reduced organelle content, and smaller nucleus. containing an 
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increased quantity of heterochromatin. which is reflective of their inactive. quiescent 
state (Schultz, 1976). 
When satellite cells are activated, in response to growth, remodelling or muscle injury. 
their morphology changes dramatically and they are more easily identifiable. Activated 
satellite cells appear as a swelling on the myofibre, with cytoplasmic processes that 
extend from one or both poles of the cell (Schultz and McCormick, 1994). The 
cytoplasmic-to-nuclear ratio and organelle content increase and there is a reduction in 
heterochromatin, indicative of upregulated mitotic activity (Schultz and McCornmick. 
1994). 
1.4.2 Satellite cell molecular markers 
The identification of satellite cells using light microscopy is not particularly effective, 
although using markers such as laminin and dystrophin to identify the basal lamina and 
sarcolemma respectively can aid satellite cell detection (reviewed in Charge and 
Rudnicki, 2004). The discovery of proteins expressed by satellite cells but not by 
myonuclei in post-mitotic fibres has made their study much easier (reviewed in Morgan 
and Partridge, 2003), as has the isolation of myofibres complete with their complement 
of satellite cells retained under the basal lamina (Beauchamp et al., 2000; Bischoff, 
1975; Bischoff, 1986; Konigsberg et al., 1975; Rosenblatt et al., 1995; Yablonka- 
Reuveni and Rivera, 1994)(see section 1.1.1). Culturing an isolated myofibre allows 
the fate of an entire cohort of satellite cells to be studied (Zammit et al., 2006a) and 
ensures that the myofibre is removed from potential exogenous sources of myogc nic 
cells (Ferrari et al., 1998; LaBarge and Blau, 2002; Tamaki et al., 2002). Myofibres can 
be cultured on a substrate or in suspension (Zammit et al., 2004)(to maintain potential 
signalling between the satellite cells and the myofibre (Beauchamp et al.. 21000)) and 
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satellite cells and their progeny can be immunologically identified by their 2 \prcý,, ion 
of several molecular markers, which are described below. The marker-expression 
discussed is mainly applicable to murine satellite cells. as mice have been u., cd for the 
majority of studies. Human satellite cells are different (e. g. they express \1-cadherin 
but some do not coexpress Pax7, or only express it weakly (Reimann et al.. 2004). 
whereas in mice the majority of satellite cells are Pax? - ). 
Molecular markers expressed by satellite cells include c-met, myocyte nuclear factor 
(MNF), syndecan3, syndecan4, vascular cell adhesion molecule 1 (%'C, -\%1 1), %l- 
cadherin, CD34, the MRFs and Pax? (reviewed in Hawke and Garry, 2001; reviewed in 
Holterman and Rudnicki, 2005; reviewed in Morgan and Partridge, 2003). Several 
satellite cell markers are restricted to the quiescent, activated, proliferative or 
differentiated state, while others are expressed more broadly (e. g. MyoD is expressed in 
activated, proliferating and differentiating satellite cell progeny (Zammit et al., 2004)). 
These markers can be used to study developmental origin of the satellite cell, cell cycle 
control and molecular regulation of satellite cell regeneration (reviewed in Hawke and 
Garry, 2001). However, not all cells in the satellite cell niche (i. e. between the basal 
lamina and the sarcolemma) express all markers described (Beauchamp et al., 2000; 
Zammit et al., 2004), suggesting that the population is heterogeneous, which may result 
in alternate cell fates. 
The receptor tyrosine kinase c-met is the receptor for hepatocyte growth factor (HGF). 
It is a marker of quiescent satellite cells and activated myogenic precursor cells (`I P('s) 
(Cornelison and Wold, 1997; reviewed in Hawke and Garry, 2001; reviewed 
in 
Holterman and Rudnicki, 2005). There are two isoforms of the winged 
helix 
transcription factor MNF, a and ß, which show differential expression patterns. \1\ 
F- 
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cx is expressed in MPCs, while MNF-ß is specifically localised to quiescent ý, itellite 
cells and is downregulated upon satellite cell activation (revviewed in Garry et at.. 2(_100: 
Garry et al., 1997; Hawke and Garry, 2001). Syndecans are transmembranc heparin 
sulphate proteoglycans that function in FGF (fibroblast growth factor) signalling 
(Rapraeger, 2000). Syndecan3 and syndecan4 are expressed in quiescent satellite cells 
and proliferating MPCs (Cornelison et al., 2001; reviewed in Holterman and Rudnicki, 
2005; Rapraeger, 2000). Cell adhesion molecules including VCAM 1 and A-cadherin 
may collectively function in the adhesion of satellite cells to the basal lamina of the 
myofibre and may participate in the migration of activated satellite cells and their 
progeny (reviewed in Hawke and Garry, 2001). VCAM 1 is expressed in both quiescent 
satellite cells and activated MPCs. Interaction between VCAM1-expressing satellite 
cells or MPCs with infiltrating lymphocytes may result in the local accumulation of 
cytokines required for satellite cell activation, and MPC proliferation and differentiation 
(Jesse et al., 1998; Rosen et al., 1992). 
M-cadherin is a calcium-dependent cell adhesion molecule present in a subpopulation of 
quiescent satellite cells. Its expression increases upon satellite cell activation 
(Beauchamp et al., 2000; Cornelison and Wold, 1997; Irintchev et al., 1994). Those 
quiescent satellite cells that express M-cadherin coexpress CD34, a haematopoietic stem 
cell marker, and Myf5 (Beauchamp et al., 2000). CD34 is involved in the maintenance 
of quiescence and coexpression of CD34, Myf5 and M-cadherin defines the majority of 
quiescent satellite cells (Beauchamp et al., 2000). Since not all cells express these 
markers, it suggests that there is heterogeneity within the satellite cell compartment, 
which may result in divergent cell fates (Beauchamp et al., ? 000). 
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Satellite cell regulation prenatally and postnatally is reliant on interplay between the 
Pax genes (Pax3 and Pax7; paired-box transcription factors) and the . %IRF. ' (\iyff. 
MyoD, myogenin and MRF4; bHLH transcription factors). During embryouenesis. 
Pax3 and Myf5 act upstream of MyoD. committing mesodermal somitic cell, to the 
myogenic cell fate (Tajbakhsh et al., 1997), and later the induction of mvogenin and 
MRF4 facilitates terminal differentiation of myoblasts into myocytes (Charge and 
Rudnicki, 2004). In the embryo, Pax3 and Pax7 specify myogenic stem cells in the 
central dermomyotome (Kassar-Duchossoy et al., 2005; Relaix et al., 2005). The role 
of Pax7 partially overlaps with its paralogue Pax3 during development (%Mansouri and 
Gruss, 1998), and hence most of the functions of Pax3 can be replaced by Pax? (Relaix 
et al., 2004). However, although Pax7 is expressed in the somite, it is only essential for 
myogenesis after birth when it is expressed in satellite cells (Relaix et al., 2005). 
In adult mouse muscle, Pax7 is expressed in the majority of quiescent satellite cells 
(Seale et al., 2000). Pax3, however, is only present in satellite cells in particular 
muscles (Relaix et al., 2006), although it has been reported that Pax3 may also be 
transiently expressed in satellite cells during activation (Conboy and Rando, 2002), but, 
controversially, this was not observed by Montarras et al. (2005). The deletion of Pax3 
results in the absence of diaphragm and limb muscles (Bober et al., 1994; Goulding et 
al., 1994), but the loss of Pax7 does not affect muscle formation (Seale et al., 2000). 
Pax7-1- mice have significant numbers of satellite cells at birth, presumably due to the 
expression and hence compensatory effects of its paralogue Pax3. However, in Pax? 
null mice, postnatal muscle growth is reduced because the satellite cell population iti 
progressively depleted as a result of cell-cycle defects and increased apoptosis. showing, 
that Pax3 cannot replace the antiapoptotic function of Pax? (Kuang et al.. 2000; 
38 
Oustanina et al., 2004; Relaix et al., 2006; Seale et al.. 2000). In the rare mice that 
survive to adulthood, the regenerative capacity of muscle is compromised (huan`g et al.. 
2006; Oustanina et al., 2004). Therefore. Pax7 appears to be required for the 
maintenance and survival of satellite cells postnatally (Zammit et al.. 2006b). 
Gene targeting experiments provided much insight into the functions of the \IRFs in 
vivo. The introduction of null mutations in mice revealed a hierarchical relationship 
between the four MRFs (Sabourin and Rudnicki, 2000). Inactivation of %I%, oD in mice 
results in an apparently normal muscle phenotype with an increase in Myf5 expression 
(Rudnicki et al., 1992). Similarly, Myf5-deficient mice display normal skeletal mine 1cs 
but die perinatally due to rib defects (Braun et al., 1992). (The introduction of 
myogenin cDNA into the Myf5 locus rescues the rib defect, resulting in viable, fertile 
mice, but is unable to fully compensate for the absence of Myf5 during nivogenic 
determination (Wang and Jaenisch, 1997; Wang et al., 1996). ) Mice deficient for both 
MyoD and Myf5, however, die at birth, due to a complete absence of skeletal myoblasts 
and muscle (Rudnicki et al., 1993). Mice lacking myogenin display a normal number of 
myoblasts but die at birth because of an absence of myofibres (Hasty et al., 1993; 
Nabeshima et al., 1993). Contrastingly, inactivation of MRF4 results in viable mice 
with apparently normal muscles but with an increase in myogenin expression (Braun 
and Arnold, 1995; Patapoutian et al., 1995; Zhang et al., 1995). The results of these 
experiments have been used to define two groups of MRFs. The primary MRFs, Nlvf5 
and MyoD, are required for the determination of myoblasts, while the secondary MRFs. 
myogenin and MRF4, regulate terminal differentiation (Sabourin and Rudnicki. 2000). 
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1.5 Satellite cell replenishment via self-renewal 
Postnatally, in response to growth signals or myotrauma quiescent satellite cells 
(Schultz et al., 1978) are activated, proliferate and differentiate to repair or replace 
damaged myofibres (reviewed in Hawke and Garry. 2001; reviewed in Morgan and 
Partridge, 2003). Despite ongoing demands for growth and repair. the number of 
quiescent satellite cells remains relatively constant over time (reviewed in Seale and 
Rudnicki, 2000)(although there is an eventual decline with age (Collins et al., 2007; 
Shefer et al., 2006)), demonstrating that the satellite cell pool must be replenished, 
although the precise mechanism has not been elucidated. Evidence. which wt ill be 
presented in this section, supports the assumption that satellite cells are characteristic 
stem cells so are capable of self-renewal (reviewed in Collins, 2006). In addition, it has 
been proposed that new satellite cells may be derived from outside the classical satellite 
cell compartment, which will be discussed in section 1.6. 
Dhawan and Rando (2005) have suggested two alternative models of satellite cell self- 
renewal, but the exact process remains elusive. In the `stochastic' model, the progeny 
of each activated satellite cell are generated by symmetric divisions and, after a period 
of proliferation, one or more of the progeny return to quiescence while the remainder 
differentiate. In the `asymmetric' model, the first division after satellite cell activation 
occurs asymmetrically, with one daughter cell forming a new satellite cell, while the 
other undergoes further symmetric divisions to generate a pool of myoblasts. some of 
which may also divide asymmetrically to generate further satellite cells, while the rest 
differentiate. The asymmetric hypothesis is supported by observations that intestinal 
epithelial stem cells (Potten et al., 2002) and a stem cell-like fibroblast cell 
line (`terok 
et al., 2002) undergo asymmetric division, during which template and newly- 
synthesised DNA strands are sorted selectively to ensure consistent retention of the 
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original template strand by the stem cell daughter. protecting it from acquirinº 
replication-induced errors (Merok et al.. 2002; Potten et al.. 2002). A'vmmetric 
segregation of the template DNA strand has in fact also been observed in satellite cells. 
where it cosegregates with Numb, an inhibitor of Notch signalling (Shinin et al.. 2006). 
Current data suggest that either model or both models may be functional, since they are 
not necessarily mutually exclusive (reviewed in Collins, 2006). 
Isolated individual myofibres (Rosenblatt et al., 1995) cultured in suspension (Zammit 
et al., 2004) provide an accessible means to study the activation, proliferation and 
differentiation of resident satellite cells that are retained in their native position 
underneath the basal lamina. This model ensures that potentially important interactions 
(i. e. cell-cell signalling) are maintained between myofibres and their associated satellite 
cells (Beauchamp et al., 2000; Zammit et al., 2004). Using, murine extensor di, (itoriun 
longus (EDL) muscle fibres, this model was utilised to study the fate of activated 
satellite cells via immunological detection of various transcription factors (Pax7 and the 
MRFs; described in section 1.4) that regulate the myogenic lineage progression of 
satellite cells and their progeny (Zammit et al., 2004). 
The majority of quiescent satellite cells express Myf5 and Pax? (reviewed in Hawke 
and Garry, 2001; Zammit et al., 2004). When Myf5+/Pax7+ quiescent satellite cells are 
activated, MyoD expression is initiated in nearly all cells within 24 hours. Most 
Pax? +/MyoD+ satellite cells undergo limited proliferation before they downregulate 
Pax? and eventually terminally differentiate, marked by the appearance of mý og 
11111 
(reviewed in Seale and Rudnicki, 2000; Zammit et al., 2004). However, a minorit\ of 
satellite cell progeny maintain Pax7 expression, lose MyoD and «ithdra\\ 
from 
differentiation. These Pax? /MyoD- cells are found located in clusters together with 
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Pax7-/MyoD` cells destined for terminal differentiation (Zammit et al.. -1004). 
suggesting that they may arise in response to microenvironmental , ignalý from other 
cells within the cluster or from the myofibre. Some of the Pax? `1 oD- cells regain 
quiescent satellite cell characteristics, halting their DNA synthesis (Shinin et al.. '006; 
Zammit et al., 2004), but they can be stimulated to re-express MyoD and proliferate 
(Zammit et al., 2004). These observations suggest that satellite cell progeny can adopt 
divergent fates and either undergo terminal differentiation or withdraw from the 
myogenic programme to replenish the satellite cell pool in a process of self-renc\\ at 
(Zammit et al., 2004). The adoption of divergent fates during differentiation has also 
been demonstrated in cultured mouse (Olguin and Olwin, ? 004; Yoshida et al.. 1998). 
chick (Halevy et al., 2004) and human (Baroffio et al., 1996) myoblasts, which generate 
a subset of undifferentiated `reserve' cells with quiescence characteristics. This 
suggests that self-renewal may be a universal mechanism underlying the maintenance of 
satellite cell populations (reviewed in Collins, 2006). 
In the Pax7 null mouse, satellite cells become rapidly depleted postnatally (reviewed in 
Kuang et al., 2006; Oustanina et al., 2004; Relaix et al., 2006; Seale et al., 2000) due to 
cell-cycle defects and apoptosis of activated cells (Relaix et al., 2006). The loss of 
satellite cells after activation favours the proposed model of self-renewal, suggesting 
that satellite cell replenishment occurs via the return to quiescence of cycling progeny 
(Zammit et al., 2004). However, although Pax7 plays a critical role in maintenance of 
the postnatal satellite cell population, ectopic expression demonstrates that it is involved 
in maintaining proliferation and preventing precocious differentiation of satellite cell 
progeny, rather than inducing quiescence (Zammit et al., 2006b). 
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1.6 The contribution of cells other than satellite cells to muscle 
regeneration 
Evidence suggests that muscle regeneration is primarily mediated by satellite cclk 
(Bischoff, 1994; reviewed in Partridge, 2004) and that the satellite cell pool is 
replenished via self-renewal (reviewed in Collins, 2006; Olguin and O1«-in. 20()4, 
Zammit et al., 2004). However, it has also been proposed that there may be a 
contribution to muscle regeneration from other cell-types. derived from outside the 
classical satellite cell compartment; either from resident, interstitial muscle cells. or 
from myogenic precursors (pericytes) originating in blood vessels of the muscle 
interstitium (Dellavalle et al., 2007), or by recruitment of pluripotent bone marrow 
(BM)-derived cells from the circulation (reviewed in Seale and Rudnicki, 2000). 
Small numbers of differentiated myonuclei and satellite cells can be generated from BN1 
grafts (Dreyfus et al., 2004; Ferrari et al., 1998; Sherwood et al., 2004), although re- 
isolation of BM-derived satellite cells has demonstrated that they have extremely 
limited myogenic potential (Sherwood et al., 2004). Haematopoietic stem cells (HSCs) 
that express distinct molecular markers such as CD45, originate in the BM and are 
proposed to generate skeletal muscle following grafting into injured muscle (Camargo 
et al., 2003; Corbel et al., 2003). However, it has been argued that CD45+ HSCs may 
not actually contribute to muscle regeneration in vivo because they are unable to travel 
through the circulation to sites of damage (reviewed in Rudnicki, 2003). A subset of 
human HSCs expressing AC 133 have, however, also been reported to generate 
significant quantities of muscle after grafting and are found in the circulation (Torrente 
et al., 2004). 
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Cells derived from the blood vessels of adult human skeletal muscle can regenerate 
skeletal muscle (Dellavalle et al., 2007), similarly to mesangioblasts. which are den< <d 
from the walls of blood vessels in the embryo or neonate (Sampaolesi et al.. 2006). 
Adult cells, however, do not express endothelial markers like mesangioblasts. but 
instead express markers of pericytes (Dellavalle et al.. 2007). These pericyte-derived 
cells are associated with microsvascular walls in adult human skeletal muscle. Thc\ 
can spontaneously form differentiated myotubes and express myogenic markers (which 
they do not normally express) in culture in vitro and give rise to new myofibres when 
injected intra-arterially in vivo (Dellavalle et al., 2007). Therefore, these pericyte- 
derived cells appear to be myogenic precursors, which are distinct from satellite cells, 
and may represent a correlate of embryonic mesangioblasts that are retained postnatally 
to potentially contribute to muscle regeneration (Dellavalle et al., 2007). 
Studies have also provided evidence that other cells with myogenic potential reside in 
the muscle interstitium, including CD45+/Scal+ cells, which form myogenic progenitors 
in response to Wnt signalling (Polesskaya et al., 2003), Pax3+ cells (Kuang et al., 2006) 
and the `side population' of cells (which exclude Hoeschst dye and express Scal but 
not satellite cell markers) that generate myonuclei after coculture with committed 
myogenic cells or transplantation into muscle (Asakura et al., 2002; Gussoni et al.. 
1999; Muskiewicz et al., 2005). This `side population', termed muscle-derived stem 
cells, are able to self-renew and differentiate into myogenic cells and other mesodermal 
cell-types (Asakura et al., 2002; Qu-Petersen et al., 2002). Whether 
interstitial 
myoblasts represent satellite cell derivatives or precursors, or comprise a 
distinct 
population remains to be determined (reviewed in Collins, 2006). 
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1.7 Notch signalling may potentiate satellite cell self-renewal 
Studying the process of satellite cell self-renewal using isolated individual mvoflbre,, 
cultured in suspension (Zammit et al., 2004) maintains potentially important toll-cell 
signalling between fibres and their associated satellite cells retained under the basal 
lamina (Beauchamp et al., 2000). Using this model, it was demonstrated that divergent 
fates arise in clusters, where satellite cell progeny either terminally differentiate or 
return to quiescence (i. e. undergo self-renewal)(Zammit et al., 2004). Alternate fates 
may arise as a result of cell-cell signalling, between cells in the cluster and or between 
the cluster and the myofibre. Notch signalling relies on cell-cell interaction to generate 
progeny with divergent fates (reviewed in Artavanis-Tsakonas et at.. 1999), and. 
therefore, represents a possible mechanism for the regulation of cell fate specification 
within clusters of satellite cell progeny. 
1.8 Functions of the Notch signalling pathway 
The development of multicellular organisms requires spatially and temporally 
coordinated cell behaviour (reviewed in Artavanis-Tsakonas et al., 1999; reviewed in 
Schweisguth, 2004). Cell-cell communication regulates cell fate, proliferation, growth, 
migration, survival, apoptosis, differentiation and morphogenesis (reviewed in 
Artavanis-Tsakonas et al., 1999; reviewed in Schweisguth, 2004). Notch signalling, an 
evolutionarily conserved mechanism that requires cell-cell interaction, can facilitate all 
of the aforementioned processes in a wide variety of developmental and physiological 
contexts in metazoans ranging from nematodes to humans (reviewed in Artavanis- 
Tsakonas et al., 1999). The Notch signalling pathway has been shown to participate in 
neurogenesis (Louvi and Artavanis-Tsakonas, 2006), vasculogenesis. an`gio`gc'ne 
is 
(Krebs et al., 2000), lymphogenesis (Kondo et al., 2001) and somite formation 
(reviewed in Artavanis-Tsakonas et al., 1999; reviewed in Conboy and Rando. 2002. 
4: 
reviewed in Gridley, 1997; McGrew and Pourquie. 1998. Pourquie. 1999. re% iewed in 
Weinmaster, 1998), and it has also been suggested to play a role durin-po, tnatal 
myogenesis (Conboy et al., 2003; Conboy et al.. 2005; Conboy and Rando. 2002). 
which will be discussed later. 
1.8.1 Modes of action of Notch signalling 
Notch signalling requires cell-cell contact to facilitate interaction between membrane- 
bound Notch receptors and ligands, which results in receptor activation and subsequent 
signalling. There are two modes of action of Notch signalling: lateral 
signalling/inhibition and inductive signalling (reviewed in Artavanis-Tsakonas et al., 
1999; reviewed in Schweisguth, 2004). Lateral inhibition is a vital patterning process 
within tissues that specifies different cell types from precursors that have similar 
developmental potential (Heitzler and Simpson, 1991; Lewis, 1998). Initially, two 
equivalent precursors express both receptors and ligands, so each precursor can send 
and receive signals, a process known as reciprocal signalling. However, stochastic 
intrinsic differences in the precursors are amplified and eventually result in receptor 
expression to predominate in one cell and ligand expression to predominate in the other, 
so that unidirectional signalling is facilitated. This asymmetry is reinforced by a 
negative feedback loop, to ensure that one cell activates Notch in its neighbour and the 
two cells adopt distinct fates (reviewed in Artavanis-Tsakonas et al., 1999; reviewed in 
Harper et al., 2003; reviewed in Lai, 2004; Lewis, 1998; reviewed in Schwcisguth. 
2004). Notch signalling can also mediate induction, which segregates two `groups of 
cells, potentiating the formation of boundaries (Bray, 1998; Pourquie, 2003). Inductive 
signalling occurs when the Notch receptor and ligand are expressed on two diftercnt 
cell-types, possibly dependent on asymmetrical inheritance of Notch regulators (e. g. 
Numb (Frise et al., 1996; Spana et al., 1995)), so that Notch signalling can only be 
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activated in the precursor cells that bear the receptor,, (r,, % iewed in Bray. 2006. 
reviewed in Harper et al., 2003; reviewed in Schweisguth, 2004). 
1.8.2 Defective Notch signalling 
The Notch signalling pathway was initially identified and studied in Drosophila and 
Caenorhabditis elegans (C. elegans) and has subsequently been investigated in 
vertebrates (reviewed in Artavanis-Tsakonas et al., 1999; reviewed in Gridley, 
1997, 
reviewed in Schweisguth, 2004). The analysis of mutations in these organisms has 
demonstrated the extent to which metazoan development relies on Notch signalling 
(reviewed in Artavanis-Tsakonas et al., 1999; reviewed in Gridley, 1997; reviewed in 
Harper et al., 2003). Indeed, there is evidence demonstrating that Notch signalling is 
required at multiple stages of development within one tissue. For example. In 
Drosophila, Notch signalling initially regulates the number of cells that acquire neural 
potential, via lateral inhibition, and subsequently it determines whether progeny will 
adopt neural or glial fates (Louvi and Artavanis-Tsakonas, 2006). Similarly, the Notch 
signalling pathway is involved in multiple aspects of vascular development, including 
proliferation, migration, smooth muscle differentiation, angiogenesis and arterial- 
venous differentiation (reviewed in Harper et al., 2003; Iso et al., 2003a). 
Haematopoietic tissues and organs are abundant in Notch pathway components and 
signalling plays important roles at several stages of haematopoiesis. including the 
regulation of HSC self-renewal and lymphocyte development (Akashi et al.. 1999; 
Kondo et al., 2001; Kumano et al., 2003). During vertebrate embryogenesis. the 
periodic involvement of Notch signalling controls formation of somites 
from the 
paraxial mesoderm (McGrew and Pourquie, 1998; Pourquie, 1999; Pourquie, 
200') and 
it has been proposed that Notch signalling also functions during postnatal myogene"i1 
(Conboy et al., 2003; Conboy et al., 2005; Conboy and Rando. 2002)(se section 
l. lct). 
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The outcome of Notch signalling throughout de\ elopment may be dependent on the 
cellular context (reviewed in Bray, 2006). so it might be inhibitory in one instance but 
beneficial in another. 
Since the Notch signalling pathway is involved in such a multitude of procc. sseý. 
throughout development and postnatally, it is unsurprising that mutations of \otch 
components often cause severe or fatal phenotypes in mice and that defective Notch 
signalling has been implicated in various human pathologies (reviewed in Gridley. 
1997; reviewed in Harper et al., 2003; Joutel and Tournier-Lasserve. 1998). The 
phenotypes arising from mutations in various Notch pathway components, which are 
fully described in section 1.9, are discussed below. 
1.8.2.1 Defective receptors 
Loss of Notch l function in mice results in embryonic lethality before El 1.5 (embryonic 
day 11.5) due to defective somitogenesis, neurogenesis and vasculogenesis (Swiatek et 
al., 1994), while gain-of-function results in the suppression of B-cell development from 
lymphoid progenitors (Pui et al., 1999) and induces T-cell acute lymphoblastic 
leukaemia (Beverly and Capobianco, 2003). Loss of murine Notch2 also induces 
embryonic lethality before E 11.5, due to cell specification and/or differentiation defects 
(Hamada et al., 1999), while gain of Notch2 function in cats plays a role in leukaemias 
induced by feline leukaemia virus (Rohn et al., 1996a; Rohn et al., 1996b). 
Aberrant Notch signalling is involved in several human cancers (reviewed in Lai. 2004). 
Indeed, the human Notch], Notch2 and Notch3 genes are located in regions of 
neoplasia-associated translocations, supporting a possible role for each of them in 
human neoplasia (Larsson et al., 1994). Notch] has certainly been identified a,, an 
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oncogene (reviewed in Gridley. 1997; reviewed in Harper et al.. 2003) and . 
Vote III 
translocations have been detected in over 50% of human T-cell acute 1% mphoblastlL 
leukaemias (Weng et al., 2004). caused by constitutively active Notchl signalling 
(Ellisen et al., 1991). In addition, Notchl and Notch2 expression is elevated in human 
cervical squamous carcinomas and adenocarcinomas (Zagouras et al.. 199-5). 
Conversely, in certain contexts Notch l can actually suppress tumorigenesis. This has 
been demonstrated in mice, whereby cells that have lost their Notch l function 
consequently form skin and corneal tumours (Nicolas et al.. 2003). 
Unlike Notchl- and Notch2-deficient mice, Notch3 (Krebs et at.. 2003) and Notch- 
(Krebs et al., 2000) null mutants are viable and fertile (Kitamoto et al., 2005; Krebs et 
al., 2003), suggesting that either Notch3 and Notch4 are not essential during embryonic 
development, or that the other receptors compensate for their absence (Kitamoto et al., 
2005). Notch3 and Notch4 must, however, play important roles postnatally, since 
aberrant signalling results in pathological phenotypes. Notch3 gain-of-function results 
in human T-cell neoplasias (Bellavia et al., 2002) and has also been shown to induce 
lung cancer (Dang et al., 2000). Cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CADASIL) is the best-characterised 
disease associated with Notch3 mutations. CADASIL is an inherited autosomal 
dominant disorder, associated with point mutations in the human Notch3 receptor 
(Joutel et al., 1996), which results in arteriolar vascular smooth muscle cell destruction, 
mainly in the brain, causing white matter tissue death (reviewed in Harper et al., 2003). 
The onset of CADASIL is around 45 years of age (Chabriat et al., 1991) and symptoms 
include migraine, mood disorder, stroke, dementia and eventual death (Joutel et al., 
1996). In mice, Notch4 overexpression results in embryonic lethality at E 10 due to 
defective vasculogenesis (Uyttendaele et al., 2001) and is associated with malignant 
NIL 
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mammary carcinomas (Gallahan and Callahan, 199 i). In humans. \otch4 mutation 
may be linked to schizophrenia (Sklar et al. ) 
2001; Wei and Hemmini,. -1000) and 
alopecia areata (Tazi-Ahnini et al., 2003). 
1.8.2.2 Defective ligands 
A null mutation of Delta-likel (D111) results in lethality by E10.5 with defects in 
neurogenesis and somitogenesis (Hrabe de Angelis et al.. 1997). Embyros heteroallelic 
for the null and a hypomorphic Dill allele survive until birth, but E18.5 foetuses are 
motionless and have a severe reduction of skeletal muscle (Schuster-Go'sler et al., 
2007). Spontaneous hypomorphic mutation of Delta-like3 (D113), resulting in loss of 
function, manifests as the `pudgy' phenotype, which is characterised by rib and 
vertebrae defects (Kusumi et al., 1998). In humans, D113 mutations are associated with 
a form of spondylocostal dysostosis (SD)(Bulman et al., 2000; Turnpenny et al., 2003). 
which produces phenotypic traits comparable with those of `pudgy' mice. SD is a 
family of related diseases where vertebral defects are associated with rib abnormalities 
and short trunk dwarfism (Bulman et al., 2000; Turnpenny et al., 2003). The autosomal 
recessive form of SD induced by D113 mutation is characterised by abnormal 
segmentation of the spine, probably due to absence of D113 function during, 
somitogenesis (Kusumi et al., 1998). Mouse embryos heterozygous for a targeted 
mutation in the gene encoding Delta-like4 (D114) exhibit haploinsufficient lethality 
because of defects in vascular remodelling, which shows that D114 is vital for embryonic 
vascular remodelling (Gale et al., 2004; Krebs et al.. 2004). In adult mice D114 is 
expressed in several haematopoietic tissues, and ectopic D114 overexpression in murine 
HSCs or lymphoid progenitors causes progressive T-cell lymphoproliferative disea, c 
(Dorsch et al., 2002). D114 mutation has not been linked to any human di,, cascs. but 
these data imply that it may contribute to human cancers. 
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Loss of Jaggedl function in mice results in embryonic lethality by El1 . 5. 
due to 
haemorrhaging subsequent to remodelling of the embryonic and yolk sac vasculature 
(Xue et al., 1999). Mutations that cause truncation or loss of human Jagged l are 
associated with Alagille syndrome (AGS)(Li et al., 1997; Oda et al., 1997). . AGS is an 
autosomal dominant developmental disease with clinical features often presented within 
the first two years postnatally. It is characterised by defects in the liver, heart, skeleton 
and eye and has a mortality rate of 15-20% (Emerick et al., 1999). Loss of Ja`zged_' 
function in mice causes severe limb and craniofacial defects and mild thymic 
abnormalities and results in perinatal mortality (Jiang et al., 1998). 
1.8.2.3 Defective modifying molecules and targets 
CSL (an acronym for CBF 1, Suppressor of Hairless, Lag l) is a transcription factor. 
which the Notch receptors usually interact with to transactivate their downstream target 
genes (reviewed in Artavanis-Tsakonas et al., 1999; reviewed in Schweisguth, 2004). 
Mouse embryos homozygous for a mutation in CSL have vascular defects, and 
conditional inactivation of CSL shows that Notch activation is essential in the 
endothelial cell lineage (Krebs et al., 2004). In the adult, CSL can be targeted by 
viruses that redirect its function (reviewed in Lai, 2004). Multiple proteins from 
Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHN) and 
adenovirus type 5 bind directly to CSL and modulate CSL-dependent transcription of 
both viral and host target genes in a Notch-independent fashion (Allenspach et al., 
2002). Most humans are latently infected with these viruses, but this is only a problem 
in immunocompromised individuals where the viruses cause oncogenic transformation 
and malignancy (reviewed in Lai, 2004). 
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Fringe molecules alter Notch receptor-ligand binding, enhancing or inhibiting signalling 
(Okajima et al., 2003). The Radical Fringe knockout mouse has no phenotype (Zhang 
et al., 2002). However, loss of Lunatic Fringe results in defective somito<gcne i,,. Some 
mice die perinatally due to respiratory difficulties caused by a malformed rib cage. 
while other mice are viable, although they also have rib and vertebral defects (EN-rard et 
al., 1998; Zhang and Gridley, 1998). Overexpression of Lunatic Fringe in immature 
T-cells induces the B-cell fate instead of the expected T-cell fate. This implies a 
potential role for Lunatic Fringe in the regulation of T-cell commitment by 'Notch I 
(Koch et al., 2001), and hence mutations may contribute to human T-cell leukaemias. 
1.9 A description of the Notch signalling pathway and its components 
1.9.1 Structure of the Notch receptors 
The gene encoding the Notch receptor was discovered in Drosophila in 1919, when 
partial loss of function resulted in notches in the wings (Mohr, 1919). Notch receptors 
are essential, single-pass type I transmembrane receptors that are evolutionarily 
conserved (see Figures 1.2 and 1.3)(reviewed in Artavanis-Tsakonas et al., 1999; 
reviewed in Schweisguth, 2004). In mammals, four Notch receptors have been 
identified: Notchl, Notch2, Notch3 and Notch4, which each have an extracellular 
domain (ECD), transmembrane domain and intracellular domain (ICD). 
Notchl and Notch2 have the highest homology, since they are predominantly 
structurally conserved (Shimizu et al., 2002), although there is debate about their 
functional similarity. The C-terminal (carboxy-terminal) of the Notch l ICD can 
functionally replace that of Notch2 (Kraman and McCright, 2005). Contrastingly, other 
data suggest that Notchl and Notch2 have diverse functions, since they differentially 
regulate expression of their downstream targets HESI and HESS (Shimizu et al., 2002). 
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and they have distinct functions during kidney development (reviewed in \Veinma:, ter 
and Kopan, 2006). Notch3 and Notch4 are structurally diverged from Notch l end 
Notch2, differing in both their ECDs and ICDs (Shimizu et al.. 2002)(the Notch 3 IC D is 
considerably shorter than that of Notch l and Notch2 (Lardelli et al.. 1994)). and \ otch 3 
also functions differently from Notchl and Notch2 (Beatus et al.. 1999), while Notch4 
has not been fully investigated. 
The basic structure of the Drosophila, C. elegans and mammalian receptors comprises 
certain conserved elements (Figure 1.2). The ECD is composed of between ten in C. 
elegans) and 36 (in Drosophila and some vertebrate Notch members) epidermal growth 
factor-like (EGF) repeats, three lin-12/Notch repeats (LNRs), two extracellular sites of 
proteolytic processing and two conserved cysteine residues (reviewed in Fleming, 1998, 
Schweisguth, 2004; Shimizu et al., 2000b). The ICD consists of a conserved valine 
residue, PEST sequences, the RAM23 domain, six cdclO/ankyrin repeats (ANK) and 
three nuclear localisation signals (NLS) that sandwich the ANK region (Fleming, 1998; 
Kopan et al., 1994; Mumm and Kopan, 2000; Shimizu et al., 2000b). 
In Drosophila, EGF repeats 11 and 12 in the ECD are necessary and sufficient for 
mediating cellular aggregation with ligand-expressing cells in tissue culture (Rebay et 
al., 1991). Repeats 11 and 12 are conserved in all vertebrate homologues, suggesting 
that they constitute a primary site for ligand/receptor interaction (Fleming, 1998). 
Particular EGF repeats may have significant functions in certain tissues, perhaps 
interacting with tissue-specific molecules to regulate Notch activity. Notch3 (Lardelli 
et al., 1994) and Notch4 possess fewer EGF repeats than Notch 1 and ti otch2. and their 
absence may confer differential regulatory activity to the receptors (Fleming, 1998). 
All Notch receptors contain the LNR domain. which is required for stability or 
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conformation of the ECD that facilitates negative regulation of receptor activation 
(Weinmaster, 1997), and hence maintains a quiescent ICD (Fleming, 199ti) in the 
absence of ligand-binding (Kimble et al., 1998). The 'Notch receptor is proteolvtically 
cleaved at two conserved extracellular sites. Proteolysis of the receptor will be fully 
described later, but briefly, the first cleavage facilitates formation of a functional 
heterodimeric receptor, while the second occurs following ligand-binding (Fleming, 
1998). The conserved cysteine residues constitute the non-covalent, reducing agent- 
sensitive bond that binds the component parts of the heterodimeric Notch receptor 
(Fleming, 1998). 
The conserved valine residue in the ICD is near the transmembrane-spanning region of 
the receptor. Intracellular proteolytic cleavage, subsequent to ligand binding and 
extracellular cleavage of the receptor, occurs immediately upstream of the valine 
residue, and liberates the ICD (Fleming, 1998). PEST sequences have a negative 
regulatory function (Mango et al., 1991), facilitating rapid turnover of the Notch ICD, 
which induces subsequent downregulation of signalling (Fleming, 1998). The Notch 
ICD binds to and interacts with several molecules, such as CSL and Numb, via the 
RAM23 domain (Fleming, 1998). In some cases binding also requires the adjacent 
ANK region (Fleming, 1998; Roehl et al., 1996). 
The ANK domain is essential for Notch signalling, but is not required for ligand binding 
(Fleming, 1998). The ANK region may facilitate homotypic interaction between Notch 
molecules (Roehl et al., 1996), and hence Notch multimerisation. In addition, the . AN K 
region acts as a binding site for various interacting molecules, including Deltex 
molecules, which are possible positive effectors of Notch signalling (Ntatsuno et al., 
1995). The three NLS facilitate translocation of the Notch ICD into the nucleus (Kopan 
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et al., 1994), possibly by acting as recognition motifs for members of the 
importin/karyopherin u and () receptor family involved in nuclear transport (Ikeuchi and 
Sisodia, 2003). The least conserved part of the Notch receptors. the RE AC 
(repression/activation) region (Beatus et al., 2001), is situated C-terminal of the AN K 
repeats (Fleming, 1998). Notch1 and Notch2 possess a transactivation domain (TAD. 
strong or weak respectively) in this position, which Notch3 and Notch4 lack (Figure 
1.3)(Radtke and Raj, 2003). This region can facilitate cross-talk between Notch 
signalling and other pathways (e. g. Dishevelled, a member of the Wingless signalling 
pathway, binds to this region and negatively regulates Notch signalling (Axelrod et al., 
1996)). 
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Figure 1.2: The basic structure of the Notch receptor 
See text for details. Si, S2, S3 and S4 are sites of receptor cleavage (see section 1.9.3 ). 
Full-length newly-synthesised Notch receptors, which are around 300kDa (kilodaltons) 
in Drosophila, and thus approximately the same size in mammals due to structural 
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conservation (reviewed in Kadesch, 2000; reviewed in Weinmaster. 199 ). are inactive 
cytoplasmic molecules (Blaumueller et al.. 1997). To form active transmembrane 
molecules, the new receptors first require proteolysis in the trans-Golgi network 
(Blaumueller et al., 1997). Cleavage is mediated by a funn-like conv-ertase at site 1 
(Si), characterised by the peptide sequence RQRR, between the EGF repeats and the 
transmembrane domain (reviewed in Kadesch, 2000; Logeat et al.. 1998). The cleaved 
receptor consists of a peptide fragment of approximately 180kDa (Weinmaster. 1998). 
which constitutes the ECD, and another of 120kDa (Logeat et al., 1998) that represents 
the intracellular membrane-tethered domain bound to a small portion of extracellular 
sequence (reviewed in Baron, 2003). The two receptor component peptides do not 
dissociate, but are transported to the plasma membrane and assembled into a 
heterodimeric receptor linked by noncovalent interactions that require calcium 
signalling (see Figure 1.4)(Blaumueller et al., 1997; reviewed in Lai, 2004; Logeat et 
al., 1998; Rand et al., 2000; reviewed in Schweisguth, 2004). 
1.9.2 Structure of the DSL ligands 
The ligands that bind and activate the Notch receptors are single-pass transmembrane 
proteins (reviewed in Artavanis-Tsakonas et al., 1999) that belong to the DSL family, 
named after the invertebrate ligands, Delta and Serrate from Drosophila and lag2 from 
C. elegans (Fleming, 1998; reviewed in Weinmaster, 1997). In vertebrates, the 
DSL 
ligands are classified into two structurally-related groups: Delta-like ligands (Dill, 
D113 
and D114) and Serrate-like ligands (Jaggedl and Jagged2)(reviewed 
in Harper et al., 
2003). The general structural elements of the DSL ligands are conserved (see 
Figure 
1.3). They possess a signal peptide followed by an N (amino)-terminal extracellular 
domain (the NT domain) of variable length that displays limited homology among the 
DSL family members (Fleming, 1998). Adjacent to this region, also within the 
ECD. is 
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the DSL motif, which contains approximately 45 amino acids and consists of a partial 
EGF repeat that lacks one of the six characteristic cysteine residues. This k followed 
by between 2 and 16 EGF repeats (Fleming, 1998). The Serrate-like ligands pos c-,,, an 
additional cysteine-rich (CR) region in the ECD. between the EGF repeat region and the 
transmembrane domain. The ICD is relatively short, ranging from 70 to 2 145 amino 
acids (Fleming, 1998). 
Although the basic arrangement of the DSL ligands is conserved, there are large 
variations in domain size and/or domain composition (Fleming, 1998). which implies 
that the different ligands may possess diverse functions (discussed in section 1.9.3.2). 
However, in Drosophila it has been demonstrated that ectopic expression of Serrate can 
partially replace Delta function during neurogenesis (Gu et al., 1995) and the ligands 
also share redundant functions during sensory organ lineage specification (Zeng et al., 
1998). Functional redundancy between ligands is also observed during C. elegans 
development (Gao and Kimble, 1995). Since structural differences between the DSL 
ligands do not appear to affect function, it is important to determine which 
compositional elements are critical for functional interactions between the ligand and 
receptor (Fleming, 1998). 
Although, the extracellular NT domain is not well-conserved between DSL family 
members, together with the DSL motif it forms the EGF-motif binding domain (EBD ), 
which facilitates ligand-receptor binding (Fleming, 1998). In addition, the EBD region 
regulates ligand recognition by other regulatory proteins, such as the Fringe molecule 
(Fleming, 1998), which will be discussed later. The EGF repeats, which are adjacent to 
the EBD region, are present in variable numbers and are not essential for sigºnalling. 
They may play a role in stabilising or modifying ligand-'receptor interactions in specific 
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cellular environments (Fleming, 1998). The CR region, specific to Serrate-like li`gands. 
is approximately 100 amino acids in length and may be involved in selecting specific 
Notch receptors (Fleming, 1998) or modulating ligand! receptor binding (reviewed in 
Weinmaster, 1997). The possession of the cysteine-rich region. in addition to double 
the quantity of EGF repeats, makes Jagged1 and Jagged2 much larger than the Delta- 
like ligands (reviewed in Weinmaster, 1997). 
It remains unclear why, but in Drosophila and vertebrates, the transmembrane domain 
and ICD of the DSL ligands are vital for effective Notch receptor activation. and ligands 
lacking one or both of these domains are dominant-negative (Chitnis et al., 199-5. 
Hukriede and Fleming, 1997; Hukriede et al., 1997; Sun and Artavanis-Tsakonas, 
1996). It has been suggested that the EBD may confer the dominant-negative function 
in the absence of the two domains (Hukriede et al., 1997). In Drosophila, DSL ligands 
have an innate dominant-negative characteristic, whereby cells that express ligand 
exhibit a reduced response to Notch signalling (Klein et al., 1997; Micchelli et al., 
1997), due to intracellular receptor/ligand interactions during protein export (Kidd et al., 
1989). 
It has been demonstrated that the ligand can itself act as a `receptor' upon 
ligand/receptor interaction, in a process of bi-directional signalling (see section 1.9.5), 
whereby the ligand is activated by the receptor and undergoes proteolytic processing 
that facilitates liberation of the ligand ICD, which may then translocate into the nucleus 
to potentially activate target genes (Bland et al., 2003; Klueg et al., 1998; Kolev et al.. 
2005; LaVoie and Selkoe, 2003; Six et al., 2003). Therefore, cells where the ICD of the 
ligand has been removed may lose or exhibit a diminished ability to receive 
information, which could lead to misregulation of ligand expression (Fleming. 1998). 
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hence preventing effective Notch receptor activation. At least one secreted form of the 
ligand is observed in cultured cells expressing Delta in the absence of receptor. 
suggesting that some ligand-processing can occur in the absence of receptor interaction 
(Fleming, 1998). Endocytosis and proteolytic processing of the ligand may be required 
to liberate the active, functional ICD (Fleming, 1998). Indeed, newly-synthesised 
inactive DSL `pro-ligands' have been shown to become active upon transit through the 
recycling endosomes where they undergo an unknown post-translational modification 
(Wang and Struhl, 2004). 
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Figure 1.3: Structure of the vertebrate Notch receptors and ligands (adapted from 
Radtke and Raj, 2003) 
See text for details. 
1.9.3 Canonical CSL-dependent Notch signalling 
Canonical CSL-dependent Notch signalling (see Figure 1.4) is facilitated by a 
mechanism of regulated intramembrane proteolysis (RIP)(revviewed 
in Schweisguth. 
2004). Notch signalling is initiated when the ECD of a DSL ligand, expressed on the 
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surface of a signalling cell interacts with the ECD of a membrane-bound hetcrodimeric 
Notch receptor on an adjacent signal-receiving cell (reviext ed in . \rtavanis-Tsakona, et 
al., 1999; reviewed in Harper et al., 2003). Ligand binding (possibly followed by 
endocytosis (Parks et al., 2000)) induces a conformational change in the "Notch receptor. 
exposing site 2 (S2) between conserved valine residue 1711 and alanine residue 1 -110 in 
the ECD (12 amino acids outside the transmembrane domain)(N1umm and Kopan. 
2000) to cleavage by extracellular proteases that belong to the ADAM (a disintegrin and 
metalloprotease domain)/TACE (TNF (tumour necrosis factor)-a converting 
enzyme)/Kuzbanian family, which facilitates release of the ectodomain of the receptor 
(reviewed in Baron, 2003; Brou et al., 2000; Mumm et al., 2000; Pan and Rubin, 1997, 
reviewed in Schweisguth, 2004). Proteolytic cleavage is irreversible and hence each 
receptor can only signal once (reviewed in Schweisguth, 2004). S2 cleavage is required 
before subsequent proteolysis can occur (Mumm et al., 2000). 
The Notch ectodomain bound to the ligand may require monoubiquitination and 
subsequent endocytosis (see section 1.9.3.1) into the signalling cell to uncouple the 
LNR region from the remainder of the receptor, because the LNR domain inhibits 
subsequent proteolytic cleavage of membrane-bound Notch (Parks et al., ? 000). 
Following S2 cleavage, the membrane-tethered Notch receptor on the signal-receiving 
cell may also require monoubiquitination, followed by endocytosis to reach the acidic 
environment where y-secretase activity is optimal (Gupta-Rossi et al., 2004; Parks et al., 
2000). 
y-secretase-mediated cleavage of Notch occurs at endomembrane site 
3 (S3) in the ICD, 
between conserved glycine residue 1743 and valine residue 1744 (Fleming, 
1998; 
Saxena et al., 2001; Schroeter et al., 1998), and site 4 (S4), near the centre of the 
60 
transmembrane domain (Okochi et al., 2002). y-secretase activity requires the 
formation of a stable, high molecular mass complex that contains an endoproteol% red 
form of presenilin and essential cofactors including nicastrin, Aph 1 and Pen? (Francis et 
al., 2002; Takasugi et al., 2003). In mammals there are two presenilin proteins 
(Mizutani et al., 2001). All four Notch receptors can be cleaved via Presenilinl- 
dependent y-secretase proteolysis (De Strooper et al.. 1999: Mizutani et al.. 2001: 
Saxena et al., 2001). Notchl can also be cleaved by Presenilin2-dependent ,; -secretase 
activity (Kostyszyn et al., 2004). Following S3/S4 cleavage, the liberated active Notch 
ICD translocates into the nucleus, facilitating direct signalling that does not require any 
secondary messenger molecules (reviewed in Baron, 2003; reviewed in Schwcisguth. 
2004; Struhl and Greenwald, 1999). A small peptide with unknown function is released 
extracellularly (Okochi et al., 2002). It may have novel signalling properties or could 
act to downregulate Notch signalling (reviewed in Schweisguth, 2004). 
In the nucleus, the DNA binding protein/transcription factor C'SL is a major 
downstream effector of Notch signalling (reviewed in Artavanis-Tsakonas et al., 1999; 
reviewed in Kadesch, 2000). CSL was originally cloned by Honjo et al. and named 
RBP-JK (Furukawa et al., 1992). It was later shown to be homologous to the 
Suppressor of Hairless (Su(H)) protein in Drosophila (Furukawa et al.. 1992) and 
implicated as an effector of Notch signalling (reviewed in Kadesch, 2000). The name 
CSL is an acronym for the analogous proteins: CBFI/RBP-JK in mammals, Su(H) in 
Drosophila and Lagl in C. elegans (reviewed in Artavanis-Tsakonas et al., 1999; 
reviewed in Kadesch, 2000; reviewed in Schweisguth, 2004). 
CSL is defined as a dual-function transcription factor because it has the ability to either 
repress or activate transcription, dependent on the proteins that are bound to it 
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(reviewed in Kadesch, 2000). CSL is normally bound to the promoter region of 
CSL/Notch target genes (reviewed in Sch« eisguth. 2004) and recruits a corepre,, ýoor 
complex that in humans includes SMRT. SKIP, SAP30. Sin3A. CIR, HDAC (histone 
deacetylase) 1 and HDAC2 (Zhou and Hayward, 2001). The presence of HDAC,, in the 
complex imply that transcriptional repression is partially mediated by, chromatin 
remodelling (Struhl, 1998), which renders the DNA less accessible to the transcription 
machinery. 
When the active Notch ICD translocates into the nucleus, it displaces the corepressor 
complex bound to CSL and recruits coactivators (CoA), converting CSL from a 
repressed state to an activated one (Hsieh et al., 1996; Zhou and Hayward, 2001). 
Coactivators that interact with the Notch ICD include Mastermind and the GCN4 and 
PCAF histone acetylases (Zhou and Hayward, 2001), which presumably render the 
chromatin accessible to the transcription machinery. The CSL/Notch ICD coactivator 
complex transcriptionally activates CSL/Notch target genes (reviewed in Schweisguth, 
2004). It has been suggested that the Notch ICD can act at a very low concentration, 
since endogenous nuclear Notch is below the immunodetection threshold (Schroeter et 
al., 1998), despite evidence confirming that it is definitely present in the nucleus (Struhl 
and Adachi, 1998). 
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Figure 1.4: Notch signalling 
Notch receptors are synthesised as full-length precursor proteins. The precursor is 
cleaved by a furin-like convertase in the Golgi apparatus, forming a heterodimer, which 
is transported to the cell surface. In the Golgi, the EGF repeats of the Notch receptor 
may undergo O-fucosylation by Pofut 1 (murine O-fucosyltransferase 1) and subsequent 
glycosylation by Frig (Fringe) molecules, which enhances or inhibits receptor/ligand 
binding. The ECD of a heterodimeric Notch receptor on the cell surface interacts with 
the ECD of a DSL ligand on the surface of an adjacent cell, allowing extracellular 
cleavage of the receptor by a member of the ADAM/TACE/Kuzbanian family to release 
the receptor ectodomain. The ligand bound to the receptor ectodomain may require 
monoubiquitination (by Mib (Mind bomb) or Neur (Neuralised)) and endocytosis before 
the receptor can undergo further proteolysis. The receptor may also require 
monoubiquitination and endocytosis before it can be cleaved again. The receptor 
undergoes intracellular y-secretase-mediated proteolysis, which releases the active 
Notch ICD (NICD) into the cell. The NICD translocates into the nucleus and binds to 
the DNA-binding protein/transcription factor, CSL, displacing the corepressor (CoR) 
complex associated with it. The NICD also recruits coactivators (CoA), thus converting 
CSL from a repressed state to an active state. The NICD/CSL/CoA transactivation 
complex transcribes target genes (e. g. HES and HERP family members). In addition, 
target genes can be activated via the CSL-independent Notch signalling pathway: the 
heterodimeric receptor is activated by Dtx (Deltex) molecules in a 11 gand- independent 
manner and activates its gene targets independently of CSL. Notch signalling can be 
inhibited by molecules such as Numb, Itch and SellO, which bind to the ICD of the 
receptor, targeting it for ubiquitination and subsequent degradation. (See main text for 
full details of Notch signalling and references. )(Figure adapted from Radtke and Raj 
(2003). ) 
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1.9.3.1 Ligand ubiquitination and endocvtosis 
Several lines of evidence have demonstrated that endocytosis of DSL liuands is 
essential for Notch receptor activation (reviewed in Le Borgne et al.. 2005). Studies in 
Drosophila have shown that dynamin-dependent endocytosis is required in both sinal- 
receiving cells and in signal-sending cells to promote Notch activation (Seugnet et al.. 
1997). To target a ligand for endocytosis it must be ubiquitinated. There are two 
candidate E3 ubiquitin ligases Neuralised (Neur) and Mind bomb (Mib) that promote 
ubiquitination and endocytosis of the ligands (Deblandre et al.. 2001; Koo et at.. 2005; 
Lai et al., 2001; Le Borgne and Schweisguth, 2003). E3 ubiquitin ligases catalyse the 
transfer of ubiquitin to target proteins. There are three modes of ubiquitination 
described by Haglund et al. (2003) with distinct biological functions. 
Monoubiquitination is defined by the addition of a single ubiquitin molecule and 
functions in endocytosis, membrane trafficking and sorting proteins in multivesicular 
bodies (MVBs). Epsins, which are endocytic proteins, may bind to monoubiquitinated 
ligands to help mediate endocytosis (Wang and Struhl, 2004). Multiubiquitination 
consists of the monoubiquitination of several lysine residues within a substrate protein 
and functions in endocytosis and membrane trafficking, while polyubiquitination is 
defined by a chain of ubiquitin molecules attaching to an individual lysine residue 
within a protein. Polyubiquitinated proteins are degraded via the 26S proteasome 
(Haglund et al., 2003). 
Two models have been proposed to suggest how ligand endocytosis may promote Notch 
signalling (reviewed in Le Borgne et al., 2005): 
1) Endocytosis of the Notch-bound DSL ligands may create pulling forces on the 
Notch receptor, which induce conformational changes that reveal its S2 or Sl 
cleavage sites (Parks et al., 2000). Monoubiquitination and endocytosis of the 
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S2-cleaved Notch ectodomain bound to a ligand uncouples the L\R region from 
the remainder of the receptor, which promotes Notch signalling as the P\ R 
domain normally inhibits subsequent S3 cleavage (Parks et al., ? 000). 
2) Newly-synthesised inactive DSL `pro-ligands' become active upon tran'. it 
through the recycling endosomes where they undergo an unknown post- 
translational modification (Wang and Struhl, 2004). 
1.9.3.2 Differential ligand expression and function 
In C. elegans, all ligands activate all receptors (Gao and Kimble, 1995). However. In 
mammals it has been proposed that specific ligands interact with and subsequently 
activate distinct receptors. Thus far, Dill, Jagged! and Jagged2 have been characterised 
as ligands for Notchl, Notch2 and Notch3 (Jarriault et al., 1998; Lindsell et al.. 1995; 
Luo et al., 1997; Shimizu et al., 2000a; Shimizu et al., 2000b). D114 can activate Notch 1 
(Rao et al., 2000) and Notch2, to a lesser extent (Hozumi et al., 2004). D114 is thought 
to activate Notchl and Notch4 during early vascular development in mice (Krebs et al.. 
2000; Shutter et al., 2000) and also activates Notch4 in primary human endothelial cells 
(Shawber et al., 2003). D113, which is structurally diverged from the other ligands, does 
not appear to activate any of the receptors, and is proposed to cell autonomously inhibit 
Notch signalling induced by other ligands (Ladi et al., 2005). Different ligand/receptor 
combinations may facilitate the transcription of distinct subsets of target genes. 
resulting in specific outcomes within a cell. 
Evidence suggests that in certain systems Delta-like and Jagged ligands potentiate 
contrasting functions. Dill and Jaggedl have different effects on myeloid progenitors 
and differentially regulate the development of granulocytic and monocytic 
lincage 
during early human haematopoiesis. Myeloid progenitors in contact with 
Jagged 1 
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upregulate Notchl, while those in contact «ith Dill upregulate Notch expression 
(Neves et al., 2006). In addition, Jagged l and D111 transmit distinct signals to T-ccll 
progenitors that result in divergent fates (Lehar et al.. 2005). Dll1. D113 and D114 induce 
the Thl cell (T helper cell type 1) fate, while Jaggedl and Jagged2 induce the Th2 cell 
(T helper cell type 2) fate (Amsen et al., 2004). The different ligands also ha\ z an 
impact on T-cell activation upon antigen contact, whereby D114 enhances T-c c11 
proliferation and expression of early activation markers, while Dill induces a partial, 
and Jaggedl an almost complete inhibition of T-cell activation (Rutz et al.. 2005). 
Jagged and Delta-like ligands also have contrasting functions in the mouse inner ear 
(Brooker et al., 2006). The inner ear contains a mosaic of sensory hair cells and 
supporting cells, generated from prosensory precursor cells. At the onset of 
differentiation Dill and Jagged2 are switched on in nascent hair cells, inhibiting 
adjacent prosensory cells from becoming hair cells and forcing them to become 
supporting cells instead, while Jaggedl shows the opposite behaviour (Brooker et al.. 
2006). 
1.9.3.3 Interplay between the Notch ICDs and the effect on target gene 
transcription 
Via RBP-JK-dependent signalling, Notchl and Notch2 act as potent transcriptional 
activators of their target genes (Beatus et al., 1999). However, Notch3 behaves 
differently (Kadesch, 2000). The Notch3 ICD can bind to RBP-JK (like Notch 1 and 
Notch2 ICDs), but it only activates transcription weakly or it acts as a transcriptional 
repressor (Beatus et al., 1999). The difference in activation capacity of the receptors 
stems from structural differences when positioned on RBP-Jx (Beatus et al., 2001). The 
ANK region and a novel region called the RE/AC (repression/activation) rc`gion, located 
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immediately C-terminal to the ANK domain, are important in explaining the different 
functions of the Notchl and Notch3 ICDs (Beatus et al., 2001). The Notchl ANK 
region confers potent activation capability to the Notchl ICD, while the RE AC region 
mediates transcriptional activation by the Notch1 ICD or repression by the Notch [CD 
(Beatus et al., 2001). 
The Notch3 ICD competes with the Notchl ICD, blocking it from binding to both 
RBP-JK and a common coactivator (PCAF (Beatus et al., 2001)), present in limiting 
amounts (Beatus et al., 1999). In addition, both the Notchl and Notch3 ICDs can 
displace the corepressors SMRT and SKIP from RBP-JK, and they compete with each 
other to displace these and bind to RBP-JK (Beatus et al., 1999, Beatus et al., 2001). It 
has been suggested that the Notch3 ICD can also inhibit Notch2 (Beres et al., 2006), 
and the Notch2 ICD may negatively regulate Notch 1 and Notch3 (Shimizu et al., 2002 ), 
presumably also via competition for binding to RBP-JK and common cofactors. 
1.9.4 CSL-independent Notch signalling 
There is a less well-characterised mode of Notch signalling, which is CSL-independent 
(see Figure 1.4). An array of evidence confirms the existence of CSL-independent 
Notch signalling, including that described in: Drosophila during peripheral nervous 
system development (Martinez Arias et al., 2002; Ramain et al., 2001), murine 
myogenic C2C12 cells (Nofziger et al., 1999; Shawber et al., 1996), avian neural crest 
development (Endo et al., 2002) and T-cell tumours of certain transgenic mice 
(Feldman et al., 2000; Hoemann et al., 2000). Normally, CSL-independent 
Notch 
signalling is cell autonomous and ligand-independent. However, 
in cells of the central 
nervous system, it has been demonstrated that F3icontactin, a member of the 
immunoglobulin superfamily can act as a ligand by binding 
directly to the Notch 
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receptor, inducing its proteolysis, which is followed by binding of the ICD to Deltex 1 
and translocation into the nucleus to transactivate specific target genes, independent of 
CSL-interaction (Hu et al., 2003). 
It has been proposed that Deltex (Dtx), a cytoplasmic protein, identified in Drosophila, 
mediates CSL-independent Notch signalling (Busseau et al., 1994). Dtx was initially 
thought to function in the Notch signalling pathway because it displays genetic 
interactions with Notch, Delta, Mastermind, Hairless and Su(H) in Drosophila (Busseau 
et al., 1994; Fortini and Artavanis-Tsakonas, 1994; Xu and Artavanis-Tsakonas. 1990). 
Overexpression of Dtx fragments in Drosophila and data from physical studies between 
Dtx and Notch suggest that Dtx binds to the ICD of the Notch receptor, interacting with 
its ANK domain, and positively regulates Notch signalling (Matsuno et al., 1995). Dtx 
is an E3 ubiquitin ligase that has self-ubiquitination activity (Takeyama et al., 2003), 
although its precise function in Notch signalling remains elusive. 
The mechanism of Dtx action in Drosophila was investigated by Hori et al. (2004). It 
was found that Dtx was able to activate the expression of gene targets of the Su(H)- 
dependent Notch signalling pathway. To do this, it required Notch and a cis-acting 
element that overlaps with the Su(H) binding site, but signalling was independent of the 
DSL ligands and Su(H). Dtx bound to the Notch ANK domain and caused the receptor 
to be moved from the apical surface of epidermal cells into the late-endosome, where it 
accumulated stably and co-localised with Dtx. Dtx-dependent activation of Notch then 
occurred in the late-endosome and subsequent signalling was independent of Su(H ). 
Several other suggestions for the mechanism by which Dtx mediates Su(H) CSL- 
independent Notch signalling are described and these have been presented here. Dtx I 
68 
could act as a transcriptional regulator by binding to the transcriptional coactivator p 30O 
(Yamamoto et al., 2001). Alternatively, Dtx E3 ubiquitin ligase action mad cause 
MEKKI (mitogen-activated pathway kinase kinase kinase 1) ubiquitination and 
degradation, thus altering various signal transduction pathways (Liu and Lai. 2005). 
Notch and Dtx could act on the transcription factor E47 by inhibiting signalling through 
the Ras protein (Ordentlich et al., 1998). 
There are three murine Dtx homologues, Dtx l, Dtx2 and Dtx3. which have been 
characterised by Kishi et al. (2001). Dtx2 has two alternatively spliced isoforms, one of 
which lacks a proline-rich motif. Dtxl and Dtx2 have a similar structure, but Dtx3 
lacks most of the domain that enables it to bind to the Notch ANK repeats. Dtx proteins 
can, however, form homotypic and heterotypic multimers, so Dtx3 may form a hetero- 
multimer with another of the Dtx proteins to facilitate binding to Notch. The divergent 
structure of Dtx3 may indicate that it has a unique function, although it does appear to 
have the same mode of action as the other Dtx proteins. 
Overexpression of Dtxl, Dtx2 or Dtx3 in mammalian tissue culture cells suppresses the 
transcriptional activity of E47, a bHLH protein (Kishi et al., 2001). In myogenic 
C2C 12 cells, overexpression of either Dtx2 isoform under differentiation-inducing 
conditions suppresses the expression of myogenin transcript (an effect also seen when 
active Notchl is constitutively overexpressed)(Kato et al., 1997; Kopan et al., 
1994: 
Lindsell et al., 1995), although contrastingly there are no significant morphological 
changes i. e. myotube formation remains unaffected. Luo et al. (2005) also stated 
(in a 
review article) that constitutive overexpression of Dtxl and 
Dtx2 in CC 12 cells 
inhibits differentiation, but this remains unpublished. The data presented suggest that 
Dtx is generally a positive regulator of Notch signalling. However, 
in haematopoietic 
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progenitors Dtx 1 actually antagonises Notch l signalling (Izon et al.. 20O A;. ). so Dtx 
function remains controversial. 
Suppressor of Deltex (Su(dx)) was identified in Drosophila as a dominant suppressor of 
Dtx and a negative regulator of CSL-independent Notch signalling (Fostier et A. 1998). 
Su(dx) is a HECT (homologous to E6AP carboxyl terminus) -type E3 ubiquitin ligasc. 
which has a murine homologue termed Itch that has been proposed to bind to the Notch 
ICD and ubiquitinate it (Qiu et al., 2000; reviewed in Sch« eis`guth, 2004). 
Ubiquitination by Itch may promote endocytosis and degradation of Notch (reviewed in 
Schweisguth, 2004). In addition, AIP4, the human orthologue of Itch, can 
polyubiquitinate Dtx to target it for degradation in the lysosome (Chastagner et al., 
2006). 
The Wingless signalling pathway may also negatively regulate Dtx-dependent, CSL- 
independent Notch signalling (Martinez Arias et al., 2002; Ramain et al., 2001), 
possibly via direct binding of Wingless to the ECD of Notch (Brennan et al., 1999: 
Wesley, 1999; Wesley and Saez, 2000) or by binding of Dishevelled to the ICD of 
Notch at the C-terminus distal to the ANK region (Axelrod et al., 1996; Ramain et al., 
2001). A complex containing Frizzled and Dishevelled can also inhibit Notch 
signalling in Drosophila (Strutt et al., 2002). Antagonistic interactions between 
Wingless and Notch signalling occur during vertebrate and Drosophila development, in 
the specification of alternate cell fates (Martinez Arias et al., 2002). 
1.9.5 Ligand-mediated signalling 
In addition to signalling mediated by the Notch receptors, there is evidence that the DSL 
ligands may also transactivate target genes. Initial work in Drosophila showed that four 
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isoforms of Delta are present during development, at least one of which wa, thought to 
be the result of Delta proteolysis (Klueg et al., 1998). Ligand proteol` i,, wa, 
confirmed in Drosophila, where it was demonstrated that membrane-bound Delta is 
cleaved by Kuzbanian, a member of the ADAM family, at alanine residue -581 (Bland et 
al., 2003), facilitating the release of the ligand ectodomain extracellularly. which «aý 
able to bind to and activate Notch receptors (Qi et al., 1999). Delta processing was 
upregulated when exposed to Notch-expressing cells (Bland et al.. 2003). suggesting 
that interaction with the receptor triggers ligand proteolysis. 
Subsequently, in vertebrates it was demonstrated that, like the heterodimeric Notch 
receptors, both Jagged and Delta-like ligands can undergo sequential proteolytic 
processing. Rodent Dill, Jagged1 and Jagged2 are subject to proteolytic cleavage by an 
ADAM family member, to release the ectodomain extracellularly, followed by 
presenilin-dependent ? -secretase processing, which results in liberation of a cytosolic 
fragment, suggested to potentially facilitate autonomous cell signalling (Ikeuchi and 
Sisodia, 2003; LaVoie and Selkoe, 2003). In Drosophila it was shown that y-secretase- 
mediated proteolysis actually induces two intracellular cleavages of Delta, at alanine 
residue 583 and a site within or close to the transmembrane domain, to release the 
intracellular fragment (Bland et al., 2003). 
Proteolysis may render the ligand inactive (Delwig et al., 2006) or induce its 
degradation (reviewed in Le Borgne et al., 2005). Alternatively, the cytosolic ligand 
fragments formed by proteolysis may translocate into the nucleus to facilitate 
transcription of target genes, potentiating bi-directional signalling (Bland et al., 200. ; 
Ikeuchi and Sisodia, 2003). In support of this, the D111 and Jagged-' ICDý ýý erc 
demonstrated to contain putative nuclear localisation signals, suggesting that they inay 
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be translocated into the nucleus via the importin pathway (Ikeuchi and Sisodia. 2003). 
Indeed, in Drosophila it has been demonstrated that the Delta lCD prominently localic,, 
in the nucleus (Bland et al., 2003). In addition, the mammalian Jagged 1 ICD can induce 
API-dependent gene expression, confirming that it is capable of activating transcription 
in the nucleus (LaVoie and Selkoe, 2003). The Dill ICD is also capable of activating 
transcription, resulting in the induction of p21-dependent inhibition of DNA synthesis. 
which leads to cell proliferation arrest (Kolev et al., 2005). Transcription mediated by 
either of these ligand ICDs was inhibited by the Notch l ICD (Kolev et al., 2005: 
LaVoie and Selkoe, 2003). These results show that both Notch and its ligands are 
processed by the same molecular machinery and suggest that the regulated 
intramembrane proteolysis (RIP) of both receptor and ligand may play important, 
potentially competitive roles in cell signalling (LaVoie and Selkoe, 2003). 
Ligand cleavage may also play an important role in the acquisition of uni-directional 
Notch signalling during development, to ensure that cells adopt alternate fates. During 
Drosophila development, Kul (Kuzbanian-like), an ADAM protein, enhances and 
maintains the asymmetrical activation of Notch, by relying on initial differences in the 
levels of Delta (Sapir et al., 2005). Kul cleaves the ligand and effectively removes it 
from cells expressing Delta at low levels, while sufficient levels of Delta are retained in 
cells that will activate Notch. Therefore, uniform Kul activity amplifies a bias in levels 
of Delta expression, leading to uni-directional Notch activation (Sapir et al., ? 005). 
which facilitates the adoption of asymmetrical cell fates. 
1.9.6 Downstream target genes of Notch signalling 
Interactions between the various Notch receptors and ligands ha% e different 
consequences for downstream gene expression (Shimizu et al., 2002). The main target 
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genes activated by Notch signalling in mammals belong to the HES (Hains Enhanc 1r o> 
Split) and HERP (HES-related protein) families (reviewed in To et al.. 2003b). 
although other, less important target genes may exist (e. g. A rai p (Pirot ctA. 'U ii i4 )). 
The HES and HERP proteins (also known as Hey, Hesr. HRT, CHF and gridlock 
(reviewed in Iso et al., 2003b; Iso et al., 2001)) are bHLH transcriptional repressor: that 
act as Notch effectors by negatively regulating the expression of downstream target 
genes such as tissue-specific transcription factors (reviewed in Iso et al.. 2003b). They 
have been implicated in a large number of developmental processes in organisms 
ranging from Drosophila to higher vertebrates (Fischer et al., 2004; Iso et at., 2003b). 
Thus far seven members of the HES family (HES 1-7)(Akazawa et al., 1992, Bae et al., 
2000; Bessho et al., 2001; Hirata et al., 2000; Ishibashi et al., 1993, Koyano-Nakagawa 
et al., 2000; Pissarra et al., 2000; Sasai et al., 1992) and three members of the HERP 
family (HERPI-3)(Chin et al., 2000; Iso et al., 2001; Kokubo et al., 1999; Leimeister et 
al., 1999; Nakagawa et al., 1999; Zhong et al., 2000a) have been identified in mammals. 
Data suggests that at least HES-l, -5, and -7, and HERP-1, -2 and -3 are potential 
targets of Notch (reviewed in Iso et al., 2003b). 
The two families share similar structural elements: the bHLH domain and its adjacent 
Orange domain. There is a high level of sequence conservation within the families. but 
less conservation between the two families (reviewed in Iso et al., 2003b). HES 
proteins contain a conserved proline residue, while in the same position HERP proteins 
possess a conserved glycine residue. These form part of a conserved tetrapeptide motif 
in each case (reviewed in Iso et al., 2003b). The HERP family have an additional 
conserved region C-terminal to the tetrapeptide motif, which is absent from HE") 
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proteins (reviewed in Iso et al., 2003b). The divergent structures of the two families 
may mediate their distinct mechanisms of transcriptional repression (Iso et al.. 2001 ý. 
HES proteins repress transcription in one of the following ways. They may function via 
DNA binding-dependent transcriptional repression (active repression). whereby HES 
proteins homodimerise, bind to DNA and recruit the corepressor Groucho TLE (Allen 
and Lobe, 1999) via the C-terminal tetrapeptide motif (reviewed in Iso et al., 2003b). 
Groucho/TLE recruits HDACs, which alter chromatin structure (Chen et al.. 1999), 
decreasing accessibility for the transcription machinery. Alternatively, HES repression 
may be mediated via protein sequestration (passive repression), whereby, for example, 
HES 1 forms a non-functional heterodimer with another bHLH factor such as E47, thus 
disrupting it from binding to its normal partner and forming a functional heterodimer 
(e. g. MyoD-E47)(reviewed in Iso et al., 2003b). Finally, the Orange domain may 
mediate repression either via direct recruitment of a corepressor or via regulation of 
tetrapeptide motif-induced repression (reviewed in Iso et al., 2003b). HERP repression 
activity resides in the bHLH domain, which recruits a corepressor complex that includes 
N-CoR, mSin3A and HDAC1 (Iso et al., 2001). Passive repression mechanisms may 
also exist (reviewed in Iso et al., 2003b). HES and HERP proteins form functional 
homodimers, but may also act as heterodimers when coexpressed in the same tissue (Iso 
et al., 2003b; Iso et al., 2001). They repress the transcription of target genes containing 
specific binding sites. In addition, certain family members can interact with CSL, to 
enable a novel mechanism of negative feedback on Notch signalling (King et al.. 2006). 
1.9.6.1 Target genes of Notch signalling during myogenesis 
According to several reports, ligand-induced CSL-dependent Notch signalling directly 
induces HES 1 expression in myogenic C2C 12 cells, which causes the downregulation 
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of MyoD-dependent transcriptional activity upon E-box containing promoter. resultin-, 
in the inhibition of myogenic differentiation (Cossins et al.. 2002. Jarriault et al.. 199S: 
Kuroda et al., 1999). However, others claim that the Notch-induced block in C2C12 
cell myogenesis does not involve HES 1-mediated antagonism of MyoD (N'ofziger et al.. 
1999; Shawber et al., 1996), so the exact role of HES 1 during myogenic differentiation 
is unclear (see section 1.10). 
HES6 participates in the developmental regulation of muscle (Pissarra et al., 2000). Its 
expression in somites and limb buds bears a striking resemblance to MyoD expression 
(Tajbakhsh et al., 1997). HES6 may also function during postnatal myogenesis. HES6 
overexpression can inhibit myogenic differentiation of C2C l2 cells (Cossins et al., 
2002). It is proposed to exert its function via protein-protein interaction rather than by 
acting as a transcription factor (Cossins et al., 2002). Indeed, HES6 can functionally 
interact with and antagonise HES 1 (Bae et al., 2000). This facilitates derepression by 
relieving factors from HES 1 inhibition. Therefore, by antagonising HES 1, HES6 could 
actually promote myogenic differentiation. 
1.9.7 Post-translational modifications that can alter Notch signalling 
The Notch receptors or ligands can undergo various post-translational modifications 
that either enhance or downregulate signalling. Thus, Notch signalling involves a 
complex network of interactions, rather than a simple, linear pathway. 
1.9.7.1 Ubiquitination 
Protein ubiquitination involves several steps. Initially, free ubiquitin is attached to a 
ubiquitin-activating enzyme (E1). This is transferred to a ubiquitin-conjugating enzyme 
(E2), which together with a ubiquitin ligase (E3) transfers ubiquitin to a specific protein 
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substrate (McGill and McGlade, 2003). There are several E3 ubiquitin li`' i that bind 
to Notch pathway proteins and mediate their ubiquitination, often targeting them for 
proteasomal degradation, which regulates levels of Notch signalling (`IcGill and 
McGlade, 2003). For example, unstimulated membrane-bound Notch receptors 
undergo ubiquitination, endocytosis and degradation to regulate steady-state levels and, 
therefore, prevent inappropriate activation in the absence of ligand-binding (re\ iewed in 
Kanwar and Fortini, 2004). However, ubiquitination does not always target proteins for 
degradation. This is dependent on the mode of ubiquitination (monoubiquitinatioil, 
multiubiquitination or polyubiquitination; described in section 1.9.3.1). Indeed. 
membrane-bound receptors or ligands may require ubiquitination and endocvtosis to: 
remove signalling inhibition, produce active forms via processing, or potentiate 
interaction with intracellular factors (Gupta-Rossi et al., 2004; reviewed in Le Borgne et 
al., 2005; Parks et al., 2000). 
1.9.7.1.1 Numb 
Numb is an evolutionarily conserved membrane-associated adaptor or scaffold protein 
that contains an amino-terminal phosphotyrosine binding (PTB) domain (Dho et al., 
1999) and a C-terminal proline-rich region (Dho et al., 1999; Verdi et al., 1996). Numb 
was first identified as a gene controlling cell fate specification during Drosophila 
neurogenesis (Uemura et al., 1989). It has a conserved role in vertebrate systems. as a 
key determinant of asymmetrical fate decisions during murine (Petersen et al., 2002; 
Zhong et al., 1996; Zhong et al., 2000b; Zhong et al., 1997), rat (Cayouette et al.. 2001) 
and avian (Wakamatsu et al., 1999) neurogenesis. Numb-like, which has extensive 
sequence homology to Numb, may also be required during murine neurogcncsi,;. 
probably functioning similarly to Numb (Petersen et al., 2002, Zhong et al., 1997). In 
dividing neural precursor cells, Numb is asymmetrically localised to one half of the cell 
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membrane, so that it becomes segregated primarily into one daughter cell following 
mitosis (Petersen et al., 2002; Zhong et al.. 2000b). The presence or absence of \ urnb 
probably facilitates the adoption of divergent cell fates via its negati\ e regulatory effect 
on Notch signalling (McGill and McGlade, 2003). In addition. reciprocal negati\ e 
regulation between Notchl and Numb/Numblike, may be relevant for stabilising, 
asymmetric cell fates (Chapman et al., 2006). Since asymmetrical localisation of Numb 
has also been observed in dividing satellite cell progeny (Conboy and Rando. 2002: 
Shinin et al., 2006), it is possible that it may play a role there too in the adoption of 
distinct cell fates. 
There are four mammalian Numb isoforms, with molecular masses of 65,66,71 and 
72kDa, that are differentially expressed in mouse tissues and cell lines (Dho et al., 
1999). Two of the isoforms vary by an 11-amino acid sequence in the PTB domain, 
potentially important in localisation of Numb to the plasma membrane, while the other 
two isoforms vary by a 49-amino acid insert in the proline-rich region (Dho et al., 
1999). Numb binds to the RAM23 domain (Fleming, 1998) in the ICD of membrane- 
bound Notchl, possibly mediated via the Numb PTB domain (McGill and McGlade, 
2003). Numb does not possess E3 ubiquitin ligase activity, so it is thought that 
following binding to the Notchl ICD, it recruits components of the ubiquitination 
machinery (i. e. E3 ubiquitin ligases such as Itch, Se110 (McGill and McGlade, 
2003) or 
LNX (Nie et al., 2002)), which promote Notchl ubiquitination at the membrane. 
Therefore, following ligand/receptor interaction and activation, the ubiquitinated 
Notch! ICD is endocytosed and targeted for proteasomal degradation (McGill and 
McGlade, 2003), and hence it does not translocate into the nucleus to activate 
downstream target genes. There is evidence to suggest that an alternative endoc`-to'»- 
independent, proteasomal-independent pathway may also facilitate negative regulation 
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of Notch signalling by Numb (Tang et al., 2005), but its mechanism of action ha,, not 
been elucidated. 
The results described thus far have predominantly focused on Notch 1-inhibition by 
Numb. However, it has recently been suggested that the Notch receptors are 
differentially targeted by the four Numb isoforms. Notch 1 is negatively regulated by all 
four Numb isoforms, Notch2 is variably repressed and Notch3 is not a target of any 
Numb protein (Notch4 has not been investigated)(Beres et al., 2006). 
1.9.7.1.2 Sell O 
SellO, an F-box protein of the CDC4 family, was first identified in C. elegans as a 
negative regulator of lin-12, a Notch-like receptor (Hubbard et al., 1997). It is a 
member of the SCF (Skpl-Cullin-F-box) class of E3 ubiquitin ligases (Hubbard et al., 
1997). Se110 may bind to substrates via its seven WD40 repeats (Gupta-Rossi et al., 
2001; Wu et al., 2001). It binds to the Notch ICD within the C-terminal region, distal to 
the ANK repeats (Wu et al., 2001). Phosphorylation of the Notch PEST domain may be 
required to mediate Sel10-binding (reviewed in Baron, 2003; Gupta-Rossi et al., 2001, 
Oberg et al., 2001; Wu et al., 2001). This phosphorylation event and subsequent 
SellO/Notch ICD-binding occurs in the nucleus (Gupta-Rossi et al., 2001; Wu et al., 
2001). The F-box domain of SellO is then proposed to mediate association with the 
ubiquitination machinery (Wu et al., 2001), facilitating ubiquitination of the Notch ICD. 
which targets it for degradation (Gupta-Rossi et al., 2001; Oberg et al., 2001; W'a'u et al.. 
2001) by the 26S proteasome (Wu et al., 2001). 
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1.9.7.1.3 Itch 
Itch is the murine homologue of Drosophila Su(dx), a HECT-type E3 ubiquitin li`_a"e. 
which is a dominant suppressor of Dtx and a negative regulator of CSI--independent 
Notch signalling (Chastagner et al., 2006; Fostier et al., 1998). It has been proposed to 
bind to the Notch ICD via its four WW domains and facilitate ubiquitination of the 
receptor (Qiu et al., 2000; reviewed in Schweisguth, 2004). Su(dx) is olle of three 
Drosophila members of the Nedd4 family of E3 ubiquitin ligases (\Vilkin et al., 2004), 
which mediate ubiquitination, internalisation and lysosomal degradation of membrane 
channels and permease proteins (Rotin et al., 2000). Therefore, Itch, like Numb, may 
negatively regulate Notch signalling by promoting ubiquitination, endocytosis and 
degradation of Notch (reviewed in Luo et al., 2005; Qiu et al., 2000; reviewed in 
Schweisguth, 2004). Itch and Numb can also function cooperatively to inhibit Notch 
signalling. In C2C 12 cells, for example, Numb binds to membrane-bound Notch 1 
within the ICD and recruits Itch, which, via its E3 ubiquitin ligase activity, promotes 
ubiquitination of the ICD (McGill and McGlade, 2003), facilitating its degradation 
following ligand-induced activation. 
AIP4, the human orthologue of Itch, can also act as a negative regulator of Notch 
signalling by polyubiquitinating Dtx, thus targeting it for lysosomal degradation 
(Chastagner et al., 2006). Therefore, Dtx is prevented from interacting with Notch and 
potentially positively regulating Notch signalling (see section 1.9.4). 
1.9.7.1.4 Mind bomb and Neuralised 
Mib and Neur are E3 ubiquitin ligases that promote ubiquitination of the DSL ligands 
and their subsequent endocytosis, mediated by Epsins (Kanwar and Fortini. -1004; 
Wang 
and Struhl, 2004; Wang and Struhi, 2005). This may generate functional ligands. 
which 
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facilitate effective Notch activation and signalling (described fully in 1.9.3.1 )(Koo et 
al., 2005; reviewed in Le Borgne et al., 2005: Le Borgne and Schwcisguth. 200. Parks 
et al., 2000; Pitsouli and Delidakis, 2005). Ubiquitination by \lib and Neur may also 
promote bi-directional Notch signalling by effecting ligand proteol`-sis (see section 
1.9.5), since ligand monoubiquitination and endocytosis may be required for the ligand 
to reach the acidic environment where y-secretase activity is optimal (Gupta-Rossi et al., 
2004; Parks et al., 2000). Ubiquitination by Mib or Neur can also play a negativ e role 
in signalling. For example, Neur can facilitate the degradation and downre`gulation of 
Delta (Deblandre et al., 2001; Lai et al., 2001). 
1.9.7.1.5 c-Cbl 
c-Cbl is an E3 ubiquitin ligase that binds to membrane-tethered Notch 1 and mediates its 
ubiquitination, endocytosis and subsequent lysosomal degradation (Jehn et al., 2002), 
possibly to regulate the steady-state level of Notch at the cell surface (reviewed in Le 
Borgne et al., 2005). 
1.9.7.2 Phosphorylation 
Notch pathway components may require phosphorylation to function effectively. For 
example, the PEST region of Notch must be phosphorylated prior to Sell0 binding, 
(reviewed in Baron, 2003; Gupta-Rossi et al., 2001; Oberg et al., 2001; Wu et al., 2001). 
In addition, it has been demonstrated that following ligand binding the Notch2 ICD can 
be hyperphosphorylated, possibly mediated by casein kinase II (Shimizu et al., 2000a), 
to facilitate its nuclear translocation and/or regulate the transactivation of target genes 
(Shimizu et al., 2000a). Also, in Drosophila, it is sometimes observed that the Notch 
ICD is phosphorylated (Kidd et al., 1998), although it is unknown how this alters its 
function. 
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1.9.7.3 O-fucosylation and glycosylation 
Notch receptor and ligand EGF repeats are modified by the addition of fuco,, c to sehne 
or threonine residues, in a process known as O-fucosylation (Okajima et al.. 20031. Shi 
and Stanley, 2003). O-fucosylation is vital in the facilitation of effective Notch 
signalling, and is mediated by the protein O-fucosyltransferase 1, termed OFUTI in 
Drosophila and Pofutl in mice (Okajima et al., 2003). OFUT1 has an additional. 
distinct, fucosyltransferase-independent function, acting as a Notch receptor-chaperone 
(Okajima et al., 2005), binding to Notch in the endoplasmic reticulum (ER) and 
facilitating its folding and trafficking out of the ER (Okajima et al., 2005). However, 
OFUT 1 predominantly mediates O-fucosylation. 
In Drosophila, OFUT1 downregulation inhibits both Delta-Notch and Serrate-Notch 
binding, demonstrating that 0-linked fucose is required for efficient binding of Notch to 
its ligands (Okajima et al., 2003). Overexpression of OFUT 1 increases Serrate-Notch 
binding but inhibits Delta-Notch binding, which is opposite to and suppressed by the 
glycosyltransferase Fringe, which specifically modifies O-linked fucose (Bruckner et 
al., 2000; Okajima et al., 2003). Therefore, Notch-ligand interactions appear to be 
dependent upon both the presence and type of O-fucose glycans (Okajima et al., 2003). 
Glycosylation, facilitated by Fringe proteins, is critical for normal Notch signalling 
(Okajima et al., 2003). Drosophila and mammalian Fringe proteins are conserved 
secreted proteins that act in the Golgi apparatus and possess a fucose-specific 131.3 N- 
acetylglucosaminyltransferase activity (i. e. glycosyltransferase activity) that catal` ses 
the addition of N-acetylglucosamine to 0-linked fucose residues in the EGF repeats of 
Notch receptors, initiating their elongation (Bruckner et al., 2000; Moloney et al.. 2O()0; 
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Moran et al., 1999). Drosophila Fringe enhances Delta-Notch binding and inhibit. 
Serrate-Notch binding (dependent on O-fucosylation of EGF repeat 11 of Notch (Lei et 
al., 2003))(Brüekner et al., 2000; Okajima et al.. 2003), implying that cell-ty pe-specitic 
modification of glycosylation may regulate ligand-receptor interactions (Bruckner et al., 
2000). Indeed, the Drosophila and mammalian Fringe proteins modulate the formation 
of compartment borders in the developing embryo by modifying ligand-receptor 
activation and hence Notch signalling (Evrard et al., 1998; Johnston et at.. 1997; Klorain 
et al., 1999; Shimizu et al., 2001; Zhang and Gridley, 1998). 
There are three mammalian proteins with functional homology to Drosophila Fringe: 
Manic Fringe (MFng), Lunatic Fringe (LFng) and Radical Fringe (RFng). MFng, LFng 
and RFng enhance Dill-Notchl binding and subsequent Notchl activation (Hicks et al., 
2000; Yang et al., 2005). Therefore, Fringe-mediated glycosylation enhances DII I- 
binding to potentiate signalling (Yang et al., 2005). RFng also enhances Jagged! - 
mediated Notch l signalling, but both MFng and LFng inhibit Jagged 1-Notch 1 
signalling (Hicks et al., 2000; Yang et al., 2005). This inhibition is proposed to be 
caused by ineffectual Notch l proteolysis (required for its activation), rather than 
reduced Jaggedl-Notchl binding (Yang et al., 2005). Both MFng and LFng induce a 
decrease in Jaggedl-Notch2 binding, although MFng induces a greater reduction in 
signalling (probably because MFng and LFng act on different EGF repeats within 
Notch2)(Shimizu et al., 2001). Neither MFng nor LFng affect D111-Notch2 binding and 
signalling (Shimizu et al., 2001). 
1.9.8 Cross-talk between the Notch signalling pathway and other pathways 
During Notch signalling the Notch receptors (and probably also the ligands) 
integrate 
the functions of signal reception at the cell surface and gene regulation in the nucleus 
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(reviewed in Schweisguth, 2004). Therefore, it is most likely that the effect of cro-, s- 
talk between Notch signalling and other pathways would be observed at the lex el of 
CSL-regulated genes or at the level of the proteins that they encode. which k indeed the 
case in the examples described in this section. 
The CSL-independent Notch signalling pathway modulates signalling by Wingless and, 
conversely, Wingless signalling can antagonise CSL-independent Notch signalling 
(Brennan et al., 1999; Martinez Arias et al., 2002; Ramain et al., 2001). Wingless 
inhibits CSL-independent Notch signalling either by directly binding to the extracellular 
domain of the Notch receptor (Brennan et al., 1999; Wesley, 1999; Wesley and Saez, 
2000), or via binding of Dishevelled (possibly in a complex with Frizzled (Strutt et al., 
2002)) to the Notch ICD within the domain C-terminal to the ANK region (Axelrod et 
al., 1996; Ramain et al., 2001). Alternatively, the active/oncogenic form of 
Armadillo/(3-catenin can bind to this region of the Notch receptor, which regulates the 
transcriptional activity of Anmadillo/ß-catenin and hence modulates Wingless signalling 
(Hayward et al., 2005). 
The bone morphogenetic proteins (BMPs) are a family of cytokines that belong to the 
transforming growth factor-ß (TGF-ß) superfamily (Hogan, 1996). BMPs are active in 
many tissues and are involved in cell fate determination in various organs (Takizawa et 
al., 2003), a function shared with the Notch signalling pathway. Indeed, the Notch and 
BMP signalling pathways function cooperatively in certain contexts. BMP2 can inhibit 
the neurogenesis of mouse neuroepithelial cells (Takizawa et al., 2003), partly via the 
induction of HESS expression, a known target of Notch signalling (Iso et al., 2003b). 
HES5 upregulation by both BMP2 and Notch implies potential cross-talk between the 
two pathways (Takizawa et al., 2003) Indeed, Notch and B`IP signalling 
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transcriptionally activate HES5 and HERP1 in a cooperative manner. confirming that 
there is cross-talk (Takizawa et al., 2003). 
BMP2 also induces osteogenesis (bone formation), and during this process Notch. Writ 
and TGF-ß signalling are activated concomitantly, confirmed by the upreggulation of 
target genes including HERP1, which suggests that there is cross-talk between the 
pathways (Zamurovic et al., 2004). Indeed, Notch l signalling, activated by Dill or 
Jaggedl, is essential in enhancing BMP2-induced osteoblastic differentiation (tiobta et 
al., 2005). 
The BMP and Notch signalling pathways are crucial for cellular differentiation and the 
two pathways often act similarly, suggesting that they may function cooperatively 
(Dahlqvist et al., 2003). For example, Notch signalling is required for the BMP4- 
mediated inhibition of satellite cell and myogenic C2C 12 cell differentiation, 
demonstrating that there is direct interaction between the Notch and BMP signalling 
pathways during myogenesis (Dahlqvist et al., 2003). 
Sonic hedgehog (Shh) is a secreted glycoprotein that functions during various 
developmental processes, patterning the embryo, and is mutated in multiple cancers 
(Izraeli et al., 2001), properties comparable with that of Notch. Similar 
functions 
suggest that there may be cross-talk between the Shh and Notch signalling pathways, 
and indeed there is evidence of interaction between the pathways 
in neural stem cells. 
whereby Notch receptor activation induces the expression of 
Shh, promoting cell 
survival (Androutsellis-Theotokis et al., 2006). 
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The Notch and JAK-STAT pathway also fulfil overlapping roles in cell fate. -, ro« th and 
differentiation regulation (Kamakura et al., 2004). STAT3 is acti% ated in the prc"ence 
of HES1 or HES5, targets of Notch signalling. HES proteins associate with JAK2 and 
STAT3, facilitating their formation into a complex, thus promoting STAT S 
phosphorylation and activation (Kamakura et al., 2004). This suggests that there are 
direct protein-protein interactions that coordinate cross-talk between Notch and JAK- 
STAT signalling, which is particularly important during central nervous system 
development (Kamakura et al., 2004). 
1.9.9 The role of Notch signalling in cell cycle regulation 
Several publications suggest that Notch signalling may be involved in cell cycle 
regulation. The cell cycle consists of four phases: GI (gap 1) phase, S (synthesis) 
phase, G2 (gap 2) phase and M (mitosis) phase. G1, S and G2 are collectively known 
as interphase (Lodish et al., 2004). In GI phase, the cell grows in size, by increasing 
the amount of cytoplasm and organelles. Some cells can exit G1 phase and reversibly 
stop dividing, entering a state of quiescence termed GO (gap 0) phase, and then re-enter 
GI phase when activated (Lodish et al., 2004). In S phase the cell duplicates its DNA. 
In G2 phase, the cell continues with growth and metabolism and in M phase the cell 
segregates its chromosomes into two separate diploid daughter cells. Cell cycle 
progression is regulated by cyclins and cyclin dependent kinases (cdks ), with 
checkpoints at each stage, to halt progression if damage has occurred (Lodish et al., 
2004). 
A variety of evidence suggests that Notch signalling may regulate the cell cycle by 
inducing changes in the expression of p21 and p27, which are cdk inhibitors (Cao et al.. 
2003). For example, active Notchl has an antiproliferativ, e effect in endothelial cells. 
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since it delays S phase entry, partly due to downregulation of p21 expression i \oseda et 
al., 2005). Notch signalling is also linked with p27 and p21 regulation in 3T3 
fibroblasts, via the F-box protein SKP2 (Sarmento et al.. 2005). Notchl-activation 
reduces the permanence of cells in GI and accelerates their entry into S phase by 
promoting transcriptional induction of SKP2. leading to subsequent proteasornal 
degradation of p27 and p2l (Sarmento et al., 2005). Thus. upregulation of SKP2 
transcription represents a mechanism by which Notch modulates the timing of cell cycle 
progression and coordinates proliferation and differentiation decisions (Sarmento et al., 
2005). In murine erythroleukaemia cells Notch l regulates multiple apoptosis and cell 
cycle mediators, including p21 and p27, with different time courses. The effects of 
Notch signalling on different targets depends on the time and mode of Notch activation 
and the level of Notch 1 expression (Jang et al., 2004). 
In vascular smooth muscle cells (VSMC) it has been shown that certain growth factors 
(mitogens) markedly downregulate Notch3 and Jagged l expression, via ERK 
(extracellular signal-regulated kinase)-dependent signalling mechanisms, which results 
in a decrease in RBP-JK-mediated gene transcription and activation (Campos et al., 
2002). It was, therefore, suggested that the Notch pathway was coupled to growth 
regulation (Campos et al., 2002). VSMC lines expressing constitutively active Notch3 
were generated and exhibited a biphasic growth behaviour in which the growth rate was 
retarded during the subconfluent phase and failed to decelerate post-confluence 
(Campos et al., 2002). The lack of cell cycle arrest was associated with attenuated 
upregulation of p27 (Campos et al., 2002). Constitutively active Notch3 also appears to 
affect actin cytoskeletal dynamics (important during cell cycle progression (Campbell et 
al., 1999)) in VSMC, which causes the cell shape to change, so cells become larger and 
rounder (Domenga et al., 2004). This is due to an increase in actin fibres and steady- 
86 
state levels of polymerised actin (Domenga et al., 2004). It was suggested that 
endogenous Notch3 might induce rearrangement of the actin cytoskeleton (Domen-'Li et 
al., 2004), which is known to be required during the cell cycle (Campbell et al., 1999). 
p21 and p27 appear to be involved in the regulation of myogenic differentiation, as they 
are highly upregulated when C2C 12 myoblast differentiation is induced (Cao et al.. 
2003). Since an array of evidence suggests that Notch signalling may control p2l and 
p27, it is possible that Notch signalling regulates their expression during mvogtncsis. 
The induction of differentiation in C2C 12 myoblasts leads to a subpopulation of cells 
undergoing terminal differentiation and forming myotubes, another subpopulation 
remaining undifferentiated reserve cells (Yoshida et al., 1998), and a subset undergoing 
apoptosis (Cao et al., 2003). It has been found that p21 is predominantly localised to 
myotubes, while p27 is concentrated in reserve cells. p27 induces and maintains a 
quiescent state in cells (Medema et al., 2000; Miskimins et al., 2001; Olashaw and 
Pledger, 2002), so more abundant p27 expression in reserve cells is consistent with their 
postulated GO arrest (Cao et al., 2003). When differentiation is induced, myogenin is 
upregulated and then p21 expression is upregulated, which causes irreversible cell cycle 
withdrawal and terminal differentiation in the subpopulation of cells that 
form myotubes 
(Andres and Walsh, 1996). Withdrawal of p21-expressing cells from the cell cycle and 
entry into differentiation occurs in G1 phase (Nadal-Ginard, 1978). 
In addition, 
upregulation of p21 and dephosphorylation of the retinoblastoma protein are critical 
regulatory components of both the post-mitotic state and an apoptosis-resistant state 
(Walsh and Perlman, 1997), suggesting that p21 expression 
inhibits apoptosis during 
myogenic differentiation. 
87 
1.10 The role of Notch signalling during myogenic regulation 
Previous studies have implicated Notch signalling in the regulation of mvogene' is. 
Notch signalling during skeletal muscle development is complex. It is involved in 
patterning and cyclic gene expression during somitogenesis (Hrabe de Angelis et al.. 
1997; Pourquie, 1999). It has also been suggested that Notch signalling functions 
during postnatal myogenesis. For example, in adult skeletal muscle, Conboy and Rando 
(2002) reported that Notchl is expressed by quiescent satellite cells and is activated 
during satellite cell activation by Dlii (expressed in both myofibres and satellite cells 
(Conboy et al., 2003)). Active Notch l promotes the proliferation of satellite cell 
progeny, thus expanding the early progenitor population, and inhibits differentiation. In 
the same studies, Numb expression increased in some progeny and was speculated to 
inhibit Notchl function, thus allowing those cells to differentiate. Asymmetric 
localisation of Numb in dividing satellite cell progeny has also been observed by Shinin 
et at. (2006). During neurogenesis, Numb localises to one half of the cell membrane of 
dividing neuronal precursors and is segregated primarily to one daughter cell, allowing 
the adoption of different fates (Petersen et al., 2002; Zhong et al., 2000b). It was, 
therefore, proposed that asymmetric localisation of Numb in dividing satellite cell 
progeny may specify daughter cells to either replenish the satellite cell pool (where 
Numb is absent and Notch 1 is active) or undergo terminal differentiation (where Numb 
is present and Notch 1 is active)(Conboy and Rando, 2002). 
As described earlier (section 1.3.1), it has not been fully elucidated whether the 
decline 
in the regenerative capacity of aged muscle is due to a decrease 
in satellite cell numbers 
or their function, or both. Above, it was suggested that 
Notch signalling regulates 
satellite cell activation, proliferative expansion and myogenic 
lineage progreýýýon 
(Conboy and Rando, 2002). In this model, satellite cell activation was 
dependent upon 
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Dlll upregulation in both satellite cells and adjacent myofibres (Conboy ct ßi1., 20011 1. 
In aged muscle, however. upon injury, satellite cells and myofibres show a decrcLý>eýi 
ability to upregulate Dill (Conboy et al.. 2003). Levels of Notch 1 did not alter and 
aged satellite cells possessed the same intrinsic regenerative potential and capacity to 
activate Notch signalling, but the extrinsic environment (i. e. the lack of Dill 
upregulation in response to injury) appeared to be responsible for the age-related loss in 
satellite cell functionality (Conboy et al., 2003). To investigate the effect of the 
extrinsic environment on Notch signalling in satellite cells, parabiotically paired mice 
were studied (Conboy et al., 2005). Two mice were connected surgically and developed 
a shared circulatory system, so that the tissues of one mouse were exposed to the 
circulating factors of the other mouse. Upon injury, satellite cell activation, 
proliferation and regeneration of aged mouse muscle was improved when an old mouse 
was paired with a young mouse, in comparison with pairings of two old mice (Conboy 
et al., 2005). This suggests that circulating factors from the young mouse were 
responsible for improved satellite cell function, which is also concluded by Collins et al. 
(2007). It was, therefore, proposed that the systemic environment of the young mouse 
was better able to potentiate Dill upregulation upon muscle injury, thereby activating 
Notch signalling in satellite cells (Conboy et al., 2005). 
Potential regulation by the Notch pathway has also been vindicated by studies of 
myogenic C2C 12 cells, which show that Notch signalling inhibits myogenic 
differentiation (Kuroda et al., 1999; Nofziger et al., 1999; Shawber et al.. 1996). 
Differentiation of murine myogenic C2C 12 cells is inhibited by ectopic expression of 
the Notchl ICD (Kato et al., 1997; Kopan et al., 1994), which is constitutively active, 
but not by full-length inactive Notchl (Kopan et al., 1994). In addition, coculture of 
C2C12 cells with cells expressing one of the ligands. Dill (Jarriault et al.. 
1998) or 
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Jaggedl (Lindsell et al., 1995), also inhibits myogenic differentiLition. Notch-mediated 
inhibition is accompanied by the downregulation of myo`genin and myosin li`, ht chain 
(Jarriault et al., 1998; Lindsell et al., 1995; Sha«ber et al.. 1996). 
In C2C12 cells, it has been shown that Notch activation can facilitate CSL-dependent 
signalling, which specifically represses myogenic differentiation through HE S 1- 
mediated, direct MyoD antagonism (Cossins et al., 2002; Jarriault et al., 1998; Kuroda 
et al., 1999; Nofziger et al., 1999). Overexpression of HES 1 in 1 OT 12 cells is also able 
to block myogenesis induced by MyoD (Sasai et al., 1992). How ever, there are 
conflicting views about the involvement of HES 1 in Notch-induced inhibition. Indeed, 
in C2C12 cells, CSL-independent Notch signalling can inhibit myogenic differentiation 
independently of HES1 upregulation, at a target upstream of MyoD (Nofziger et al., 
1999; Shawber et al., 1996), possibly via direct interaction between the Notch 1CD and 
E47 (Ordentlich et al., 1998). Constitutively active forms of Notchl lacking most or all 
of the sequences required for CBF1 interaction were shown to inhibit myogenic 
differentiation without interaction with CSL or upregulation of HES 1 expression 
(Shawber et al., 1996). Ligand-induced Notch signalling in C2C 12 myoblasts 
expressing a dominant negative form of CBF 1 produced similar results (Nofziger et al., 
1999). In addition, it was demonstrated that Jagged-Notch interactions prevented the 
expression of muscle specific genes but did not involve the upregulation of endogenous 
HES 1 (Shawber et al., 1996). Indeed, it was shown that exogenous expression of H ES I 
in C2C 12 cells did not block myogenesis (Shawber et al., 1996), conflicting with the 
data obtained using IOTI/2 cells (Sasai et al., 1992). Therefore, other factors aside from 
HES1 must be capable of inhibiting myogenesis (reviewed in Luo et al., 2 005). 
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HES6, for example, may regulate myogenesis. Overexpression of HESS can inhibit 
C2C12 differentiation by blocking induction of the cyrclin-dependent kinasc inhibitor 
p21, thus preventing cell cycle withdrawal (Cossins et al., 2002). Conxcrý'cly. other 
evidence suggests that HES6 may upregulate myogenic differentiation. Its expression 
increases during C2C12 differentiation (Cossins et al., 2002), and via its antagonisill of 
HES 1 (Bae et al., 2000), or its suppression of MyoR (Lu et at.. 1999). a \1 %-oD- 
antagonist, it may promote myogenesis (Gao et al., 2001). 
1.11 Aims 
The aim of this project is to investigate the role of Notch signalling in satellite cc11 
regulation and maintenance. In order to do this, individual myofibres isolated fron 
murine EDL muscles (Rosenblatt et al., 1995) will be cultured in suspension (Zarnmit et 
al., 2004) in vitro. Using this approach, the complement of satellite cells associated 
with each myofibre is retained beneath the basal lamina, maintaining cell-cell 
interactions, which are particularly important during Notch signalling. Satellite cell- 
derived primary cultures will also be utilised. All initial studies will be carried out 
using the murine myogenic cell line C2C 12 (Yaffe and Saxel, 1977; Blau et al., 1983). 
which represents an accessible model of the early stages of myogenic differentiation. In 
the presence of a high concentration of serum, C2C 12 cells proliferate as 
undifferentiated myoblasts, expressing MyoD and Myf5 (Yoshida et al., 1998). Serum 
depletion induces differentiation in 40-60% of cells: myogenin is expressed and cells 
withdraw from the cell cycle, fusion occurs and myotubes are formed (Yoshida et al.. 
1998). However, a proportion remain undifferentiated and mononucleated and are 
known as reserve cells. These cycle very slowly, downregulate their expression of 
MyoD and Myf5 (Yoshida et al., 1998) and express CD34 (Beauchamp et al., 2000). 
Furthermore, reserve cells can be induced to proliferate by restimulation with high- 
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serum medium, and can again yield a heterogeneous population of differentiated kind 
undifferentiated cells in the same proportions as originally observed (Yo,, hida et al.. 
1998). These characteristics make reserve cells a useful model of quiescent satellite 
cells. Using these approaches, the role of the Notch signalling pathway during 
myogenesis and satellite cell regulation will be investigated. 
Specific aims of this project are: 
1) To examine the expression of components of the Notch signalling pathway 
(receptors, ligands and modifying molecules) during C2C 12 cell myog ncsis. 
2) Components of Notch signalling suggested to play a role in regulating CC 12 
myogenesis will be overexpressed or inhibited to ascertain their function and 
determine their effect on specifying cell fate. 
3) Notch pathway component expression will be examined during satellite cell 
quiescence, activation, proliferation and differentiation. 
4) Components of Notch signalling suggested to play a role in satellite cell 
regulation will be overexpressed to ascertain their function and determine their 
effect on specifying cell fate in satellite cell progeny. 
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CHAPTER 2: Materials and Methods 
All reagents were obtained from Sigma-Aldrich unless otherwise stated, and ww ere 
prepared in distilled water (dH2O) unless alternativ-ely specified. Tissue culture 
practices were carried out in a Class II Laminar Flow Biological Safety Cabinet 
(Envair) and all solutions used inside the cabinet were sterile when purchased, or 
sterilised using a 0.2µM filter (Sartorius). In all tissue culture experiments, the 
Dulbecco's modified Eagle medium (DMEM) that was used contained 0.1 1 ti ,l sodium 
pyruvate, 4.5g/1 D-glucose and 3.7g/1 sodium bicarbonate (GIBCO K; Invitrogcin). 
Unless otherwise stated, all agarose gels were prepared using IX TBE (Tris-bormc 
EDTA) buffer (see section 2.12.2) and contained 1µg/ml ethidium bromide. DNA 
(deoxyribonucleic acid) and cDNA (complementary DNA) samples were prepared in 
1X DNA loading buffer (section 2.12.2), loaded onto gels and run in 1X TBC; buffer. 
RNA (ribonucleic acid) samples were prepared in IX RNA loading buffer (section 
2.12.2) and run on gels made with RNase (ribonuclease)-free reagents. Samples were 
electrophoresed until loading dye had run 50-75% down each gel. 
2.1 Cell lines 
2.1.1 C2C12 cells 
The myogenic cell line C2C 12 was subcloned from the C2 line, which was derived from 
the crush-injured thigh muscle of an adult female C3H mouse (Blau et al., 1983: Yaffe 
and Saxel, 1977). 
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2.1.2 HEK 293T cells 
Human embryonic kidney (HEK) 293 cells are an epithelial cell line derived from the 
embryonic human kidney. 293 cells were generated by the transformation of normal 
HEK cells with sheared adenovirus type 5 DNA (Graham et al.. 19' T. Louis et al.. 
1997). This cell line is straightforward to culture and transfect. HEK 293T cells 
contain the SV40 (simian virus 40) large T antigen, which allows episomal replication 
of transfected plasmids that contain the SV40 origin of replication (DuBridge et al.. 
1987). Therefore, plasmids of interest (e. g. retroviral vectors) may be transfected into 
these cells, amplified and desired gene products can be isolated. 
2.2 Cell culture 
2.2.1 Preparation of plastic surfaces for cell culture 
Cell lines were maintained on tissue culture grade plastic surfaces (BD Falcon" , 
Marathon). Plastic surfaces (except chamber slides; see below) were pre-coated with 
0.0 1% gelatin (BDH) when propagating C2C12 myoblasts. Permanox "' (plastic) 8- 
well Lab-TekTM chamber slides (Scientific Laboratory Services; SLS) were pre-coated 
with growth factor-reduced Matrigel 
TM (BD Biosciences) prior to C2C 12 cell culture. 
MatrigelTM stock solution (1mg/ml) was stored at -20°C, thawed on ice to prevent 
gelling of the components and diluted 1: 10 in cold DMEM. The plastic was pre-coated 
with diluted Matrigel TM , excess 
liquid was removed and slides were incubated at 37°C 
in a humidified atmosphere with 5% carbon dioxide (C02) for 30 minutes, to 
facilitate 
setting of the Matrigel 
TM 
prior to the addition of cells. 
2.2.2 Growth conditions 
All cell cultures were grown at 37°C in a humidified atmosphere, with 
5'o CO,. All 
solutions and media were pre-warmed to 37°C prior to addition to cell cultures. 
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2.2.3 Conditions for cell proliferation 
2.2.3.1 C2C12 cell proliferation 
Proliferating myoblasts were maintained in growth medium that consisted of D\1E\1 
supplemented with 20% (v/v)(volume/volume) foetal calf serum (FCS: PAA 
Laboratories), 4mM L-glutamine (L-glut), 100U/ml penicillin and 100pg ml 
streptomycin. 
2.2.3.2 HEK 293T cell proliferation 
Cells were maintained in growth medium that consisted of DMEM supplemented with 
10% FCS, which was heat inactivated at 56°C for 30 minutes prior to use, 4m\l L-glut, 
I 00U/ml penicillin and 100µg/ml streptomycin. 
2.2.4 Subculture of cells 
2.2.4.1 Subculture of C2C12 cells 
To prevent terminal differentiation, myoblasts were maintained at a low density in 
growth medium. When myogenic cell cultures reached approximately 50% confluence, 
cells were replated at a lower density. Growth medium was removed from the cells and 
they were briefly washed in a small volume of trypsin/EDTA (TE) solution (0.05% 
trypsin and 0.02% EDTA in Cat+/Mg2+ (calcium/magnesium ion)-free Hank's balanced 
salt solution (HBSS)). A volume of fresh TE, equivalent to the original volume of 
growth medium in the culture vessel, was added to the cells and they were incubated at 
room temperature until they began to detach. Efficient detachment of the cells was 
ensured by gentle tapping of the culture vessel. TE containing the cell suspension %ý as 
pipetted from the culture vessel into a sterile universal tube (SLS). An equal volume of 
growth medium was used to rinse the culture vessel, to collect the remaining cells, and 
95 
was transferred into the universal tube. Serum in the growth medium inhibited the 
action of the trypsin (Homer et al., 1963). Cells ww ere pelleted by centrifugation at 3- 0_ 
(G-force i. e. relative centrifugal force) for ten minutes at 4°C and resuspended in an 
appropriate volume of growth medium. A viable cell count (section 2.2.6) was 
performed and cells were replated at a lower density, around 6.5x 10- cells per cm`. 
2.2.4.2 Subculture of HEK 293T cells 
When HEK 293T cell cultures reached approximately 60-70° o confluence, cells were 
replated at a lower density. Growth medium was removed and cells were briefly 
washed in a small volume of fresh growth medium, ensuring that the cells, which detach 
easily, were not dislodged. A volume of fresh growth medium was added and the 
culture vessel was gently tapped to detach cells from the surface. The cell suspension 
was pipetted from the culture vessel into a sterile universal tube. An equal volume of 
growth medium was used to rinse the culture vessel, to collect the remaining cells, and 
was transferred into the universal tube. At this stage cells could be thoroughly 
resuspended and replated without counting, usually adding one tenth of the suspension 
to a new culture vessel. Alternatively, cells were pelleted by centrifugation at 350g for 
ten minutes at 4°C, resuspended very thoroughly in an appropriate volume of growth 
medium and counted (section 2.2.6). Cells were replated at around 5.3x 103 cells per 
cm2. 
2.2.5 Induction of differentiation of C2C12 cells 
Proliferating myoblasts were subcultured and resuspended in a vessel that was not pre- 
coated with gelatin (chamber slides were still coated with Matrigel T" ), at a density of 
1.06x104 cells per cm2. The cultures were propagated in `growth medium for 24 hour, 
before differentiation was induced. Growth medium was removed, cells were rinsed 
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twice in DMEM and differentiation medium was added. consistinu, of DLIE\1 
supplemented with 5% (v/v) FCS, 4mM L-glut, 100Urm1 penicillin and lOOu`g ml 
streptomycin. Cultures were propagated for 96 hours unless otherwise stated. 
2.2.6 Viable cell counts 
Cell counts were performed in order to estimate the number of viable cells within a cell 
suspension. Viable cells were considered to be those which, when incubated in a dilute 
solution of trypan blue (50% (w/v) in PBS (phosphate-buffered saline) ), were capable of 
excluding it from their cytoplasm (Tennant, 1964). A 50«1 aliquot of the cell 
suspension was combined with l00µ1 trypan blue. The number of cells excluding 
trypan blue was counted in a modified Fuchs-Rosenthal haemocytometer slide (%AN R), 
and then the total number of viable cells present in the original cell suspension was 
calculated. 
2.2.7 Storage of cells under liquid nitrogen 
To maintain stocks of cell lines, cells were frozen and stored under liquid nitrogen. 
Cells were detached from their substrate and pelleted by centrifugation, as described for 
subculture (section 2.2.4). The pellet was resuspended in freezing medium, consisting 
of growth medium mixed with 10% (v/v) dimethyl sulphoxide (DMSO), at a 
concentration of 5x105 C2C12 cells/ml or 8x 105 HEK 293T cells/ml, and aliquotted into 
lml cryovials (Nunc). Cryovials were placed in a `Mr. Frosty' freezing container 
(Nalgene®), which ensured that cells froze slowly (1 °C per minute) when transferred to 
a -80°C freezer. They were stored at -80°C for up to a month and then transferred to 
liquid nitrogen for long-term storage. 
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Cells stored under liquid nitrogen were recovered by rapidly thawing cr` oo\ ials at - C. 
The cell suspension was transferred into 20m1 growth medium. mixed and pelleted by 
centrifugation. The pellet was resuspended in 20ml growth medium and centrifuged 
again to remove DMSO from the medium. This step was repeated once more. a viable 
cell count was performed (section 2.2.6) and cells were seeded at an appropriate density 
in culture vessels. 
2.3 Separation of differentiated myotubes and undifferentiated reserve 
cells by differential trypsinisation 
2.3.1 Solutions used for separation 
All media and solutions were sterile when purchased or sterilised using a 0.2uM filter 
(Sartorius), and they were pre-warmed to 37°C. 
Supplemented DMEM (S-DMEM) 
DMEM was supplemented with 4mM L-glut, lOOU/ml penicillin and 100µg/ml 
streptomycin. 
PBS 
Sterile PBS (GIBCO®) was Cat+/Mg2+-free and at pH7.4. 
Trypsin 
0.15% (w/v) trypsin (GIBCO®) was prepared in PBS. 
Protein extraction buffer 
1% (w/v) SDS (sodium dodecyl sulphate) 
IX protease inhibitor cocktail (for general use; Sigma (P2714)) 
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This was prepared in PBS and kept at 4°C for a maximum of one week. 
2.3.2 Separation of myotubes and reserve cells for subsequent R\r or 
protein isolation 
C2C 12 cells seeded in T75cm2 tissue culture flasks (M. arathon) were induced to 
differentiate (section 2.2.5). After 96 hours, cultures were separated into differentiated 
myotubes and undifferentiated reserve cells. Differentiation medium was removed, 
cells were washed with 8m1 PBS and 5m1 trypsin was added. After approximately one 
minute, the myotubes were released into suspension and poured into a 25m] universal 
tube. From this point onwards, the protocol varies dependent on whether RNA or 
protein was extracted. 
2.3.2.1 RNA isolation from myotubes and reserve cells 
The trypsinised culture was rinsed twice with 8ml PBS to remove residual myotubes, 
which were then added to the universal tube with the other myotubes. Differentiation 
medium was added to the remaining reserve cells and the flask was returned to the 
incubator for one hour. Myotubes were centrifuged at 350g for ten minutes at 4°C' to 
pellet them. The supernatant was removed, Iml TRlzol"' reagent (Invitrogen) was 
added to the pellet and cells were triturated using an RNase-free pipette tip. They were 
then triturated further using a lml syringe with a sterile needle, to ensure that myotubes 
were thoroughly resuspended, and then transferred into an RNase-free 
Eppendorf tube 
and stored at -80°C. Medium was removed 
from the reserve cells and they were rinsed 
twice with differentiation medium to remove dead cells. TRlzo1 
F reagent 0 ml) was 
added to the flask and cells were scraped from the surface using a sterile scraper 
(Sarstedt), triturated, transferred to an RNase-free Eppendorf tube and stored at -80°C 
for subsequent processing. 
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2.3.2.2 Protein extraction from myotubes and reserve cells 
Following trypsinisation, after myotubes had been poured into a 25m1 universal tube. 
the culture was rinsed twice with 8m1 differentiation medium, to remove residual 
myotubes, which were added to the tube. Serum in the media inhibited the proteoly tic 
action of trypsin (Homer et al., 1963), so myotube proteins were not degraded. 
Myotubes were centrifuged at 350g for ten minutes at 4°C. The myotube pellet was 
resuspended in 20ml S-DMEM and centrifuged again, to wash the pellet and remove 
serum. To ensure that there was enough protein in each sample (for Western blotting). 
the separated samples from three T75em2 flasks were pooled. Each myotube pellet was 
thoroughly resuspended in 300µl protein extraction buffer and the samples were pooled 
in an Eppendorf tube and stored at -80°C. Differentiation medium was added to the 
flask containing reserve cells and it was returned to the incubator for an hour, and then 
rinsed twice with 8m1 S-DMEM to remove serum. Protein extraction buffer (300µl) 
was added to the flask and cells were scraped from the surface using a sterile scraper, 
triturated, transferred to an Eppendorf tube and stored at -80°C for subsequent 
processing. 
2.4 Mice 
C57B1/10 mice were maintained in the Biological Services Unit of the Imperial College 
School of Medicine, Hammersmith Campus, in accordance with the Animals (Scientific 
Procedures) Act 1986. Mice were used for single fibre isolation and were 
approximately 12 weeks old. 
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2.5 Single fibre preparation 
2.5.1 Solutions for single fibre preparation 
Supplemented DMEM (S-DMEM) 
DMEM was supplemented with 4mM L-glut, 100U, ml penicillin and 100« `g ml 
streptomycin. 
Collagenase solution 
0.2% (w/v) collagenase type I was prepared in S-DMEM. Two millilitres of 
collagenase solution was used to digest one muscle. 
5% BSA solution 
5% (w/v) bovine serum albumin (BSA) was prepared in PBS and heat-inactivated at 
56°C for 30 minutes. 
Activation medium 
10% (v/v) horse serum (HS; GIBCO®) 
0.5% (v/v) chick embryo extract (CEE; PAA laboratories) 
This was prepared in S-DMEM. 
2.5.2 Protocol for single fibre isolation 
Mice were culled by cervical dislocation. Single muscle fibres were isolated from 
extensor digitorum longus (EDL) muscles (one in each hind-limb) as described by 
Rosenblatt et al. (1995). The EDL muscles were dissected and handled by the tendons 
alone to prevent damage to the muscle bulk. Muscles were digested in collagenase 
solution for 60 to 90 minutes in a shaking waterbath at 35°C. Bacterial-grade petri 
dishes (Marathon) were used and were pre-coated with 5°'ö BSA solution. to prevent the 
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attachment of myofibres, ensuring that myofibres remained in suspenýion. Heat- 
polished glass Pasteur pipettes were also pre-coated with 5% BSA solution. S-D\IE\i 
was added to the pre-coated dishes and incubated for 30 minutes at 37°C in a 
humidified atmosphere with 5% CO2. 
Following digestion, individual muscles were transferred into separate dishes containing 
S-DMEM and incubated for 20 minutes at 37°C in a humidified atmosphere with 5° o 
CO2. To disaggregate the muscles into individual fibres, they v ere triturated using the 
heat-polished glass pipettes. Myofibres were transferred into dishes containing fresh 
S-DMEM to ensure the removal of any contaminating tissue (e. g. vascular or 
connective tissue), and kept at 37°C in a humidified atmosphere with 5% CO,. Some 
myofibres were utilised in experiments immediately, to try and ensure that the 
associated satellite cells remained quiescent. Alternatively, fibres were transferred into 
activation medium, to activate resident satellite cells, and incubated for variable lengths 
of time before use. 
2.6 Retroviral infection of C2C12 cell cultures or single fibres 
2.6.1 Retroviral vectors 
For full cloning protocols see section 2.7. All dideoxy-sequencing was carried out by 
the Genomics Core Laboratory, Imperial College School of Medicine, Hammersmith 
Hospital campus. 
2.6.1.1 pMSCVpuro vector 
pMSCVpuro is a Murine Stem Cell Virus (MSCV) vector. MSCV vectors were derived 
from the Murine Embyronic Stem Cell Virus (MESV) and the LN retroviral vectors 
(Grez et al., 1990; Miller and Rosman, 1989). Upon transfection into a packaging cell 
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line, pMSCVpuro (Clontech; Figure 2.1) transiently expresses. or inte 
expresses, a transcript containing the extended % it al 
resistance gene, and a gene of interest. The 5' long terminal repeat (LTR) is derived 
from the murine stem cell virus PCMV (PCC4-cell-passaged myeloproliferative 
sarcoma virus) and drives high-level constitutive expression of a target gene in stem 
cells or other mammalian cell lines (Hawley et al., 1994), which made it appropriate for 
use with C2C12 cell cultures and satellite cells resident on myofibres. Target genes 
were cloned into the multiple cloning site (MCS) downstream of the 5' LTR. 
MCS 
Hind III (1942) 
Cla I(2613) 
1410 1420 1430 
AG ATCTCTCGAGGTTAACGAATTC 
Bp! II Xbo I Hpa I EcoR I 
Figure 2.1: The pMSCVpuro vector 
The 5' and 3' LTRs are from the murine stem cell virus, PCMV. Downstream of the 5' 
LTR is the extended packaging signal V. Target genes were cloned into the multiple 
cloning site (MCS), details of which are specified at the bottom of the diagram. The 
MCS contains the unique restriction sites Bg/II, Xhol, Hpal and EcoRl. HindlIl and 
ClaI are also unique restriction sites. The murine phosphoglycerate kinase (PGK) 
promoter (PPGK) controls expression of the puromycin resistance gene (Puro`) for 
antibiotic selection in eukaryotic cells. The pUC plasmid origin of replication (Col El 
ori) and Escherichia coli (E. coli) ampicillin resistance (Amp) gene facilitate 
propagation and antibiotic selection in bacteria. 
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2.6.1.2 eGFP-NIC/puro vector 
The EGFP-NIC plasmid was a kind gift from Dr K Tezuka (Gifu Lniverity. Japan). 
Mouse Notch l intracellular domain (NIC) cDNA was cloned into the Hindl I I'E& oRI 
sites of the pEGFP-GA vector (derived from the pEGFP-C 1 vector; Clontech). The 
EGFP-NIC plasmid encoded an enhanced green fluorescent protein (eGFP)-ti IC fusion 
protein (Tezuka et al., 2002). 
The DNA fragment encoding the eGFP-NIC fusion protein (1.99kb) was excised from 
the EGFP-NIC plasmid using the restriction enzymes Nhel and Dral. The fragment was 
blunt-ended and ligated into the Hpal site of pMSCVpuro. The new plasmid was 
termed eGFP-NIC/puro. Dideoxy-sequencing confirmed that the eGFP-NIC fragment 
was in the correct orientation and the sequence was accurate. 
2.6.1.3 pMSCV-IRES-eGFP ('mig') 
mig was an acronym for the pMSCV-IRES-eGFP vector, a gift from Dr PS Zammit 
(Kings College, London, UK). The pMSCVpuro vector was modified to replace the 
puromycin selection gene with an internal ribosome entry site (IRES) and enhanced 
green fluorescent protein (eGFP)(Zammit et al., 2006b). The 1.5kb IRES-eGFP 
sequence was ligated into the pMSCVpuro vector between the EcoRI and Clal sites and 
altered the size of the vector to 6.7kb. Target genes were cloned into the MCS of mig 
and resulted in encoding of a bi-cistronic transcript for the gene of interest and eGFP, 
separated by an IRES. 
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2.6.1.4 dnRBP-J/mig 
The pCMX-N/RBP-J (R2 l 8H) plasmid, produced by Chung er al. (1994). was obtained 
from the RIKEN BioResource Center DNA Bank. It contains the dominant ne, -, ati% c 
form of mouse RBP-Jx under the control of the CW (cytomegalov irus) promoter. The 
DNA fragment encoding dominant negative RBP-JK was excised from pC`IX-\\ RBP-J 
using the restriction enzymes EcoRI and BamHI. The fragment was blunt-ended and 
ligated into the Hpal site of the mig vector. Dideoxy-sequencing confirmed that the 
DNA fragment was inserted in the correct orientation and was accurate. The new 
plasmid, encoding dominant negative (dn) RBP-JK with eGFP, was termed dnRBP- 
J/mig. 
2.6.1.5 Numb/mig 
Numb/pBluescript was a kind gift from Dr W Zhong (Yale University, USA) and 
consisted of full-length murine Numb cDNA (3.3kb; accession number: U70674; Numb 
isoform 1) cloned between the EcoRI/Xhol sites of the pBluescript (sk-) vector 
(Stratagene). Numb/pBluescnpt was digested using EcoRI, Xmnl and Xhol. The 3.3kb 
Numb cDNA fragment was blunt-ended and ligated into the Hpal site of mig. Dideoxy- 
sequencing confirmed that it was inserted in the right orientation and was the correct 
sequence. The new plasmid, encoding full-length Numb with eGFP, was termed 
Numb/mig. 
2.6.1.6 Notch3/mig 
Notch3lC-HA/pcDNA3 was a generous gift from Dr I Screpanti (Uni% ersity "La 
Sapienza", Rome, Italy). cDNA encoding the intracellular (IC) domain of mouse 
Notch3 was fused at the C-terminal-encoding-end to an HA (haemagglutinin) tag motif 
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to make N3IC-HA (Beatus et al., 1999: Lardelli et al.. 1996). which %v as subcloned into 
the BamHI/EcoRI sites of pcDNA3 (Fell] et al., 2005). 
The DNA fragment encoding N3IC-HA was excised from pcDNA3 using the restriction 
enzymes EcoRI and BamHI. N3IC-HA was blunt-ended and ligated into the Hpal site 
of the mig vector. Dideoxy-sequencing confirmed that it was inserted in the correct 
orientation and the sequence was accurate. The new plasmid, encoding the H. -A-ta`g`ged 
intracellular domain of Notch3 and eGFP, was termed Notch3 mig. 
2.6.1.7 Dtx3/mig 
Full-length murine Dtx3 cDNA (accession number: NM_030714) was generated from 
96 hour-differentiated C2C 12 cDNA using native Pfu (Pyrococcus firriosii s) DNA 
polymerase (Stratagene) and PCR (polymerase chain reaction) primers 
5'-AGCTCGAGGATCAA ATGTCGTTCGTCCT-3' (forward) and 
5'-GAGAATTCGGAGCTGTCCCTCAGTCGTC-3' (reverse), according to the 
manufacturer's protocol. The forward primer contained a Xhol restriction site, while 
the reverse primer contained an EcoRI site (underlined). Therefore, the PCR product 
was digested using Xhol and EcoRI and ligated into the Xhol/EcoRI sites of mig. The 
new plasmid, encoding full-length Dtx3 cDNA and eGFP, was termed Dtx3/mig and 
dideoxy-sequencing confirmed that the orientation of the Dtx3 cDNA was correct and 
the sequence was accurate. 
2.6.1.8 MigRl 
MigRi was a kind gift from Dr M Bevan (University of Washington, USA). The eGFP- 
expressing retroviral vector, MigRi, was constructed by three-way ligation of a 5kb 
MSCV2.2 vector (see section 2.6.1.1, regarding MSCV vectors; (Hawley et al.. 1994). a 
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0.5kb IRES fragment from pCITE and a 0.8kb eGFP fragment (Pear et al.. 199S). 
Target genes were cloned into the MCS of MigRi. This encoded a bi-cistronic 
transcript for the gene of interest and eGFP, separated by an IRES. 
2.6.1.9 Jaggedl/MigRi 
The Jaggedl/MigRi vector was also a gift from Dr M Bevan. Full-length murine 
Jaggedl cDNA (accession number: BC058675) was cloned into the EcoRI site of 
MigR 1 (Lehar et al., 2005). Dideoxy-sequencing was used to confirm that the Jagged I 
cDNA sequence was correct. 
2.6.1.10 D114/MigRl 
D114/MigRl was a kind gift from Dr A Freitas (Pasteur Institute, France). Full-length 
mouse D114 cDNA was subcloned into the XhoUEcoRI sites of MigRI (de La Costc et 
al., 2005). The sequence of D114 was confirmed via dideoxy-sequencing. 
2.6.1.11 D111/MigRl 
Dlll/MigRi was also a gift from Dr A Freitas. Full-length murine Dill cDNA was 
subcloned into the BgiII/Xhol sites of the MigRi vector (de La Coste et al., 2005). 
Dideoxy-sequencing was used to confirm that the Dill sequence was accurate. 
2.6.1.12 Dtxl/MigRl 
The Dtxl/MigRl vector was a generous gift from Dr W Pear (University of 
Pennsylvania, USA). Full-length murine Dtx 1 cDNA was ligated into %, 1igR 1 (Izon et 
al., 2002). The sequence of Dtxl was confirmed using dideoxy-sequencing. 
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2.6.1.13 pCL-ECO 
pCL-ECO (Imgenex) is an ecotrophic packaging vector designed to maximise 
recombinant-retrovirus titres. pCL-ECO was co-transfected into packaging cells with 
the vector containing the target gene. RNA encoded by the -vector of interest was 
packaged into infectious, replication-incompetent retroviral particles. pCL-ECO 
contains the structural genes gag, pol and env, which enabled the retroviral particles to 
be packaged and become replication-competent. The packaged particles were used to 
infect target cells and transmit the gene of interest to them. 
2.6.2 Transfection of HEK 293T cells 
HEK 293T cells were the packaging cell line used to produce retroviral supernatants 
from the vectors specified in section 2.6.1. Cells were seeded at a density of 5.3x 103 
cells per cm2 in a 100mm diameter tissue culture dish and cultured for 72 hours. The 
cells were detached from their substrate and pelleted by centrifugation, as described for 
subculture (section 2.2.4). The pellet was resuspended and one tenth of the cell 
suspension (derived from one dish) was added to IOml growth medium in a 100mm 
diameter tissue culture dish. After approximately 24 hours, cells had reached 30-50% 
confluency. The medium was replaced with 9m1 fresh growth medium per dish, and 
then cultures were returned to the incubator for one hour, while transfection complexes 
were prepared. 
2.6.2.1 Preparation of transfection complexes 
For each 100mm dish, the transfection complex consisted of: 
- 61, tg DNA (3µg retroviral plasmid of interest + 3µg pCL-ECO helper plasmid) 
- 18µ1 FuGENE® 6 transfection reagent (Roche) 
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This was prepared in Optimem + GlutaMAXTM I medium (GIBCOF-) to give a final 
volume of 300µ1, according to the description below. 
First, the appropriate volume of Optimem + GlutaMAX TM I medium was placed in a 
sterile cryovial. To avoid adversely affecting transfection efficiency. FuGE, E® 6 was 
added directly to the medium, ensuring that undiluted reagent did not come into contact 
with the cryovial surface. The tube was flicked gently to mix the contents and 
incubated at room temperature for five minutes. Plasmid DNA was added, the tube was 
flicked to mix and then the complex was incubated for a further 45 minutes at room 
temperature. The dish was gently swirled while 300µl transfection complex was added 
in a drop-wise manner. The dish was incubated at 37°C in a humidified atmosphere 
with 5% CO2. 
2.6.2.2 Retroviral supernatant harvest 
Twenty-two hours post-transfection, medium was removed from the dish and l0mi 
fresh growth medium was added. After two hours, this was replaced with 3.5m1 fresh 
growth medium. Twelve hours later, the first retroviral harvest was collected. The 
medium, which contained the retroviral supernatant, was removed from the cells and 
collected in a sterile tube (Fisher Scientific; Marathon). This was centrifuged at 500g 
for ten minutes at 4°C to pellet any cells. The retroviral supernatant was transferred 
into a new tube, aliquotted into cryovials and stored at -80°C. When the medium was 
removed from the dish, it was replaced with 3.5m1 fresh growth medium and the dish 
was returned to the incubator. After 12 hours, a second batch of retroviral supernatant 
was harvested in the same way as for the first harvest. Again the medium was replaced 
and the dish was returned to the incubator for another 12 hours before the final 
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retroviral harvest was collected. Retroviral supernatant was stored at -80°C long-term. 
However, once it had been thawed it was stored at 4°C. 
2.6.3 Retroviral infection of C2C12 cells 
Tissue culture flasks were seeded at a density of 8x102 C2C 12 cells per cm` and 
propagated for 24 hours in growth medium. Growth medium was removed and 
undiluted retroviral supernatant (thawed on ice), containing polybrene (also known as 
hexadimethrine bromide) at a final concentration of 4µg/ml, was added to each flask. 
Cells were returned to the incubator for three hours, to allow the retrovirus to infect the 
cells and transmit the target gene into them. The retroviral supernatant was removed 
and cells were washed with growth medium. Fresh growth medium was added and the 
infected cells were incubated for approximately 48 hours. 
2.6.3.1 Fluorescence-activated cell-sorting (FACS) analysis of infected C2C12 cells 
Forty-eight hours post-infection, cells were pelleted, counted (section 2.2.6) and 
resuspended at a density of lx 106 cells/ml in FACS buffer: 
1X PBS 
2mM EDTA (ethylenediaminetetraacetic acid) 
25mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
1% (v/v) FCS (heat-inactivated for 30 minutes at 56°C) 
One millilitre of the cell suspension was transferred into a capped, sterile 6ml 
polypropylene FACS tube (Marathon) and kept on ice. Cells were sorted using a FACS 
DiVa flow cytometer and cell sorter (Becton Dickinson), and GFP+, retrovirally- 
infected cells were collected. Retroviral DNA integration causes damage to the host 
cell chromosome and repair of this damage is required to complete the inte`ration 
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process. If damage is not repaired apoptosis may occur (Skalka and Katz. 2005). so 
successfully infected cells are viable and GFP-. The GFP+ cells were subcultured twice 
and then reanalysed, using a FACScan flow cytometer (Becton Dickinson). to ensure 
that the percentage of GFP+ cells remained high, prior to use in experiments (Western 
blot analysis, immunostaining, coculture etc. ). Infected cells were co-infected with a 
second retroviral supernatant, following the original protocol, if necessary. Infected cell 
lines were frozen to maintain stocks (section 2.2.7). 
Flow cytometry analysis was carried out using CellQuest software version 3.3 (Becton 
Dickinson). For every sort or count two dot plots were drawn (Figure 2.2 ). In the first 
plot, forward scatter (FSC) was placed on the x-axis and side scatter (SSC) was on the 
y-axis. FSC measures cell size while SSC measures cell granularity (Shapiro, 2003). 
The second plot measured the fluorescence of the cells following excitation with a laser. 
Green fluorescence (i. e. GFP expression) was measured using the FL (fluorescence) I 
filter (515nm-545nm) and orange-red fluorescence was measured using the FL2 filter 
(564nm-606nm). The FLl values were plotted on the x-axis (termed GFP) and FL2 
values on the y-axis. 
Uninfected cells were used as a negative control in each experiment to determine the 
range of green fluorescence values, and hence the proportion of GFP+ cells present in 
retrovirally-infected samples (Figures 2.2 and 2.3). The FSC versus SSC plot allowed 
the identification of healthy cells. Live cells scatter more light forward due to their 
intact plasma membrane, while dead cells scatter light perpendicularly due to increased 
cytoplasmic granularity (Shapiro, 2003). Healthy cells were gated and their fluorescent 
intensity values were used in the FL1 versus FL2 plot. The presence of GFP in the cells 
was determined by an increase in the intensity in the FL 1 channel without a concurrent 
increase in the FL2 channel. 
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Figure 2.2: FACS analysis of C2C12 myoblasts 
C2C l2 myoblasts were counted using a FACScan flow cytometer. Forward scatter 
(FSC) is plotted against side scatter (SSC)(a). Healthy cells were gated and their green 
fluorescence expression (GFP/FL 1) was plotted against orange-red fluorescence 
(FL2)(b). A plot summarises the GFP expression of all healthy cells (c). The range of 
GFP-expression is shown (line in c). Approximately 2% of myoblasts (2.18% in this 
case) are included in the range, despite being GFP-. This ensures that infected cells that 
express low-level GFP will be included in the GFP+ population, when compared with 
uninfected myoblasts, which act as a negative control. 
The GFP expression value for each healthy cell was 
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Figure 2.3: FACS analysis of mig-infected C2C12 myoblasts 
C2C 12 myoblasts infected with mig were counted using a FACScan flow cytometer. 
Forward scatter (FSC) is plotted against side scatter (SSC)(a). Healthy cells were gated 
and their green fluorescence expression (GFP/FL 1) was plotted against orange-red 
fluorescence (FL2)(b). A plot summarises the GFP expression of all healthy cells (c). 
The range of GFP-expression is shown, determined using uninfected myoblasts as a 
negative control (Figure 2.2). Approximately 98.74% of cells are GFP+ and hence 
infected. 
2.6.3.2 Coculture of retrovirally-infected C2C12 cells with uninfected cells 
Retrovirally-infected myoblasts were mixed with an equal number of uninfected C2C 12 
myoblasts and they were seeded in Permanox "" 8-well Lab-Tek "'chamber slides. and 
after 24 hours differentiation was induced. Alternatively, uninfected C2C 12 myoblasts 
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were seeded in Permanox " 8-well Lab-TekTM chamber slides. and differentiation «as 
induced. Twenty-four hours after the induction of differentiation, an equal number 
(corrected to take into account division of the cells seeded initially) of retrovirally- 
infected myoblasts were added to the uninfected cells. All cultures were propagated for 
a total of 96 hours in differentiation medium to establish the effect of the retrovirally- 
infected cells on determining cell fate in the uninfected cells. 
2.6.3.3 Coculture of retrovirally-infected C2C12 cells with reserve cells 
Retrovirally-infected myoblasts were propagated in Permanox TM 8-well Lab- 
TekTM chamber slides for 24 hours in growth medium. After 24 hours, uninfected, 
differentiated (96 hours) C2C12 cell cultures (see section 2.2.5) were differentially 
trypsinised (section 2.3.2), myotubes were poured away and the culture was rinsed 
twice with PBS to remove residual myotubes. Remaining reserve cells were isolated by 
trypsinisation. A volume of TE, equivalent to the original volume of medium in the 
culture vessel, was added to the reserve cells and they were incubated at room 
temperature until they began to detach. Efficient detachment was ensured by gently 
tapping the side of the culture vessel. The TE containing the reserve cell suspension 
was pipetted from the culture vessel into a sterile universal tube. An equal volume of 
differentiation medium was used to rinse the culture vessel, to collect the remaining 
cells, and was transferred into the universal tube. The cells were pelleted by 
centrifugation at 350g for ten minutes at 4°C and resuspended in an appropriate volume 
of differentiation medium. Reserve cells were resuspended in differentiation medium to 
prevent their reactivation (Yoshida et al., 1998). A viable cell count (section ?. 2.6) was 
performed and an equal number of reserve cells (corrected to take into account division 
of the cells seeded initially) were added to the retrovirally-infected myohlasts in growth 
medium in chamber slides. Cocultures were propagated for a further -14 
hours to 
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determine the effect of the retrovirally-infected cells on reserve cell reactivation and 
proliferation. 
2.6.4 Retroviral infection of single fibres 
2.6.4.1 Retroviral infection of plated fibres 
Permanox TM 8-well Lab-Tek TM chamber slides were pre-coated with Ni atri gel "' (BD 
Biosciences), prior to the addition of myofibres. Undiluted Matrigel T" was used, but 
otherwise the protocol followed was the same as that described in section 2.2.1. 
Retroviral supernatant was thawed on ice and diluted 1: 8 to 1: 12 with single fibre 
activation medium, dependent on the retroviral titre. Activation medium alone was 
used in negative control experiments. An individual fibre (in 3 p11 S-DMEM) was 
transferred into the centre of each well of a pre-coated chamber slide. Activation 
medium containing retroviral supernatant was carefully added (200u l per well), 
ensuring that the fibre was not dislodged. The slides were returned to the incubator for 
approximately 16 hours and were then supplemented with additional retroviral 
supernatant at the same dilution that was used initially. The slides were returned to the 
incubator and remained there for a total of 48-96 hours after the initial infection, 
allowing satellite cell progeny to migrate off the fibre onto the substrate and proliferate. 
Some fibres were left for a longer period (eight days) in activation medium, potentiating 
myoblast fusion and myotube formation. In this case, three fibres were added to each 
well at the start of the experiment and activation medium was replaced after four days, 
so that it remained fresh. 
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2.6.4.2 Retroviral infection of single fibres in suspension 
Retroviral supernatant was thawed on ice and diluted 1: 8 to 1: 12 with activation 
medium. Activation medium alone was used in negative control experiments. Twelv-e- 
well plates (Marathon) were pre-coated with HS, to prevent myofibres from adhering to 
the surface, which ensured that fibres remained in suspension. Activation medium 
containing retroviral supernatant was placed in each well (lml/well) and approximately 
20 fibres were added (this number prevented overcrowding 'tangling). (If more than one 
well was used for infection with a specific retrovirus, then the fibres from those wells 
were pooled at the end of the experiment. ) The plates were returned to the incubator for 
approximately 16 hours and then fibres were supplemented with additional retroviral 
supernatant at the same dilution that was used initially. Plates were returned to the 
incubator for a total of 72 hours after the initial infection, which allowed satellite cells 
to activate, proliferate and form clusters of progeny under the basal lamina of the 
myofibres. 
2.7 Cloning 
All restriction endonucleases, DNA modifying enzymes and reaction buffers were 
supplied by New England Biolabs, unless otherwise stated. 
2.7.1 Amplification of retroviral plasmids 
2.7.1.1 Transformation of the plasmid into bacteria 
Plasmids that were received as gifts were sent in solution in a tube, or dehydrated on a 
piece of filter paper. Plasmids sent in solution could be used directly for 
transformation, but those on paper required rehydration. The paper was soaked in IX 
TE (Tris-EDTA) buffer (see section 2.12.2) and incubated at room temperature for one 
hour and the solution containing plasmid DNA was then used to transform chemically- 
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competent XL I Blue E. coli cells (Stratagene), according to the manufacturer's 
instructions. Transformed bacterial cells were grown overnight on LB (Luria Bertani ) 
agar plates containing an antibiotic appropriate for selection of colonies containing the 
specific plasmid. Most plasmids were ampicillin- or kanamycin-resistant so LB agar 
contained 100µg/µ1 ampicillin or 30µg/µl kanamycin respectively. 
2.7.1.2 Amplification and purification of the plasmid 
A sterile inoculating loop (SLS) was used to scrape colonies from the plate and transfer 
them into a sterile flask containing 200m1 LB broth with the appropriate antibiotic, at 
the same final concentration as used in the LB agar. Colonies were grown overnight at 
37°C in a shaking incubator. Bacteria were harvested and the plasmid was purified 
using the QIAGEN® Plasmid Purification Maxi Kit, according to the manufacturer's 
protocol. 
2.7.2 Restriction digestion of retroviral plasmids 
Restriction digestion of plasmids, to isolate the DNA fragment of interest or to linearise 
a vector in preparation for ligation, were carried out using the restriction endonucleases 
specified in section 2.6.1. Between 2-5µg plasmid DNA was digested in a 50µl 
reaction, using restriction endonucleases according to the manufacturer's instructions, 
with 1X reaction buffer, 3mM spermidine hydrochloride and 1X BSA if required. 
2.7.3 Filling in 5' overhangs to form blunt ends 
Where specified in section 2.6.1, isolated DNA fragments were blunt-ended prior to 
ligation into the appropriate vector. Restriction digestions (50µl reactions) were treated 
with Klenow, a proteolytic product of E. coli DNA polymerase I. which tills in 5' 
overhangs to form blunt ends (Sambrook et al., 1989) One microlitre of Klenow and 
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1.65µl 1mM dNTPs (deoxynucleotide triphosphates: Invitrogen) were added. but 
additional reaction buffer was not required since it "-as already incorporated in the 
digestion reaction. This reaction was incubated at room temperature for 15 minutes and 
then the blunt-ended DNA was purified (see section 2.7.5). 
2.7.4 CIAP-treatment of linearised vectors 
Calf intestinal alkaline phosphatase (CIAP; Promega) catalyses the hydrolysis of 5' 
phosphate groups in DNA and RNA (Sambrook et al., 1989). CIAP was used to 
prevent recircularisation and religation of linearised DNA by removing phosphate 
groups from both 5' termini. All linearised vectors, whether blunt- or sticky-ended, 
required treatment with CIAP to prevent recircularisation. 
2.7.4.1 CIAP-treatment of linearised vectors with blunt-ends 
The restriction digestion reaction (50µl), containing linearised plasmid DNA, was 
mixed with 1µl CLAP, 6 t1 l OX CIAP reaction buffer (Promega) and 2µl dH2O. The 
reaction was incubated at 37°C for 15 minutes and then at 56°C for 15 minutes. 
Another 1 µ1 CIAP was added to the reaction and the two incubations were repeated. 
The higher temperature potentiates blunt end-accessibility (Perbal, 1988). CLAP-treated 
linearised DNA was then purified (section 2.7.5). 
2.7.4.2 CIAP-treatment of linearised vectors with sticky-ends 
The restriction digestion reaction (50µ1) was mixed with 1µl CLAP, 6µl I OX CLAP 
reaction buffer and 2µl dH2O, and incubated at 37°C for 30 minutes. Another 1µl CIAP 
was added to the reaction and the incubation was repeated 
DNA was then purified (section 2.7.5). 
CLAP-treated linearised 
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2.7.5 Gel purification 
Klenow-treated blunt-ended DNA fragments, restriction-digested DN. A fragments with 
sticky ends and CIAP-treated linearised DNA required gel purification to remove 
enzymes. An agarose gel (0.75% (w/v)) was prepared and samples were run on the gel 
and purified using the QlAquick Gel Extraction Kit (QIAGEN R ). according to the 
manufacturer's instructions. 
2.7.6 Ligation 
T4 DNA ligase catalyses the formation of a phosphodiester bond between juxtaposed 5' 
phosphate and 3' hydroxyl termini in duplex DNA or RNA (Sambrook et al., 1989). 
Therefore, this enzyme was used to join purified DNA fragments of interest (removed 
from their original vectors) with appropriate linearised vectors (see section 2.6.1). 
Purified samples were run on an agarose gel (0.75% (w/v)) beside a low mass DNA 
ladder (Invitrogen), to approximately quantify the DNA. In the ligation reaction, the 
quantity of `insert' DNA used was around ten times greater than the amount of 
linearised vector DNA. Ten microlitre ligation reactions were prepared, containing I u1 
I OX T4 DNA ligase reaction buffer, 1µl recombinant T4 DNA ligase (400 units of 
enzyme) and variable quantities of linearised vector DNA, insert DNA and dH2O. The 
ligation reaction mix was incubated overnight, for approximately 16 hours, at 16°C. and 
then stored at -20°C until it was required for transformation into bacteria. 
2.7.7 Transformation of ligated retroviral plasmids 
Plasmid DNA from ligation reactions (5µl) was predominantly used to transform XLI 
Blue subcloning grade chemically-competent E. coli cells (Stratagene), according to the 
manufacturer's instructions. However, to transform the dam (DNA adenine methvla, c )- 
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sensitive eGFP-NIC plasmid (section 2.6.1.2). SCSI 10 chemically-competent E. cull 
cells (Stratagene), which were dam-deficient, were used according to the 
manufacturer's instructions. Transformed bacterial cells were grown o% crnight on LB 
agar plates containing ampicillin or kanamycin, as appropriate, to select for colonies 
containing the plasmid of interest, which confer antibiotic resistance. 
2.7.8 Amplification of correctly-ligated retroviral plasmids 
2.7.8.1 Amplification of plasmid DNA from individual colonies 
Ten to fifteen colonies were picked individually using sterile tips and transferred into 
sterile tubes (Fisher; Marathon), which each contained 3ml LB broth with the 
appropriate antibiotic, at the same final concentration as used in the LB agar. Colonies 
were grown overnight at 37°C in a shaking incubator. Bacteria were harvested and the 
plasmid in each sample was purified using solutions from the QIAGEN® Plasmid 
Purification Maxi Kit, as described. Approximately 1.5m1 bacterial cell suspension was 
transferred into an Eppendorf tube and centrifuged at 14,000g for 30 seconds at 4°C to 
pellet the bacteria. The supernatant was poured away, 100µl Pl buffer was added to the 
pellet and cells were thoroughly resuspended by vortexing. To lyse cells, 100u1 P2 
buffer was added, samples were mixed by several inversions, then incubated at room 
temperature for precisely five minutes, which ensured that nuclei did not lyse. To 
neutralise the alkaline P2 buffer, 100µl cold P3 buffer (stored at 4°C) was added and 
mixed by several inversions. The tube was centrifuged at 14,000g for five minutes at 
4°C. The supernatant, containing plasmid DNA, was removed and transferred into a 
new Eppendorf tube with 750µ1 cold absolute ethanol (stored at -20°C), to remove salt 
from the DNA. This was centrifuged at 14,000g for five minutes at 4°C. the 
supernatant was poured away and the pellet was washed with lml cold 70°-0 (v v) 
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ethanol (stored at -20°C). The pellet. containing purified plasmid DNA. was air-dried 
and resuspended in 30µl 1X TE buffer. 
2.7.8.2 Confirmation of plasmid DNA sequences and plasmid amplification 
Purified plasmid DNA isolated from individual transformed bacterial colonies were 
analysed by several diagnostic restriction digestion reactions, carried out according to 
the manufacturer's instructions, to determine whether the vector contained the inserted 
DNA and if the inserted fragment was the correct size and orientation. A colony 
containing correctly-ligated plasmid DNA was then chosen for amplification. The 
colony was originally amplified in 3ml LB broth, so 200ýt 1 of this bacterial cell 
suspension was transferred into a sterile flask containing 200ml LB broth with the 
appropriate antibiotic, at the same final concentration as used in the original LB agar. 
Bacteria were grown overnight at 37°C in a shaking incubator, harvested and the 
plasmid was purified using the QIAGEN® Plasmid Purification Maxi Kit, according to 
the manufacturer's protocol. The sequence of the purified plasmid was confirmed by 
dideoxy-sequencing, carried out by the Genomics Core Laboratory, Imperial College 
School of Medicine, Hammersmith Hospital Campus. 
2.8 Fixation of C2C12 cell cultures or single fibres 
Paraformaldehyde (PAF) was prepared in PBS at a concentration of 4% (w/v) and 
aliquots were stored at -20°C. PAF was thawed and pre-warmed at 37°C prior to use. 
DMEM or PBS used during fixation was also pre-warmed to 37°C before use. 
2.8.1 Fixation of C2C12 cell cultures 
Medium was removed from C2C12 cell cultures in 8-well chamber slides and they were 
rinsed with PBS. PAF (200µl/well) was added and cultures were incubated at room 
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temperature for five minutes (unless previously BrdL-treated - ee section -" 10). PAF 
was removed and cultures were washed twice with PBS. PBS was added and culture, 
were either immunostained immediately, or stored at 4°C with the slides covered in 
Parafilm® (SLS) to prevent evaporation. 
2.8.2 Fixation of single fibres 
2.8.2.1 Fixation of myofibres cultured in suspension 
Freshly-isolated myofibres cultured in suspension in S-DMEM (section 2.5), with 
associated satellite cells that had not been activated (termed TO, meaning Time 0, or 0 
hours), were fixed for immunostaining. Fibres were also cultured in suspension, in pre- 
coated (with HS) bacterial-grade dishes that contained activation medium, for 24 J24), 
48 (T48) or 72 hours (T72), to activate the associated satellite cells, prior to fixation. 
Up to 100 myofibres from a specific time point were transferred into an Eppendorf tube 
and excess medium was removed. The tube was filled with PAF and fibres were fixed 
at room temperature for 20 minutes. PAF was removed and fibres were rinsed twice in 
PBS, then PBS was added and fibres were used immediately for immunostaining or 
stored at 4°C. 
2.8.2.2 Fixation of retrovirally-infected plated myofibres 
Retrovirally-infected plated fibres were cultured in 8-well chamber slides (section 
2.6.4.1). To fix the cultures, approximately half of the medium (100µl) was removed 
from each well, 200µl PAF was added and slides were incubated at room temperature 
for ten minutes. PAF was removed and cultures were rinsed twice with PBS. 
PBS was 
added and cultures were immunostained immediately, or slides were covered with 
Parafilm® prior to storage at 4°C. 
1'' 
2.9 Immunostaining C2C12 cell cultures or single fibres 
2.9.1 Solutions used for immunostaining 
0.1% Triton 
0.1% (v/v) Triton X-100 was prepared in PBS. 
6%HS 
6% (v/v) horse serum (HS; GIBCO®) was diluted in PBS. 
0.025% PBS-T 
0.025% (v/v) Tween-20 was diluted in PBS. 
2.9.2 Immunostaining of C2C12 cell cultures or plated myofibres 
Fixed cells required permeabilisation if the antigen of interest was expressed 
intracellularly, but if it was expressed on the cell surface then permeabilisation was not 
required. Cells co-immunostained for both types of antigen were permeabilised. PBS 
was removed from fixed cultures and 0.1% Triton was added, to permeabilise cells, for 
ten minutes, if required. Triton was removed and cultures were rinsed twice with PBS. 
Cells were blocked in 20% serum (DAKO) diluted with PBS for 30 minutes, to prevent 
non-specific antibody-binding. The serum used for blocking was from the same species 
that the secondary or tertiary antibody was raised in. Primary antibodies (see Table 2.1) 
were diluted in 6% HS and applied for approximately 16 hours at 4°C. Slides were 
covered with Parafilm® to prevent evaporation. 
Primary antibodies were removed and cultures were rinsed three times with 0.025°-ö 
PBS-T. Cultures were incubated with secondary antibodies (Table 2.2) diluted 
in 6° o 
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HS for one hour at room temperature, protected from the light. Antibodies were 
removed and cultures were washed three times with 0.025% PBS-T. If necessary. 
cultures were incubated for 45 minutes in tertiary antibodies (Table 2.2) and then 
washed as before. Excess liquid was tipped off slides. cultures were mounted in 
DakoCytomation fluorescent mounting medium (DAKO) containing 100n`g ml 
4', 6-diamidino-2-phenylindole (DAPI) and a glass coverslip (SLS) was added. Two 
fluorescence microscopes were used to examine slides: a ZeissAxiophot microscope 
(Carl Zeiss, Inc. ), with a MicroMAX frame transfer CCD (charge-coupled device) 
camera, or a Leica DM RB microscope (Leica) with a Coo1SNAPHQ CCD camera. 
MetaMorph software (version 6.3r1) or IP Lab Q plus software (version 3.6.1) 
respectively was utilised for image acquisition and processing. 
2.9.3 Immunostaining of single fibres cultured in suspension 
Approximately 30 fixed myofibres were transferred into a bacterial-grade dish 
(Marathon) containing PBS that was pre-coated with HS to prevent fibres from adhering 
to it. Fibres in suspension were immunostained following the same protocol as for 
C2C 12 cultures or plated fibres. 
2.9.4 Analysis of immunostaining data 
All immunostaining carried out in 8-well chamber slides (C2C 12 cultures and plated 
fibres) was analysed as follows. At least 100 nuclei per well in three individual wells 
were counted. Positively- and negatively-stained nuclei, or nuclei within positively- 
and negatively-stained cells were counted. When examining the expression of myosin 
heavy chain, a marker of differentiated cells, each individual nucleus within an \IHC 
multinucleated myotube was separately counted as MHC+. In retrovirally-infected 
C2C12 cultures that coexpressed GFP with the target gene, and contained over 90° o 
GFP+ cells (determined via FACS analysis), DAPI+ nuclei were counted (as most of the 
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population was infected). The mean percentage of positively-stained nuclei acroý, " the 
three wells (and the standard deviation) was calculated and statistically compared 
between treatments (i. e. uninfected versus infected)(see section 2.15). 
Immunostaining of retrovirally-infected satellite cell progeny on myofibres cultured in 
suspension (section 2.6.4.2) was analysed as follows. Approximately 20 fibres were 
analysed. Fibres were stained using an anti-GFP antibody with an anti-Pax7 or anti- 
MyoD antibody (section 2.9.3). The number of cells within each GFP+ (retrovirally- 
infected) cluster on all infected fibres was counted. The numbers of clusters containing 
1,2-3 or 4+ (i. e. 4 or more) cells was recorded, and the mean percentage of each 
cluster-type per fibre was calculated. The number of myoblasts within clusters gave an 
indication of the effect of the retrovirus on proliferation. In addition, Pax7 or MyoD 
expression of each GFP+ cell on all fibres was recorded and the mean percentage of 
positively-stained cells per infected cluster per fibre was calculated. Ten randomly- 
chosen uninfected clusters (containing 4+ progeny) on infected and uninfected fibres 
were counted to determine the proportion of Pax7+ or MyoD+ cells. The mean 
percentage of positively-stained cells per uninfected cluster was calculated. This acted 
as a negative control to show that the retroviral supernatant only affected GFP+, infected 
cells, and that the gene of interest was having a genuine effect. Statistical comparisons, 
as described in section 2.15) were made between uninfected fibres versus infected 
fibres. 
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2.10 BrdU pulsing, fixation and immunostaining of C2C12 cells or 
single fibres 
Bromodeoxyuri dine (5-bromo-2-deoxyuridine, BrdU) is a synthetic nucleoside. which 
is an analogue of thymidine (Kriss and Revesz, 1962; Zhang and McLennan, 1909) 
BrdU was used to detect proliferating cells. BrdU is incorporated into the newly 
synthesised DNA of replicating cells during S (synthesis) phase of the cell cycle, since 
it substitutes for thymidine during DNA replication. A BrdU-specific antibody was 
used to detect incorporated BrdU and hence indicate cells that were actively replicating 
their DNA. The DNA was denatured using acid to allow the antibody to bind 
effectively. 
2.10.1 Solutions 
BrdU 
The 4mM stock solution was stored in aliquots at -20°C and thawed at room 
temperature for use. 
DMEM 
DMEM was pre-warmed to 37°C prior to use. 
PAF 
PAF was prepared in PBS at a concentration of 4% (w/v) and aliquots were stored at 
-20°C. PAF was thawed and pre-warmed at 
37°C prior to use. 
PBS 
PBS was pre-warmed to 37°C before use. 
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70% ethanol 
70% (v/v) ethanol (Fisher) 
0.5% BSA 
0.5% (w/v) BSA was prepared in PBS. 
2M hydrochloric acid 
Concentrated hydrochloric acid (BDH) was diluted using PBS. 
O. 1M borate buffer 
0.1M sodium borate required heating to dissolve in dH2O. The solution was altered to 
pH8.5 using hydrochloric acid. 
0.1% Triton 
0.1% (v/v) Triton X-100 was diluted in PBS. 
6%HS 
6% (v/v) HS was diluted in PBS. 
0.025% PBS-T 
0.025% (v/v) Tween-20 was diluted in PBS. 
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2.10.2 BrdU-pulsing and fixation of C2C12 cell cultures or plated my ofibre 
cultures 
BrdU was added to C2C12 cell cultures or plated myofibres in 8-well chamber slides. soy 
that it was at a final concentration of 40µM in the existing medium. Cultures were 
returned to the incubator for three hours to allow BrdU incorporation. The medium xv-a 
removed and cells were washed with DMEM. They were fixed with PA F for 20 
minutes and rinsed twice with PBS. PBS was added and cultures were immunostained 
immediately, or Parafilm® was used to cover the slides prior to storage at 4°C. 
2.10.3 BrdU-pulsing and fixation of single fibres cultured in suspension 
BrdU was added to the fibre activation medium so that it was at a final concentration of 
40µM. Fibres were returned to the incubator for three hours, to allow BrdU 
incorporation, and then fixed as described in section 2.8.2.1. 
2.10.4 Immunodetection of BrdU incorporated into C2C12 cell cultures, 
plated fibre cultures or single fibres cultured in suspension 
If cultures or fibres were co-stained to detect expression of another protein in addition 
to BrdU, then they were immunostained for that protein first (sections 2.9.2 and 2.9.3). 
prior to beginning the protocol for BrdU-detection. Permeabilisation was excluded 
from the BrdU-detection method if it had been carried out previously. 
To detect BrdU incorporation, cultures or fibres were initially incubated in 70° o ethanol 
for ten minutes. They were then washed with 0.5% BSA and incubated with 
2\1 
hydrochloric acid for 15 minutes. To neutralise the acid, cultures or fibres were washed 
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with 0.1 M borate buffer for two minutes. If required, Triton was added for ten minutes. 
to permeabilise plasma membranes. This was followed by two rinses with PBS. To 
block non-specific antibody-binding. 20% goat serum (DAKO) diluted in PBS way 
added for 30 minutes. Cultures or fibres were incubated (covered in ParafilmF to 
prevent evaporation) for approximately 16 hours at 4°C with monoclonal rat anti-BrdL' 
antibody (Abcam) diluted 1: 500 in 6% HS. 
The primary antibody was removed and cultures or fibres were rinsed three times with 
0.025% PBS-T. Alexa Fluor® 594- or 488-conjugated goat anti-rat secondary antibody 
(Molecular Probes, Invitrogen) diluted 1: 200 in 6% HS, was added for one hour at room 
temperature, protected from the light. Antibodies were removed and cultures wci-c 
washed three times with 0.025% PBS-T. Cultures or fibres were mounted and observed 
as described in section 2.9.2. 
2.11 Lysenin treatment of C2C12 cell cultures 
Sphingomyelin is an integral lipid component of mammalian cell membranes. 
Sphingomyelin can be detected using lysenin, a protein isolated from the earthworm 
Eiseniafoetida (Sekizawa et al., 1997). Lysenin binds specifically to sphingomyelin 
(Yamaji et al., 1998). Undifferentiated reserve cells have high levels of sphingomyelin 
in their plasma membranes so bind lysenin, but proliferating myoblasts and 
differentiated myotubes do not (Nagata et al., 2 006). 
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2.11.1 Solutions 
2% BSA 
2% (w/v) BSA was diluted in PBS. 
Lysenin 
1 µg/ml lysenin was prepared in 2% BSA. 
2.11.2 Protocol for lysenin treatment of cell cultures 
Fixed cell cultures were blocked with 2% BSA for 30 minutes, then incubated with 
lysenin for one hour, which allowed the lysenin to bind to sphingomyelin on plasma 
membranes. Cultures were then co-immunostained for lysenin and another antigen, as 
described in section 2.9.2. 
2.12 Analysis of transcript expression in C2C12 cell cultures and single 
fibre preparations 
2.12.1 Preparation of RNase-free glassware and solutions for Northern blot 
analysis 
Where required, glassware was made RNase-free by filling it completely with 0.21"o 
diethylpyrocarbonate (DEPC) in dH2O, leaving it overnight at room temperature. 
autoclaving and then discarding the contents prior to use. Where possible, RNase-free 
chemicals were used. To prepare RNase-free solutions, they were treated with 0.2% 
DEPC, left at room temperature overnight and autoclaved. 
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2.12.2 Solutions 
lOX TBE (Tris-borate/EDTA) buffer 
89mM Tris 
89mM boric acid 
3mM EDTA 
This was prepared in dH2O, adjusted to pH8.3 and diluted with dH, O to make 1N TBF 
buffer. 
0.2M sodium phosphate buffer 
0.12M Na2HPO4 
0.8M NaH2PO4 
This was prepared in dH2O, adjusted to pH7 and treated to make it RNase-free. It was 
diluted as appropriate to produce other solutions. 
10mM sodium phosphate buffer 
0.2M sodium phosphate buffer was diluted as appropriate with RNase-free dH2O. 
20X SSC buffer 
3M NaCl 
0.3M Na3citrate. 2H20 
This was prepared in dH2O, adjusted to pH7 and treated to make it RNase-free. This 
was diluted as appropriate to make other solutions. 
10% SDS 
10% (w/v) SDS was diluted in sterile dH2O and was a constituent of several buffers. 
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2% (w/v) SDS 
10% (w/v) SDS was diluted in RNase-free dH-O so it was at a final concentration of 2",, 
(w/v). 
RNA loading buffer 
50% (v/v) glycerol 
5% (v/v) 20X SSC buffer 
0.1 % (w/v) bromophenol blue 
This was prepared in RNase-free dH2O and autoclaved. 
lOX DNA loading buffer 
50% (v/v) glycerol 
0.25% (w/v) bromophenol blue 
This was prepared in dH2O and sterilised using a 0.2µM filter (Sartorius). 
10X TE (Tris-EDTA) buffer 
100mM Tris 
10mM EDTA 
This was prepared in dH2O, adjusted to pH7.6 and autoclaved. It was diluted in sterile 
dH2O to make 1X TE buffer. 
Glyoxal 
To deionise glyoxal, 25g mixed bed resin was added to 25m1 40% (w v) glyoxal in an 
RNase-free bottle, and stirred for one hour at room temperature. The bottle was 
protected from the light using aluminium foil, and the glyoxal was stored over the resin 
at 4°C. 
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Denaturation solution 
1.5M NaCl 
0.5M NaOH 
This was prepared in dH2O and autoclaved. 
Neutralisation solution 
1.5M NaCl 
0.5M TrisHCl 
This was prepared in dH2O, adjusted to pH7.5 and autoclaved. 
1M acetic acid 
17.4M glacial acetic acid was diluted to the appropriate concentration using sterile 
dH2O. 
Methylene blue solution 
0.2% (w/v) methylene blue 
0.4M sodium acetate 
0.4M acetic acid 
This was prepared in sterile dH2O. 
Stripping buffer 
5% (w/v) SDS was prepared by diluting 10% (w/v) SDS in sterile dH2O. 
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2X SSC + 0.1% (w/v) SDS 
20X SSC and 10% (w/v) SDS were diluted in sterile dH2O so the; were at the 
appropriate final concentration. 
5X SSC + 0.1% (w/v) SDS 
20X SSC and 10% (w/v) SDS were diluted in sterile dH2O. 
Wash solution 1 
2X SSC buffer 
0.05% (w/v) SDS 
20X SSC and 10% (w/v) SDS were diluted in sterile dH2O so they were at the correct 
final concentration. 
Wash solution 2 
0.1X SSC buffer 
0.1% SDS 
20X SSC and 10% (w/v) SDS were diluted in sterile dH2O as appropriate. 
2.12.3 RNA isolation from C2C12 cell cultures 
Total RNA was isolated using TRIzol® reagent (Invitrogen). according to the 
manufacturer's instructions. C2C 12 cell cultures were grown in T75cm2 tissue culture 
flasks in preparation for RNA isolation. RNA was extracted from proliferating 
myoblasts, differentiated cultures and separated myotube and reserve cell samples 
(sections 2.2 and 2.3) for Northern blot and RT-PCR analysis. One millilitre of TRlzol'- 
reagent was added to each T75cm` flask (or sample derived from a T75 cm, 
flask e. g. 
myotubes) and the cells were scraped, triturated and transferred to an R\ ase-free 
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Eppendorf tube. Samples were stored at -80°C and thawed at room temperature prior to 
processing. 
Following thawing, samples were incubated at room temperature for five rninutes. to 
allow the complete dissociation of nucleoprotein complexes, and then 0.2ml chloroform 
was added per Iml TRIzol® reagent. Tubes were shaken vigorously for 15 seconds and 
then incubated at room temperature for two minutes. The samples were centrifuged at 
12,000g for 15 minutes at 4°C. Following centrifugation, the upper aqueous phase. 
which contained RNA, was transferred to a new RNase-free tube, while the lower red, 
phenol-chloroform phase and the inter-phase, containing DNA and protein, were 
discarded. RNA was precipitated from the aqueous phase by mixing it with O. 5ml 
isopropanol per lml TRlzol® reagent used initially. Samples were mixed, incubated at 
room temperature for ten minutes, and then centrifuged at 12,000g for ten minutes at 
4°C to pellet the precipitated RNA. The supernatant was removed and 1 ml 75% ethanol 
was added per Iml TRIzol® reagent used originally. Samples were vortexed and 
incubated at room temperature for ten minutes to wash the RNA, then centrifuged at 
7,500g for five minutes at 4°C. The supernatant was removed, and the RNA pellet was 
air-dried for approximately one hour and then resuspended in 30µl RNase-free water. 
Samples were stored at -80°C for up to six months. 
2.12.4 Northern blot analysis of C2C12 cell culture transcripts 
2.12.4.1 Sample preparation and running the gel 
A gel tank was filled with 2% SDS, left to soak for 1-24 hours, and then rinsed 
thoroughly with RNase-free dH2O. An agarose gel (1.5% (xv v)) was prepared. in an 
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RNase-free conical flask using RNase-free agarose and lOm\1 , odium phosphate 
buffer, and poured into the tank. 
RNA samples and two RNA molecular weight markers (0.16-1.77kb and 0.24-9.5kb: 
Invitrogen) were prepared in RNase-free Eppendorf tubes so they « ere at a volume of 
32µl, which incorporated: 
25.2[d RNase-free dH2O containing 10-25µg total RNA (or 5ul molecular weight 
marker) 
1.6µ10.2M sodium phospate buffer 
5.2µl glyoxal 
Samples were incubated at 50°C for one hour to glyoxylate them, which removed 
secondary RNA structures, then chilled on ice. To make a final volume of 4Oµ1,8µl 
RNA loading buffer was added. Samples were loaded and run on the gel in 10mM 
sodium phosphate buffer. If possible, the sample size was reduced, whilst maintaining 
the same ratios of components and ensuring that the quantity of total RNA was still 10- 
25µg. 
2.12.4.2 Capillary blotting 
Northern blotting was carried out in an RNase-free glass dish. A platform was created 
in the dish, using an RNase-free glass plate. A piece of 3MM Whatman 
chromatography (Chr) paper (SLS) was cut and placed over the platform. ensuring both 
ends touched the base of the dish, to create a wick. I OX SSC buffer was poured over 
the wick and any bubbles were removed. Additional buffer was poured in to the bottom 
of the dish to a depth of approximately 2cm. The gel was placed onto the wick and a 
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piece of Hybond-N+ charged nylon membrane (GE Healthcare). the same size as the 
gel, was applied to it, ensuring that there were no bubbles between the gel and the 
membrane and that the membrane did not get wet or touch the gel prior to application. 
Strips of Parafilm ® were placed around the edge of the gel. to prevent blotting 
components from touching the surface of the wick and affecting transfer. Two pieces of 
3MM Chr paper were cut to the same size as the membrane and placed on top of it. 
followed by a stack of 14 sheets of QuickDrawT" blotting paper (Sigma). Clingfilm 
was used to cover the blot and the dish. A glass plate and a 500g weight were placed on 
top of the blotting stack to facilitate transfer of RNA from the gel onto the membrane 
overnight, for approximately 16 hours. 
The membrane was laid RNA-side upwards on a fresh piece of 3MM Chr paper, and 
air-dried for ten minutes. It was then sealed in an envelope of 3MM Chr paper and 
baked at 80° C for two hours, which removed glyoxal. The membrane was stored at 
room temperature until required for hybridisation (section 2.12.4.4). 
2.12.4.3 Methylene blue staining of molecular weight markers 
Prior to hybridisation, the portion of the membrane with the two RNA molecular weight 
markers was removed and rehydrated using 5X SSC + 0.1% SDS in a plastic tray. The 
buffer was replaced with IM acetic acid and incubated for 30 minutes at room 
temperature to fix the RNA. The acid was removed and methylene blue solution was 
added. This was incubated at room temperature for 30 minutes to stain the markers, and 
then washed repeatedly in dH2O to remove background staining. The membrane was 
blotted dry and the markers were used to confirm the size of each transcript of interest. 
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2.12.4.4 Hybridisation 
Hybridisation of cDNA probes to membrane-bound target sequence-, «as performed 
using ExpressHyb 
TM (BD Biosciences) solution, according to the manufacturer", 
protocol. 5X SSC + 0.1% SDS and ExpressHyb T" solution were pre-warmed to 68°C in 
a hybridisation oven (Hybaid). A tray was filled with 5X SSC + 0.1% SDS. and a piece 
of nylon support mesh (SLS) was added. The membrane was laid RNA-side up on the 
mesh, rolled up and placed in a clean glass hybridisation bottle (Hybaid). For 
prehybridisation, l 0ml ExpressHyb 
TM 
solution was added and the bottle was placed in 
the oven at 68°C, rotating slowly for approximately one hour. 
During prehybridisation, the radiolabelled cDNA probe was prepared. The cDNA 
probe solution (section 2.12.4.7; lOng/µl) was thawed at room temperature and 2ýt1 was 
added to 43µl 1X TE buffer in an Eppendorf tube. This was labelled with 50! Ci 
32P-dCTP (-deoxycytidine triphosphate; GE Healthcare), by random priming using 
Ready-To-Go T' DNA labelling beads (-dCTP; GE Healthcare), following the 
manufacturer's instructions. 
A NICK column (GE Healthcare) was utilised according to the manufacturer's protocol, 
to remove unincorporated 32P-dCTP, and to collect the purified radiolabelled probe in a 
final volume of 400µl 1X TE buffer. The radiolabelled probe was denatured at 100°C 
for five minutes, placed on ice for two minutes to prevent it from re-annealing and 
added to 10ml ExpressHyb 
TM 
solution. This was used to replace the prehybridisation 
solution on the membrane in the bottle. The bottle was returned to the oven, rotating for 
a further one hour to allow hybridisation of the labelled probe to the target sequence on 
the membrane. 
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2.12.4.5 Washing and exposure 
Hybridisation solution was removed and the membrane «-as washed several times over 
a period of 40 minutes, using Wash solution 1 at room temperature. with continual 
rotation. The membrane was subsequently rinsed with Wash solution 2 for 40 minutes 
at 50°C, with one change of solution. 
The membrane was removed from the bottle and its support mesh and rinsed in 5X SSC 
+ 0.1% SDS in a clean tray. The membrane was wrapped in Clingfilm and transferred 
to a phosphorimager cassette for overnight (16 hour) exposure. The latent image of the 
membrane was transferred onto the cassette screen, recorded using a Storms 
phosphorimager (GE Healthcare) and analysed using ImageQuant "' software (GE 
Healthcare). The membrane was stored at -80°C and was thawed, stripped and re- 
probed if required. 
2.12.4.6 Stripping and re-probing the membrane 
A hybridisation oven was set to 90°C to pre-warm stripping buffer and 2X SSC + 0.1 % 
SDS. The membrane was thawed at room temperature and laid on a piece of nylon 
support mesh in 2X SSC + 0.1% SDS in a tray. It was placed into a hybridisation 
bottle, stripping buffer was added and the bottle was rotated slowly in the oven at 90°C 
for 30 minutes. The buffer was poured off and replaced with 2X SSC + 0.1 % SDS. 
The bottle was returned to the oven and then the temperature was set to 68°C. After 
approximately 30 minutes, once the oven temperature had reached 68°C, the membrane 
was removed and exposed in a phosphorimager cassette for at least one hour to ensure 
that the previous probe had been removed. The membrane was then re-hybridised as 
before to detect expression of a different transcript. 
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2.12.4.7 cDNA probe preparation 
cDNA probes for hybridisation were prepared from murine E11.5 RNA (embryonic day 
11.5 RNA; Sigma). cDNA was prepared by reverse transcription of 5 «` total RNA in a 
20µl reaction using Superscript' reverse transcriptase (Invitrogen). according to the 
manufacturer's instructions, with an oligo (oligonucleotide) dT,, _18 primer (Invitrogen), 
which is a poly-T (poly-thymidine) primer directed against the pol`-A (poly-adenine) 
tail of mRNAs (messenger RNAs). One microlitre of cDNA was subsequently 
amplified in a 25µl PCR reaction using Taq (Thermus aquaticus) DNA polvmerase 
(derived from Thermus aquaticum bacteria; Invitrogen) with an appropriate internal 
primer set (Table 2.4) for up to 35 cycles, according to the manufacturer's protocol. 
The PCR product was cloned using the TOPO TA Cloning K Kit, pCR®2.1-TOPO vector 
and One Shot® chemically-competent E. coli (all from Invitrogen). Plasmid DNA was 
isolated from approximately five transformed bacterial colonies using solutions from 
the QIAGEN® Plasmid Purification Maxi Kit, as described in section 2.7.8.1. The 
plasmid DNA was analysed by EcoRI restriction digestion, according to the 
manufacturer's instructions, to determine whether the vector contained the PCR product 
and it was the correct size. A colony containing the vector with the inserted PCR 
product was amplified using the QIAGEN® Plasmid Purification Maxi Kit (see section 
2.7.8.2). The sequence of the purified plasmid was confirmed by dideoxy-sequencing. 
carried out by the Genomics Core Laboratory, Imperial College School of Medicine, 
Hammersmith Hospital Campus. 
Probes were excised from the vector DNA using EcoRI and purified using the 
QlAquick Gel Extraction Kit (QIAGEN®), according to the manufacturer's protocol. 
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The probe was quantified by running 1 ul on a 1.5'o (% v) agarose `gel 
beside a low mass 
DNA ladder (Invitrogen), and diluted with 1X TE buffer so that it way at a final 
concentration of IOng/µl. The probe was stored at -20°C. 
(The 173bp a-skeletal muscle actin cDNA probe, was produced using the protocol 
described by Sassoon et al. (1988). ) 
2.12.5 RT-PCR (reverse transcription-PCR) analysis of C2C12 cell culture 
transcripts 
2.12.5.1 RT-PCR 
Two micrograms of total RNA (from myoblasts, unseparated differentiated cultures, 
myotubes or reserve cells; section 2.12.3) were reverse transcribed in 40µl reactions, 
using Superscript® reverse transcriptase with an oligo dT12_18 primer (both Invitrogen), 
according to the manufacturer's instructions. Two microlitres of the resultant cDNA 
were amplified using Taq DNA polymerase (Invitrogen) for a limited number of PCR 
cycles (between 12 and 25), with appropriate external primers (Table 2.3), according to 
the manufacturer's protocol. This resulted in a semi-quantitative measure of the 
transcript expressed. 
2.12.5.2 Sample preparation and running the gel 
A 1.2% (w/v) agarose gel was prepared in a large tank. RT-PCR products were 
combined with lOX DNA loading buffer, so the buffer was at a final concentration of 
IX, and loaded onto the gel beside a molecular weight marker. An image of the gel «as 
taken at this stage, to determine the location of the molecular weight marker bands, to 
later confirm the size of target transcripts. 
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2.12.5.3 Denaturation and neutralisation 
The gel was placed in a clean tray. The gel was covered in denaturation buffer. 
Clingfilm was used to cover the tray and it was placed on an orbital shaker, shaking 
slowly for 15 minutes. The buffer was poured off. replaced and the tray iN as returned to 
the shaker for another 15 minutes. This process was repeated using neutralisation 
buffer, and then the gel was covered with lOX SSC buffer. 
2.12.5.4 Capillary blotting, hybridisation, washing and exposure 
Capillary blotting was carried out as described in section 2.12.4.2. However, glassware 
was sterile rather than RNase-free. Hybridisation of radiolabelled cDNA probes to 
membrane-bound target sequences was performed using ExpressHyb "' solution, 
according to the manufacturer's protocol, as described in section 2.12.4.4, but 
prehybridisation and hybridisation were carried out at 60°C. Washes and subsequent 
exposure of the membrane in a phosphorimager cassette was carried out in the same 
way as described in section 2.12.4.5. 
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2.12.6 Microarray analysis of C2C12 cell culture transcripts 
An oligo GEArray ' microarray (SuperArray) was utilised to study differences in the 
gene expression profiles of proliferating myoblasts, myotubes and resew e ce11. The 
array was specific to the mouse Notch signalling pathway and contained 113 gene- 
specific oligonucleotide probes representing genes involved in Notch signalling. Notch 
pathway binding genes, receptor processing genes and putative Notch target genes were 
represented, as well as genes from other signalling pathways that cross-talk with the 
Notch signalling pathway. 
2.12.6.1 Analysis of RNA concentration, integrity and purity 
Total RNA was isolated from proliferating myoblasts, differentiated myotubes and 
undifferentiated reserve cells, using TRIzo1K reagent (Invitrogen), as described in 
section 2.12.3. One microlitre of each sample was run on a 1.4% (w/v) agarose gel to 
confirm the integrity of the RNA. Additionally, the RNA was quantified using a 
spectrophotometer, recording the optical density of samples at wavelengths of x, 230, 
X260 and X280. Total RNA concentration was determined by the X260 reading and was 
greater than 1 ing/µl per sample, as required according to SuperArray instructions. The 
X260: 
, 280 ratio was greater than two to ensure that there was no protein contamination, 
while the k260: A., 230 ratio was greater than 1.7, to ensure there was no salt or guanidine 
contamination. 
In addition to checking the concentration, integrity and purity of the RNA, CD34 and 
myogenin transcript expression were analysed to confirm efficient myotube and reserve 
cell separation. One microlitre of myotube or reserve cell RNA was reverse transcribed 
in a 20µl reaction, using Superscript® reverse transcriptase with an oligo dT12 18 primer 
(both Invitrogen) according to the manufacturer's instructions. One microlitre of the 
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resultant cDNA was amplified in a 25u1 PCR reaction using Taq DNA po1vmeraý, c 
(Invitrogen) with CD34 or myogenin external primer sets (Table 2.3). The resultant 
PCR products were run on a I% (w/v) agarose gel. 
2.12.6.2 Labelling and amplification of RNA 
The pure total RNA was used to synthesise and amplify biotin-16-L'TP-labelled 
antisense RNA, termed cRNA (complementary RNA). This was carried out using the 
TrueLabelling-AMP T' 2.0 kit (SuperArray), according to the manufacturer's 
instructions. 
2.12.6.3 Hybridisation and detection 
The biotin-16-UTP-labelled cRNA derived from each sample was hybridised to an 
individual array (three arrays were used), according to the manufacturer's protocol. 
Following hybridisation, the arrays were washed and then alkaline phosphatase- 
conjugated streptavidin was bound to each array for chemiluminescent detection of gene 
expression using X-ray film (Hyperfilm"; GE Healthcare). 
2.12.6.4 Statistical analysis of arrays 
The arrays were analysed using the GEArray® Expression Analysis Suite. Each of the 
113 genes on the array was represented by 4 repeated dots, containing oligonucleotide 
probes, arranged in a square called a tetra-spot. Several settings for analysis were 
chosen and were kept constant for each array. To take the array background into 
account, the lowest average density spot on the array was determined and the average 
across that spot was used as the background correction value (termed the `minimum 
value'). The `average density' of each spot was defined as the total density divided by 
the number of pixels. `Clover mode' was switched off, so the space within each of the 
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four individual spots constituting a tetra-spot was captured as expres-sion data. rather 
than the area covered by the entire tetra-spot. House-keeping genes on the arra% «ere 
used to normalise the data. Comparisons were made between each array and statistical 
analysis identified genes with a greater than 1.5-fold change in transcript expression 
between samples. 
2.12.7 Lysis and RT-PCR of single fibres 
TO, T24 or T48 myofibres cultured in suspension (explained in section 2.8.2.1) were 
used for RT-PCR analysis. Myofibres were individually transferred in 3µl medium, 
using RNase-free pipette tips, into RNase-free Eppendorf tubes on ice, containing 10ýt1 
lysis buffer (150mM NaCl, 1mM MgCl2, lOmM TrisHCl pH7.4,0.5% (v, 'v) Igepal' 
(CA-630) and IU/[t1 RNasin (Promega) prepared in RNase-free dH2O ), and they were 
incubated on ice for 30 minutes. Ten to twelve fibres were lysed at each time point. A 
negative control was included, consisting of 3µl medium minus a fibre in l0µ1 lysis 
buffer; and positive controls, containing 50ng undifferentiated or differentiated C2C 12 
RNA in RNase-free water, were also prepared. Following lysis, samples were stored at 
-80°C so that TO, T24 and T48 samples could be processed together. 
Multiplex RT-PCR (One Step Kit, QIAGEN®) was performed according to the 
manufacturer's protocol, using up to 3 sets of external primers simultaneously. 
including hypoxanthine guanine phosphoribosyl transferase (HPRT) each time as a 
control, along with Notchl, Notch2, Notch3, D114 or Jaggedl primers (see Table 2.3). 
RT-PCR reaction components were prepared as a `master mix' and aliquots «vere added 
to each lysed individual fibre sample to give a final volume of 50µl. Separate second- 
round nested PCR reactions were performed using 1µl from the first-round reaction. 
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appropriate internal primers (see Table 2.4) and Taq DNA polymerase (Invitro`gen) in 
25µl reactions. All products were run on 1.5% (« 'v) agarose gels. 
2.13 Analysis of C2C12 cell culture proteins 
2.13.1 Solutions 
10% SDS 
10% (w/v) SDS was prepared in sterile dH2O and diluted to make other solutions. 
Protein extraction buffer 
Described in section 2.3.1. 
RIPA (radioimmunoprecipitation) buffer 
150mM NaCl 
1% (v/v) Igepal® (CA-630) 
0.5% (v/v) deoxycholate (DOC) 
0.1 % (w/v) SDS 
50mM Tris, pH8 
IX protease inhibitor cocktail (for general use; Sigma) 
This was prepared in sterile dH2O and kept on ice. It was kept for up to one week at 
4°C. 
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Resolving gel 
25% (v/v) 1.5M Tris-HCI, pH8.8 
0.1% (w/v) SDS 
10% (v/v) acrylamide/bis acrylamide 
This stock solution was prepared in sterile dH2O and stored at 4°C for up to one month. 
0.05% (w/v) ammonium persulphate (APS) and 0.05% (vv) TEMED (N. N. V. 
N'-tetramethylethylenediamine) were added immediately prior to pouring the gel. 
Stacking gel 
25% (v/v) 0.5M TrisHCl, pH6.8 
1% (w/v) SDS 
4% (v/v) acrylamide/bis acrylamide 
This stock solution was prepared in sterile dH2O and stored at 4°C for up to one month. 
0.05% (w/v) APS and 0.1 % (v/v) TEMED were added immediately prior to pouring the 
gel. 
Water-saturated butanol 
One millilitre of dH2O was added to 5m1 n-butanol (BDH) and the solution was shaken 
vigorously. 
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5X sample buffer 
12.5% (v/v) 0.5M TrisHCI, pH6.8 
10% (v/v) glycerol 
2% (w/v) SDS 
5% (v/v) ß-mercaptoethanol 
0.05% (w/v) bromophenol blue 
This was prepared in sterile dH2O. 
5X running buffer 
15g Trizma Base 
72g glycine 
5g SDS 
This was prepared to give a final volume of one litre in dH2O, kept as a stock solution at 
room temperature, and diluted to 1X with dH2O prior to use. 
Transfer buffer 
3g Trizma Base 
14.4g glycine 
This was freshly-prepared with dH2O to a volume of 800m1,200m1 methanol (BDH) 
was added, and it was pre-cooled to 4°C. 
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lOX TBS (Tris-buffered saline) 
25m1 1M TrisHCl, pH7.5 
89 NaCl 
0.2g KCl 
This was prepared to give a final volume of 100ml in dH2O. kept as a stock solution at 
room temperature and diluted as appropriate for use. 
TBS-T 
0.2% (v/v) Tween-20 
IX TBS 
This was prepared in dH2O. 
Blocking solution 
7% (w/v) Marvel milk (Cadbury) 
This was prepared in TBS-T. 
Stripping buffer 
100mM ß-mercaptoethanol 
2% (w/v) SDS 
62.5mM TrisHCl, pH6.7 
This was freshly-prepared in dH2O prior to use. 
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Coomassie blue stain 
0.5g Coomassie blue (G-250) 
50m1 acetic acid 
250m1 methanol 
200m1 dH2O 
De-stain solution 
100ml acetic acid 
300m1 methanol 
600ml dH2O 
2.13.2 Protein extraction and quantification 
Protein was extracted from proliferating myoblasts (cultured for 24 hours), unseparated 
differentiated cultures, myotubes and reserve cells (sections 2.2 and 2.3). Cultures or 
samples were rinsed with DMEM and between 300µl (section 2.3.2.2) and 1 ml of ice- 
cold protein extraction buffer or RIPA buffer (for immunoprecipitation) was added. 
Cells were scraped with a sterile scraper (Sarstedt) if required, triturated, transferred to 
an Eppendorf tube and stored at -80°C so that they could be processed when needed. 
Samples were thawed on ice and the protein concentration was determined using 
Bradford reagent (Bio-Rad), according to the manufacturer's instructions. BSA 
standards were used to create a curve to quantify protein. 
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2.13.3 Western blot analysis of protein samples 
2.13.3.1 SDS-polyacrylamide gel electrophoresis 
A Bio-Rad Mini- PROTEAN ®3 Cell Kit was used to perform SDS-pol,, acrylamide gel 
electrophoresis (SDS-PAGE), according to the manufacturer's instructions. Spacer and 
short glass plates were cleaned using sterile dH2O and methanol and clamped together 
in a casting frame so there was a 0.75mm space between them. A casting stand was 
used to secure the gel cassette assembly prior to gel casting. Resolving gel was poured 
into the space between the plates until it was 75%-full and a layer of water-saturated 
butanol was poured on the top. When the resolving gel had polymerised, after 
approximately 45 minutes, the butanol was removed and the gel surface «-as rinsed with 
dH2O. Stacking gel was poured above the resolving gel, until the cassette was full, and 
a comb was placed on top. The gel required approximately 30 minutes to polymerise 
before the combs were removed. 
Samples were prepared in dH2O so that they contained an equal quantity of protein, 
between 10 and 25µg, and their final volumes were equal. 5X sample buffer was added 
so it was at a final 1X concentration and the samples were denatured by heating them at 
37°C for ten minutes if studying membrane-bound proteins, or at 100°C for three 
minutes if investigating intracellular proteins. 
Two gel cassettes were inserted into the electrode assembly, creating a central chamber 
between them, and then placed in a mini-tank. 1X running buffer was used to fill the 
central chamber and a smaller quantity was added to the external chambers. Samples 
were loaded into the wells beside molecular weight markers and electrophoresed at 90 
volts until the markers reached the bottom of the resolving gel. 
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2.13.3.2 Western blotting and hybridisation 
Following electrophoresis, gels were blotted onto Hybond-P membrane (PVDF. 
polyvinylidene difluoride; GE Healthcare) using the Mini Trans-B1otR Electrophoretic 
Transfer Cell (Bio-Rad), according to the manufacturer's instructions. The gel was 
sandwiched against the membrane inside the transfer cell and immersed in cold transfer 
buffer. Transfer took place at 0.15 amps for approximately 16 hours at 4°C. 
Membranes were rinsed in dH2O, air-dried and immersed briefly in methanol. All 
washing, blocking and hybridisation stages were carried out on an orbital shaker. Each 
wash took ten minutes. Membranes were washed three times in TBS-T and then 
incubated in blocking solution for one hour, to prevent non-specific antibody-binding. 
Primary antibodies (Table 2.1) were diluted in blocking solution, applied to the 
membranes and incubated at 4°C for 16 hours. Membranes were washed once with 
250mM NaCl diluted in blocking solution, then another three times with blocking 
solution. Secondary antibodies (Table 2.2) were diluted in blocking solution and 
applied to membranes for one hour at room temperature, followed by tertiary antibodies 
if required (Table 2.2). Membranes were washed once with 250mM NaCl diluted in 
TBS-T, twice with TBS-T and then once more for at least an hour with TBS-T. 
Immunoblotted proteins were detected by chemiluminescence using the ECL Plus"' kit 
(GE Healthcare), according to the manufacturer's protocol, with HyperfilmR (GE 
Healthcare), a film cassette and an XOgraph film processor (XOgraph Healthcare Ltd. ). 
2.13.3.3 Stripping Western blots 
Membranes could be stripped once and re-probed if necessary to detect expression of a 
second protein. The membrane was submerged in stripping buffer and incubated at 
50°C for 30 minutes, with occasional agitation It was washed twice in TBS-T and then 
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exposed using the ECL Plus TM kit with Hyperfilm" to confirm that antibodies %N cre 
removed. The membrane was incubated for one hour in blocking, solution and 
immunodetection continued as described in section 2.13.3.2. 
2.13.3.4 Coomassie blue staining of Western blots 
Coomassie blue staining was utilised to confirm that protein-transfer was efficient. 
Following protein-transfer from the gel to the membrane (section 2.13.1.2). the 
membrane was rinsed in dH2O, dried and immersed briefly in methanol. It was washed 
once in TBS-T and then transferred into Coomassie blue stain for two minutes, which 
bound to all peptide bands. De-stain solution was used to repeatedly wash the 
membrane to remove background staining. 
2.13.4 Immunoprecipitation of D114 protein from myotubes and reserve cells 
Separated myotube and reserve cell protein samples were extracted in RIPA buffer and 
quantified, as described in section 2.13.2. For each sample, 500µg protein was prepared 
in a final volume of I ml cold RIPA buffer. Cell debris was pelleted by centrifugation at 
10,000g for ten minutes at 4°C. The supernatant was transferred into a new Eppendorf 
tube. Protein A/G PLUS-Agarose beads (0.5m1 agarose in 2ml; Santa Cruz 
Biotechnology, Inc. ) were thoroughly resuspended and l Oµ 1 was added to the 
supernatant along with 1µl (equivalent to 1µg) rat immunoglobulins to preclear the 
sample. This was incubated on ice for 30 minutes, and then the agarose beads were 
pelleted by centrifugation at 1000g for five minutes at 4°C. The supernatant was 
transferred into a new Eppendorf tube and 2 t1 (1µg) monoclonal rat anti-D114 antibody 
(R&D Systems) was added, prior to incubation on ice for one hour. Protein A, GPL L'S 
Agarose was thoroughly resuspended and 20µl was added, then samples were incubated 
on an orbital shaker for a further hour at 4°C. The immunoprecipitate was collected by 
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centrifugation at 1000g for five minutes at 4JC. The supernatant , %-a discarded and the 
pelleted immunoprecipitate was washed four times with cold PBS (stored at 4°C ). 
repeating the centrifugation step after each wash. 
The immunoprecipitate was resuspended in 40µl 1X Western blotting sample buffer 
(5X sample buffer was diluted with dH2O) and half of it was boiled for three minutes. 
while half was incubated at 37°C for ten minutes. prior to loading on a `gel for SDS- 
PAGE and Western blotting (sections 2.13.3.1 and 2.13.3.2). Aliquots of supernatants 
and pellets were removed at each stage and also run on the gel, to confirm specific 
isolation of D114 in the final immunoprecipitates. The Western blot was initially probed 
using a polyclonal goat anti-D114 antibody (Santa Cruz Biotechnology, Inc. ), and then 
stripped (section 2.13.3.3) and re-probed using a monoclonal mouse anti-ubiquitin 
antibody. 
2.14 DNA content analysis of C2C12 myoblasts 
2.14.1 Solutions 
PBS 
Sterile PBS (pH7.4; GIBCO®) was Cat+/Mg2+-free. 
70% Ethanol 
70% (v/v) ethanol (Fisher) was prepared in sterile dH2O and stored at -20°C. 
Propidium iodide solution 
10mg/ml propidium iodide was prepared in sterile dH2O and kept on ice. It was stored 
at 4°C long-term. 
161 
RNaseA solution 
10mg/ml RNaseA was prepared in sterile dH2O and kept on ice. It %ti as stored at -Vif)°C 
long-term. 
Staining mix 
100µl propidium iodide solution 
50µl RNaseA solution 
10ml sterile dH2O 
This was prepared on ice immediately prior to use. 
2.14.2 Propidium iodide staining of C2C12 myoblasts 
The DNA content of the cell can provide an array of information about the cell cycle, 
and consequently the effect on the cell cycle of overexpression of specific genes. 
Propidium iodide is a biomolecule that intercalates into the DNA helix and emits red 
fluorescence (Arndt-Jovin and Jovin, 1989; Waring, 1965), which can be detected by 
flow cytometry. Propidium iodide was, therefore, used to assess the DNA content of 
untreated C2C 12 myoblasts versus Notch3/mig-infected myoblasts (generated as 
described in section 2.6). Propidium iodide also stains RNA (Waring, 1965), 
necessitating treatment with a ribonuclease (RNaseA) to remove RNA. 
Proliferating C2C 12 myoblasts to be analysed were counted (section 2.2.6) and 
resuspended in cold PBS so they were at a concentration of lx106 cells/ml, and lml was 
transferred into a 15ml tube (Fisher; Marathon). The cells were washed twice in PBS 
(via centrifugation at 350g for ten minutes at 4°C and resuspension each time) and the 
supernatant was aspirated. While vortexing at low speed, lml cold ethanol was added 
to the pellet and the cells were thoroughly resuspended. The suspension was stored 
162 
overnight for approximately 16 hours at 4°C to fix and permeabilise the cells. which 
rendered them non-viable. 
The cell suspension was centrifuged at 2500rpm (revolutions per minute) for ten 
minutes at 4°C. Meanwhile, the staining mix was prepared. The ethanol was aspirated 
from the pellet. While vortexing at low speed, lml staining mix was added to the pellet 
and it was ensured that the cells were well-dispersed. The cell suspension was 
transferred into a 6m1 capped FACS tube (Marathon) and incubated at 4°C for one hour 
to allow the propidium iodide to stain the DNA in the cells. 
2.14.3 FACS analysis of propidium iodide-stained myoblasts 
Cell counting was performed on a FACScan flow cytometer (Becton Dickinson) and 
analysed using CeliQuest software v3.3 (Becton Dickinson). Two dot plots were 
drawn. In the first plot, FSC, measuring cell size, was placed on the x-axis and SSC, 
measuring cell granularity, was on the y-axis. This allowed identification of healthy 
cells, which were gated and their fluorescent intensity values were utilized in the second 
plot. The second plot measured the fluorescence of cells following excitation with a 
laser. Orange-red fluorescence was measured using the FL2 filter (564nm-606nm ). 
FL2-A (area) values were plotted on the x-axis and FL2-W (width) values on the y-axis. 
The area under the curve (of the histogram produced) is indicative of the height and is 
representative of the intensity of the staining (i. e. DNA content), while width indicate,, 
the length of time taken for cells to pass through the laser and hence determines whether 
they are haploid doublets or individual diploid cells, since the intensity will be the same 
for both. A third plot summarised the FL2-H (height) values (i. e. DNA content) of each 
healthy cell, thus demonstrating which stage of the cell cycle each cell %t as 
in. 
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2.15 Statistical analysis 
Data was analysed using SPSS 11 software (version 11.0.4 for Mac OS X) and graphs 
were drawn using Microsoft Excel (version 10.1.6). Independent-samples t-tests were 
carried out to determine statistical significance, which was ascribed to probability (p) 
values of <0.05 (*), <0.01 (**) and <0.001 (***). 
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CHAPTER 3: Expression of Notch signalling pathway 
components during differentiation of C2C 12 cells 
3.1 Introduction 
The myogenic C2C12 cell line was used as an accessible model of the early stages of 
myogenic differentiation to characterise the expression of the Notch signalling pathway 
components during myogenesis. Phase-contrast images of the stages analysed during 
myogenesis are shown in Figure 3.1. Proliferating myoblasts were maintained in a high 
level of serum and differentiation was induced by reducing the amount of serum. 
Samples were isolated for examination at 24-hour intervals after the induction of 
differentiation, over a total period of 96 hours. During the first 24 hours after 
differentiation was induced, cells underwent one final round of division and then 
withdrew from the cell cycle. Fusion of myoblasts into myotubes was first observed 
after 48 hours and continued over the next 48 hours. Many large, multinucleated 
myotubes were observed after 96 hours in culture. 
When C2C 12 cell cultures are induced to differentiate, a proportion of cells, termed 
reserve cells (Yoshida et al., 1998), withdraw from the cell cycle and remain 
undifferentiated in a similar way that some satellite cell progeny withdraw from 
differentiation on individual myofibres (Zammit et al., 2004). Therefore, alternate fates 
(i. e. differentiated and quiescent) within the same C2C 12 cell culture represent a 
possible model of satellite cell self-renewal. Since Notch signalling is implicated in 
determining cell fate (reviewed in Artavanis-Tsakonas et al., 1999), differences in the 
distribution of pathway components in C2C 12 cultures may result in the specification of 
distinct fates. To investigate the expression of components in differentiated cultures. 
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undifferentiated reserve cells and differentiated myotubes were separated by differential 
trypsinisation. Using this system, the expression of Notch signalling components was 
followed throughout myogenesis and during the adoption of alternate fates. 
Figure 3.1: Phase-contrast images showing the morphology of proliferating and 
differentiated C2C12 cells 
Proliferating myoblasts (a) were maintained in a high level of serum. Differentiation 
was induced by serum-reduction and cultures were differentiated for 24 (b), 48 (c), 72 
(d) or 96 (e) hours. During the first 24 hours after differentiation was induced the cells 
underwent one further round of division and then withdrew from cell cycle. Fusion of 
myoblasts into myotubes was first visible after 48 hours (arrow in c) and continued over 
the next 48 hours. Many large, multinucleated myotubes were visible after 96 hours. 
(Arrows in d and e indicate myotubes. ) (Bar: 30µM. ) 
3.2 Analysis of Notch signalling pathway component transcript 
expression levels during myogenesis in C2C12 cultures 
Notch pathway component transcript profiles were characterised during C2C12 cell 
myogenesis by semi-quantitative RT-PCR. Total RNA was extracted from proliferating 
myoblasts and from cultures induced to differentiate for up to 96 hours. Total RNA was 
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obtained at 24-hour intervals, reverse transcribed and subjected to a limited number of 
PCR cycles before hybridisation with sequenced probes (see Materials and \lethod,,. 
section 2.12). 
Figures 3.2 and 3.3 show semi-quantitative analysis of transcript expression of the 
Notch receptors, ligands and several modifying molecules involved in the pathway. 
Expression of ribosomal protein S16 (Stern et al., 1988) transcript was consistent, 
confirming equal loading of the samples, and the expected upregulation of N1v oD 
expression (Kitzmann et al., 1998) was observed during differentiation. The Notch4 
receptor was not expressed in C2C12 cells. Notchl, Notch2 and Notch3 transcripts 
were all present in proliferating myoblasts (Notch3 was slightly less abundant than the 
other two receptors). The Notch receptors were all upregulated after 24 hours of 
differentiation. Notchl and Notch3 transcript levels then remained constant. Notch? 
transcript levels, however, declined 48 hours after the induction of differentiation. when 
myoblast fusion began and myotubes first appeared, and then remained constant. 
D113 was absent from C2C12 cells. D111 and D114 transcripts were expressed at a low 
level in proliferating myoblasts, but were markedly upregulated when differentiation 
was induced. Both ligands were highly expressed 72 hours after differentiation was 
induced, a time when many myotubes were observed. Jagged1 and Jagged2 transcripts 
were expressed in proliferating myoblasts and throughout differentiation. 
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Figure 3.2: Semi-quantitative RT-PCR analysis of Notch receptor and ligand 
expression during myogenic differentiation 
Total RNA was extracted from proliferating C2C 12 myoblasts and at 24-hour intervals 
after differentiation was induced. RT-PCR for Notch signalling components was 
performed and products were blotted onto nylon membranes and probed. The PCR 
cycle numbers are listed next to the corresponding bands. S16 was used as a loading 
control. MyoD was used to demonstrate the progression of myogenic differentiation. 
(Results were reproducible. The same set of cDNA samples were probed twice or more 
on independent occasions and achieved the same results; and cDNA produced using a 
different set of mRNA samples also produced the same data when probed. ) 
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Figure 3.3: Semi-quantitative RT-PCR analysis of Notch signalling pathway- 
modifying molecules during myogenic differentiation 
Total RNA was extracted from proliferating C2C12 myoblasts and at 24-hour intervals 
after differentiation was induced. RT-PCR of Notch signalling-modifiers was 
performed and products were blotted onto nylon membranes and probed. The PCR 
cycle numbers are listed next to the corresponding bands. 
Figure 3.3 shows the transcript expression levels of molecules involved in modification 
of the Notch signalling pathway. Numb, an inhibitor of Notch signalling, was 
expressed in proliferating myoblasts and then upregulated within 24 hours after 
differentiation was induced, subsequently remaining constant. RT-PCR could 
potentially detect all four Numb isoforms (Dho et al., 1999), because the region of the 
transcript that was amplified was conserved. Of the three Fringe molecules that modify 
ligand-receptor binding to enhance or inhibit signalling, LFng was expressed in 
proliferating cells, upregulated within 24 hours after differentiation was induced and 
then declined; MFng was absent from proliferating myoblasts, but expression xN as 
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upregulated when differentiation was induced; and RFng was : expressed in myoblasts 
and throughout myogenesis. MFng and RFng were relatively highly expressed 4S hours 
after differentiation was induced. 
Dtxl, Dtx2, Dtx3 and Itch, all possibly involved in regulation of the CSL-independent 
Notch signalling pathway (see section 1.9.4), were expressed in proliferating myoblas-ts. 
Dtxl, Dtx2 and Itch were upregulated within 24 hours after differentiation was induced 
and then levels declined, while Dtx3 transcript expression remained constant throughout 
myogenesis. 
3.3 Analysis of Notch signalling pathway component protein 
expression during myogenesis in C2C12 cultures 
To investigate the expression of Notch signalling components at the protein level, 
whole cell lysates were prepared from myoblasts and cultures differentiated for up to 96 
hours. Protein was extracted at 24-hour intervals, separated by SDS-PAGE and 
analysed by Western blotting (see Materials and Methods, section 2.13), where effective 
antibodies were available (Figure 3.4). Proliferating cultures were also immunostained 
where possible, to determine spatial expression of Notch signalling components (see 
Materials and Methods, section 2.9)(Figure 3.5). 
Figure 3.4 shows that expression of x-tubulin, a microtubule component (Campbell et 
al., 1999), was consistent throughout myogenesis, confirming equal loading of the 
samples. Furthermore, cyclinA, which functions in S phase and mitosis (Yam et al., 
2002), so disappears as cells withdraw from the cell cycle (Fung and Poon, 2005) and 
differentiate, was downregulated as expected In addition, skeletal muscle-specific 
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myosin heavy chain (MHC) was progressively upregulated with time. cunfirmin`ý 
myogenic differentiation. 
Antibodies used for Western blot analysis of the Notch receptors were specifically 
directed against the intracellular domain (ICD) of the protein. The size of the 
membrane-bound form of each receptor has a higher molecular weight than the cleaved. 
active, intracellular form that translocates to the nucleus, since upon cleavage a small 
portion of the receptor is lost extracellularly (Okochi et al.. 2002). Since the I CD- 
specific antibodies could detect both forms of the receptor it was, therefore, possible to 
determine activation status during myogenesis from the size of the bands detected. 
When protein extracts from proliferating myoblasts were probed with antibodies 
specific to Notchl, Notch2 or Notch3, two predominant peptide bands were detected. 
In each case, the larger molecular weight band corresponds to the membrane-tethered, 
inactive form of the receptor, while the smaller molecular weight band is the activated, 
cleaved form, suggesting that proliferating myoblasts contained the membrane-bound 
and activated forms of Notchl, Notch2 and Notch3 (Notch3 appeared to be less 
abundant than the other two receptors). This was consistent with immunostaining of 
proliferating myoblasts, where the Notch1 and Notch2 receptors (detected using ICD- 
specific antibodies) were predominantly localised to the nuclei (Figure 3.5). showing 
that Notch activation, cleavage and subsequent nuclear translocation of the ICD had 
occurred. Figure 3.4 shows that cleaved, active Notch l was expressed at a fairly 
constant level throughout myogenic differentiation, but was transiently upregulated 
after 48 hours. The active form of Notch2 increased during the 24 
hours after 
differentiation was induced, but was no longer detectable after a 
further 24 hours. 
Active Notch3 markedly increased within 24 hours after differentiation was 
induced. 
171 
reached a peak after a further 24 hours and then declined. but was , till detectable. In all 
cases, protein expression of the Notch receptors was consistent with transcript 
expression (Figure 3.2). 
Western blot analysis of the D114 and Jagged1 ligands showed contrasting patterns of 
expression. Jaggedl protein was highly expressed in proliferating myoblasts. This is 
consistent with the standard model of Notch signalling whereby transmembrane ligands 
interact with Notch receptors on adjacent cells, resulting in receptor activation 
(reviewed in Artavanis-Tsakonas et al., 1999). Jaggedl expression declined as 
differentiation proceeded. In contrast, D114 was absent from proliferating cells, but 
appeared within 24 hours after differentiation was induced and subsequently increased 
during myogenesis. There was complete correlation between protein and transcript 
expression of Jaggedl and D114 (Figure 3.2), so Jaggedl was present throughout 
myogenic differentiation, while D114 was only expressed after 24-48 hours. 
Numb and Itch, were relatively constantly expressed in proliferating myoblasts and 
throughout myogenic differentiation (Figure 3.4)(although Itch was transiently 
upregulated 48 hours after differentiation was induced), consistent with the expression 
of their transcripts (Figure 3.3). The antibody used to identify Numb was able to detect 
all four isoforms of the protein, so it was not clear which isoforms were expressed 
during myogenic differentiation because the sizes are so similar, ranging from 65 to 
72kDa (Dho et al., 1999). Unfortunately, no antibodies were available to investigate 
Dill and Jagged2 or the other Notch pathway modifying molecules. However, the 
transcript levels (Figure 3.2 and 3.3) were consistent with protein expression. where 
analysed by Western blotting (Figure 3.4), suggesting that transcript expression may 
reflect protein expression during myogenesis. 
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Figure 3.4: Western blot analysis of Notch signalling pathway receptors, ligands 
and modifying molecules during myogenic differentiation 
Protein was extracted from proliferating C2C12 myoblasts and at 24-hour intervals after 
differentiation was induced, then analysed by Western blotting. Sizes of the proteins in 
kilodaltons (kDa) are listed next to the corresponding bands. x-tubulin was used as a 
loading control. CyclinA and myosin heavy chain expression were used to confirm the 
progression of myogenic differentiation. An antibody against the ICD of each Notch 
receptor was used to determine its size and, therefore, activation status (membrane- 
bound or cleaved, intracellular). Two NotchI and Notch2 peptide bands of 1 lOkDa and 
120kDa and two Notch3 bands around 97kDa were detected in proliferating myoblasts. 
The higher molecular weight band in each case was the membrane-bound form. while 
the lower molecular weight band was the cleaved form. 
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Figure 3.5: Immunostaining of Notch receptors in proliferating C2C12 cultures 
Proliferating myoblasts were grown for 24 hours, fixed and immunostained for Notch I 
(b) or Notch2 (e) and counterstained with DAPI (a and d respectively). Notch l and 
Notch2 were expressed predominantly in the nuclei of proliferating myoblasts (c and f 
respectively). (Bar: 10µM. ) 
3.4 Analysis of Notch signalling pathway component transcript 
expression in separated myotubes and reserve cells 
Data presented in sections 3.2 and 3.3 show that Notch signalling components are 
expressed in differentiated cultures, which contain both differentiated myotubes and 
quiescent reserve cells. To investigate where the Notch signalling components are 
expressed, differentiated cultures were separated into undifferentiated reserve cells and 
differentiated myotubes. Proliferating myoblasts were grown for 24 hours, and then 
differentiation was induced by serum-reduction. After 96 hours, cultures were 
separated by differential trypsinisation, which caused detachment of the myotubes and 
their release into suspension (Figure 3.6), whilst the reserve cells remained attached. 
Myotubes were collected and the RNA or protein was extracted. RNA or protein was 
also isolated from the residual reserve cells. 
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3.4.1 Validation of separation 
Myotube and reserve cell total RNA was analysed by Northern blotting (Figure 3.6). 
Blots were hybridised with radiolabelled cDNA probes against CD 34, a marker of 
reserve cells (Beauchamp et al., 2000) and x-skeletal muscle actin, which is only 
expressed in differentiated muscle cells (reviewed in Charge and RudnicLi. 
2004)(Figure 3.6). The results showed that CD34 expression was solely expressed in 
the reserve cell fraction and x-skeletal muscle actin was more abundant in the rnvotube 
fraction as expected. Separation was, therefore, successful in highly enriching each 
cell-type although there was slight contamination between fractions. Some myogcimic 
cells would have differentiated as myocytes (i. e. without fusion), so wN ould have 
remained in the reserve cell fraction, while some reserve cells may have been released 
into the myotube fraction. 
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Figure 3.6: Myotube and reserve cell separation 
Proliferating myoblasts were grown for 24 hours and then differentiation was induced. 
After 96 hours (a), cultures were differentially trypsinised to release myotubes into 
suspension (b)(yellow arrows in (a) and (b) indicate detachment of a myotube). RNA 
and protein was then isolated from the remaining reserve cells (c) and the collected 
myotubes. (Bar: 30µM. ) RNA from two identical sets of myotubes (MT) and reserve 
cells (RC) was run on an agarose gel (d) to confirm loading and integrity (18S and 28S 
ribosomal RNA (rRNA) bands were intact). Northern blot analysis of these myotubes 
and reserve cells (e) showed that a -skeletal muscle actin was predominantly expressed 
in myotubes while CD34 was expressed in reserve cells. Two sets of myotubes and 
reserve cells are shown to demonstrate reproducibility. 
3.4.2 Notch component transcript expression 
Semi-quantitative RT-PCR analysis of myotube and reserve cell RNA is shown in 
Figure 3.7. Analysis revealed the expected enrichment of MyoD in myotubes, which 
was predicted as it is upregulated during myotube formation (Kitzmann et al.. 1998). 
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MT RC ý MT RC 
CD34, a reserve cell marker (Beauchamp et al., 2000), was highly elevated in reserve 
cells as expected. Notchl, Notch2 and Notch3 transcripts were expressed in both 
myotubes and reserve cells, but all were highly enriched in the reserve cell fraction. 
particularly Notch3. Dill and D114 were also expressed in both fractions. However. 
Dli i expression was slightly elevated in reserve cells while D114 was raised in 
myotubes. Jaggedl transcript was highly expressed in reserve cells only, while Jagged2 
was equivalent in both fractions. 
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Figure 3.7: Semi-quantitative RT-PCR analysis of Notch receptor and ligand 
expression in separated myotubes and reserve cells 
Total RNA was extracted from two sets of myotubes (MT) and reserve cells (RC) 
separated by partial trypsinisation. RT-PCR of Notch signalling components was 
performed and products were blotted onto nylon membranes and probed. PCR cycle 
number for most components is shown in Figure 3.2. In addition, HPRT required 12 
cycles and CD34 required 20. HPRT was used as a loading control, and MyoD and 
CD34 were used to demonstrate efficient purification of the two fractions. 
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Figure 3.8 shows semi-quantitative RT-PCR of Notch signalling pathway-modifying 
molecules. Numb, MFng and RFng transcripts were expressed in both fractions, but 
Numb and MFng were elevated in the reserve cells and RFng was upregulated in the 
myotubes. LFng was expressed in the reserve cell fraction only. Dtx 1, Dtx2, Dtx3 and 
Itch were expressed in both fractions. Dtx2 was slightly elevated in the reserve cell 
fraction. 
Numb 
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Figure 3.8: Semi-quantitative RT-PCR analysis of Notch signalling pathway- 
modifying molecules in separated myotubes and reserve cells 
Total RNA was extracted from two sets of myotubes (MT) and reserve cells (RC) 
separated by partial trypsinisation. RT-PCR of Notch signalling modifying molecules 
was performed and products were blotted onto nylon membranes and probed. PCR 
cycle number for these components is shown in Figure 3.3. 
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3.5 Analysis of Notch signalling pathway component protein 
expression in separated myotubes and reserve cells 
MT RC I MT RC 
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Figure 3.9: Western blot analysis of Notch signalling pathway components in 
separated myotubes and reserve cells 
Protein extracted from separated myotubes and reserve cells was analysed by Western 
blotting. Sizes of the proteins are listed next to the corresponding bands. x-tubulin was 
used as a loading control and myosin heavy chain expression confirmed efficient 
separation, as it was elevated in myotubes. An anti-activated Notch 1 antibody was used 
to detect the active form of Notch 1. Antibodies against the ICD of Notch2 and Notch3 
were used to determine their size and, therefore, activation status (membrane-bound or 
cleaved, intracellular). Two Notch2 peptide bands of 1 IOkDa and 120kDa and two 
Notch3 bands around 97kDa were observed. The higher molecular weight band in each 
case was the membrane-bound form, while the lower molecular weight band was the 
cleaved form. There appeared to be additional low-resolution Notch2 peptide bands. 
Delta-like4 was expressed in both fractions, but in myotubes the peptide appeared to 
have a slightly larger molecular weight than 75kDa. 
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Protein was extracted from two sets of myotubes and reserve cells. separated by SL)'- - 
PAGE and analysed by Western blotting (Figure 3.9). An antibody against the 
activated form of Notch l was used to detect the cleaved, active form of the receptor 
(this antibody does not detect membrane-bound ti otch 1). Active Notch 1 was found in 
both fractions but at an elevated level in reserve cells, consistent with expression of the 
transcript (Figure 3.7). The membrane-tethered form was also expressed at a low level 
(data not shown). Antibodies used for Western blot analysis of the Notch2 and Notch 
receptors were directed against the ICD, allowing determination of their activation 
status. When protein extracts were probed with antibodies specific to Notch-2 or 
Notch3, two predominant peptide bands were detected in the reserve cell fraction only 
(suggesting that in myotubes, the transcripts expressed in myotubes were degraded or 
untranslated, or the protein was below the threshold level for detection). In each case, 
the larger molecular weight band corresponded to the membrane-bound inactive form of 
the receptor, while the smaller molecular weight band was the activated, cleaved form 
of the receptor. In addition, there were several Notch2 receptor peptide bands around 
the same size as the two main bands, which may correspond to hyperphosphorylated 
forms of the active, cleaved receptor (Shimizu et al., 2000a). Reserve cells contained 
the membrane-bound and activated forms of Notch!, Notch2 and Notch3. This was 
consistent with immunostaining of differentiated C2C 12 cultures (Figure 3.10), where 
Notch l (detected using an ICD-specific antibody) was predominantly localised to the 
nuclei of mononucleated cells found adjacent to myotubes; in contrast, myotubes were 
only stained in the cytoplasm. This suggests that in reserve cells, Notchl is activated, 
cleaved and subsequently translocated into the nucleus. 
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Figure 3.10: Immunostaining to detect Notch1 expression in differentiated C2C12 
cultures 
Proliferating myoblasts were grown for 24 hours and then differentiation was induced by serum-reduction. After 96 hours, cultures were fixed and immunostained to detect 
Notch l (b), and counterstained with DAPI (a). The Notch l receptor was expressed in 
the cytoplasm of myotubes and was absent from their nuclei (yellow arrows). Notch I 
was expressed in the nuclei of mononucleated cells (white arrows) found adjacent to the 
myotubes. (Bar: 10µM. ) 
Western blot analysis of Jagged l (Figure 3.9) was consistent with transcript expression 
data (Figure 3.7), showing that it was very highly expressed in reserve cells only. This 
suggests that Jaggedl is expressed on the surface of reserve cells. D114 protein 
expression also reflected its transcript expression. According to Western blot analysis. 
D114 was expressed in both myotubes and reserve cells, but appeared to be of greater 
mass in myotubes, suggesting that it may be post-translationally modified in myotubes. 
Since it is known that ligands are often ubiquitinated prior to endocytosis (revie"'ed in 
Le Borgne et al., 2005)(see section 1.9.3.1), immunoprecipitation of separated myotube 
and reserve cell samples was carried out to determine whether D1l4 was ubiquitinated in 
myotubes (see section 3.6). Ubiquitination may determine whether D114 is active and 
hence expressed specifically on the surface of either myotubes or reserve cells and. 
therefore, which cells it can potentially activate Notch receptors in. 
Western blot analysis showed that Numb was expressed at a low level in reserve cells. 
reflecting the expression of its transcript (Figure 3.8). Itch was expressed in both 
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fractions but at an elevated level in reserve cells, also consistent with transcript 
expression. 
3.6 Immunoprecipitation of D114 to investigate ubiquitination 
Western blot analysis of separated myotubes and reserve cells illustrated that the size of 
D114 differed in the two fractions (Figure 3.9). Since it is known that the Delta-like 
ligands are often ubiquitinated (reviewed in Le Borgne et al., 2005), D114 was 
immunoprecipitated and then probed to detect ubiquitination, following Western 
blotting. 
Protein extracts from myotubes and reserve cells were immunoprecipitated using a 
monoclonal D114 antibody, as described in the Materials and Methods (section 2.13.4). 
Aliquots were removed from supernatant and pellet samples at each stage during the 
immunoprecipitation and separated by SDS-PAGE, along with the final 
immunoprecipitates. Consistent with the Western blot analysis of myotubes and reserve 
cells shown in Figure 3.9, the immunoprecipitation results in Figure 3.11 show that D114 
was expressed equally in both myotubes and reserve cells, and boiling or treating the 
immunoprecipitates at 37°C had no effect. When the same blot was stripped (the blot 
was checked using a chemiluminescence reaction kit and Hyperfilm® to ensure that all 
D114 antibody was removed, but since the second antibody layer was not reapplied there 
was no control to prove definitively that the primary antibody was removed and/or was 
not detected by the second secondary antibody) and re-probed with an antibody against 
ubiquitin, it was observed that ubiquitin was bound to D114 in both fractions, as the 
band 
was the same size as the D114 protein. However, the myotube fraction 
had a larger 
ing quantity of ubiquitin bound to it than the reserve cells, suggest that 
D11 in myotubes 
is predominantly ubiquitinated, while a small portion of D114 
in reserN e ce1k is 
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that as few as one ubiquitin molecule may be added (ubiquitin is 8.5kDa). In addition. 
the size of ubiquitinated D114 (Figure 3.11) is still very close to 75kDa. the size of D114 
normally, suggesting that it may only be monoubiquitinated. 
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Figure 3.11: Immunoprecipitation of D114 to investigate its ubiquitination in 
myotubes and reserve cells 
Proliferating myoblasts were grown for 24 hours and differentiation was induced. After 
96 hours, cultures were separated into myotubes (MT) and reserve cells (RC) by 
differential trypsinisation and protein was extracted. Immunoprecipitation was carried 
out using a monoclonal D114 antibody. At each stage during the immunoprecipitation, 
aliquots of supernatants or pellets were removed to analyse along with the final 
immunoprecipitates. Immunoprecipitates (IPs) were either boiled for three minutes 
('boiled') or treated for ten minutes at 37°C (`37°C'), as it was unknown if boiling 
would denature the ligand. Aliquots of the supernatant and pellets and the `boiled' or 
`37°C' IN were analysed by Western blotting. A polyclonal D114 antibody was used to 
probe the blot (a) and showed that there were multiple peptide bands present in the 
lanes loaded with supernatant and pellet aliquots (these may represent non-specific 
antibody binding and possibly dimerised D114), but in the four final lanes there were 
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equal quantities of D114 in the MT and RC IPs. The blot was stripped and re-probed 
using anti-ubiquitin antibody (b). In the lanes loaded with IPs. ubiquitin was bound toi 
D114, as the band was around 75kDa. There was more ubiquitin bound to D114 in MT 
than RC. Boiling the samples or treating them at 37°C had no effect. 
3.7 Notch pathway-specific oligonucleotide array analysis 
C2C12 total RNA samples were analysed using Notch pathway-specific oligonucleotide 
arrays (SuperArray). The Oligo GEArray® Mouse Notch Signalling Pathway 
Microarray was used to profile expression of 113 genes involved in Notch signalling: 
the arrays used contain gene-specific oligonucleotide probes representing the Notch 
pathway's binding genes, receptor-processing genes and putative Notch target genes, as 
well as genes from other pathways that cross-talk with the Notch signalling pathway. 
Total RNA was extracted from proliferating myoblasts, differentiated myotubes and 
undifferentiated reserve cells and was used to generate biotin-16-UTP-labelled cRNA, 
according to the manufacturer's instructions. 
The arrays were analysed using the GEArray® Expression Analysis Suite. Each of the 
113 genes on the array was represented by 4 repeated dots, containing oligonucleotide 
probes, arranged in a tetra-spot. Several settings for analysis were chosen and were 
kept constant for each array. To take the array background into account, the lowest 
average density spot on the array was determined and the average across that spot was 
used as the background correction value (the `minimum value'). The `average 
density' 
of each spot was defined as the total density divided by the number of pixels. `Clover 
mode' was switched off, so the space within each of the four 
individual spots 
constituting a tetra-spot was captured as expression data, rather than the area covered 
h} 
the entire tetra-spot. The house-keeping genes on the array were used to normalise 
the 
data. Comparisons were made between each array and statistical analysis 
identified 
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genes with a greater than 1.5-f ]1 chanec in transcript cvpression bet- een samples. A 
complete list of gene changes, including numerical values of increases or decreases in 
expression, is included in the Appendix. 
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Figure 3.12: Notch pathway-specific oligonucleotide arrays 
Total RNA was extracted from proliferating myoblasts, differentiated myotubes and 
undifferentiated reserve cells. The integrity of the RNA was confirmed by the presence 
of intact 18S and 28S rRNA bands (a). RT-PCR analysis of myotube and reserve cell 
RNA confirmed efficient separation (b). CD34, a reserve cell marker, was enriched in 
reserve cells, while myogenin, a marker of terminal myogenic differentiation, was 
elevated in myotubes. Each sample was used to synthesise and amplify biotin-16-UTP- 
labelled cRNA, which was hybridised to an array. Chemiluminescent detection of gene 
expression on the arrays was visualised using X-ray film (c, d and e). 
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Transcript expression changes greater than 1.5-fold in proliferating 
myoblasts 
INCREASE COMPARED TO: DECREASE COMPARED TO: 
MT RC MT+RC MT RC NIT+RC 
ADAM 17 ADAM 10 Cyclin D1 Dtx2 Dtx I RBP-JK 
Cyclin E1 Jaggedl Sellh 
Notch3 
Table 3.1: Transcript expression increases or decreases greater than 1-5-fold in 
proliferating myoblasts compared with myotubes (MT) or reserve cells (RC) 
Table 3.1 shows that, as expected, proliferating myoblasts expressed cyclins D1 and E 1, 
which regulate G1 phase of the cell cycle (Musgrove, 2006), at a greater than 1.5-fold 
level compared to both myotubes and reserve cells. ADAM 10 and ADAM 17 were 
more highly expressed in proliferating myoblasts, compared with myotubes or reserve 
cells respectively. 
In proliferating myoblasts, there was lower expression of RBP-Jx, a DNA binding 
protein that forms a complex with active Notch receptors in the nucleus to transactivate 
target genes (reviewed in Kadesch, 2000; reviewed in Schweisguth, 2004). Thus RBP- 
JK-dependent Notch signalling may be less important in proliferating myoblasts, 
perhaps indicating a role there for RBP-JK-independent Notch signalling, since the 
Notch 1, Notch2 and Notch3 receptors are known to be active. Since RBP-JK expression 
is higher in myotubes and reserve cells, Notch signalling there may be RBP-JK- 
dependent (see chapter 4). Expression of Sel lh ((suppressor of lin-12) 1 homologue). a 
negative regulator of Notch signalling (Donoviel et al., 1998) that is part of the same 
suppressor of lin-12 family as SellO (Sundaram and Greenwald, 1993), was relatively 
low in proliferating myoblasts compared with myotubes and reserve cells. It 
is possible 
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that Sellh functions analogously to SellO. so may ubiquitinate Notch rý, ýýtýýr", 
targeting them for degradation (Gupta-Rossi et al., 2001: Oberg et al.. 200 1; \Vu ct al.. 
2001), leading to subsequent inhibition of signalling in myotubes and reserve ce1k 
Figure 3.4 shows that Notch l, 2 and 3 were active in reserve cells, consistent ww ith Sell h 
playing a greater inhibitory role in myotubes. Alternatively, Sel lh may regulate steady- 
state levels of the receptors in reserve cells. 
Transcript expression changes greater than 1.5-fold in myotubes compared 
to reserve cells 
INCREASE DECREASE 
Dtx2 Dtx I 
Notch l Dtx3 
Numb (isoform 1) Jagged l 
HES 1 
Table 3.2: Transcript expression increases or decreases greater than 1.5-fold in 
myotubes, compared with reserve cells 
Jaggedl transcript was expressed at a higher level in reserve cells than in both myotubes 
and proliferating myoblasts (Tables 3.1 and 3.2). Previous results (Figures 3.4 and 3.9) 
showed that Jagged1 is expressed in proliferating myoblasts and that in differentiated 
cultures, it is localised to reserve cells. This suggests that it may play a role in both 
proliferating myoblasts and reserve cells in activating Notch receptors on adjacent cells. 
especially in reserve cells where expression is particularly high. Notch3 was also 
highly expressed in reserve cells compared to proliferating myoblasts (Table 3.1). 
Previous results showed that Notch3 is expressed at a lower level to the other 
Notch 
receptors in proliferating myoblasts (Figure 3.4), and in differentiated cultures 
it iti 
localised to reserve cells (Figure 3.9). The potential role of Notch3 
in reserve cells is 
further analysed in chapter 6. 
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Notch1 and Numb transcripts (Table 3.2) were expressed at a higher level in mvotubeý, 
than in reserve cells. Figures 3.7 and 3.8 suggest that both transcripts are expres,, cd in 
myotubes and reserve cells, but are more highly expressed in reserve cells. This 
expression pattern was corroborated by protein analysis and was reproduced in more 
than one set of myotubes and reserve cells. Indeed, active Notch 1 protein expression in 
myotubes was observed (Figure 3.9), but at a lower level than in reserve cells, perhaps 
because inhibitory molecules caused degradation of the Notch l receptor. Numb protein 
appeared to be localised to reserve cells rather than myotubes (Figure 3.9). possibly 
suggesting a role in regulating steady-state levels of Notch receptor activity. 
HES1, a downstream target gene of the Notch signalling pathway (reviewed in Iso et 
al., 2003b), was highly expressed in reserve cells compared with myotubes, suggesting 
that active Notch receptors may facilitate HES 1 transcription. This is consistent with 
the high level of expression of active Notchl, Notch2 and Notch3 receptors (Figure 3. (i) 
in reserve cells, which could potentially effect target gene transcription. 
Dtx family members are thought to be involved in ligand-independent RBP-JK- 
independent Notch signalling (Kishi et al., 2001). Dtx proteins may activate Notch 
signalling autonomously by binding to the ANK domain in the 
ICD of the Notch 
receptor (Matsuno et al., 1995), possibly ubiquitinating it (Takeyama et al.. 
2003). 
Dtxl was more highly expressed in reserve cells compared with either proliferating 
myoblasts or myotubes (Tables 3.1 and 3.2), suggesting that 
Dtxl may specifically 
activate Notch receptors in reserve cells. Semi-quantitative 
RT-PCR suggested that 
Dtx 1 is expressed at a similar level throughout myogenesis 
(Figure 3.3) and in both 
myotubes and reserve cells (Figure 3.8). Therefore, Dtxl may not play a 
defined role in 
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activating Notch signalling specifically in reserve cells. This i discuscd turther in 
chapter 4. 
Dtx2 is expressed at an elevated level in myotubes. compared to both proliferating 
myoblasts and reserve cells (Tables 3.1 and 3.2), suggesting that it may activate \ otch 
receptors specifically in myotubes. However, semi-quantitative RT-PCR showed that 
expression of Dtx2 transcript was slightly elevated in reserve cells compared to 
myotubes (Figure 3.8). This is discussed further in chapter 4. 
Dtx3 was expressed at a higher level in reserve cells than in myotubes (Table 3.2). 
However, expression of Dtx3 transcript (Figures 3.4 and 3.8), was very similar in 
proliferating myoblasts, throughout myogenesis and in separated myotubes and reserve 
cells. As with Dtxl and Dtx2, this is further analysed in chapter 4 to attempt to 
determine a specific role for Dtx3. 
3.8 Discussion 
The aim of the experiments presented in this chapter was to examine the expression of 
Notch signalling pathway components during myogenic differentiation of the C2C 12 
cell line. The results demonstrate that myogenic differentiation is accompanied by 
changes in the expression profiles of several Notch components, consistent with a role 
for Notch signalling in cell fate decisions made during myogenesis. 
3.8.1 Proliferating myoblasts 
Notch 1, Notch2 and Notch3 were expressed in C2C12 cell cultures. Semi-quantitativ e 
RT-PCR and Western blot analysis showed that all three receptors are expressed in 
proliferating myoblasts (but Notch3 appears to be expressed less abundantly than the 
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other two receptors). The inactive transmembrane form and active. cleaved form of 
each receptor protein is present. Immunostaining confirmed that Notch l and \ etch 
are predominantly localised to the nuclei of proliferating myoblasts and had, therefore. 
undergone cleavage at the cell surface to release the active ICD which subsequently 
translocates into the nucleus to activate target genes (reviewed in Schweisguth, 2004). 
The efficiency of Notch receptor antibodies has previously been questioned. Indeed, in 
1998, when Struhl and Adachi demonstrated for the first time that the Notch IC D enters 
the nucleus in response to ligand activation, they used a reporter gene mechanism due to 
the lack of an effective intracellular epitope-specific Notch antibody. Ho«vcv cr, the 
immunostaining data presented here was supported by the Western blot results, 
suggesting that the antibodies are effective in C2C 12 cells. 
Since active Notchl, Notch2 and Notch3 are expressed in proliferating myoblasts it 
suggests that they may play a role in maintaining a proliferative state. Active Notch3 is 
thought to perform functions distinct from Notchl and Notch2, and although the active 
Notch3 ICD can bind to RBP-JK, it is a poor transcriptional activator (Kadesch, 2000). 
Indeed, Notch3 acts as a transcriptional repressor by competing with the Notch 1 IC'D 
and blocking its ability to bind to a common coactivator present in limiting amounts 
(Beatus et al., 1999). The Notch3 ICD also competes with the Notch 1 ICD to prevent it 
binding to RBP-JK and activating target genes (Beatus et al., 1999). In addition, the 
Notch2 ICD may be inhibited by Notch3 (Beres et al., 2006), and conversely it may 
negatively regulate Notch l and Notch3 (Shimizu et al., 2002), presumably via 
competition for binding. Therefore, in proliferating myoblasts, possible interactions 
include competition between the Notchl/Notch3 ICDs and Notch2/Notch) ICDti for 
binding to RBP-Jx or common cofactors, while the Notch2 ICD may negatively 
regulate the Notchl and Notch3 ICDs. The Notch receptors may transact Ovate different 
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sets of target genes, so if one of the receptors has a dominant effect within a cell it may 
define the cell's phenotype. The outcome of these interacting regulatory mechanism. 
may result in the maintenance of proliferating myoblasts. 
Activation of the Notch receptors in proliferating myoblasts requires interaction with 
ligands on the surface of adjacent cells (reviewed in Artavanis-Tsakonas et al., 1999), or 
autonomous activation by Dtx proteins (Kishi et al., 2001). RT-PCR ana1vsis showed 
that D111 and D114 are expressed at a very low level in proliferating myoblasts and D114 
protein was undetectable by Western blot. In contrast, RT-PCR showed that Jagged I 
and Jagged2 transcripts are expressed at a high level in proliferating myoblasts. 
Furthermore, Western blot analysis confirmed the elevated expression of Jagged 1 in 
myoblasts. It is possible, therefore, that Jaggedl (and possibly Jagged2) expressed on 
the cell surface activates transmembrane Notch receptors on adjacent myoblasts, which 
signal via the RBP-JK-dependent pathway to transactivate target genes. It has also been 
shown that activated Notch can autonomously induce Jaggedl activity (Ross and 
Kadesch, 2004), such that active Notch receptors and Jagged 1 can be expressed 
simultaneously within a cell. Induced Jagged l has no autocrine effect on Notch 
signalling, but can promote signalling in adjacent naive cells (Ross and Kadesch, 2004). 
Therefore, proliferating myoblasts may exist as a homogeneous population where all 
cells express Jagged 1, and potentially Jagged2, with active Notch receptors. 
In proliferating myoblasts Dtxl, Dtx2 and Dtx3 transcripts were all expressed, 
suggesting another potential mechanism by which Notch receptors may be activated. 
Protein expression, however, could not be confirmed. It is possible that Dtx 1, Dtx2 or 
Dtx3 may activate Notch receptors autonomously (Kishi et al.. 2001) and that specific 
Dtx-Notch receptor activation combinations may exist. If Dtx proteins are able to 
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activate Notch receptors in proliferating myoblasts, it is possible that all cells exprý-,, 
every Dtx protein, active Notch receptor and Jaggedl. Alternatively. then may be a 
heterogeneous population of myoblasts, particularly in subconfluent cultures. Some 
cells may express Jaggedl (and/or potentially Jagged2) on the surface, which activates 
Notch receptors on adjacent cells where there is cell-cell contact, and those cells can 
subsequently induce Jaggedl autonomously to activate Notch in adjacent naive cells. In 
the absence of cell-cell contact, isolated cells may not undergo ligand-induced 
activation, but may be subject to Dtx-mediated, ligand-independent Notch activation 
and subsequent RBP-Jx-independent signalling. Indeed, RBP-JK transcript expression 
was low in proliferating myoblasts, according to the array analysis, suggesting that 
RBP-JK-independent signalling in myoblasts is likely to occur. 
If different ligands or Dtx proteins activate distinct Notch receptors in a cell, potentially 
resulting in the dominance of one receptor, it is possible that there may be 
heterogeneous functional dominance of receptors within cultures of proliferating 
myoblasts. Such a mechanism may pre-determine which members of the population 
will become myotubes and which will be reserve cells when differentiation is induced. 
In proliferating myoblasts, several modifying molecules were expressed which may also 
regulate Notch signalling. LFng and RFng could enhance or inhibit ligand-receptor 
signalling. In 293T cells and NIH 3T3 cells RFng enhances Jagged1-induced Notch 
signalling while LFng inhibits signalling (Yang et al., 2005), so expression of LFng and 
RFng in myoblasts may determine whether receptors are activated by Jagged 1 or not 
and thus whether Notch receptors are instead activated autonomously by Dtx proteins. 
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The inhibitory molecules Numb and Itch are both expressed in proliferating myoblast". 
as shown by Western blot analysis. Numb binds to the ICD of membrane-bound 
Notchl and is thought to recruit components of the ubiquitination machinery. which 
target the ICD for degradation following activation (McGill and %IcGlade, 200"). 
preventing translocation into the nucleus to activate downstream target `_enes. The 
Notch receptors are differentially targeted by the four Numb isoforms (65.66.71 and 
72kDa (Dho et al., 1999)). Notchl is targeted by all four Numb isoforms. Notch2 i, 
variably repressed and Notch3 is not a target of any Numb protein (Beres et al., 2006). 
Therefore, in proliferating myoblasts, Numb could inhibit signalling of Notch I and 
Notch2, but not Notch3, perhaps regulating the amount of each activated receptor. 
Since the membrane-bound form of each receptor was detected in myoblasts by 
Western blot analysis, there must be a significant amount of receptor, which could all be 
activated. Numb may control the quantity of membrane-bound Notch receptors in each 
cell that become activated or are ubiquitinated and degraded, thus regulating levels of 
Notch activation and signalling (reviewed in Kanwar and Fortini, 2004; Sakata et al., 
2004; Wilkin et al., 2004). 
In C2C12 cells, Itch can interact with Numb to cooperatively promote ubiquitination of 
membrane-bound Notchl (McGill and McGlade, 2003), or Itch can independently 
ubiquitinate Notch facilitating its subsequent degradation (Qiu et al., 2000; reviewed in 
Schweisguth, 2004). Therefore, in proliferating myoblasts, Itch may play a role 
alongside Numb in regulating the levels of Notch receptors that are activated (Kanwar 
and Fortini, 2004). Itch can also ubiquitinate Dtx (Chastagner et al., 2006), which may 
prevent positive regulation of Notch signalling by Dtx, again regulating the levels of 
active receptors. Levels of Dtx transcripts are indeed low in proliferating myoblastti. 
consistent with potential degradation by Itch. 
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Reciprocal negative regulation between Notch and Numb has been reported in C2C 1 
cells (Chapman et al., 2006). Therefore, tiumb'Itch and Notch receptor elpresý'ion may 
vary, with some proliferating cells expressing high levels of Numb 'Itch and hence low 
levels of active Notch, while others express high levels of active Notch receptors and 
low levels of Numb/Itch. Such heterogeneity may pre-determine the fate of a myoblast 
upon induction of differentiation. 
ADAM 10 and ADAM 17 transcripts were identified by the array as being expressed at 
high levels in proliferating myoblasts. ADAM proteins cleave transmembrane Notch 
receptors following ligand-binding (reviewed in Baron, 2003; Brou et A. 2000; Mumm 
et al., 2000; Pan and Rubin, 1997; reviewed in Schweisguth, ? 004), allowing 
subsequent y-secretase-mediated cleavage and release of the active Notch ICD, which 
translocates into the nucleus (Fleming, 1998; Okochi et al., 2002; Saxena et al., 2001; 
Schroeter et al., 1998). Membrane-bound and active forms of Notch 1, Notch2 and 
Notch3 were expressed in proliferating myoblasts (Figure 3.4). Therefore, it is possible 
that in proliferating myoblasts the ADAM proteins cleave the Notch receptors, leading 
to their activation. An alternative function for ADAM 10 and ADAM 17 in proliferating 
myoblasts may be to mediate proteolysis of Jagged 1. Jagged l is highly expressed in 
myoblasts (Figure 3.4), and ADAM-induced cleavage would allow shedding of the 
ectodomain and subsequent intramembrane cleavage to release the Jagged1 ICD that 
can activate gene expression via the transcription factor API (LaVoie and Selkoe, 
2003). Cleaved forms of Jaggedl may account for observed non-specific peptide bands 
on the Western blot (data not shown). 
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3.8.2 Differentiated cultures 
The induction of differentiation in C2C12 cultures led to changes in the cxpreýý, ion 
levels of the Notch signalling components. These changes were most apparent after 24 
to 48 hours, coincident with the onset of morphological differentiation. This , ugkestý 
that Notch signalling may determine whether cells become myotubes or are maintained 
as reserve cells. 
RT-PCR and Western blotting showed that expression of activated Notch 1 remained 
relatively constant throughout myogenic differentiation, although it was transiently- 
upregulated after 48 hours. Membrane-bound and active Notch 1 were expressed at a 
highly-elevated level in reserve cells, although there was a low level of expression in 
myotubes, confirmed by immunostaining. Western blot analysis showed that active 
Notch2 was expressed initially but then began to disappear 48 hours after differentiation 
was induced. However, membrane-bound and active variants of Notch2, possibly 
including hyperphosphorylated active forms induced by ligand-binding (Shimizu et al.. 
2000a), were expressed and were localised entirely in reserve cells. The disappearance 
of Notch2 from unseparated cultures may be explained because the meagre amount of 
Notch2 that is expressed is present in reserve cells, which constitute a smaller 
proportion of the total protein in the culture (myotubes contain a large amount of 
contractile proteins), so the signal is diluted and hence is not detected. In contrast, 
Notch 1 is expressed in both fractions and was, therefore, detectable. 
Expression of active Notch3 markedly increased within 24 hours after differentiation 
was induced, reached a peak within 48 hours and then declined. Membrane-bound and 
active Notch3 were localised entirely in reserve cells. Notch3 was detected in 
unseparated cultures throughout myogenic differentiation, even though it was onl% 
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expressed in the reserve cells, indicating particularly high levels of Notch3 expression 
in reserve cells, where it could potentially be the dominant Notch receptor. 
Since active Notchl, Notch2 and particularly Notch3 are expressed in reserve cells it is 
possible that Notch signalling plays a role there in reserve cell specification. Acti% C 
Notch receptors may inhibit differentiation of a subset of cells (Nofziger et al.. 1999: 
Shawber et al., 1996), ensuring that they are maintained as reserve cells. As described, 
active Notch3 performs distinct functions from Notch 1 and Notch2. High expression of 
the active Notch3 ICD may prevent the Notch1 (Beatus et al., 1999) and Notch2 ICDs 
(Beres et al., 2006) from binding to RBP-Jic and/or a common coactivator, preventing 
transactivation of downstream target genes. Any unbound active Notch3 ICD may bind 
to RBP-Jx, to act as a weak transcriptional activator or possibly even a repressor of its 
target genes (Beatus et al., 1999; Kadesch, 2000). The outcome of the interacting 
regulatory mechanisms could result in the expression of a particular set of target genes 
(including the transcriptional repressor HES 1 according to the array data) and hence 
specify the maintenance of reserve cells. 
Activation of the Notch receptors in reserve cells would require interaction between 
transmembrane Notch receptors with ligands on the surface of adjacent cells (reviewed 
in Artavanis-Tsakonas et al., 1999), or autonomous activation by Dtx proteins (Kishi et 
al., 2001). RT-PCR analysis showed that D111 and D114 expression is upregulated upon 
the induction of differentiation, and Western blot analysis demonstrated that same 
increase in D114 protein expression during myogenesis. D114 was expressed in 
myotubes and reserve cells, but immunoprecipitation revealed that D114 wa-s 
ubiquitinated in myotubes to a greater extent than in reserve cells. Monoubiquitination 
is often required to facilitate ligand endocytosis, which enhances Notch si`ýnnalling in 
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adjacent cells (reviewed in Le Borgne et al.. 2005: Parks et al.. 20()()). Therefore. it i' 
feasible that D114 is expressed on the surface of myotubes and because it iý 
monoubiquitinated, it is endocytosed and can effectively activate Notch "ionalling in 
adjacent reserve cells. In contrast. D114 that is expressed in reserve cells is generally not 
monoubiquitinated, so would not be endocytosed, which may prevent it from activating, 
Notch receptors in adjacent cells. Unlike D114, D111 transcript is more abundant in 
reserve cells, suggesting that it could play a different role to that of D114. 
Jagged1 and Jagged2 transcripts are expressed at a relatively constant level throughout 
differentiation. However, Western blot analysis demonstrated a gradual decrease in 
Jaggedl protein expression, which contrasts with increasing expression of the Delta-like 
ligands. Following differentiation, Jaggedl was expressed in reserve cells, presumably 
at a high level, since it was observed in unseparated cultures where the signal is diluted 
by the presence of myotube proteins. It is possible, therefore, that transmembrane 
Jaggedl on reserve cells activates transmembrane Notch receptors on adjacent cells, 
which signal via the RBP-JK-dependent pathway to transactivate target genes that 
specify those cells as reserve cells. Hence, Jagged1 could recruit more reserve cells. In 
addition, Jagged1 activation of Notch receptors in adjacent cells may be regulated by 
inhibitory molecules, such as Sellh or SellO, to ensure that the expression of active 
Notch l remains low and Notch2 and Notch3 are degraded. Those cells can, therefore, 
differentiate due to the lack of Notch signalling. 
It is possible that Dtx-dependent RBP-JK-independent Notch signalling may be induced 
autonomously in reserve cells. Dtxl, Dtx2 and Dtx3 transcripts were expressed 
throughout myogenesis, providing another potential mechanism by which the Notch 
receptors may be activated Dtxl and Dtx3 were expressed in both mvotubes and 
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reserve cells, but Dtx2 was relatively higher in reserve cells. It is possible that Dtx l. 
Dtx2 or Dtx3 may autonomously activate the three receptors in resew e cells but are 
inhibited in myotubes (perhaps by Itch (Chastagner et A. 2006). which is CyprC,, ýCd at i 
low level). 
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Figure 3.13: Proposed model of Notch signalling in myotubes and reserve cells 
See text for details. 
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Figure 3.13 outlines a model, for the potential role of Notch signalling, in determining, 
myotube and reserve cell fates when differentiation is induced. `lonoubiquitination 
promotes endocytosis of D114 in nascent myotubes, which promotes the ability of D114 
to activate Notch receptors in adjacent cells (a). Therefore, Notch 1, Notch-' and Notch3 
are activated in adjacent cells, which are hence maintained as undifferentiated reserve 
cells due to the expression of downstream target genes (a). Active Notch receptors 
autonomously induce Jaggedl expression (and possibly also Jagged? ) on the surface of 
reserve cells, which can then lead to further activation of Notch receptors in adjacent 
naive cells, so that they too are maintained as reserve cells (b). The receptors may be 
largely degraded in myotubes by inhibitory molecules, so Jaggedl cannot activate 
Notch receptors in myotubes. The Dtx molecules may also induce additional 
autonomous activation of Notch receptors in reserve cells (c). Additionally, expression 
of modifying molecules may enhance or inhibit interactions within the proposed model. 
Several modifying molecules affect Notch signalling. RT-PCR shows that LFng, RFng 
and MFng expression increases within 24 hours after differentiation is induced and then 
declines again. LFng and MFng transcripts were elevated in reserve cells, while RFng 
was raised in myotubes. The Fringe molecules may differentially modify 
receptor/ligand binding and signalling. Numb and Itch are also both expressed 
throughout differentiation, as shown by RT-PCR and Western blot analysis. Both are 
relatively upregulated in reserve cells, although Itch is also expressed at a low leN el in 
myotubes. Numb and Itch act individually or cooperatively to negatively regulate 
Notch signalling. Therefore, in reserve cells. Numb and Itch could inhibit signalling of 
Notch 1, Notch2 and Notch3 to regulate the amount of each receptor that is activated. 
This is consistent with the different levels of receptor expression in reserve cells. Since 
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Numb and Itch are not expressed at a high level in myotubes. other inhibitory factors. 
including Sellh (Selch transcript was expressed in myotubes and reserve ce11s. 
according to the array), SellO and molecules from pathways that cross-talk with the 
Notch signalling pathway (e. g. Dishevelled), may be upregulated and cause degradation 
of the Notch receptors. 
This chapter has examined expression of the Notch signalling pathway components and 
demonstrated that myogenic differentiation is accompanied by changes in the 
expression profiles of Notch components. These changes were often observed after 24 
to 48 hours, coincident with the onset of morphological differentiation, which suggests 
that the levels of the Notch signalling components may be involved in determining cell 
fate. Different receptor/ligand profiles are expressed in proliferating myoblasts, 
differentiated myotubes and undifferentiated reserve cells. This may result in distinct 
outcomes: regulating both the proliferation of muscle precursors through interaction 
with other myoblasts and, through interaction with differentiated cells, the specification 
of reserve cells. 
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CHAPTER 4: Overexpression analysis of Notch signalling 
components in C2C12 cells 
4.1 Introduction 
Results presented in chapter 3 suggest that Notchl, Notch2 and Notch3 may play a role 
in maintaining proliferating myoblasts and specifying reserve cells. To investigate this, 
the Notch 1 ICD was overexpressed in C2C12 cells, so Notch 1 was constitutively active. 
Notch2 has a high level of structural homology with Notchl (Shimizu et al., 2002) and 
may function similarly (Kraman and McCright, 2005), so it was not investigated in this 
project. (Its function would need to be examined by overexpression of active Notch2 in 
C2C 12 cells, to determine whether it is indeed similar to Notch 1. ) Notch 3 is 
structurally diverged from Notchl and Notch2 (Lardelli et al., 1994; Shimizu et al., 
2002), suggesting a different function, and hence it was also investigated via 
overexpression of the ICD in C2C 12 cells. Overexpression of constitutively active 
Notch3 produced particularly interesting results, leading to further investigations, which 
are shown in chapter 6. 
As well as overexpression analysis, two y-secretase inhibitors (y-secretase inhibitor 11 
(Calbiochem®) and L-685,458 (Bachem)) were utilised to inhibit Notchl signalling in 
C2C12 cells. However, Western blot analysis demonstrated that neither inhibitor was 
effective (data not shown). Therefore, Numb (isoform 1), an antagonist of Notch 
signalling (Dho et al., 1999; McGill and McGlade, 2003), was overexpressed in C2C 12 
cell cultures, to attempt to inhibit signalling. Also, a dominant negative form of 
RBP-JK, which should specifically inhibit RBP-Jx-dependent Notch signalling, way 
overexpressed. 
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In chapter 3, it was suggested that several DSL ligands might be involved in activating 
Notch signalling in proliferating myoblasts and reserve cells. D114 and Jagged l 
characterisation suggested that the two ligands may have distinct roles in C2C12 cell 
myogenesis, so they were studied to a greater extent than the other ligands. by, C 2C 1' 
overexpression and coculture studies in chapter 5. During myogenesis. the expression 
of the Delta-like ligand transcripts, Dill and D114, was similar. Dill function was 
investigated via overexpression in C2C 12 cells, since it was not fully-investigated in 
chapter 3 due to the lack of an available antibody. In addition to ligand-dependent 
signalling, it was suggested that the Notch receptors might be autonomously activated 
by Dtxl, Dtx2 and Dtx3. Therefore, Dtxl and Dtx3 were analysed by overexpression in 
C2C12 cells, but unfortunately attempts to produce full-length Dtx2 eDNA to clone into 
a retroviral vector were unsuccessful. 
4.2 Notch signalling component overexpression in C2C12 cells 
Notch pathway components were overexpressed in C2C 12 cells using retroviral vectors. 
Most of the vectors contained the target gene, followed by an IRES and eGFP (see 
Materials and Methods, section 2.6.1), so overexpression of the gene of interest could 
be detected via GFP expression since they were encoded by the same transcript. 
(Therefore, an anti-GFP antibody could be used alone to confirm infection, where 
effective antibodies were unavailable to detect the target gene. ) Unlike the other 
vectors, the eGFP-NIC/puro vector encoded a fusion protein consisting of the Notch I 
ICD bound to eGFP (section 2.6.1.2). Retroviral supernatant was used to infect 
proliferating myoblasts (as described in Materials and Methods, section 2.6.3). Forty- 
eight hours post-infection, the cells were sorted using FACS and GFP+ cells were 
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collected. (Independent infections were undertaken to confirm the reproducibility of 
results obtained. ) 
4.2.1 Overexpression of active Notch1 
C2C12 myoblasts were infected with eGFP-NIC/puro and FACS-sorted. After to 
rounds of subculture, approximately 95.66% of FACS-counted cells were GFP' (Figure 
4.1). Western blot analysis (see Materials and Methods, section 2.13.3) showed that 
active Notchl was expressed at the same level in uninfected, eGFP-NIC/puro-infected 
and puro- infected cultures (Figure 4.1). However, analysis was carried out using an 
antibody specific to the N-terminus of the active Notch l receptor. Therefore, the 
antibody detected endogenous active Notch l (110kDa) in infected and uninfected cells, 
but it did not detect the eGFP/NotchI ICD fusion protein (predicted to be approximately 
136kDa) in the eGFP-NIC/puro-infected cells because GFP was bound to the N- 
terminus of active Notchl, masking the epitope that the antibody would bind to. 
However, in eGFP-NIC/puro-infected cells, an anti-GFP antibody detected an abundant 
GFP peptide band around l 36kDa, which probably represents the active Notch l 
(110kDa)/GFP (26kDa) fusion protein, thus confirming that active Notch l is 
overexpressed. (Post-translational modifications of the fusion protein, may explain the 
second band with a slightly heavier molecular weight. ) Furthermore, GFP expression in 
the nuclei of eGFP-NIC/puro-infected myoblasts (data not shown) suggests that active 
Notch1 was definitely overexpressed, as the Notch1 ICD portion of the fusion protein 
would induce nuclear translocation. 
? 03 
a 
co 
1f1 
. b-- IJD iT 
0 r_a 
r, _ý 
Lý 
\Q 
b 
ýý, ýcý Ito Cý a, Q 
110kDa qýý ýý ýý. activated Notch I 
136kDa = GFP 
Figure 4.1: Expression of active Notchl in eGFP-NIC/puro-infected cells 
C2C12 myoblasts infected with eGFP-NIC/puro retrovirus were FACS-sorted to obtain 
the infected GFP cells. These were subcultured twice and then reanalysed by flow 
cytometry. A plot summarises the GFP expression of all healthy cells (a). The range of 
GFP-expression is shown, determined using uninfected C2C12 cells as a negative 
control. Approximately 95.66% of cells were GFP+. Protein was extracted from eGFP- 
NIC/puro-infected myoblasts, from untreated cells (C2C 12) and from cells infected 
with puro. The protein samples were separated by SDS-PAGE and analysed by 
Western blotting (b), using an antibody against activated Notchl and an anti-GFP 
antibody. Sizes of the proteins are listed next to the corresponding bands. Active 
Notch l was expressed in all samples. GFP was only expressed in eGFP-NIC/puro- 
infected cells. There were two peptide bands around 136kDa. 
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4.2.2 Overexpression of dominant negative RBP-Jx 
Figure 4.2 shows that after dnRBP-J/mig-infected C2C 12 myoblasts were FACS-sorted 
and subcultured twice, approximately 95.76% of cells, counted by flow cytometry. were 
GFP }. Western blot analysis showed that GFP was expressed in dnRBP-J mig-infected 
cells and mig-infected cells, as expected. Expression of GFP in the dnRBP-J mig- 
infected myoblasts suggests that dominant negative RBP-Jx is coexpressed. 
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Figure 4.2: Expression of dominant negative RBP-JK in dnRBP-J/mig-infected 
cells 
C2C 12 cells infected with dnRBP-J/mig retrovirus were FACS-sorted to obtain infected 
GFP+ cells. These were subcultured twice and then reanalysed by flow cytometry. A 
plot summarises the GFP expression of all healthy cells (a). The range of GFP- 
expression is shown, determined using uninfected C2C 12 cells as a negative control. 
Approximately 95.76% of cells were GFP+. Protein was extracted from 
dnRBP-J/mig-infected myoblasts, from untreated cells (C2C 12) and from cells infected 
mig. The protein samples were separated by SDS-PAGE and analysed by Western 
blotting (b), using an anti-GFP antibody. GFP was expressed in dnRBP-J mig-infected 
cells and mig-infected cells. 
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4.2.3 Numb overexpression 
C2C 12 cells were infected with Numb/mig and FACS-sorted. After two rounds of 
subculture, approximately 70.68% of FACS-counted cells were GFPt (Figure 4.3). The 
percentage of GFP+ cells was lower than observed in any other infected culture. 
suggesting that infection with Numb/mig may have been less efficient, perhaps due to 
difficulty in translating such a large vector (10kb; Numb cDNA alone was 3. kb; 
section 2.6.1.5), or may have induced cell death. 
Western blot analysis showed that Numb was expressed in uninfected and mig control 
infected cells, but was more abundant in Numb/mig-infected cells (Figure 4.3). The 
antibody used could detect all four Numb isoforms (65,66,71 and 72kDa). Since they 
are similar sizes (which could not be differentiated between at the resolution used) it 
was unclear which isoforms were expressed in the uninfected and mig-infected cells, 
but it was known that isoform 1 (72kDa) was overexpressed in the Numb/mig-infected 
cells. GFP was expressed in mig-infected cells, but appeared to be absent from 
Numb/mig-infected cells. However, FACS analysis demonstrated that there definitely 
were GFP+ Numb/mig-infected cells (Figure 4.3), but these cells appeared to express 
low-level GFP, which may be below the threshold for detection by Western blotting. 
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Figure 4.3: Numb expression in Numb/mig-infected cells 
C2C 12 myoblasts infected with Numb/mig retrovirus were FACS-sorted to obtain the 
infected GFP+ cells. These were subcultured twice and then reanalysed by flow 
cytometry. A plot summarises the GFP expression of all healthy cells (a). The range of 
GFP-expression is shown, determined using uninfected C2C 12 cells as a negative 
control. Approximately 70.68% of cells were GFP+. Protein was extracted from 
Numb/mig-infected myoblasts, from untreated cells (C2C 12) and from cells infected 
with mig. The protein samples were separated by SDS-PAGE and analysed by Western 
blotting (b), using anti-Numb and anti-GFP antibodies. Sizes of the proteins are listed 
next to the corresponding bands. Numb was expressed in all samples, but was more 
abundant in Numb/mig-infected cells. GFP was expressed in mig-infected cells. 
4.2.4 Dtx3 overexpression 
Figure 4.4 shows that after Dtx3/mig-infected myoblasts were FACS-sorted and 
subcultured twice, approximately 98.4% of cells were GFP, determined via flow 
cytometry. Western blot analysis shows that GFP was expressed in Dtx3imig-infected 
cells and mig-infected cells. Expression of GFP in Dtx3/mig-infected myoblasts 
suggests that Dtx3 is coexpressed. 
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Figure 4.4: Dtx3 expression in Dtx3/mig-infected cells 
C2C12 myoblasts infected with Dtx3/mig retrovirus were FACS-sorted to obtain the 
infected GFP+ cells. These were subcultured twice and then reanalysed by flow 
cytometry. A plot summarises the GFP expression of all healthy cells (a). The range of 
GFP-expression is shown, determined using uninfected C2C 12 cells as a negative 
control. Approximately 98.4% of cells were GFP. Protein was extracted from 
Dtx3/mig-infected myoblasts, from untreated cells (C2C 12) and from cells infected 
with mig. The protein samples were separated by SDS-PAGE and analysed by Western 
blotting (b), using an antibody against GFP. GFP was expressed equally in Dtx3/mig- 
infected cells and mig-infected cells. 
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4.2.5 Dtxl overexpression 
C2C 12 myoblasts were infected with Dtx I . VligR I and F ACS-ported- : Ater mo round 
of subculture, approximately 89.02% of FACS-counted cells were GFP (Fiure 4-5)- 1 
Western blotting showed that GFP was expressed in Dtx 1 /MigR l -infected cells and 
MigRi -infected cells (Figure 4.5). Expression of GFP in Dtx l- MigR l -infected 
myoblasts suggests that Dtx 1 is coexpressed. 
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Figure 4.5: Dtx1 expression in Dtxl/MigRl-infected cells 
C2C12 cells infected with Dtxl/MigRl retrovirus were FACS-sorted to obtain the 
infected GFP+ cells. These were subcultured twice and then reanalysed by flow 
cytometry. A plot summarises the GFP expression of all healthy cells (a). The range of 
GFP-expression is shown, determined using uninfected C2C 12 cells as a negative 
control. Approximately 89.02% of cells were GFP+. Protein was extracted from 
Dtx l /MigR 1-infected myoblasts, from untreated cells (C2C 12) and from cells infected 
with MigRl. The protein samples were separated by SDS-PAGE and analysed by 
Western blotting (b), using an anti-GFP antibody. GFP was expressed in Dtx I 'MigR 1- 
infected cells and MigR 1-infected cells. 
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4.2.6 Dill overexpression 
Figure 4.6 shows that after Dlll/MigRi -infected myoblasts were FACS-sorted and 
subcultured twice, approximately 93.78% of FACS-counted cells were GFP . 
Western 
blot analysis shows that GFP was expressed in Dill/MigRi -infected cells and MigRl- 
infected cells. Expression of GFP in the Dll I /MigR 1-infected myoblasts suggests that 
Dill is coexpressed. 
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Figure 4.6: D111 expression in D111/MigR1-infected cells 
C2C12 cells infected with D111/MigRl retrovirus were FACS-sorted to obtain the 
infected GFP+ cells. These were subcultured twice and then reanalysed by flow 
cytometry. A plot summarises the GFP expression of all healthy cells (a). The range of 
GFP-expression is shown, determined using uninfected C2C 12 cells as a negative 
control. Approximately 93.78% of cells were GFP. Protein was extracted from 
D111/MigRI-infected myoblasts, from untreated cells (C2C 12) and from cells infected 
with MigRl. The protein samples were separated by SDS-PAGE and analysed by 
Western blotting (b), using an anti-GFP antibody. GFP was expressed in DII I M-1igiR 1- 
infected cells and MigR 1-infected cells. 
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4.2.7 Expression of control vectors 
Notch pathway target genes were ligated into mig, ''1igR1 or puro retroviral vectors. 
Therefore, these vectors were used to infect C2C 12 myoblasts to use as controls. 
C2C12 myoblasts were infected with mig, MigRi or puro and mig- or NI i`gR1-infected 
cells were FACS-sorted. After two rounds of subculture, cells were counted by flow 
cytometry and approximately 98.74% of mig-infected cells, 97.92'o of MigR 1-infected 
cells and 2.94% of puro-infected cells were GFP+ (Figure 4.7). puro-infected cells did 
not actually express GFP. However, when the range of GFP+ values is determined. 
using uninfected C2C12 cells as a negative control (see Materials and %lethods, section 
2.6.3.1), a small proportion of cells that do not express GFP is included, to ensure that 
infected cells that express low-level GFP are detected. Protein from mig-, M1igR 1- or 
puro-infected myoblasts was utilised in Western blot analysis, as described in sections 
4.2.1 to 4.2.6. 
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Figure 4.7: FACS analysis of mig-, MigR1- and puro-infected C2C12 cells 
C2C 12 myoblasts were infected with mig-, MigR 1- or puro- retroviruses. mig- and 
MigRi-infected cells were FACS-sorted to obtain the infected GFP' cells. Infected 
cells were subcultured twice and analysed by flow cytometry. Plots summarise the GFP 
expression of all healthy cells. The GFP-expression is shown, determined using 
uninfected C2C 12 cells as a negative control. Approximately 98.74% of mig-infected 
cells (a), 97.92% of MigR 1-infected cells (b) and 2.94% of puro-infected cells (c) were 
GFP+ respectively. 
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4.3 Effects of Notch signalling component overexpression in C2C 12 cell 
cultures 
To investigate the effects of Notch signalling components on mvoblast proliferation. 
infected myoblasts were cultured for 24 hours in growth medium, BrdU-pulsed, fixed 
and immunostained to detect BrdU incorporation (see Materials and Methods. section 
2.10). Cultures propagated for 24 hours were also fixed and immunostained to 
determine the effect of overexpressed genes on MyoD expression. Pax7 expression was 
not analysed, as both Pax7+ and PaxT C2C l2 clones were described by laboratory 
members. 
The effect of overexpressed Notch pathway genes on cell fate determination was 
investigated as follows. Infected myoblasts were cultured for 24 hours and then 
differentiation was induced by serum-reduction. After 96 hours, cultures were either 
BrdU-pulsed, fixed and immunostained or fixed and immunostained with an antibody 
against myosin heavy chain (MHC), a marker of differentiated cells. When examining 
MHC expression, nuclei were counted rather than cells, so each nucleus within an 
MHC+ multinucleated myotube was counted as an MHC+ `cell' . 
4.3.1 Effect of active Notchl overexpression on C2C12 cell cultures 
Figure 4.8 shows the mean percentages of BrdU+ and MyoD+ cells in cultures of 
proliferating myoblasts overexpressing constitutively active Notch l. as determined by 
immunostaining. The mean percentages of BrdU+ and MyoD+ cells in untreated control 
cultures were similar to those of puro-infected cultures (BrdU+: 55.49--t4.10 versus 
53.5±3.08 respectively; MyoD+: 47.24±4.98 versus 42.13±0.88 respectively), is 
expected. The mean percentage of BrdU+ cells in eGFP-N IC, puro-infected cultures 
(60.65±9.91) was similar to the controls. However, there was a significant decrease 
'13 
(p<0.05) in the proportion of : MoD- cells in eGFP-\IC puro-infected culture 
(12.75±6.81), when compared with the controls. Therefore, in proliferating` myoblasts. 
overexpression of constitutively active Notchl appeared to have no effect on 
proliferation, but caused a decrease in MyoD expression. 
Figure 4.9 shows the mean percentages of BrdU+ and MHC nuclei in differentiated 
cultures overexpressing constitutively active Notch 1, as determined by immunostaining. 
The mean percentages of BrdU+ and MHC+ nuclei in untreated control cultures were 
similar to those of puro-infected cultures (BrdU+: 9.6±2.48 versus 8.76+2.65 
respectively; MHC+: 44.53±4.53 versus 41.44: ±1.03 respectively), as expected. There 
was a significant increase (p<0.05) in the mean percentage of BrdU+ cells in eGFP- 
NIC/puro-infected cultures (20.71--t: 4.92) compared with puro-infected cultures. In 
addition, there was an extremely significant decrease (p<0.001) in the percentage of 
MHC+ cells in eGFP-NIC/puro-infected cultures (2.9±2.19), compared with puro- 
infected cultures. Therefore, in differentiated cultures, overexpression of constitutively 
active Notchl appeared to inhibit differentiation and increase the number of cycling 
cells. 
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Figure 4.8: Effect of active Notchl overexpression on proliferation and \lyoD 
expression in proliferating C2C12 myoblasts 
Untreated C2C12 myoblasts or cells infected with puro or eGFP-NIC, 'puro were 
propagated for 24 hours. Cultures were either fixed and immunostained with an anti- 
MyoD antibody, or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. 
Cells were counterstained with DAPI. For each culture, at least 100 nuclei per well in 
three individual wells were counted. The mean percentages of BrdU+ (a) or MyoD ' (b) 
nuclei were calculated. Error bars represent the standard deviation. Untreated control 
cultures were compared with puro-infected cultures, and were not statistically 
significantly different, and eGFP-NIC/puro-infected cultures were compared with puro- 
infected cultures. * (p<0.05) denotes that there was a significant decrease in MyoD 
expression in eGFP-NIC/puro-infected cultures compared with puro-infected cultures, 
but there was no significant difference in BrdU incorporation in eGFP-NIC puro- 
infected cultures compared with puro-infected cultures. 
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Figure 4.9: Effect of active Notchl ov, erexpression on proliferation and 
differentiation in differentiated C2C12 cultures 
Untreated C2C 12 myoblasts or cells infected with puro or eGFP-\IC puro \% ere 
propagated for 24 hours, and then differentiation was induced by serum-reduction. 
Cultures were either fixed and immunostained with an anti-`IHC antibody. or BrdL- 
pulsed, fixed and immunostained with an anti-BrdU antibody. Cells were 
counterstained with DAPI. For each culture. at least 100 cells per well in three 
individual wells were counted. The mean percentages of BrdU' (a) or \IHC (b) cells 
were calculated. Error bars represent the standard deviation. Untreated control cultures- 
were compared with puro-infected cultures, and were not statistically significantly 
different, and eGFP-NIC/puro-infected cultures were compared with puro-infected 
cultures. * (p<0.05) denotes that there was a significant increase in BrdU incorporation 
in eGFP-NIC/euro-infected cultures compared with puro-infected cultures. while *** 
(p<0.001) denotes a significant decrease in MHC expression in eGFP-NIC puro- 
infected cultures compared with puro-infected cultures. Fluorescence microscopy 
images of the differentiated cultures immunostained with MHC/DAPI are shown (c-k). 
Untreated cultures (c, d, e) and puro-infected cultures (f, g, h) contained large numbers 
of differentiated cells, while eGFP-NIC/puro-infected cultures (i, j, k) contained very 
few. (Bar: 10µM. ) 
4.3.2 Effect of dominant negative RBP-JK overexpression on C2C12 cell 
cultures 
Figure 4.10 shows the mean percentages of BrdU+ and MyoD+ cells in cultures of 
proliferating myoblasts overexpressing dominant negative RBP-JK. The mean 
percentages of BrdU+ and MyoD+ cells in untreated control cultures were similar to 
those of mig-infected cultures (BrdU+: 55.49±4.10 versus 54.44±4.10 respectively; 
MyoD+: 47.24±4.98 versus 44.58±2.95 respectively), as expected. The mean 
percentages of BrdU+ (50.47±2.11) and MyoD+ (46.08±2.55) cells in dnRBP-J/mig- 
infected cultures were similar to those of mig-infected cultures. Therefore, in 
proliferating myoblasts, overexpression of dominant negative RBP-JK appeared to have 
no effect on proliferation or MyoD expression. 
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Figure 4.10: Effect of dominant negative RBP-JK overexpression on proliferation 
and MyoD expression in proliferating C2C12 myoblasts 
Untreated C2C 12 myoblasts or cells infected with mig or dnRBP-J/mig were 
propagated for 24 hours. Cultures were either fixed and immunostained with an anti- 
MyoD antibody, or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. 
Cells were counterstained with DAPI. For each culture, at least 100 nuclei per well in 
three individual wells were counted. The mean percentages of BrdU+ (a) or MyoD* (b) 
nuclei were calculated. Error bars represent the standard deviation. Untreated control 
cultures were compared with mig-infected cultures and dnRBP-J/mig-infected cultures 
were compared with mig-infected cultures. There were no statistically significant 
differences between any of the cultures. 
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Figure 4.11 shows the mean percentages of BrdUY and `1HC+ celk in differentiated 
cultures overexpressing dominant negative RBP-JK, as determined by immunostainin`L. 
The mean percentages of BrdU+ and MHC * cells in untreated control cultures %ti ere 
similar to those of mig-infected cultures (BrdU-: 9.6±2.48 versus 10.1 1±1.4 
respectively; MHC+: 44.53-}4.53 versus 44.06±1.52 respectively). as expected. There 
was a significant decrease (p<0.05) in the mean percentage of BrdU+ cells in dnRBP- 
J/mig-infected cultures (3.49±2.68), compared with mig-infected cultures. There was 
no significant difference in the percentage of MHC+ cells in RBP-J, mig-infected 
cultures (46.38±3.31), compared with mig-infected cultures. which was evident in the 
fluorescence microscopy images. Therefore, in differentiated cultures, overexpression 
of dominant negative RBP-Jx appeared to slightly decrease the number of cycling cells, 
but did not affect differentiation. 
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Figure 4.11: Effect of dominant negative RBP-Jx overexpression on proliferation 
and differentiation in differentiated C2C12 cultures 
Untreated C202 myoblasts or cells infected with mig or dnRBP-Jjmi %ý ere 
propagated for 24 hours, and then differentiation was induced. Cultures were either fixed and immunostained with an anti-MHC antibody, or BrdU-pulsed. fixed and 
immunostained with an anti-BrdU antibody. Cells were counterstained with DAPI. For 
each culture, at least 100 cells per well in three individual wells were counted. The 
mean percentages of BrdU+ (a) or MHC (b) cells were calculated. Error bars represent 
the standard deviation. Untreated control cultures were compared with mig-infected 
cultures, and were not statistically significantly different, and dnRBP-J/mig-infected 
cultures were compared with mig-infected cultures. * (p<0.05) denotes that there was a 
significant decrease in BrdU incorporation in dnRBP-J/mig-infected cultures compared 
with mig-infected cultures, but there was not significantly different MHC expression in 
dnRBP-J/mig-infected cultures compared with mig-infected cultures. Fluorescence 
microscopy images of the differentiated cultures immunostained with MHC/DAPI are 
shown (c-k). Untreated cultures (c, d, e), mig-infected cultures (f. g, h) and dnRBP- 
J/mig-infected cultures (i, j, k) contained large numbers of differentiated cells. (Bar: 
10 µM. ) 
4.3.3 Effect of Numb overexpression on C2C12 cell cultures 
Figure 4.12 shows the mean percentages of BrdU+ and MyoD+ cells in cultures of 
proliferating myoblasts overexpressing Numb, as determined by immunostaining. The 
mean percentages of BrdU+ and MyoD+ cells in untreated control cultures were similar 
to those of mig-infected cultures (BrdU+: 55.49±4.1 versus 54.44±4.1 respectively; 
MyoD+: 47.24±4.98 versus 35.04±4.72 respectively), as expected. The mean 
percentage of BrdU+ cells in Numb/mig-infected cultures (50.27±8.55) was similar to 
those of mig-infected cultures, but there was a significant increase (p<0.01) in MyoD+ 
cells in Numb-mig-infected cultures (62.29±2.66). Therefore, in proliferating 
myoblasts, overexpression of Numb appeared to have no effect on proliferation, but 
caused an increase in MyoD expression. 
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Figure 4.12: Effect of Numb overexpression on proliferation and MyoD expression 
in proliferating C2C12 myoblasts 
Untreated C2C 12 myoblasts or cells infected with mig or Numb/mig were propagated 
for 24 hours. Cultures were either fixed and immunostained with an anti-MyoD 
antibody, or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. Cells 
were counterstained with DAPI. For each culture, at least 100 nuclei per well in three 
individual wells were counted. The mean percentages of BrdU+ (a) or MyoD- (b) 
nuclei were calculated. Error bars represent the standard deviation. Untreated control 
cultures were compared with mig-infected cultures, 1v 
significantly different. There was no significant 
between the Numb/mig- and mig-infected cultures, 
was a significant increase in MyoD expression 
compared with mig-infected cultures. 
and were not statisticall\ 
difference in BrdU incorporation 
but ** (p<0.01) denotes that there 
in Numb/mig-infected cultures 
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Figure 4.13 shows the mean percentages of BrdL and `IHC cells in differentiated 
cultures overexpressing Numb, as determined by immunostaining. The mean 
percentages of BrdU+ and MHC+ nuclei in untreated control cultures were similar to 
those of mig-infected cultures (BrdU+: 9.6±2.48 versus 10.11±1.4 respectively: \1 HC 
44.53±4.53 versus 44.06±1.52 respectively), as expected, and there were no significant 
differences in BrdU incorporation or MHC expression in Numb mig-infected cultures 
(BrdU+: 4.79±3.39; MHC+: 46.34±4.98), compared with mig-infected cultures. 
Therefore, in differentiated cultures, overexpression of Numb appeared to have no 
effect on proliferation or differentiation. 
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Figure 4.13: Effect of Numb overexpression on proliferation and differentiation in 
differentiated C2C12 cultures 
Untreated C2C12 myoblasts or cells infected with mi`, or Numb/mig were propa, ated 
for 24 hours, and then differentiation was induced by serum-reduction. Cultures ww ere 
either fixed and immunostained with an anti-MHC antibody. or BrdU-pulsed. fixed and 
immunostained with an anti-BrdU antibody. Cells were counterstained with DAPI. For 
each culture, at least 100 cells per well in three individual wells were counted. The 
mean percentage of BrdU+ (a) or MHC (b) cells in the three wells was calculated. 
Error bars represent the standard deviation. Untreated control cultures were compared 
with mig-infected cultures and Numb/mig-infected cultures were compared with mig- 
infected cultures. There were no statistically significant differences between the 
cultures. Fluorescence microscopy images of the differentiated cultures immunostained 
with MHC/DAPI are shown (c-k). Untreated cultures (c, d, e). mig-infected cultures (f, 
g, h) and Numb/mig-infected cultures (i, j, k) contained large numbers of differentiated 
cells. (Bar: 10µM. ) 
4.3.4 Effect of Dtx3 overexpression on C2C12 cell cultures 
Figure 4.14 shows the mean percentages of BrdU+ and MyoD+ cells in cultures of 
proliferating myoblasts overexpressing Dtx3, as determined by immunostaining. The 
mean percentages of BrdU+ and MyoD+ cells in untreated control cultures were similar 
to those of mig-infected cultures (BrdU+: 55.49±4.1 versus 54.44±4.1 respectively; 
MyoD+: 58.06±4.92 versus 54.58±2.95 respectively), as expected. The mean 
percentages of BrdU+ and MyoD+ cells in Dtx3/mig-infected cultures (BrdU ` 
57.44±4.56; MyoD+: 57.08±4.66) were similar to those of control cultures. Therefore, 
in proliferating myoblasts, overexpression of Dtx3 did not affect proliferation or MyoD 
expression. 
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Figure 4.14: Effect of Dtx3 overexpression on proliferation and MyoD expression 
in proliferating C2C12 myoblasts 
Untreated C2C 12 myoblasts or cells infected with mig or Dtx3/mig were propagated for 
24 hours. Cultures were either fixed and immunostained with an anti-MyoD antibody. 
or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. Cells were 
counterstained with DAPI. For each culture, at least 100 nuclei per well in three 
individual wells were counted. The mean percentages of BrdU- (a) or MyoD * (h 
nuclei were calculated. Error bars represent the standard deviation. Untreated control 
cultures were compared with mig-infected cultures and Dtx3/mig-infected cultures were 
compared with mig-infected cultures. There were no statistically signit1cant d1017ercnLc, 
between any of the cultures. 
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Figure 4.15 shows the mean percentages of BrdU+ and MHC cells in differentiated 
cultures overexpressing Dtx3, as determined by immunostaining. The mean 
percentages of BrdU+ and MHC+ cells in untreated control cultures were similar to those 
of mig-infected cultures (BrdU+: 8.03: 0.9 versus 10.11± 1.4 respectively: \I HC 
53±2.48 versus 49.88±1.48 respectively). There was a significant decrease (p<0.05) in 
the mean percentage of BrdU+ cells in Dtx3/mig-infected cultures (2.42±0.9). but no 
significant difference in the percentage of MHC+ cells (53.4±3.69), compared with mig- 
infected cultures. Therefore, in differentiated cultures, overexpression of Dtx3 appeared 
to decrease the number of cycling cells (i. e. induce quiescence in more cells), but had 
no effect on differentiation. 
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Figure 4.15: Effect of Dtx3 ov, erexpression on proliferation and differentiation in 
differentiated C2C12 cultures 
Untreated C2C 12 myoblasts or cells infected with mig or Dtx3 mig were propagated for 24 hours, and then differentiation was induced. Cultures ýv ere either fixed and immunostained with an anti-MHC antibody, or BrdU-pulsed. fixed and immunostained 
with an anti-BrdU antibody. Cells were counterstained with DAPI. For each culture, at least 100 cells per well in three individual wells were counted. The mean percentages 
of BrdU+ (a) or MHC+ (b) cells were calculated. Error bars represent the standard 
deviation. Untreated control cultures were compared with migg-infected cultures. and 
were not statistically significantly different. * (p<0.05) denotes that there was a 
significant decrease in BrdU incorporation in Dtx3/mig-infected cultures compared with 
mig-infected cultures, but there was no significant difference in MHC expression. 
Fluorescence microscopy images of the differentiated cultures immunostained with 
MHC/DAPI are shown (c-k). Untreated cultures (c, d, e), mig-infected cultures (f. (-', h) 
and Dtx3/mig-infected cultures (i, j, k) contained large numbers of differentiated cells. 
(Bar: 10µM. ) 
4.3.5 Effect of Dtxl overexpression on C2C12 cell cultures 
Figure 4.16 shows the mean percentages of BrdU+ or MyoD+ cells in cultures of 
proliferating myoblasts overexpressing Dtxl, as determined by immunostaining. The 
mean percentages of BrdU+ and MyoD+ nuclei in untreated control cultures were similar 
to those of MigRi -infected cultures (BrdU+: 59.61±3.91 versus 61.69±9.05 
respectively; MyoD+: 47.24±4.98 versus 42.16±1.59 respectively), as expected. The 
mean percentage of BrdU+ cells in Dtxl/MigRl-infected cultures (59.37±3.26) was 
similar to those of control cultures, but there was a significant increase (p<0.05) in 
MyoD expression in Dtxl/MigRl-infected cultures (52.07±3.32) compared with 
controls. Therefore, in proliferating myoblasts, overexpression of Dtx 1 appeared to 
have no effect on proliferation, but caused an increase in MyoD expression. 
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Figure 4.16: Effect of Dtxl overexpression on proliferation and MyoD expression 
in proliferating C2C12 myoblasts 
Untreated C2C 12 myoblasts or cells infected with MigRi or Dtx l /MigR l were 
propagated for 24 hours. Cultures were either fixed and immunostained with an anti- 
MyoD antibody, or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. 
Cells were counterstained with DAPI. For each culture, at least 100 nuclei per well in 
three individual wells were counted. The mean percentages of BrdU' (a) or MyoD ' (h t 
nuclei were calculated. Error bars represent the standard deviation. Untreated control 
cultures were compared with MigRi-infected cultures, and were not statisticall\ 
significantly different. There was no significant difference in BrdU incorporation 
between the Dtx l /MigR l- and MigR 1-infected cultures, but * (p<0.05) denotes that 
there was a significant increase in MyoD expression in Dtx I 'MigR 1-infected culture 
compared with MigR 1-infected cultures. 
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Figure 4.17 shows the mean percentages of BrdU; and %, IHC cells in differentiated 
cultures overexpressing Dtxl, as determined by immunostaining. The mean 
percentages of BrdU+ and MHC- cells in untreated control cultures were statistically 
analogous with those of MigRi-infected cultures (BrdU-: 7.03±0.95 versus 4.59±1.49 
respectively; MHC+: 56.4±2.92 versus 47.06±3.37 respectively), as expected. and there 
were no significant differences in the percentages of BrdU+ or MHC- cells between 
Dtxl/MigRl-infected cultures (BrdU+: 9.68±1.9; MHC: 49.15±3.01) and control 
cultures. Therefore, in differentiated cultures, overexpression of Dtx 1 had no effect on 
proliferation or differentiation. 
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Figure 4.17: Effect of Dtxl overexpression on proliferation and differentiation in 
differentiated C2C12 cultures 
Untreated C2C12 myoblasts or cells infected with MigRl or Dtxl \liuRl «ere 
propagated for 24 hours, and then differentiation was induced. Cultures were either 
fixed and immunostained with an anti-MHC antibody, or BrdU-pulsed. fixed and 
immunostained with an anti-BrdU antibody. Cells were counterstained with DAPI. For 
each culture, at least 100 nuclei per well in three individual wells were counted. The 
mean percentages of BrdU+ (a) or MHC+ (b) cells were calculated. Error bars represent 
the standard deviation. Untreated control cultures were compared with N'11(YRI -Infected 
cultures and Dtx l/MigR 1-infected cultures were compared with MigR 1-infected 
cultures. There were no statistically significant differences in BrdU incorporation or 
MHC expression between any of the cultures. Fluorescence microscopy images of the 
differentiated cultures immunostained with MHC/DAPI are shown (c-k). Untreated 
cultures (c, d, e), MigRi-infected cultures (f, g, h) and Dtxl 'MigRI-infected cultures (i, 
j, k) contained large numbers of differentiated cells. (Bar: 10µM. ) 
4.3.6 Effect of D111 overexpression on C2C12 cell cultures 
Figure 4.18 shows the mean percentages of BrdU+ and MyoD+ cells in cultures of 
proliferating myoblasts overexpressing Dli 1, as determined by immunostaining. The 
mean percentages of BrdU+ and MyoD+ cells in untreated control cultures were similar 
to those of MigRi-infected cultures (BrdU+: 55.49±4.1 versus 54.27±1.4 respectively; 
MyoD+: 47.24±4.98 versus 40.92± 1.65 respectively), as expected. There were no 
significant differences in the percentages of BrdU+ or MHC+ cells between 
D111 /MigR 1-infected cultures (BrdU+: 53.84± 1.51; MyoD+: 45.69±7.5) and control 
cultures. Therefore, in proliferating myoblasts, overexpression of Dill appeared to have 
no effect on proliferation or MyoD expression. 
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Figure 4.18: Effect of Dill overexpression on proliferation and MyoD expression in 
proliferating C2C12 myoblasts 
Untreated C2C12 myoblasts or cells infected with MigRl or D111/MigRl were 
propagated for 24 hours. Cultures were either fixed and immunostained with an anti- 
MyoD antibody, or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. 
Cells were counterstained with DAPI. For each culture, at least 100 cells per well in 
three individual wells were counted. The mean percentages of BrdU; (a) or MyoD ' (b) 
nuclei were calculated. Error bars represent the standard deviation. Untreated control 
cultures were compared with MigR 1-infected cultures and DIl l /MigR 1-infected 
cultures were compared with MigRl-infected cultures. There were no statistically 
significant differences in BrdU incorporation or MyoD expression between any of the 
cultures. 
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Figure 4.19 shows the mean percentages of BrdU+ and MHC+ cells in differentiated 
cultures overexpressing Dill, as determined by immunostaining. The mean percentages 
of BrdU+ and MHC+ cells in untreated control cultures were similar to those of \1i, -! Rl- 
infected cultures (BrdU+: 8.82±1.1 versus 6.65±0.41 respectively: \IHC': 46.88±l. ý4 
versus 45.88±2.83 respectively), as expected. There was a significant increase (p<0.01) 
in the mean percentage of BrdU+ cells in Dill/MigRl-infected cultures (9.6+O. _' 8 ). 
compared with MigRi-infected cultures. In addition, there was a significant decrease 
(p<0.001) in the percentage of MHC+ cells in Dill Mi`gR l -infected cultures 
(6.18±1.55), compared with MigRi-infected cultures, which was clearly evident in the 
fluorescence microscopy images (Figure 4.19). Therefore, in differentiated cultures, 
overexpression of Dill appeared to increase the number of cycling cells and inhibit 
differentiation. 
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Figure 4.19: Effect of Dill overexpression on proliferation and differentiation in 
differentiated C2C12 cultures 
Untreated C2C 12 myoblasts or cells infected with MigR 1 or Dill Nti`TR 1 %% ere 
propagated for 24 hours, and then differentiation was induced. Cultures were either 
fixed and immunostained with an anti-MHC antibody. or BrdU-pulsed, fixed and 
immunostained with an anti-BrdU antibody. Cells were counterstained with DAPI. For 
each culture, at least 100 nuclei per well in three individual wells were counted. The 
mean percentages of BrdU+ (a) or MHC (b) cells were calculated. Error bars represent 
the standard deviation. Untreated control cultures were compared with \1i`gRl-infected 
cultures, and were not statistically significantly different. ** (p<0.01) denotes that there 
was a significant increase in BrdU incorporation in D111, MigRl-infected cultures 
compared with MigRi-infected cultures, while *** (p<0.001) denotes a significant 
decrease in MHC expression in D111 /MigR l -infected cultures compared with \l i gR l- 
infected cultures. Fluorescence microscopy images of the differentiated cultures 
immunostained with MHC/DAPI are shown (c-k). Untreated cultures (c, d, e) and 
MigRi-infected cultures (f, g, h) contained large numbers of differentiated cells. while 
D111/MigRI-infected cultures (i, j, k) contained very few. (Bar: 10 uM. ) 
4.4 Discussion 
In chapter 3, several Notch signalling pathway components were identified as playing a 
potential role in the maintenance of proliferating myoblasts or in determining alternate 
cell fates upon the induction of differentiation. In this chapter, the specified Notch 
signalling components were overexpressed in C2C l2 cell cultures to establish their 
function. 
It was suggested (section 3.3) that Notchl, Notch2 and Notch3 might play a role in 
maintaining proliferating myoblasts. Overexpression of constitutively active Notch 1 in 
myoblasts had no effect on proliferation, as demonstrated by BrdU incorporation. 
However, it is possible that exogenous active Notchl had no effect on proliferation 
because endogenous active Notch1 was already maintaining maximal proliferation. 
When differentiation is induced, the effect of exogenous active Notch l becomes 
apparent, suggesting that endogenous active Notch l may normally be downregulated 
upon the induction of differentiation, perhaps due to degradation by inhibitory 
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molecules (e. g. Numb (Conboy and Rando, ? 002)). 0,, erexpression of con titutivel" v 
active Notch l increased the number of proliferating cells in cultures induced to 
differentiate, suggesting that active Notchl normally promotes proliferation. When 
differentiation was induced, constitutively active Notchl also significantly inhibited 
myogenic differentiation, which has been observed previously (Kopan et al.. 1994 
Nofziger et al., 1999; Shawber et al., 1996). In section 3.5 it was suggested that active 
Notch l might play a role in specifying reserve cells. Active Notch 1 may be involved in 
reserve cell specification by inhibiting their differentiation. In fact it has been recently 
demonstrated that activation of Notchl is important in maintaining reserve cells in an 
undifferentiated state (Kitzmann et al., 2006). Notch signalling was inhibited in C2.7 
cells, primary human myoblasts or zebrafish embryos by Numb overexpression or by 
treatment with DAPT (a y-secretase inhibitor). This induced myotube hypertrophy, by 
recruiting reserve cells that do not normally fuse. However, this paper did not specify 
which of the Notch receptors was responsible for reserve cell maintenance and did not 
investigate the role of the various ligands and modifying molecules in reserve cell 
specification, as studied in this thesis. Although active Notchl may inhibit 
differentiation in reserve cells, it may not be responsible for inducing their withdrawal 
from the cell cycle, if it also promotes proliferation as suggested by the results 
presented in this thesis. 
The mechanism by which active Notchl inhibits differentiation has previously been 
suggested to be either via RBP-JK-dependent direct inhibition of MyoD or by RBP-JK- 
independent inhibition of myogenesis at a target upstream of MyoD, which would also 
lead to MyoD downregulation (Kopan et al., 1994; Kuroda et al., 1999, Nofzi`Ter et al.. 
1999, Shawber et al., 1996). In the experiments presented in this chapter, constitutively 
active Notchl caused a decrease in the expression of MyoD in proliferating myoblastý. 
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Therefore, it is possible that overexpressed active Notch! interacted with RBP-JK. 
leading to antagonism of MyoD, potentially mediated by the transcriptional repreýý, Or 
HES 1 (Kuroda et al., 1999; Nofziger et al., 1999), which subsequently blocked 
myogenic differentiation of C2C 12 cells. Alternatively. active Notch l may have 
signalled via the RBP-Jx-independent pathway, which also ultimately led to \lyoD 
downregulation and inhibition of differentiation. It is possible that upon the induction 
of differentiation, endogenous Notchl remains active in a subset of cells. where it 
downregulates MyoD expression and inhibits differentiation, to ensure that those 
reserve cells remain undifferentiated. Reserve cells are in fact known to downregulate 
their expression of MyoD (Yoshida et al., 1998), suggesting that this hypothesis may be 
correct. 
The mechanics of Notch signalling in proliferating myoblasts and reserve cells were 
further examined via overexpression of dominant negative RBP-JK, which should 
inhibit RBP-Jx-dependent Notch signalling. Overexpression of dominant negative 
RBP-JK had no effect on myoblast proliferation or MyoD expression, suggesting that 
endogenous Notch signalling may have been maintained via the RBP-Jx-independent 
pathway. When differentiation was induced, there was a slight decrease in the number 
of cycling cells in the culture overexpressing dominant negative RBP-JK. In addition, 
there was a small, insignificant (statistically) increase in the number of differentiated 
cells, as demonstrated by MHC immunostaining (if more cells were counted this result 
may become significant). This suggests that when differentiation was induced. 
endogenous Notch1 signalling (which normally promotes proliferation and inhibits 
differentiation) may have been slightly inhibited. Although endogenous Notch l 
signalling was mainly maintained by RBP-JK-independent signalling (as inhibition was 
hl minimal), this result suggests that in differentiated cultures endogenous actin 'ý otc 
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may normally signal (partly at least) via the RBP-JK-dependent pathway. \\ hethcr 
overexpression of dominant negative RBP-JK definitely induces RBP-JK-independent 
signalling requires confirmation using a reporter construct (e. g. HESI 
promoter/luciferase) before the results presented can be believed and the role of 
RBP-Jx-independent signalling in C2C12 cells can be effectively deduced. Therefore. 
it remains unknown whether there is a preference for RBP-JK-independent signalling in 
normal C2C12 cultures, if the two pathways act cooperatively or independently, or if 
they have distinct functions during myogenesis. 
Numb binds to the ICD of membrane-bound Notch, promoting its ubiquitination, which 
facilitates its degradation following activation, thus preventing target gene transcription 
(McGill and McGlade, 2003). Although Notchl and Notch2 are negatively regulated 
by Numb (all isoforms), as described, Notch3 is not a target of any Numb protein 
(Beres et al., 2006). Overexpression of Numb (isoform 1) in proliferating myoblasts, 
where Notchl, Notch2 and Notch3 are expressed (Notch3 is less abundant than the 
other two receptors; see section 3.3), had no effect on proliferation but caused an 
increase in MyoD expression. The upregulation of MyoD suggests that Numb 
overexpression in myoblasts inhibits Notch signalling (via Notchl and Notch2), which 
results in a decrease in MyoD-antagonism. Overexpressed Numb may not degrade all 
endogenous active Notch l (and Notch2) in myoblasts, however, because the receptors 
are still able to maintain maximal proliferation. 
Results presented show that Notchl signalling inhibits myogenic differentiation. 
Therefore, antagonising Notch signalling should remove this block. However. in 
C2C 12 cultures where differentiation was induced, Numb overexpression did not 
enhance differentiation, suggesting that Notch signalling was not inhibited. This result 
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conflicts with that of Kitzmann et al. (2006). who found that overexpression of Numb 
led to an increase in differentiation in C2.7 mouse myoblasts and primary human 
myoblasts. It is possible that C2.7 myoblasts and human myoblasts normally 
differentiate less effectively than C2C 12 cells, which would make their enhanced 
differentiation easier to observe. It is also feasible that the level of Numb that was 
overexpressed in C2C 12 cell cultures was not high enough to inhibit Notch signalling 
and produce an observable effect. In addition, endogenous levels of the active Notch 
receptors in C2C12 reserve cells may have been too high for overexpressed Numb to 
effectively inhibit them, whereas in C2.7 myoblasts and human myoblasts the levels of 
receptors may be lower. Alternatively, in C2C 12 cultures, Numb may actually have 
been effective at inhibiting Notch1 and Notch2 in reserve cells, but it is possible that 
Notch3 signalling (which was not inhibited by Numb (Beres et al., 2006)) maintained 
the reserve cells in an undifferentiated state (see chapter 6, section 6.3). Thus, if Notch3 
is expressed at a lower level (or even absent) in C2.7 reserve cells than in C2C 12 
reserve cells, then differentiation may be more likely to occur. 
In chapter 3 it was shown that Numb was expressed in proliferating myoblasts and was 
more abundant in reserve cells than myotubes when differentiation was induced. This 
parallels the high levels of expression of Notch 1, Notch2 and Notch3 in myoblasts and 
reserve cells. Therefore, it is possible that endogenous Numb controls the quantity of 
membrane-bound Notch receptors that become activated in myoblasts and reserve cells. 
and perhaps determines distinct levels for each of the three receptors in the 
different 
cell-types (reviewed in Kanwar and Fortini, 2004; Sakata et al.. 2004. 
Wilkin et al., 
2004). Many other molecules may potentially regulate Notch signalling, 
including 
Pofutl, Fringe molecules, Itch and SellO. These would need to be overexpressed 
in 
C2C12 cell cultures to determine their effect during myogenesis. 
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Dtxl overexpression in proliferating myoblasts led to a slight increase in \1voD 
expression and when differentiation was induced, it caused a slight increase in the 
number of differentiated cells, implying that Dtxl was antagonising Notch signalling. 
Although most published data suggests that the Dtx molecules enhance Notch signalling, 
(Busseau et al., 1994; Matsuno et al., 1995), the result presented here is consistent with 
the observed antagonism of Notchl signalling caused by Dtxl overexpression in 
haematopoietic progenitors, whereby Dtxl inhibits coactivator recruitment (Izon et at., 
2002). Therefore, it is possible that endogenous Dtx 1 may play a similar role to Numb, 
antagonising the Notch receptors to control the levels of signalling in specific cell- 
types. 
Dtx3 overexpression did not alter myoblast proliferation, MyoD expression or 
myogenic differentiation, possibly due to endogenous Dtx3 expression already having 
its maximal effect. When differentiation was induced, overexpression of Dtx3 induced 
a slight decrease in the number of cycling cells. Endogenous Dtx3 may have decreased 
when differentiation was induced (perhaps due to Itch upregulation), as the effect of 
ectopic Dtx3 became apparent: it appears to inhibit proliferation, perhaps by 
antagonising Notch 1 signalling (if this is the case, co-overexpression of active Notch 1 
should rescue the effect on proliferation). Alternatively, Dtx3 may function 
independently from Notch signalling, since it is structurally divergent from Dtx 1 and 
Dtx2 (Kishi et al., 2001), and could possibly play a role in cell cycle withdrawal during 
myogenic differentiation. 
To further characterise Dtx/Notch signalling during myogenesis. it would be necessary 
to overexpress Dtx2. This was not possible in this project. due to difficulty in 
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producing full-length Dtx2 cDNA. However, it is possible that Dtx2 ma` activate 
autonomous Notch signalling and suppress myogenic differentiation in proliferating 
myoblasts and reserve cells, as it has been reported that Dtx2 overexpression in C2('12 
cells suppresses myogenin expression (Kishi et al., 2001). However, these results are 
controversial, as Dtx2 overexpression did not affect morphological differentiation (i. e. 
myotube formation)(Kishi et al., 2001). 
When Dill was overexpressed, it had no significant effect on proliferating myoblasts. 
but when differentiation was induced, D111 produced changes that were similar to those 
observed when Notchl was constitutively active. These results suggest that in 
proliferating myoblasts Dill does not alter endogenous Notch signalling, perhaps 
because it cannot bind to the receptors due to inhibition by Fringes. Endogenous Dill 
transcript is expressed at a low level in proliferating myoblasts (section 3.2), suggesting 
that it does not normally activate Notch signalling in myoblasts. 
When differentiation was induced, overexpressed Dill appeared to enhance Notch 
activation and signalling, causing a decrease in the number of differentiated cells and an 
increase in the number of cycling cells as a result. This suggests that when 
differentiation is induced, Dill/Notch-signalling, and hence also binding, can occur. 
Distinct Fringe molecules that enhance D111/Notch signalling may be upregulated 
(Bruckner et al., 2000; Hicks et al., 2000; Okajima et al., 2003; Yang et al., 2005). 
Endogenous Dill transcript is expressed predominantly in reserve cells (section 3.4), so 
it is possible that D111 on reserve cells may play a role in activating Notch receptors in 
adjacent cells to inhibit their differentiation and thus specify more reserve cells. 
Alternatively, D111 may activate Notchl signalling in myotubes, perhaps affecting their 
growth or apoptosis (reviewed in Artavanis-Tsakonas et al., 1999). 
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CHAPTER 5: Overexpression analysis of D114 and JaggedI in 
C2C12 cells 
5.1 Introduction 
Evidence suggests that Delta-like and Jagged ligands can induce divergent cell fates in 
myeloid (Neves et al., 2006), T-cell (Amsen et al., 2004; Lehar et al., 2005. Rutz et al.. 
2005) and prosensory precursor cells (Brooker et al., 2006)(see Introduction, section 
1.9.3.2). Results presented in chapter 3 (section 3.8) suggest that Jagged 1 may play a 
role in activating Notch receptors in proliferating myoblasts, whereas differential 
expression of D114 and Jagged1 might be involved in determining alternate cell fates 
following the induction of differentiation (Figure 3.13). To investigate this, D114 and 
JaggedI were retrovirally overexpressed in C2C12 cells. 
5.2 D114 and Jagged! overexpression in C2C12 cells 
D114 and Jagged 1 were overexpressed in C2C12 cells using the retroviral vector MigR 1 
(Pear et al., 1998). The vectors contained full-length D114 or Jagged l cDNA, followed 
by an IRES and eGFP (see Materials and Methods, sections 2.6.1.9 and 2.6.1.10). 
Retroviral supernatant was produced and used to infect proliferating myoblasts (as 
described in Materials and Methods, sections 2.6.2 and 2.6.3). Forty-eight hours post- 
infection, the cells were FACS-sorted and GFP-expressing cells were collected. 
5.2.1 D114 overexpression 
C2C12 myoblasts were infected with D114/MigRl and FACS-sorted. After two rounds 
of subculture, approximately 94.36% of FACS-counted cells were GFP+ (Figure 5.1). 
Western blot analysis showed that D114 was expressed at a low level in uninfected and 
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MigR 1 control-infected cultures, but was more abundant in D114/MigR 1-infected cells 
GFP was expressed in the D114/MigRI-infected cells and the \liLT Ri -ww: t",, .Jý:,: ' . I, 
expected. 
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Figure 5.1: D114 expression in D114/MigRl-infected C2C12 cells 
C2C12 cells infected with D114/MigRl retrovirus were FACS-sorted to obtain the 
infected GFP-expressing cells. These were subcultured twice and then reanalysed by 
flow cytometry. A plot summarises the GFP expression of all healthy cells (a). The 
range of GFP-expression is shown, determined using infected C2C12 cells as a negative 
control. Approximately 94.36% of cells were GFP+. Protein was extracted from 
D114/MigRl-infected myoblasts, from untreated cells (C2C12) and from cells infected 
with MigR 1. The protein samples were separated by SDS-PAGE and analysed by 
Western blotting (b), using an antibody against D114 and an antibody against GFP. 
Sizes of the proteins are listed next to the corresponding bands. D114 was expressed in 
all samples, but was more abundant in the D114/MigRl-infected myoblasts. GFP was 
expressed in D114/MigR l- and MigR l -infected cells. 
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5.2.2 Jaggedl overexpression 
Figure 5.2 shows that after Jaggedl \ligR I 
subcultured twice. approximately 94.53°o of'F. ACS-counted coil, vticrc (i} 1) \\ 
blot analysis showed that JaggedI was highly expressed in the lagged 1 OIiLR I -infected 
cells. (Jagged] was probably not observed in control cultures h ccLiuý, c the hlo)t vv l,, 
exposed against the film for a short time, due to extremely high Jagged 1 expression in 
the Jagged I /MigR I -infected cells. ) GFP was expressed in the JaguredI y1igR1-infCctcd 
cells and the MigR 1-infected cells, as expected. 
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Figure 5.2: Jagged! expression in Jagged l/NIigRi-infected C2C12 cells 
C2C12 cells infected with Jaggedl/MigRi retrovirus were FACS-sorted to obtain the 
infected GFP-expressing cells. These were subcultured twice and then reanalysed b% 
flow cytometry. A plot summarises the GFP expression of all healthy cells (a). 
The 
range of GFP-expression is shown, determined using infected C2C 12 cells as a negati\ e 
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control. Approximately 94.53% of cells were GFP -. Protein E\ as extracted i rom Jagged l/MigRl -infected myoblasts, from untreated cells (CC I") and from cells infected with MigRi. The protein samples were separated by SDS-PAGE and analysed 
by Western blotting (b), using an antibody against Jaggedl and an antibody against 
GFP. Sizes of the proteins are listed next to the corresponding bands. Jagged 1 was 
abundant in the Jagged I/MigRI-infected myoblasts, but not observed in the control 
cultures. GFP was expressed in Jaggedl/MigRi- and MigRl-infected cells. 
5.3 Effects of D114 and Jaggedl overexpression in C2C12 cell cultures 
To investigate the effects of D114 and Jaggedl on myoblast proliferation, infected 
myoblasts were cultured for 24 hours in growth medium, BrdU-pulsed, fixed and 
immunostained to detect BrdU incorporation (Materials and Methods, section 2.10). In 
addition, infected cells were cultured for 24 hours and then differentiation was induced 
by serum-reduction. After 96 hours, cultures were BrdU-pulsed, fixed and 
immunostained. Cultures propagated for 24 hours were also fixed and immunostained 
to determine the effect of D114 or Jagged 1 on MyoD expression. 
5.3.1 Effect of overexpression of D114 on proliferating myoblasts 
Figure 5.3 shows the mean percentages of BrdU+ and MyoD+ cells in cultures of 
proliferating myoblasts, as determined by immunostaining. The mean percentages of 
BrdU+ and MyoD+ cells in untreated control cultures were similar to those in MigR 1- 
infected cultures (BrdU+: 55.49±4.10 versus 54.27-t: 1.4 respectively; MyoD' : 
47.24±4.98 versus 40.92± 1.65 respectively), as expected. The mean percentage of 
BrdU+ cells in the D114/MigRl-infected cultures was similar to the controls 
(55.66±3.83). However, there was a significant decrease (p<0.001) in the percentage 
of MyoD+ cells in the D114/MigRl-infected cultures (23.15+2.46), when compared with 
MigRi-infected or uninfected cultures. Therefore, in proliferating myoblasts. 
overexpression of D114 appeared to have no effect on proliferation, but caused a 
decrease in MyoD expression. 
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Figure 5.3: Effect of D114 overexpression on proliferation and MyoD expression in 
proliferating C2C12 myoblasts 
Untreated C2C 12 myoblasts or cells infected with MigR 1 or D114/MigR l were 
propagated for 24 hours. Cultures were either fixed and immunostained with an anti- 
MyoD antibody, or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. 
Cells were counterstained with DAPI. For each culture, at least 100 cells per well in 
three individual wells were counted to determine the number of positively-stained 
nuclei. The mean percentage of BrdU+ (a) or MyoD+ (b) nuclei was calculated. Error 
bars represent the standard deviation. Untreated control cultures were compared with 
MigR 1-infected cultures, and were not statistically significantly different, and 
D114/MigR 1-infected cultures were compared with MigR 1-infected cultures. *** 
(p<0.001) denotes that there was a significant decrease in MyoD expression in 
D114/MigR 1-infected cultures compared with MigR 1-infected cultures, but there was no 
significant difference in BrdU incorporation in D114/MigR l -infected cultures compared 
with MigR 1-infected cultures. 
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5.3.2 Effect of overexpression of Jaggedl on proliferating myoblasts 
Figure 5.4 demonstrates the mean shows the mean percentages of BrdU I and %I%-oD 
cells in cultures of proliferating myoblasts overexpressing Jagged 1. as determined by 
immunostaining. The mean percentages of BrdU+ and MyoD+ cells in untreated control 
cultures were similar to those in MigRi-infected cultures (BrdU-: 55.49±4.10 versus 
54.27± 1.4 respectively; MyoD+: 47.24±4.98 versus 40.92± 1.65 respectively). There 
was no significant statistical difference between the mean percentages of BrdU+ cells in 
MigR 1-infected cultures compared with Jagged 1 /MigR 1-infected cultures (55.76. t4.35). 
However, there was a significant decrease (p<0.01) in the percentage of MyoD+ cells in 
Jagged I /MigR I -infected cultures (24.18±1.35), when compared with MigR1-infected 
cultures. Therefore, in proliferating myoblasts, Jagged l appeared to have no effect on 
proliferation, but caused a decrease in MyoD expression. 
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Figure 5.4: Effect of Jaggedl overexpression on proliferation and MyoD 
expression in proliferating C2C12 myoblasts 
Untreated C2C 12 myoblasts or cells infected with MigR 1 or Jagged 1 /MigR 1 were 
propagated for 24 hours. Cultures were either fixed and immunostained with an anti- 
MyoD antibody, or BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. 
Cells were counterstained with DAPI. For each culture, at least 100 cells per well in 
three individual wells were counted to determine the number of positively-stained 
nuclei. The mean percentage of BrdU+ (a) or MyoD+ (b) nuclei was calculated. Error 
bars represent the standard deviation. Untreated control cultures were not statistically 
significantly different compared with MigRi -infected cells, and Jagged l /MigR l- 
infected cultures were compared with MigR 1-infected cultures. ** (p<0.01) denotes 
that there was a significant decrease in MyoD expression in Jagged 1/ MigR 1-infected 
cultures compared with MigRl-infected cultures. There was no significant difference in 
BrdU incorporation in Jagged l/MigRI-infected cultures compared with %, IigR l -infected 
cultures. 
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5.3.3 Effects of D114 or Jaggedl overexpression on differentiated cultures 
The effect of D114 and Jagged1 on cell fate determination was investigated as follows. 
Infected myoblasts were cultured for 24 hours and then differentiation was induced by 
serum-reduction. After 96 hours, cultures were fixed and immunostained with an 
antibody to detect MHC, a marker of differentiated cells. 
Figure 5.5 shows the mean percentages of BrdU+ and MHC- cells in differentiated 
cultures overexpressing D114 or Jaggedl, as determined by immunostaining. When 
examining MHC expression, nuclei were counted rather than cells, so each nucleus 
within an MHC+ multinucleated myotube was counted as an MHC' `cell'. The mean 
percentages of BrdU+ and MHC+ nuclei in untreated control cultures were similar to 
those in MigRI-infected cultures (BrdU+: 7.03±0.95 versus 2.23±0.44 respectively; 
MHC+: 44.53±4.53 versus 44.36±2.39 respectively). There was a significant decrease 
(p<0.001) in the mean percentage of MHC+ cells in both D114/MigR 1-infected cultures 
(1.89±0.92) and Jagged 1 /MigR 1-infected cultures (7.84± 1.24) compared with M igR 1- 
infected cultures. The decrease in the number of differentiated cells in both D114- and 
Jagged I -overexpressing cultures is apparent in cultures immunostained for MHC 
(Figure 5.6). Figure 5.5 shows that there was no significant difference in BrdU 
incorporation in D114/MigR 1-infected cultures (1.66±0.87) or Jagged 1 /MigR 1-infected 
cultures (5.05. t: 1.46) compared with MigRi-infected cultures. Therefore. in 
differentiated cultures, overexpression of D114 and Jagged l. both appeared to inhibit 
differentiation, but had no effect on the number of cycling cells. 
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Figure 5.5: Effects of D114 or Jaggedl overexpression on proliferation and 
differentiation in differentiated C2C12 cultures 
Untreated C2C12 myoblasts or cells infected with `1igRl. D114 %1i`; Rl or- 
Jaggedl/MigRl were propagated for 24 hours, and then differentiation was induced. 
Cultures were either fixed and immunostained with an anti-`1 HC antibody. or BrdU- 
pulsed, fixed and immunostained with an anti-BrdU antibody. Cells were 
counterstained with DAPI. For each culture, at least 100 nuclei per well in three 
individual wells were counted. The mean percentages of BrdU+ (a and c) or `1 HC ' (b 
and d) cells were calculated. Error bars represent the standard deviation. Untreated 
control cultures were compared with MigRI-infected cultures, and were not statistically 
significantly different. D114/MigR1-infected cultures or Jagged1 MigRI -infected 
cultures were compared with MigRi-infected cultures. *** (p<0.001) denotes that 
there was a significant decrease in MHC expression in both D114 NligR 1-infected 
cultures and Jagged l/MigRi-infected cultures in comparison with MigRi-infected 
cultures. There was no significant difference in BrdU incorporation in D114 11 igR l- 
infected cultures or Jagged 1 /MigR 1-infected cultures compared with MigR 1-infected 
cultures. 
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Figure 5.6: Fluorescence microscopy images of MHC-immunostained 
differentiated cultures overexpressing D114 or Jagged! 
Untreated C2C 12 myoblasts or cells infected with MigR l, D114/MigRI or 
Jagged 1 /MigR 1 were propagated for 24 hours, and then differentiation was induced by 
serum-reduction. Cultures were fixed and immunostained with an anti-MHC antibody 
and counterstained with DAPI. Fluorescence microscopy images of the MHC/DAPI- 
immunostained differentiated cultures are shown (a-1). MHC was expressed in 
differentiated cells. Untreated cultures (a, b, c) and MigR 1-infected cultures (d, e, f) 
contained large numbers of differentiated cells, while Jagged 1 /MigR 1-infected cultures 
(g, h, i) and D114/MigRl-infected cultures (j, k, 1) contained very few. (Bar: 20µM. ) 
5.4 Effects of D114 and Jagged! expression on determining cell fate in 
adjacent cells 
To explore the effect of D114 and Jaggedl on determining the cell fate of adjacent cells, 
coculture experiments were carried out. The aim of the first coculture experiment was 
to determine the effect of the membrane-bound ligands on activating Notch receptors in 
uninfected C2C 12 cells. Uninfected cells or myoblasts infected with MigR 1. 
D114/MigR 1 or Jagged 1 /MigR 1 were mixed with an equal number of uninfected C2C 12 
myoblasts and propagated for 24 hours before differentiation was induced by serum- 
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reduction. After 96 hours, cultures were fixed and immunostained with an antibody 
against MHC, a marker of differentiated cells, and an anti-GFP antibody. which 
detected GFP, infected cells only. Cocultures were counterstained with DAPI. 
Figure 5.7 shows the mean percentages of GFP+/MHC+ and GFP-i11HC- cells in the 
cocultures, as determined by immunostaining. When examining \IHC expression, 
nuclei were counted rather than cells, so each nucleus within an MHC+ multinucleated 
myotube was counted as an MHC+ `cell'. Since the aim was to determine the effect of 
the membrane-bound ligands on the uninfected C2C 12 cells, the GFP- cells (i. e. 
uninfected cells) were compared between cultures. There was a significant decrease 
(p<0.01) in the mean percentage of GFP-/MHC+ nuclei in C2C 12+MigR 1-infected 
cocultures (30.71±2.03) compared with untreated control cultures (59.37±4.69). The 
GFP+ myotubes in the C2C12+MigR1-infected cocultures consist of both uninfected 
C2C 12/MigR 1-infected-cell hybrids and MigR 1-infected-cell-only fusions. Therefore, 
the apparent reduction of fusion may be due to the contribution of GFP- cells to hybrid 
myotubes. If a non-muscle cell line could be retrovirally-infected and used for 
coculture studies (e. g. NIH 3T3 cells), fusion of GFP- C2C 12 cells into hybrid 
myotubes would not occur and could confirm that this caused the loss of GFP-/MHC' 
cells in this experiment. 
There was a significant decrease in the mean percentages of GFP-/MHC- cells in both 
C2C 12+D114/MigRl -infected cocultures (4.13±5.22) and C2C 12+Jagged 1 /MigR 1- 
infected cocultures (0.5±0.86; p<0.01 and p<0.05 respectively) compared with 
C2C12+MigR1-infected cocultures (30.71±2.03). The reduction in MHC* cells implies 
that exposure to either D114 or Jagged1 inhibit differentiation of the uninfected cells by 
causing an increase in Notch receptor activation. There appeared to also be a decrease 
in the mean percentages of GFP+/MHC+ cells in both C? C 1 _'+D114'\tigR 
l -infected 
25 5 
cocultures (4.32± 1.08) and C2C 12+Jagged 1 'M igR 1-infected cocultures ( 17.31 ±0.5 ) 
compared with C 2C 12+MigR 1-infected cocultures (59.69±1O. 6). Either D114 or 
Jagged l prevent differentiation (section 5.3.3). and, therefore. the lack of GFP' /M 1 HC+ 
myotubes shows that uninfected cells were unable to fuse with infected cells or each 
other. 
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Figure 5.7: Effects of coculture with D114- or Jagged I-expressing my oblasts on the differentiation of C2C12 ms oblasts Uninfected C2C12 myoblasts or cells infected with MigRI, D114 \1i`gR1 or Jaggedl/MigRI were mixed with an equal number of uninfected C2C 12 myohlasts. 
propagated for 24 hours and then induced to differentiate. After 96 hours, cocultures 
were fixed and immunostained with an anti-MHC antibody and an anti-GFP antibody. Cells were counterstained with DAPI. For each culture, at least 100 nuclei per well in three individual wells were counted. The mean percentages of GFP+/`IHC (Green bars) 
or GFP7/MHC+ (red bars) cells were calculated (a). Error bars represent the standard deviation. ** (p<0.01) denotes that there was a significant decrease in the percentage of GFP-/MHC+ cells in C2C12+MigR1-infected cocultures compared with uninfected 
C2C 12 cultures. ** (p<0.01) and * (p<0.05) denote that there were significant decreases in MHC expression in GFP- cells in C2C 12+D114! MigR 1-infected cocultures 
and C2C12+Jaggedl/MigRl-infected cocultures respectively compared with 
C2C 12+MigR1-infected cocultures. Fluorescence microscopy images of the 
differentiated cocultures immunostained to detect MHC/'GFP/DAPI are shown (b-q). 
Uninfected C2C 12 cultures (b, c, d, e) contained large numbers of GFP- differentiated 
cells. C2C12+MigRl-infected cultures (f, g, h, i) contained large numbers of GFP- and 
GFP+ differentiated cells. C2C12+D114/MigRl-infected cocultures (j. k. 1, m) and 
C2C12+Jaggedl/MigRl-infected cocultures (n, o, p, q) contained very few GFP- and 
GFP+ differentiated cells. (Bar: 20µM. ) 
A second series of coculture experiments were carried out to investigate the effects of 
exposure to D114 and Jagged l on cells that had already begun to differentiate. 
Uninfected cells were propagated for 24 hours and then induced to differentiate. After 
24 hours an equal number (corrected for division of the cells seeded initially) of 
uninfected cells or myoblasts infected with MigR 1, D114/MigR 1 or Jagged 1 /MigR 1 
were added. After a further 72 hours, cocultures were fixed and immunostained to 
detect MHC and GFP expression, as in the previous experiment. Cocultures were 
counterstained with DAPI. 
Figure 5.8 shows the mean percentages of GFP+/MHC- and GFP-/MHC+ nuclei in the 
cocultures. There was a significant decrease (p<0.05) in the mean percentage of 
GFP-/MHC+ nuclei in C2C12+MigRl-infected cultures (34.27±9.84) compared with 
untreated control cultures (58,62±3). As discussed previously, this may be due to the 
incorporation of GFP- myoblasts into hybrid myotubes, thus reducing the number of 
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differentiated GFP- cells. There were no siLr; Jt cant differences in the mean percentýt, e, 
of GFP-/MHC * cells in both C2C12---Dl14'MigRl-infected cultures (36.3-±-'. 4-1) and 
C2C12+JaggedI/MigRl-infected cultures (19.13±1.94) compared with C2CI-'-\li`gR1- 
infected cultures (34.27±9.84). Therefore, when D114- or Jagged I-expressin`T cells are 
added to uninfected cells 24 hours after differentiation has been induced, D114 and 
Jagged 1 have no effect on differentiation of the uninfected cells. 
Results of the two coculture experiments show that exposure to either D114 or Jagged 1 
prevents differentiation of adjacent cells. However, once differentiation has been 
initiated, these ligands do not do not inhibit subsequent steps towards myotube 
formation. 
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Figure 5.8: Effects of coculture with D114- or Jagged] -expressing mý oblast' on the differentiation of C2C12 cells that had entered the differentiation programme Untreated C2C 12 myoblasts were propagated for 24 hours., and then induced to 
differentiate. After 24 hours, an equal number (corrected for cell division) of uninfected 
cells or myoblasts infected with MigR 1, D114/MigR 1 or Jagged 1, `1i aR l were added. 
After a further 72 hours, cultures were fixed and immunostained With an anti-\IHC 
antibody and an anti-GFP antibody. Cells were counterstained with DAPI. For each 
culture, at least 100 nuclei per well in three individual wells were counted. The mean 
percentages of GFP+/MHC+ (green bars) or GFP-/MHC+ (red bars) cells were calculated 
(a). Error bars represent the standard deviation. * (p<0.05) denotes that there was a 
significant decrease in the percentage of GFP-/MHC- cells in C2C 12+N1igR l -infected 
cocultures compared with uninfected C2C12 cultures. There were no significant 
differences in percentages of GFP-/MHC+ cells in C2C12+D114 MigR1-infected 
cocultures or C2C12+Jaggedl/MigRl-infected cocultures compared with 
C2C12+MigR1-infected cocultures. Fluorescence microscopy images of the 
differentiated cocultures immunostained to detect MHC; 'GFP/DAPI are shown (b-q). 
Uninfected C2C12 cultures (b, c, d, e) contained large numbers of GFP- differentiated 
cells. C2C12+MigR1-infected cocultures (f, g, h, i) contained large numbers of GFP- 
and GFP+ differentiated cells. C2C 12+D114/MigR 1-infected cocultures (j, k. 1, m) and 
C2C12+Jaggedl/MigRl-infected cocultures (n, o, p, q) contained slightly fewer GFP- 
and GFP+ differentiated cells compared to control cultures. (Bar: 20uM. ) 
5.5 Effects of D114 and Jaggedl expression on reserve cell activation 
To examine the effect of exposure to D114 or Jaggedl on reserve cell activation, 
proliferating myoblasts infected with MigR 1, D114/MigR 1 or Jagged 1 /Mi gR 1 were 
propagated for 24 hours and then mixed with an equal number (corrected for division of 
the cells seeded initially) of uninfected C2C 12 reserve cells (RC). When RC are 
transferred to growth medium, which contains a higher level of serum than 
differentiation medium, they upregulate their expression of MyoD and begin to 
proliferate (Yoshida et al., 1998). After 24 hours in growth medium, cocultures were 
BrdU-pulsed, fixed and immunostained with an antibody against BrdU (see Materials 
and Methods, section 2.10), to determine the numbers of RC that had re-entered the cell 
cycle. Other cocultures were fixed, treated with lysenin and immunostained with an 
anti-lysenin antibody (see Materials and Methods, section 2.1 1) to determine the 
number of RC in the culture that had not been reactivated (lvsenin 
binds to 
sphingomyelin, which is highly expressed on the surface of reserve cells, 
but not in 
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myoblasts or differentiated cells)(Nagata et al., ? 006). Cocultures were 
coimmunostained with an anti-GFP antibody to distinguish GFP- infected cell, and 
uninfected RC, and counterstained with DAPI. 
Figure 5.9 shows the mean percentages of GFP+/BrdU+ and GFP- BrdU nuclei in the 
cocultures. There was a significant increase (p<0.05) in the mean percentage of 
GFP-/BrdU+ nuclei in RC+MigRl -infected cultures (56.66±4.71) compared with 
cultures that were seeded with RC only (43.96±3.04). It therefore appears that mixing 
the RC with proliferative MigRl -infected myoblasts enhanced the entry of RC into the 
cell cycle. There was a significant decrease (p<0.05) in the mean percentage of 
GFP-/BrdU+ cells in RC+D114/MigRl-infected cultures (37.08±8.33) compared with 
RC+MigRl -infected cultures (56.66±4.71). This shows that D114 caused a reduction in 
the number of RC that re-entered the cell cycle, suggesting that D114 may maintain 
Notch signalling in the RC to specify quiescence. However, there was no significant 
difference in the percentage of GFP-/BrdU+ cells in RC+Jagged l /MigR 1-infected 
cultures (55.51±4.53) compared with RC+MigRl-infected cultures, suggesting that 
Jagged l (unlike D114) has no effect on the Notch signalling pathway involved in 
specifying the reserve cell phenotype. 
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Figure 5.9: Effects of coculture with Dl14- or Jaggedl-expressing niyyoblasts on 
reserve cell proliferation 
Untreated C2C12 myoblasts or cells infected with `ligRl. D114 `liLRl or 
Jagged 1 /MigR 1 were propagated in growth medium for 24 hours. and then an equal 
number (corrected for cell division) of untreated C2C 12 reserve cells (RC) were added. 
After a further 24 hours, cultures were BrdU-pulsed. fixed and immunostained with an 
anti-BrdU antibody and an anti-GFP antibody. Cells were counterstained with DAPI. 
For each culture, at least 100 nuclei per well in three individual wells were counted. 
The mean percentages of GFP+/BrdU+ (green bars) or GFP-/BrdU- (red bars) cells were 
calculated (a). Error bars represent the standard deviation. * (p<0.05) denotes that 
there was a significant increase in the percentage of GFP-/BrdU+ cells in RC+Nl i`, R l- 
infected cocultures compared with cultures containing RC only. * (p<0.05) denotes that 
there were significantly fewer GFP"/BrdU+ cells in RC+D114/MigRl-infected cocultures 
compared with RC+MigRl-infected cocultures. There was no significant difference in 
the percentage of GFP-/BrdU+ cells in RC+Jagged l /MigR 1-infected cocultures 
compared with RC+MigRl-infected cocultures. Fluorescence microscopy images of 
the cocultures immunostained to detect BrdU/GFP/DAPI are shown (b-q). Cultures that 
were only seeded with RC (b, c, d, e) contained large numbers of GFP- proliferating 
cells. RC+MigRl -infected cocultures (f, g, h, i) and RC+Jagged l /MigR 1-infected 
cocultures (n, o, p, q) contained large numbers of GFP- and GFP+ proliferating cells, but 
RC+D114/MigRl-infected cocultures (j, k, 1, m) contained fewer GFP- proliferating 
cells. (Bar: 20µM. ) 
Figure 5.10 shows the mean percentages of GFP+/lysenin+ and GFP-/lysenin+ cells in 
the cocultures. There were no significant differences in the mean percentages of 
GFP-/lysenin+ cells between any of the cocultures. The mean percentage of 
GFP-/lysenin+ cells in RC+D114/MigRl-infected cocultures was greater than the other 
cocultures, but did not reach statistical significance, possibly due to the large standard 
deviation (increasing the number of cells counted may produce a significant result). 
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Figure 5.10: Effects of coculture with D114- or Jagged 1-expressing myoblasts on 
reserve cell activation (lysenin-binding) 
Untreated C2C 12 myoblasts or cells infected with MigR 1, D114f'Mi`gR l or 
Jagged 1 /MigR 1 were propagated in growth medium for 24 hours, and then an equal 
number (corrected for cell division) of untreated C2C12 reserve cells (RC) were added. 
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After a further 24 hours, cultures were fixed, treated with lvvsenin and immunotained 
with an anti-lysenin antibody and an anti-GFP antibody. Cells were counterstained «ith DAPI. For each culture, at least 100 nuclei per well in three individual «elk were 
counted. The mean percentages of GFP{ lysenin+ (green bars) or GFP- 1` senin (red bars) cells were calculated (a). Error bars represent the standard deviation. Culture, 
seeded with RC only were compared with RC+MigRI-infected cocultures while RC+D114/MigR l -infected cocultures and RC+Jagged l; M igR 1-infected cocultures were 
compared with RC+MigRl-infected cocultures. There were no statistically- significant differences in the mean percentages of GFP-/lysenin+ cells between any of the 
cocultures, although the percentage of GFP-/lysenin+ cells in RC+D114 %i igR l -infected 
cocultures appeared to be higher than any of the other cocultures. Fluorescence 
microscopy images of the cocultures immunostained to detect lysenin GFP/DAPI are 
shown (b-q). Cultures that were only seeded with RC (b. c, d, e) contained several 
GFP-/lysenin+ cells. RC+MigR 1-infected cocultures (f, g, h, i) and RC+Jagged I /N 1 i, -, R 1. 
-infected cocultures (n, o, p, q) contained several GFP-/lysenin+ and GFP /lysenin+ 
cells, but RC+D114/MigRI-infected cocultures (j, k, 1, m) contained more GFP- lvsenin+ 
cells. (Bar: 20µM. ) r 
5.6 Discussion 
The model presented in Figure 3.13 (section 3.8) suggests that D114 and Jagged 1 may 
fulfil different functions in proliferating and differentiated myogenic cultures. The aim 
of the experiments described in this chapter was to examine the effects of 
overexpression of D114 and Jaggedl on myoblast behaviour and the effects of exposure 
to the same ligands on other myoblasts or reserve cells in a coculture system. 
Overexpression of D114 or Jagged l in proliferating myoblasts, where levels of all three 
Notch receptors are high (Notch3 is the least abundant), had no effect on proliferation 
but caused a decrease in MyoD expression. This suggests that overexpression of D114 
or Jaggedl in myoblasts activates Notch signalling, leading to a decrease in the level of 
MyoD expressed (Jarriault et al., 1998; Kopan et al., 1994; Kuroda et al., 1999). 
Endogenous D114 is expressed at a very low level in proliferating myoblasts. suggesting 
that although D114 has the potential to activate Notch receptors, it is not functional in 
proliferating cultures. Endogenous Jaggedl, however, is abundant in proliferating 
myoblasts (section 3.3), and may, therefore, activate Notch receptors in proliferating 
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cells. When differentiation was induced, overexpressed D114 caused a decrcLtý'e in the 
number of differentiated cells, presumably by maintaining Notch activation. Thee 
results are consistent with the model in which endogenous monoubiquitinated D114 
expressed on the surface of nascent myotubes activates Notch in adjacent cell', to inhibit 
their differentiation, specifying them as reserve cells. As with D114. when 
differentiation was induced, overexpressed Jagged l caused differentiation to be 
inhibited. Therefore, endogenous Jaggedl on reserve cells may potentially activate 
Notch signalling in adjacent cells to inhibit their differentiation and specify them as 
reserve cells. Alternatively, JaggedI expressed in reserve cells may activate Notch 1 in 
adjacent myotubes, which may affect cell growth or apoptosis (reviewed in 
Schweisguth, 2004) of the myotubes. 
Coculture experiments were carried out to determine the effect of membrane-bound 
ligands on the behaviour of uninfected C2C 12 cells. Soluble ligands were not used 
because it has been demonstrated that they can act in a dominant negative manner 
(Hukriede et al., 1997; Sun and Artavanis-Tsakonas, 1996; Sun and Artavanis- 
Tsakonas, 1997). Indeed, it has been suggested that ligand stabilisation is essential for 
Notch activation (Varnum-Finney et al., 2000), which is why membrane-bound ligands 
were used. 
When cells overexpressing D114 or Jagged1 were mixed with uninfected cells and 
differentiation was induced, either ligand decreased differentiation of adjacent 
uninfected cells, presumably by activating Notch signalling. However, if differentiation 
was induced in uninfected cells and D114- or Jagged I -expressing cells were added -14 
hours later, the same ligands did not affect differentiation of the uninfected cells. These 
results suggest that a cell-fate decision is made during the first 24 hours after 
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differentiation is induced. During that time cells may be influenced by D114 or Jag`gcýi 1 
ligand expression, presumably through increased Notch receptor activation resulting in 
the inhibition of differentiation. 
Coculture experiments were also carried out to determine the effect of exposure to 
membrane-bound ligands on the reactivation of reserve cells. Cells overexpressingD114 
or Jaggedl were mixed with reserve cells and cocultured in growth medium, which 
should induce an increase in MyoD expression in the reserve cells and re-entry into the 
cell cycle (Yoshida et al., 1998). However, exposure to D114 inhibited cells from re- 
entering the cell cycle, suggesting that D114 may maintain Notch signalling in the 
reserve cells, possibly mimicking the effect of ligands encountered by reserve cells in 
differentiated cultures. In addition, the number of cells that were retained as 
sphingomyelin-expressing (i. e. lysenin)(Nagata et al., 2006) reserve cells when 
exposed to D114 was increased, confirming the cell cycle data above. Thus, endogenous 
D114 may be responsible for activating Notch receptors in reserve cells to specify and 
maintain them in an undifferentiated state (knocking out the expression of D114 (with 
shRNA for example) may confirm that this is the function of endogenous D114). Since 
adjacent cell-cell contact is required for ligand-receptor activation, this is consistent 
with the model described previously, whereby monoubiquitinated D114 on the surface of 
nascent myotubes activates Notch receptors in adjacent cells to specify them as 
undifferentiated reserve cells. 
Expression of Jagged1 had no effect on the number of reserve cells that re-entered the 
cell cycle, or that were maintained as sphingomyelin-expressing reserve cells. This 
suggests that Jaggedl may be unable to maintain Notch signalling pathways specific to 
the maintenance of reserve cells. Since Jagged! was suggested to possibly regulate 
268 
Notch signalling in proliferating myoblasts (sec section 3.8), it is feasible that Ja`_lýcýi 1 
may activate Notch signalling pathways in the reserve cells that facilitate the transition 
of reserve cells from a quiescent state to a proliferative state. 
D114 and Jaggedl presumably both activate Notch signalling in adjacent cells. The 
results in this chapter suggest that endogenous Jaggedl may control Notch signalling 
appropriate for maintaining proliferation of myoblasts, but when differentiation is 
induced expression of D114 on nascent myotubes may be responsible for activating the 
Notch pathways in undifferentiated cells to specify and maintain them as reserve cells. 
Since Notch signalling induced by the different ligands results in distinct outcomes for 
the cell, it is likely that the ligands differentially activate the three Notch receptors. 
Therefore, one receptor may predominate in a specific cell-type, causing differentiation 
to be inhibited and the cells to either proliferate or become quiescent as appropriate. 
Evidence from another system may indicate preferential ligand-receptor activation 
combinations. For example, human myeloid progenitors exposed to Jagged I upregulate 
Notchl, while those in contact with D111 upregulate Notch3 expression (Neves et al., 
2006). 
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CHAPTER 6: Overexpression analysis of constitutively, active 
Notch3 in C2C12 cells 
6.1 Introduction 
In chapter 3, the expression profiles of Notch signalling pathway components were 
characterised during C2C 12 cell myogenesis. It was shown that active Notch 1, Notch2 
and Notch3 are expressed in proliferating myoblasts, and during differentiation they are 
highly expressed in reserve cells. Notch3 is structurally diverged from Notch l and 
Notch2 (Lardelli et al., 1994; Shimizu et al., 2002) and so may function differently to 
the other receptors. The aim of the experiments described in this chapter was to analyse 
the effects of Notch3 on C2C 12 cells. Specifically, the roles of Notch3 signalling in 
cell cycle regulation (p21 and p27 expression) and apoptosis (see Introduction, section 
1.9.9) were investigated. Potential interaction between the Notchl and Notch3 
receptors (described in section 1.9.3.3) was also examined. 
6.2 Overexpression of active Notch3 in C2C12 cells 
Constitutively active Notch3 was overexpressed in C2C 12 cells using a retroviral vector 
that contained cDNA encoding the Notch3 ICD followed by an IRES and eGFP 
(Notch3/mig)(see Materials and Methods, section 2.6.1.6). Forty-eight hours post- 
infection, the number of GFP+ myoblasts was counted using a FACScan flow cytometer 
(Figure 6.1). Some of these cells were analysed immediately, while others (from the 
same population of cells infected initially) were plated and subcultured four or eight 
times prior to analysis. 
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Figure 6.1 shows that immediately post-infection. 92.341', '0 of Notch3/mig-infected cells 
were GFP+, with the majority expressing high levels of GFP. After four pas a`_cs. 
89.78% of the cells expressed GFP, although approximately half expressed lower le\ els 
of GFP and half maintained the high level. Infected cells that were passaged eight times 
still contained 89.29% GFP+ cells, but the majority of these cells expressed the lower 
level of GFP. This suggests that as the infected cells were subcultured, the cells 
expressing a high level of GFP were progressively lost and low-level GFP-expressing 
cells, therefore, increased in relative abundance. 
Protein extracted from Notch3/mig-infected myoblasts (passage 0 and passage 4) and 
from untreated myoblasts and control mig-infected myoblasts were analysed by 
Western blotting (Figure 6.1). The Western blot was probed with anti- x -tubulin, anti- 
Notch3 and anti-GFP antibodies. The Notch3 antibody used was directed against the 
ICD and, therefore, able to detect both the transmembrane and cleaved, intracellular 
forms. Two Notch3 peptide bands around 97kDa were detected in all samples. The 
higher molecular weight band in each case was the membrane-bound form, while the 
lower molecular weight band was the cleaved, active form of the receptor. The 
untreated myoblasts and mig-infected cells contained endogenous membrane-bound and 
active Notch3, as demonstrated previously in chapter 3. As expected, active Notch3 
was much more abundant in Notch3/mig-infected passage 0 (P0) cells in comparison 
with untreated and mig-infected cells. This was consistent with the high level of GFP 
expressed in the Notch3/mig-infected PO cells, observed by both FACS analysis and 
Western blot analysis (Figure 6.1). After Notch3/mig-infected cells were passaged four 
times (P4), active Notch3 was still highly expressed, but at a lower level than in PO 
cells, consistent with the level of GFP expression, which had also decreased according 
to Western blot analysis. FACS analysis showed that the percentage of GFP+ cc11ti In 
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the culture was approximately the same as in the PO culture, but the number of cell, 
expressing a high level of GFP had decreased so that half of the cells expressed a le,, ý: r 
quantity of GFP. The loss of cells expressing a higher quantity of GFP may be 
facilitated by apoptosis (Walsh and Perlman, 1997), perhaps caused by Notch 
signalling (see Introduction, section 1.9.9). 
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Figure 6.1: Expression of Notch3 in Notch3/mig-infected cells 
C2C 12 myoblasts were infected with Notch3/mig retrovirus and attcº ýý 
hour ýt ýr` 
analysed by flow cytometry to determine the number of GFP+, 
infected cells in the 
culture (a; Passage 0). Infected cells were passaged four (Passage 
4 or ei ght times 
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10'I 10 2 10 1 Ci a 
GFP 
141 14,103 104 
GFP 
(Passage 8) and reanalysed by flow cytometry. Plots summarise the GF P expression of 
all healthy cells after 0,4 or 8 passages (a). The range of GFP-expression is shoýti n. 
determined using uninfected C2C12 cells as a negative control. Approximately 02.34 , 
of Passage 0 cells were GFP+, and these mostly expressed a high level of GFP. 81). 7, S9, ", 
of Passage 4 cells were GFP+. Approximately half of this population expressed 
high-level GFP, while half expressed low-level GFP. 89.29°%ö of Passage 8 cells were 
GFP+ and these mainly expressed GFP at a low level. Protein «as extracted from 
Passage 0 (P0) and Passage 4 (P4) Notch3/mig-infected myoblasts. from untreated cell', 
(C2C12) and from cells infected with mig. The protein samples were analysed b`- 
Western blotting (b), using an antibody against the Notch3 ICD and an antibody against 
GFP. Sizes of the proteins are listed next to the corresponding bands. Two Notch 
peptide bands around 97kDa were detected in all samples. The higher molecular weight 
band was the membrane-bound form of Notch3, while the lower molecular weight band 
was the cleaved, active form. Active Notch3 was more abundant in Notch 3 "mi g- 
infected myoblasts compared with uninfected and mig-infected cultures. It was more 
highly expressed in PO cells than P4 cells. GFP was highly expressed in Notch3'mig- 
infected PO cultures and mig-infected cultures and expressed at a lower level in 
Notch3/mig-infected P4 cultures. a-tubulin was included as a loading control and was 
expressed equally in all samples. 
6.3 Effect of active Notch3 overexpression on proliferation and 
differentiation in C2C12 cell cultures 
The effects of active Notch3 upon proliferation and cell fate determination following 
the induction of differentiation were examined in both PO and P4 Notch3/mig-infected 
cells. To investigate the effect of active Notch3 on proliferation, infected myoblasts 
were cultured for 24 hours in growth medium, BrdU-pulsed, fixed and immunostained 
to detect BrdU incorporation (as described in Materials and Methods, section 2.10). 
Proliferating cultures were also immunostained for MyoD expression. The effect of 
constitutively active Notch3 on cell fate determination was investigated using 
differentiated cultures. Infected cells were propagated for 24 hours and then induced to 
differentiate. After 96 hours, cultures were BrdU-pulsed, fixed and immunostained to 
detect BrdU incorporation, or fixed and immunostained to detect MHC. 
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Figure 6.2 shows the mean percentages of BrdU+ cells in cultures of proliferating 
myoblasts overexpressing constitutively active N'otch3. The mean percentages of 
BrdU+ cells in untreated cultures (60.57±1.44) were similar to those of mig-infected 
cultures (54.44±4.1), as expected. However, there was a significant decrease (p 0.01) 
in the percentage of BrdU+ cells in Notch3/mig-infected PO cultures (34: t-2-23), 
compared with mig-infected cultures. In contrast, there was no significant difference in 
BrdU incorporation between Notch3/mig-infected P4 cultures (52.37±6.92) and mi`g- 
infected cultures. Therefore, in freshly-infected myoblasts, constitutively active Notch3 
caused a decrease in proliferation, but the level of active Notch3 was not high enough to 
affect proliferation in cells that had been subcultured four times. Interestingly, 
Notch3/mig-infected myoblasts appeared to be much larger than the cells in the control 
cultures (Figure 6.2). 
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Figure 6.2: Effect of active Notch3 overexpression on proliferation in proliferating 
C2C12 myoblasts 
Untreated C2C12 myoblasts or cells infected with mig or Notch3'mi`r were propagated 
for 24 hours. Cultures were BrdU-pulsed, fixed and immunostained with an anti-BrdU 
antibody. Cells were counterstained with DAPI. For each culture. at least 100 cells per 
well in three individual wells were counted. The mean percentages of BrdU+ nuclei 
were calculated (a). Error bars represent the standard deviation. Untreated control 
cultures were compared with mig-infected cultures, and were not statistically 
significantly different. ** (p<0.01) denotes that there was a significant decrease in 
BrdU incorporation in Notch3/mig-infected Passage 0 cultures compared with micy- 
infected cultures, but there was no significant difference in BrdU incorporation in 
Notch3/mig-infected Passage 4 cultures compared with mig-infected cultures. 
Fluorescence microscopy images of the cultures immunostained for BrdUi DAPI are 
shown (b-m). Proliferating cells were present in untreated cultures (b, c, d), mig- 
infected cultures (e, f, g) and Notch3/mig-infected Passage 0 (h, i, j) and Passage 4 
cultures (k, 1, m). There appeared to be fewer BrdU+ cells in Notch3 mig-infected 
Passage 0 cultures. The cells were larger in Notch3/mig-infected cultures compared 
with control cultures. (Bar: 20µM. ) 
Figure 6.3 shows that the mean percentages of MyoD+ cells in untreated cultures 
(43.99±2.62) were similar to those of mig-infected cultures (44-58.: t2.95). However, 
MyoD was absent from Notch3/mig-infected PO myoblasts (p<0.001) and was still 
significantly reduced (p<0.05) in Notch3/mig-infected P4 cultures (16.48±9.41) 
compared with mig-infected cultures. These results show that in proliferating 
myoblasts, constitutively active Notch3 inhibits MyoD expression, and after 
four 
passages Notch3 expression was still high enough to reduce, but not completely 
inhibit 
MyoD. 
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Figure 6.3: Effect of active \ otch3 overexpression on MyoD expression in 
proliferating C2C12 myoblasts 
Untreated C2C12 myoblasts or cells infected with mig or Notch3 mig were propagated for 24 hours. Cultures were fixed and immunostained with an anti-Mv, oD antibody and 
counterstained with DAPI. For each culture, at least 100 cells per well in three 
individual wells were counted. The mean percentages of MyoD+ nuclei were calculated 
(a). Error bars represent the standard deviation. Untreated control cultures were 
compared with mig-infected cultures, and were not statistically significantly different. 
*** (p<0.001) denotes that there was a significant decrease in MyoD expression in 
Notch3/mig-infected Passage 0 cultures compared with mig-infected cultures, and there 
was also a significant decrease (* (p<0.05)) in MyoD expression in Notch3'mig- 
infected Passage 4 cultures compared with mig-infected cultures. Fluorescence 
microscopy images of the cultures immunostained to detect MyoD/DAPI are shown (b- 
m). MyoD was expressed in many myoblasts in untreated cultures (b, c, d) and mig- 
infected cultures (e, f, g) but was absent from Notch3/mig-infected Passage 0 cultures 
(h, i, j) and was expressed in fewer cells in Passage 4 cultures (k, 1, m). In Notch3 mig- 
infected cultures several small apoptotic cells were observed, which were not as 
abundant in untreated cultures. (Bar: 20µM. ) 
When differentiated cultures were pulsed with BrdU, the mean percentages of BrdU+ 
cells in untreated cultures (11.19±1.84) were similar to those of mig-infected cultures 
(10.11±1.4)(Figure 6.4). However, there was a significant increase in the percentage of 
BrdU+ cells in Notch3/mig-infected PO cultures (56.61±1.56; p<0.001), compared with 
mig-infected cultures (Figure 6.4). Again, the effect of active Notch3 decreased 
following subculture, corresponding with a diminished quantity, but it was still high 
enough to increase BrdU incorporation. Thus, the percentage of BrdU+ cells in P4 
cultures (19.44±2.39; p<0.05) was significantly higher than in mig-infected cultures 
(Figure 6.4). In contrast to proliferating cultures, constitutively active Notch3 appears 
to maintain proliferation to some extent in cultures induced to differentiate. 
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Figure 6.4: Effect of active Notch3 overexpression on proliferation in 
differentiated C2C12 cultures 
Untreated C2C12 myoblasts or cells infected with mig or tiotch 3'miýý crc propa, ' tted 
for 24 hours and then induced to differentiate. After 96 hours. cultures vv ere BrdU- 
pulsed, fixed and immunostained with an anti-BrdU antibody. Celli were 
counterstained with DAPI. For each culture, at least 100 cells per well in three 
individual wells were counted. The mean percentages of BrdU+ nuclei were calculated 
(a). Error bars represent the standard deviation. Untreated control cultures were 
compared with mig-infected cultures, and were not statistically significantly different. 
*** (p<0.001) denotes that there was a significant increase in BrdU incorporation in 
Notch3/mig-infected Passage 0 cultures compared with mig-infected cultures, and there 
was also a significant increase in BrdU incorporation in Notch3, mig-infected Passage 4 
cultures (* (p<0.05)) compared with mig-infected cultures. Fluorescence microscopy 
images of the cultures immunostained to detect BrdU/DAPI are shown (b-m). A small 
number of proliferating cells were present in untreated cultures (b, c, d) and mi`g- 
infected cultures (e, f, g). There appeared to be more proliferating cells in Notch3-m1g- 
infected Passage 0 (h, i, j) and Passage 4 cultures (k, 1, m). (Bar: 20 tM. ) 
To investigate the effect of active Notch3 on differentiation, cultures were 
immunostained to detect MHC and compared with cells infected with control retrovirus 
(Figure 6.5). When examining MHC expression, nuclei were counted rather than cells, 
so each nucleus within an MHC+ multinucleated myotube was counted as an MHC+ 
`cell'. Figure 6.5 shows that the mean percentages of MHC+ cells in untreated cultures 
(46.88±1.54) were similar to those of mig-infected cultures (49.88±1.48), as expected. 
MHC was absent in differentiated cultures derived from Notch3/mig-infected PO 
myoblasts. However, in cultures derived from P4 myoblasts some cells differentiated 
and expressed MHC (22.67%±4.49), although there was a significantly reduced number 
(p<0.001). 
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Figure 6.5: Effect of active Notch3 overexpression on differentiation in differentiated C2C12 cultures 
Untreated C2C12 myoblasts or cells infected with mig or Notch3'mi L, were prop igated for 24 hours and then differentiation was induced. After 96 hours. cultures were fixed 
and immunostained with an anti-MHC antibody. Cells were counterstained with D. -%PI. For each culture, at least 100 cells per well in three individual wells were counted. The 
mean percentages of MHC+ cells were calculated (a). Error bars represent the standard deviation. Untreated control cultures were compared with mig-infected cultures, and 
were not statistically significantly different. *** (p<0.001) denotes that there was a 
significant decrease in MHC expression in Notch3/mig-infected Passage 0 cultures and 
Passage 4 cultures compared with mig-infected cultures. Fluorescence microscopy 
images of the cultures immunostained to detect MHC/DAPI are shown (b-m). There 
was a large number of differentiated cells in untreated cultures (b, c. d) and miýg- 
infected cultures (e, f, g), but MHC was absent from Notch3, mig-infected Passa`geý0 
cultures (h, i, j) and was expressed in fewer cells in Passage 4 cultures (k, 1, m). In 
Notch3/mig-infected cultures several small apoptotic cells were observed, which wt ere 
not as abundant in control cultures. (Bar: 20µM. ) 
Together, these results suggest that expression of active Notch3 inhibits both 
proliferation and MyoD expression in proliferating myoblasts. Furthermore, following, 
the induction of differentiation active Notch3 prevented differentiation (consistent with 
MyoD downregulation) and also maintained proliferation to some extent. 
Immunostaining shows that constitutively active Notch3 might induce an increased rate 
of apoptosis (Figures 6.3 and 6.5). Therefore, it is possible that cells expressing a high 
level of Notch3 may be lost due to apoptosis as the passage number increases. 
6.4 Effect of active Notch3 overexpression on the size of C2C12 cells 
Notch3/mig-infected proliferating myoblasts appeared to be larger than control cells 
(Figure 6.2). This may be because they contain a greater quantity of DNA. perhaps due 
to a block in the cell cycle. Since active Notch3 influences BrdU incorporation in 
proliferating myoblasts and in cultures induced to differentiate (section 6.1). it is 
possible that Notch3 may play a role in regulation of the cell cycle during C2C 12 
myogenesis (see section 1.9.9). 
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The DNA content of the cell can provide an array of information about the cell cw c. 
To investigate the DNA content of Notch3 mig-infected myoblasts (PO and P4). 
compared with untreated myoblasts, cells were stained with propidium iodide (see 
Materials and Methods, section 2.14) and analysed by flow cytometry (Figure 6-6). A 
plot measuring FSC versus SSC shows that Notch3/mig-infected PO cells were slightly 
larger and denser than untreated cells (Figure 6.6), suggesting the DNA content may be 
increased. The proportions of Notch3/mig-infected cells and uninfected cells in each 
phase of the cell cycle were approximately the same, suggesting that active Notch3 may 
not block cell cycle progression. Notch3/mig-infected cultures contained an increased 
number of apoptotic cells (Figure 6.6), suggesting that active Notch3 may enhance 
apoptosis, consistent with immunostaining (Figures 6.3 and 6.5). FL2-H values show 
that Notch3/mig-infected cells have a higher DNA content than untreated cells (Figure 
6.6), suggesting that constitutively active Notch3 may increase DNA content. 
In Figure 6.7 it was shown that Notch3/mig-infected P4 cells possessed the same 
characteristics as PO cells. However, untreated cultures contained more apoptotic cells 
than Notch3/mig-infected P4 cultures, suggesting that the level of active Notch3, and 
hence its potential pro-apoptotic effect, had decreased. 
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Figure 6.6: Effect of active Notch3 overexpression on DNA content in proliferating 
myoblasts (Passage 0) 
Uninfected proliferating myoblasts or cells that were freshly-infected with Notch3 miu, 
(48 hours previously) were fixed and stained with propidium iodide, then counted using 
a FACScan flow cytometer. Forward scatter-height (FSC-H), which measures cell size, 
was plotted against side scatter-height (SSC-H), which measures cell granularity, for the 
untreated cells (a) and the Notch3/mig-infected cells (c). Notch3/mig-infected 
myoblasts appeared to be larger/denser than untreated cells. Healthy cells were gated 
(RI) and their orange-red fluorescence expression values (FL2) were plotted (a and c). 
FL2-A (area) values, which represent the intensity of staining (i. e. DNA content), were 
plotted against FL2-W (width) values, which indicate the time taken for cells to pass 
through the laser, thus differentiating between true diploid cells and haploid doublets, 
which were excluded via gating (R2). Plots summarise FL2-H (height) values, which 
represent DNA content of all healthy cells excluding haploid doublets, for untreated (b) 
and Notch3/mig-infected myoblasts (d). Lines drawn on the plot denote each phase of 
the cell cycle. The percentages of cells in each phase were approximately the same in 
infected versus uninfected cultures. 27.24% of untreated cells and 33.96% of 
Notch3/mig-infected cells were in GO/GI phase, while 30.9% of untreated cells and 
33.29% of Notch3/mig-infected cells were in S phase. 14.61% of untreated cells and 
22.44% of Notch3/mig-infected cells were in G2/M phase and 4.05% of untreated cells 
and 1.88% of Notch3/mig-infected cells may have been aneuploid. Cells with FL2-H 
values lower than those in GO/G 1 phase may have been apoptotic. Notch3/mig-infected 
cultures appeared to contain more apoptotic cells than untreated cultures. The final plot 
shows FL2-H values of healthy Notch3/mig-infected cells (purple) overlaid with 
untreated cells (green)(e). Notch3/mig-infected cells appear to have a higher DNA 
content than untreated cells. 
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Figure 6.7: Effect of active Notch3 overexpression on DNA content in proliferating 
myoblasts (Passage 4) 
Uninfected proliferating myoblasts or cells that were infected with Notch3/mig and 
subcultured four times (P4) were fixed and stained with propidium iodide, then counted 
by flow cytometry. FSC-H, which measures cell size, was plotted against SSC-H, 
which measures cell granularity, for the untreated cells (a) and the Notch3/mig-infected 
cells (c). Notch3/mig-infected myoblasts appeared to be larger/denser than untreated 
cells. Healthy cells were gated (R1) and their orange-red fluorescence expression 
values (FL2) were plotted (a and c). FL2-A values, which represent the intensity of 
staining (i. e. DNA content), were plotted against FL2-W values, which indicate the time 
taken for cells to pass through the laser, thus differentiating between true diploid cells 
and haploid doublets, which were excluded via gating (R2). Plots summarise FL2-H 
values, which represent DNA content of all healthy cells excluding haploid doublets, for 
untreated (b) and Notch3/mig-infected myoblasts (d). Lines drawn on the plot denote 
each phase of the cell cycle. The percentages of cells in each phase were approximately 
the same in infected versus uninfected cultures. 42.38% of untreated cells and 40.8% of 
Notch3/mig-infected cells were in GO/GI phase, while 26% of untreated cells and 
25.1% of Notch3/mig-infected cells were in S phase. 21.06% of untreated cells and 
21.7% of Notch3/mig-infected cells were in G2/M phase and 2.53% of untreated cells 
and 1.28% of Notch3/mig-infected cells may have been aneuploid and hence contained 
additional chromosomes. Cells with FL2-H values lower than those in GO/G l phase 
may have been apoptotic. Untreated cultures appeared to contain more apoptotic cells 
than Notch3/mig-infected P4 cultures. The final plot shows FL2-H values of healthy 
Notch3/mig-infected cells (purple) overlaid with untreated cells (green)(e). 
Notch3/mig-infected cells appear to have a higher DNA content than untreated cells. 
6.5 Analysis of proliferation in cells overexpressing active Notch3 
In proliferating myoblasts, overexpressed constitutively active Notch3 appeared to 
inhibit proliferation, while upon the induction of differentiation it seemed to enhance 
proliferation (section 6.3). Therefore, the role of active tiotch3 in regulating 
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proliferation during myogenesis was further investigated. Untreated cells and 
Notch3/mig-infected cells were propagated for 24 hours and then induced to 
differentiate. At intervals up to 48 hours, cultures were BrdU-pulsed, fixed and 
immunostained using an anti-BrdU antibody. Pilot experiments su`gested that 
confluency might affect BrdU incorporation in ti otch3 mi g-infected cultures. To 
investigate this, the experiment was replicated with cells either seeded at low density 
(5.3x 103 cells per cm2) or high density (1.07x 104 cells per cm). 
Figure 6.8 shows that the mean percentage of BrdU+ cells in low-density and 
high-density untreated cultures decreased as differentiation proceeded. In low- and 
high-density cultures, at TO there was a significantly lower percentage (p<0.0) of 
BrdU+ cells in Notch3/mig-infected cultures (low density: 28.26±14.51; high density: 
53.77±1.67) compared with untreated cultures (low density: 62.46±3.21; high density: 
61.87±3.41), as shown previously (Figure 6.2), suggesting that in proliferating 
myoblasts constitutively active Notch3 inhibits proliferation. Forty-eight hours after 
differentiation was induced (T48) there was a significantly higher percentage (p<0.01) 
of BrdU+ cells in low-density Notch3/mig-infected cultures (41.7±6.85) compared with 
untreated cultures (8.44±3.05), as previously observed (Figure 6.4), suggesting that 
when differentiation is induced constitutively active Notch3 enhances proliferation. In 
high-density cultures, at T24 and T48 there were also significantly higher (p<0.05 and 
p<0.01 respectively) percentages of BrdU+ cells in Notch3/mig-infected cultures (T24: 
40.87±6.06; T48: 18.08±2.75) compared with untreated cultures (T24: 24.68±3.91: T48: 
1.82± 1.35). However, the percentage of BrdU+ cells in the low-density Notch3 mig- 
infected culture increased as differentiation proceeded, as expected, while the 
percentage of BrdU+ cells in the high-density culture decreased with time (but at a 
slower rate than those cells in the untreated culture). This suggests that cell confluenc\, 
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and, therefore, probably cell-cell signalling, affects the ability of constitutively active 
Notch3 to enhance proliferation Mien differentiation is inducedl. 
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Figure 6.8: Effect of active Notch3 overexpression on proliferation in low- and 
high-density differentiating C2C12 cultures 
Untreated C2C 12 myoblasts or cells freshly-infected with Notch3/mig were seeded at 
low density (5.3x103 cells per cm`) or high density (1.07x104 cells per cm2) in 8-well 
chamber slides, propagated for 24 hours and induced to differentiate. After 0 (TO), 6 
(T6), 12 J12), 24 (T24), 36 (T36) or 48 (T48) hours, cultures were BrdU-pulsed, fixed 
and immunostained with an anti-BrdU antibody. Cells were counterstained with DAPI. 
For each culture, at least 100 cells per well in three individual wells were counted. The 
mean percentages of BrdU+ nuclei were calculated. Low-density untreated cultures 
were compared with corresponding Notch3/mig-infected cultures (a) and high-densit\ 
untreated cultures were compared with corresponding Notch3/mig-infected cultures N. 
Error bars represent the standard deviation. * (p<0.05), ** (p<0.01) and *** (p- (). W 
denote statistical significance between cultures. See text for details. 
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6.6 Effect of active Notch3 overexpression on apoptosis 
When differentiation is induced, while a subpopulation of C2C 12 m}-obla is undergo 
terminal differentiation and form myotubes and a subpopulation remain undifferentiated 
reserve cells, a subset of cells undergo apoptosis (Cao et al., 2003). Immunostaining 
(Figures 6.3 and 6.5) suggests that cultures overexpressing constituti\ eh' active Notch3 
may contain a higher number of cells with an apoptotic phenotype. Flow cytometry of 
propidium iodide-stained cultures also suggests that active Notch3 may be pro-apoptotic 
(Figures 6.6 and 6.7). Therefore, the role of active Notch3 in regulating apoptosis 
during myogenesis was further investigated. 
Untreated cells and Notch3/mig-infected P2 or P4 cells were propagated for 24 hours 
and then differentiation was induced. After 24 hours, cultures were fixed and 
immunostained using an anti-caspase 8 antibody. Caspases are a group of cysteine 
proteases that are the central effectors of apoptosis (Fesik and Shi, 2001). Therefore, 
caspase 8 expression should identify cells that have begun to apoptose. 
Figure 6.9 shows that there was a significant increase in the mean percentage of cells 
that expressed caspase 8 in Notch3/mig-infected Passage 2 (p<0.01) and Passage 4 
(p<0.001) cells compared with untreated cells. There was no significant difference in 
caspase 8 expression between Passage 2 and Passage 4 Notch3/mig-infected cultures. 
This suggests that constitutively active Notch3 enhanced apoptosis in myoblasts 
induced to differentiate. Therefore, endogenous Notch3 may function to enhance 
apoptosis during myogenesis. 
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Figure 6.9: Effect of active Notch3 overexpression on caspase 8 expression in 
differentiating C2C12 cells 
Untreated C2C 12 myoblasts or cells infected with Notch3/mig, passaged two or four 
times, were propagated for 24 hours and then induced to differentiate. After 24 hours, 
cultures were fixed and immunostained with an anti-caspase 8 antibody. Cells were 
counterstained with DAPI. For each culture, at least 100 cells per well in three 
individual wells were counted. The mean percentages of caspase 8' cells were 
calculated. Error bars represent the standard deviation. There was a significant increase 
in the mean percentage of caspase 8+ Notch3/mig-infected Passage 2 (** (p<0.01)) and 
Passage 4 (*** (p<0.001)) cells compared with untreated cells. There was no 
significant difference in caspase 8 expression between Passage 2 and Passage 4 
Notch3/mig-infected cultures (p=0.116). 
6.7 Effect of active Notchl and Notch3 co-overexpression on C2C12 
myoblasts and differentiated cultures 
In chapter 5 it was shown that D114 and Jaggedl function in the maintenance of 
proliferating myoblasts and in determining alternate cell fate. It was suggested that 
Jaggedl may upregulate Notchl in proliferating myoblasts, while D114 may upregulate 
Notch3 in reserve cells, and the two receptors may have distinct functions in the 
different cell-types. Double-infection of cells with constitutively active Notch I and 
Notch3 was carried out to investigate whether the receptors were differentially 
dominant in proliferating myoblasts and reserve cells. 
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Cells overexpressing constitutively active Notch I or N otch3. or both « crc cultured for 
24 hours in growth medium and they were BrdU-pulsed, fixed and immunostained to 
detect BrdU, or were immunostained for MyoD. There was no significant difference in 
BrdU incorporation between any of the cultures (Figure 6.10), suggesting that neither 
overexpressed receptor had a predominant effect on myoblast proliferation. However. 
the percentage of MyoD+ cells in Notch3/mig-infected cultures and eGFP- 
NIC/puro+Notch3/mig-infected cultures (0±0 for both) was significantly lower (p<O. 01) 
than in eGFP-NIC/puro-infected cultures (5.08±0.85). 
293 
a 
IA 
u 
a 
G 
D 
Co 
0 
a) 
a) u I- a) a 
a) f 
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 
b 
50 
d V 
CL 40 
G 
o 30 
i 
04- 0 
20 
c 
d u 10 
CL 
C 
f0 
w0 
ýo 
`QJ 
ý. SG 
ýQ. 
eG 
t0 
QJ 
SGý 
eGý 
r3ý 
loo 
ýýý 
r3ý 
cý ýo 
(o 
Q, ýS 
e, ýo x 
1(° 
Qýýa ßr FI 
Figure 6.10: Effect of active Notchl and Notch3 co-overexpression on proliferation 
and MyoD expression in C2C12 proliferating myoblasts 
Myoblasts infected with eGFP-NIC/puro, Notch3/mig or eGFP-NIC/puro+Notch3, mig 
were propagated for 24 hours in growth medium. Cultures were either fixed and 
immunostained with an anti-MyoD antibody, or BrdU-pulsed, fixed and immunostained 
with an anti-BrdU antibody. Cells were counterstained with DAPI. For each culture, at 
least 100 nuclei per well in three individual wells were counted. The mean percentages 
of BrdU+ (a) or MyoD+ (b) nuclei were calculated. Error bars represent the standard 
deviation. There was no significant difference in BrdU incorporation between any of 
the cultures. ** (p<0.01) denotes that MyoD expression in Notch3 mig-infected 
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cultures and eGFP-NIC/puro-±\otch3 mig-infected cultures was significantly lower 
than in eGFP-NIC/puro-infected cultures. However, there was no si`_nificant difference in the percentage of MyoD+ cells in Notch3/mig-infected cultures and doubly-infected 
cultures. 
The effect of coexpressed active Notchl and Notch3 on cell fate determination 
following the induction of differentiation was also investigated. Double-infected cells 
were cultured for 24 hours and then induced to differentiate. After 96 hours. cultures 
were BrdU-pulsed, fixed and immunostained to detect BrdU incorporation, or fixed and 
immunostained for MHC expression. Figure 6.11 shows the mean percentages of 
BrdU+ cells in Notch3/mig-infected cultures (56.61±0.56) and eGFP- 
NIC/puro+Notch3/mig-infected cultures (45.73± l . 
63) were significantly higher 
(p<0.01) than in eGFP-NIC/puro-infected cultures (14.86.: t5.15). The percentage of 
BrdU+ cells in Notch3/mig-infected cultures was significantly different (p<0.05), 
compared with doubly-infected cultures, suggesting that in doubly-infected cultures 
active Notch l may have the predominant effect on proliferation. There was no 
significant difference in MHC expression between any of the cultures, although none of 
the Notch3-mig infected cells or doubly-infected cells differentiated, while some of the 
eGFP-NIC/puro-infected cells did differentiate. This suggests that active Notch I and 
Notch3 both inhibit differentiation. 
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Figure 6.11: Effect of active Notchl and Notch3 co-overexpression on proliferation 
and differentiation in differentiated C2C12 cultures 
Myoblasts infected with eGFP-NIC/puro, Notch3/mig or eGFP-NIC/puro+Notch 3 nil(-, 
were propagated for 24 hours in growth medium and induced to differentiate. After 96 
hours, cultures were either fixed and immunostained with an anti-MHC antibody, or 
BrdU-pulsed, fixed and immunostained with an anti-BrdU antibody. Cells were 
counterstained with DAPI. For each culture, at least 100 cells per well in three 
individual wells were counted. The mean percentages of BrdU- (a) or MHC (b) cell, 
were calculated. Error bars represent the standard deviation. ** (p<0.0I) denotes that 
BrdU incorporation in Notch3/mig-infected cultures and eGFP-NIC, puro+Notch3 mig- 
infected cultures was significantly higher than in eGFP-NIC/puro-infected cultures. 
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The percentage of BrdU+ cells in Notch3imig-infected cultures was ý, iumificantlv higher (* (p<0.05)) than in doubly-infected cultures. There was no significant difference in MHC expression between any of the cultures. 
6.8 Effects of active Notchl or Notch3 overexpression on regulation of 
the cdk inhibitors p21 and p27 in C2C12 cells 
Several of the results obtained in this chapter suggest that active tiotch3 may function 
in cell cycle regulation. For example, constitutively active Notch3 appears to inhibit 
myoblast proliferation, but enhances proliferation when differentiation is induced. In 
addition, active Notch3 increases the size and DNA content of C2C 12 cells and may 
upregulate apoptosis (section 6.6). 
A variety of evidence (see section 1.9.9) suggests that Notch signalling may regulate the 
cell cycle by inducing changes in the expression of p2l and p27, which are cdk 
inhibitors (Cao et al., 2003). To investigate whether the receptors differentially regulate 
p2l and p27, their expression was investigated in cells overexpressing active Notch 1 or 
Notch3. Untreated or infected myoblasts were propagated in growth medium for 24 
hours, protein was extracted and samples were analysed by Western blotting, using anti- 
p21 and anti-p27 antibodies. Figure 6.12 shows that p27 was expressed in all samples, 
but was more abundant in Notch3/mig-infected myoblasts, suggesting that Notch3 may 
induce p27 expression. p21 expression is a prerequisite for irreversible cell cycle 
withdrawal that precedes differentiation (Cao et al., 2003), and as expected, it was not 
expressed in proliferating myoblasts. 
Untreated myoblasts and Notch3/mig-infected myoblasts were propagated in growth 
medium for 24 hours and then differentiation was induced. After 96 hours, cells were 
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fixed and stained with an anti-p27 antibody, to detect quiescent cells, and an anti-MHC 
antibody. Untreated cultures contained a large number of differentiated cells as well as 
p27+ nuclei (Figure 6.12). The p27 antibody was not completely accurate since it was 
expressed in the nuclei of some myotubes (see section 1.9.9; p27 is normally expressed 
in reserve cells). However, it was more highly expressed in nuclei outside of myotubes, 
which are presumably quiescent reserve cells. Notch3/mig-infected cultures did not 
contain any differentiated cells, but p27 was expressed in all nuclei, suggesting that 
constitutively active Notch3 induces expression of p27, consistent with Western blot 
data (Figure 6.12). 
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Figure 6.12: Effects of active Notchl or Notch3 overexpression on the regulation of 
p21 and p27 in C2C12 cells 
Untreated C2C 12 myoblasts or cells infected with Notch3/mig, eGFP-NIC1 puro, mig or 
puro were propagated for 24 hours, protein was extracted and was analysed by Western 
blotting (a). Sizes of the proteins are listed next to the corresponding bands. x-tubulin 
was used as a loading control and confirms that the samples were loaded equally. An 
antibody against p27 demonstrated that p27 was expressed in all samples, but was more 
abundant in Notch3/mig-infected myoblasts. An anti-p2l antibody showed that p21 
was absent from proliferating myoblasts. Untreated myoblasts or Notch3/mig-infected 
cells were propagated for 24 hours and then induced to differentiate. After 96 hours. 
cultures were fixed and immunostained with an anti-MHC antibody and an anti-p2-7 
antibody. Cells were counterstained with DAPI. Fluorescence microscopy images of 
the cultures are shown (b-i). There were a large number of differentiated cells in 
untreated cultures and p27 was expressed in several nuclei (b, c, d, e). Notch3 mw- 
infected cultures contained no differentiated cells, but p27 was expressed in all nuclei (f. 
g, h, i). (Bar: 20µM. ) 
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6.9 Discussion 
Active Notch 1, Notch2 and Notch3 are expressed during differentiation of CC' l2 
cultures, particularly in proliferating cells (Notch1 and Notch2) and in reserve cells 
(Notch1, Notch2 and Notch3). This suggests potential roles in maintaining proliferation 
and specification of reserve cells, possibly through differential activation of receptors. 
Indeed, Notch 1 and Notch2 are structurally similar, and may have conserved functions 
(Kraman and McCright, 2005; Shimizu et al., 2002), whereas Notch3 (which is 
structurally and functionally diverged (Lardelli et al., 1994; Shimizu et al., 2002)) may 
play a distinct role from the other two receptors. 
Overexpressed constitutively active Notch3 was capable of inhibiting myogenic 
differentiation to an even greater extent than Notch l (section 4.3.1). In proliferating 
myoblasts, constitutively active Notch3 completely inhibited MyoD expression and 
completed inhibited differentiation when it was induced. It is possible, therefore, that 
the mechanism of inhibition of differentiation by active Notch3 is the same as that of 
Notchl; either via RBP-JK-dependent direct inhibition of MyoD or by RBP-JK- 
independent inhibition of myogenesis at a target upstream of MyoD, resulting in MyoD 
downregulation (Kopan et al., 1994; Kuroda et al., 1999; Nofziger et al., 1999; Shawber 
et al., 1996). This could be investigated by overexpressing MyoD in Notch3/mig- 
infected cells. 
Overexpressed active Notch3 had several effects that suggest it is involved in regulation 
of the cell cycle. Freshly-infected cultures showed uniform high levels of Notch 
expression. When subcultured, the number of cells that expressed GFP (and ti otch3 ) 
remained approximately the same, but the proportion of high-expressing cells declined 
with an increasing number of passages, while the proportion of cells expressing low 
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levels of Notch3 increased. It is possible that the cells containing a high level of 
Notch3 may have undergone apoptosis. resulting in relative expansion of cells 
expressing lower levels of Notch3. Indeed, Notch3-infected cells were shown to have a 
higher rate of apoptosis, demonstrated by FACS analysis of propidium iodide-stained 
cells, immunostaining and increased caspase 8 expression. 
Increased levels of apoptosis may have been regulated by the cdk inhibitors p2l and 
p27 (see section 1.9.9). Active Notch3 markedly upregulated p27 expression and, 
therefore, may have induced downregulated expression of p21 (this would need to be 
confirmed by Western blotting). Upregulation of p21 and dephosphorylation of the 
retinoblastoma protein are critical regulatory components of both the post-mitotic state 
and an apoptosis-resistant state (Walsh and Perlman, 1997). The potential 
downregulation of p21 expression in cells overexpressing constitutively active Notch3. 
would, therefore, confer a lack of apoptotic resistance to those cells. 
Overexpressed constitutively active Notch3 appeared to inhibit proliferation in 
myoblasts, but enhanced proliferation once differentiation was induced. However, the 
density of the cultures determined the effect of Notch3 during proliferation, since 
cultures seeded at a low density (the same normal seeding density) showed this pattern. 
while cultures seeded at a high density were unaffected. A similar density-dependence 
has been observed in VSMC, where it was suggested that Notch signalling might 
regulate cell growth. VSMC expressing constitutively active Notch3 exhibited a 
biphasic growth behaviour in which proliferation was retarded during the subconfluent 
phase but failed to decelerate post-confluence (Campos et al., 2002). This suggests that 
as well as mitogens, confluency can affect Notch3 signalling in VSMC (Campos et al., 
2002). 
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In C2C12 cells expressing constitutively active ', sotch3. proliferation was extremely 
slow in cultures seeded at a low density that were subconfluent. but only slightly slower 
than control cultures when seeded at a higher density. When differentiation NN as 
induced, control cells withdrew from the cell cycle and entered terminal differentiation. 
However, in Notch3-infected cultures seeded at a low density, proliferation significantly 
increased, reaching a peak level when the culture contained a threshold density of cells 
capable of incorporating BrdU, after which proliferation began to slowly decrease 
again. The Notch3-infected cultures seeded at a higher density already contained this 
threshold density of cells before differentiation was induced, and so the rate of 
proliferation slowly decreased with time (after differentiation was induced), as cells 
became more confluent. This suggests that the presence or absence of mitogens had no 
effect on Notch3 signalling and that regulation of proliferation via Notch3 signalling 
appears to be determined by the confluency of the culture i. e. cell-cell contacts. 
In low-density cultures, where there are few cell-cell contacts, signalling via 
constitutively active Notch3 is probably the predominant mode of Notch signalling and 
facilitates a lower rate of proliferation. This is consistent with the high-level expression 
of the cdk inhibitor p27 observed in Notch3-expressing cells, which should induce cells 
to enter GO phase (Cao et al., 2003). In cultures that are initially seeded at a higher 
density, or as the confluency of the culture increases with time, more cell-cell contacts 
are made, facilitating activation of the other Notch receptors (Notchl and Notch2). 
which inhibit Notch3 signalling (and consequently p27 expression), leading to an 
increased rate of proliferation. However, once a certain threshold level of confluence 
has been reached, Notch signalling results in a decrease in proliferation. perhaps 
because Notch3 predominates and via p27 expression induces quiescence. Therefore. in 
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proliferating myoblasts Notch 1 and Notch2 signalling must predominate over \ otch- so 
that the cells can undergo proliferation. When differentiation is induced, Notch I and 
Notch2 continue to predominate until a certain threshold lee el of confluence is reached. 
at which Notch3 is activated in specific cells. specifying them to remain 
undifferentiated quiescent reserve cells via upregulation of p27. 
If the above is correct, it would predict that FACS analysis of propidium iodide-stained 
myoblasts overexpressing active Notch3 would indicate a greater number of cells in the 
GO phase, due to high p27 expression. However, this was not the case. probably 
because the cells were actually seeded at a higher density than normal, thus increasing 
cell-cell contacts, which would upregulate other modes of Notch signalling that 
facilitate proliferation. 
The amount of DNA in Notch3-infected cells was slightly higher than it was in control 
cells, although this was not due to increased ploidy. C2C 12 cells are aneuploid 
normally (Anastasia et al., 2006), so can contain extra chromosomes, but constitutively 
active Notch3 appeared to enhance aneuploidy. This effect of overexpressed Notch3 
may be related to the multifaceted role of Notch signalling in cancer (Roy et al., 2007). 
As well as affecting proliferation of C2C12 cultures, constitutively active Notch3 
appeared to cause an increase in the size of C2C 12 cells. In VSMC constitutively active 
Notch3 affects the cell shape in a similar way, so cells are larger and rounder than 
control cells. This is because active Notch3 alters the actin cytoskeletal dynamics in 
VSMC, so there is an increase in actin fibres and steady-state levels of polymerised 
actin (Domenga et al., 2004). Therefore, in C2C 12 cells Notch3 o ere pression may 
also increase cell-size by altering actin dynamics, which may enhance cell motility and 
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migration (Chakravarti et al., 2005). 
In chapter 5, it was established that D114 and Jaggedl both activate 'Notch signalling in 
adjacent cells, inhibiting differentiation. It was suggested that membrane-bound 
Jaggedl expressed by proliferating myoblasts might activate Notch receptors in 
adjacent myoblasts. However, when myoblasts are induced to differentiate, 
monoubiquitinated D114 expressed on the surface of nascent myotubes may inhibit 
differentiation of adjacent cells so they are maintained as undifferentiated reserve cells. 
Furthermore, Jaggedl on the surface of reserve cells may activate Notch receptors in 
adjacent cells and increase recruitment. Alternatively, Jagged l may activate 'Notch 
signalling in adjacent myotubes, affecting their growth or apoptosis. Since signalling 
via the two ligands results in different outcomes, it is possible that they differentially 
activate the three receptors. Thus, one receptor may predominate in a specific cell-type, 
causing the cells to either proliferate or become quiescent as appropriate: Jagged 1 may 
activate Notchl in proliferating myoblasts, while D114 may activate Notch3 in reserve 
cells, and the two receptors may have distinct functions. 
Interaction between Notchl and Notch3 could also determine the predominant 
signalling pathway. The Notchl ICD is a potent activator of the HES promoter, while 
the Notch3 ICD is a much weaker activator and can repress Notchl ICD-mediated HES 
activation in some contexts (Beatus et al., 1999). Both Notch1 and Notch3 ICDs can 
displace the corepressor SMRT from RBP-JK on the HES promoter, and compete to 
displace it. Both ICDs can also bind to RBP-JK but their difference in activation 
capacity stems from their structural differences when positioned on 
RBP-JK. The 
Notchl ANK region confers potent activation capability to the 
Notchl ICD. In 
addition, the structure of the RE/AC region facilitates Notch 
l LCD's ability to activate 
304 
and Notch3 ICD's ability to repress a HES promoter (Beatus et al., 2001'). As ýt e11 a, 
direct competition between Notchl and Notch3 ICDs for binding to RBP-JK and 
subsequent activation or repression of target genes. it has also been shown that the 
Notch receptors are differentially targeted by the various Numb isoforms for 
ubiquitination and degradation. Notchl is targeted by all four Numb isoforms while 
Notch3 is not a target of any Numb protein (Beres et al., 2006). These data represent an 
additional mechanism by which Notchl (and Notch2) or Notch3 may predominate in 
specific cell-types. 
To address this, double-infection of cells with constitutively active Notch l and 
constitutively active Notch3 was carried out. When active Notch 1 and Notch3 were 
coexpressed in proliferating myoblasts there was no effect on BrdU incorporation. 
Earlier it was suggested that if Notch 1 signalling is active in C2C 12 cells in addition to 
Notch3 signalling (activated by cell-cell contact and subsequent ligand-Notch receptor 
interaction), that the decrease in proliferation caused by Notch3 would be overridden, 
resulting in proliferation. The coexpression data is, therefore, consistent with the 
suggestion that when Notch l. and Notch3 are both active, Notch l signalling controls 
proliferation of myoblasts (endogenous Notchl signalling ensures that proliferation is 
maximal). Overexpressed active Notchl or Notch3 both inhibit MyoD expression in 
proliferating myoblasts. In cells that co-overexpressed both receptors. MyoD 
expression was highly inhibited, which could have been mediated via activity of the 
receptors individually or cooperatively. 
When differentiation was induced, Notchl had a lesser effect on proliferation than 
Notch3, but when the receptors were coexpressed although the level of proliferation 
was still high, the upregulation of Notch l did appear to cause a decrease in 
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proliferation, again suggesting that endogenously Notch 1 may regulate the number of 
cycling cells present in differentiated cultures. In cells that co-o,, erexpres,, ed hoth 
receptors, differentiation was highly inhibited. which could have been mediated via 
activity of the receptors individually or cooperatively. Coexpression suggests that 
active Notch3 inhibits differentiation slightly more effectively than acti\ e Notch 1. 
Since Notch3 also highly upregulated p27 expression, which induces cells to enter a 
quiescent state, it is likely that high levels of Notch3 may predominate in reserve cells. 
both inhibiting differentiation and ensuring that the cells become quiescent. 
In proliferating cultures, Notchl and Notch3 may both be activated by Jaggedl 
expressed on adjacent myoblasts. However, subsequent competition between the 
Notchl and Notch3 receptors for binding to RBP-Jx or a common coactivator may 
result in the dominance of Notchl signalling, which maintains proliferation and 
downregulates MyoD. When differentiation is induced, Notchl and Notch3 may be 
activated by monoubiquitinated D114 expressed on the surface of adjacent nascent 
myotubes. However, subsequent competition between the Notch 1 and Notch3 receptors 
for binding to RBP-JK or a common coactivator, in addition to expression of Numb 
isoforms that may cause degradation of Notch 1 but not Notch3, may result in dominant 
Notch3 signalling. High levels of active Notch3 in reserve cells may cause 
downregulation of MyoD expression and subsequent inhibition of differentiation as well 
as upregulation of p27 expression, which causes the cells to become quiescent. 
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CHAPTER 7: Expression of Notch signalling pathway 
components in satellite cells 
7.1 Introduction 
Results presented in previous chapters suggest that Notch l (and hence potentially 
Notch2) and Notch3 may function in the maintenance of proliferating myoblasts and in 
specifying reserve cells. It was proposed that Jagged l might activate receptors in 
proliferating myoblasts, while upon the induction of differentiation monoubiquitinated 
D114 on nascent myotubes may activate receptors in adjacent reserve cells. Experiments 
presented in this chapter were carried out to investigate endogenous expression of the 
Notch receptors, D114 and Jaggedl in satellite cells on single fibres, to determine 
whether they may regulate satellite cell behaviour as proposed in the model of C'-IC 12 
cell myogenesis described in chapter 3 (Figure 3.13). 
7.2 Expression of Notch signalling component transcripts in single 
fibre preparations 
To investigate the expression of Notch component transcripts in quiescent and activated 
satellite cells, cDNA was prepared from individual myofibres (complete with their 
associated satellite cells) cultured in suspension for 0 (TO), 24 (T24) or 48 (T48) hours. 
and nested PCR was carried out (see Materials and Methods, section 2.12.7). Figure 7.1 
shows that Notchl transcripts were present in 5/12 TO individual fibre preparations and 
3/12 at T24. At T48, Notchl was expressed in all 10 preparations. Although nested 
RT-PCR is not quantitative, Notch l mRNA appeared to be less abundant in the positiv e 
T24 preparations, compared with TO and T48 preparations. It is unknown whether 
transcripts are expressed in the myofibre, satellite cells (if so. how many) or both. 
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Figure 7.1: Notchl transcript expression in individual myofibre preparations 
Murine EDL muscles were collagenase-digested to disaggregate the myofibres. Fibres, 
complete with their resident satellite cells, were cultured in suspension for 0 (TO), 24 
(T24) or 48 (T48) hours in activation medium. At each time point, ten to twelve fibres 
were individually lysed to isolate RNA. A negative control, containing culture medium 
without a fibre (control), and two positive controls, containing 50ng undifferentiated 
C2C 12 RNA (TO C2C 12) or differentiated C2C 12 RNA (T96 C2C 12) were also lysed. 
Multiplex RT-PCR was carried out using external HPRT and Notch l primers. 
Resultant cDNA was amplified in individual nested PCR reactions and products were 
run on agarose gels (sizes are indicated next to the corresponding bands). HPRT and 
Notchl transcripts were present in the positive controls but absent from the negative 
controls, confirming that there was no contamination during the nested RT-PCR 
reactions. HPRT, a housekeeping gene, acted as a loading control and confirmed that 
there was a fibre present in each preparation at all time points. 
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Figure 7.2: Notch2 transcript expression in individual myofibre preparations 
Murine EDL muscles were collagenase-digested and disaggregated myofibres, complete 
with their resident satellite cells, were cultured in suspension for 0 (TO), 24 (T24) or 48 
(T48) hours in activation medium. At each time point, ten to twelve fibres were 
individually lysed to isolate RNA. A negative control, containing culture medium 
without a fibre (control), and two positive controls, containing 50ng undifferentiated 
C2C 12 RNA (TO C2C 12) or differentiated C2C 12 RNA (T96 C2C 12) were also lysed. 
Multiplex RT-PCR was carried out using external HPRT and Notch2 primers. 
Resultant cDNA was amplified in individual nested PCR reactions and products were 
run on agarose gels (sizes are indicated next to the corresponding bands). HPRT and 
Notch2 transcripts were present in the positive controls but absent from the negative 
controls. HPRT acted as a loading control and was expressed in all fibre preparations at 
each time point. 
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Figure 7.3: Notch3 transcript expression in individual myofibre preparations 
Murine EDL muscles were collagenase-digested and disaggregated myofibres, complete 
with their resident satellite cells, were cultured in suspension for 0 (TO), 24 (T24) or 48 
(T48) hours in activation medium. At each time point, twelve fibres were individually 
lysed to isolate RNA. A negative control, containing culture medium without a fibre 
(control), and two positive controls, containing 50ng undifferentiated C2C12 RNA (TO 
C2C 12) or differentiated C2C 12 RNA (T96 C2C 12) were also lysed. Multiplex RT- 
PCR was carried out using external HPRT and Notch3 primers. Resultant cDNA was 
amplified in individual nested PCR reactions and products were run on agarose gels 
(sizes are indicated next to the corresponding bands). HPRT and Notch3 transcripts 
were present in the positive controls but absent from the negative controls. HPRT acted 
as a loading control and was expressed in all fibre preparations at each time point. 
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Notch2 transcripts were expressed in 12/12 TO individual myofibre preparations and 
9/12 at T24 (Figure 7.2). At T48, Notch2 was expressed in 8110 preparations. Figure 
7.3 shows that Notch3 transcripts were present in 9 12 TO individual myofibre 
preparations and 8/12 at T24. At T48, Notch3 was expressed in 10,12 preparations. 
Nested RT-PCR is not quantitative, but, like Notch 1. both N otch2 and \ otch 
transcripts appeared to be expressed at a lower level in positive T24 samples. compared 
with TO and T48 preparations. 
D114 transcripts were expressed in 10/12 TO individual myofibre preparations, but only 
1/12 at T24 and T48 (Figure 7.4). D114 mRNA seemed to be less abundant in the 
positive T24 sample than in the positive TO and T48 preparations. Figure 7.5 shows 
that Jaggedl transcripts were present in 12/12 of the TO, T24 and T48 myofibre 
preparations. Jaggedl mRNA was expressed at a lower level in 1/12 preparations at TO, 
7/12 at T24 and 1/12 at T48, compared with the other preparations at each time point. 
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Figure 7.4: Dll4 transcript expression in individual myofibre preparations 
Murine EDL muscles were collagenase-digested and disaggregated myofibres. complete 
with their resident satellite cells, were cultured in suspension 
for 0 (TO), 24 (T24) or 4`N 
(T48) hours in activation medium. At each time point, twelve fibres were 
individually 
lysed to isolate RNA. A negative control, containing culture medium without a 
fibre 
(control), and two positive controls, containing 50ng undifferentiated 
C2C12 RNA (To 
C2C12) or differentiated C2C12 RNA (T96 C2C2) were also 
lysed. Multiplex RT- 
PCR was carried out using external HPRT and D114 primers. 
Resultant cDNA wwwa' 
amplified in individual nested PCR reactions and products were run on agarose gek 
(sizes are indicated next to the corresponding bands). HPRT and 
D114 transcripts were 
present in the positive controls but absent from the negative controls. 
HPRT acted aa" a 
loading control and was expressed in all fibre preparations at each time point. 
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Figure 7.5: Jagged! transcript expression in individual myofibre preparations 
Murine EDL muscles were collagenase-digested and disaggregated myofibres, complete 
with their resident satellite cells, were cultured in suspension for 0 (TO), 24 (T24) or 48 
(T48) hours in activation medium. At each time point, twelve fibres were individually 
lysed to isolate RNA. A negative control, containing culture medium without a fibre 
(control), and two positive controls, containing 50ng undifferentiated C2C 12 RNA (TO 
C2C 12) or differentiated C2C 12 RNA (T96 C2C 12) were also lysed. Multiplex 
RT- 
PCR was carried out using external HPRT and Jagged 1 primers. Resultant cDNA 
amplified in individual nested PCR reactions and products were run on agarose gc 
(sizes are indicated next to the corresponding bands). HPRT and 
Jagged l transcrip 
were present in the positive controls but absent from the negative controls. 
HPRT acta. 
as a loading control and was expressed in all fibre preparations at each time point. 
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7.3 Notch protein expression in satellite cells 
RT-PCR analysis revealed the presence of Notch pathway component tran criptN in 
preparations of individual myofibres. To investigate where protein expression «as 
localised (i. e. in satellite cells or fibres), individual myofibres were immunostained after 
0 (TO), 24 (T24), 48 (T48) or 72 (T72) hours in suspension culture. \Iyofibres at each 
time point were fixed, permeabilised and co-immunostained (see Materials and 
Methods, sections 2.8.2.1 and 2.9.3) for Pax7 and the Notchl extracellular domain 
(Notch 1 e), Notch l intracellular domain (Notch l i) or Notch2 intracellular domain. 
Fibres were counterstained with DAPI. Attempts were made to immunostain fibres 
using all Notchl, Notch2, Notch3, D114, Jaggedl and Numb antibodies listed in Tabic 
2.1, as well as monoclonal goat anti-mouse Notch3 (R&D Systems) and polyclonal goat 
anti-D111 (H20 and T20; Santa Cruz Biotechnology, Inc. ) antibodies, without success, 
even using the protocol described by Conboy and Rando (2002). 
Figure 7.6 shows that Notch1 and Notch2 are either absent of expressed at a very low 
level on the surface of Pax7+ quiescent satellite cells at TO. The ECD-specific Notch 1 
antibody only detects membrane-bound Notch 1, but the ICD-specific Notch antibodies 
should be capable of detecting both inactive, membrane-bound Notch and active, 
nuclear Notch. The ICD-specific antibodies showed that, where present, Notch 1 and 
Notch2 were expressed on the cell surface, suggesting that Notchl and Notch2 were 
inactive. Interpretation was also confounded by high levels of background staining on 
the myofibres (also shown in Figures 7.7,7.8 and 7.9), a common problem encountered 
with many antibodies (e. g. ß-galactosidase-stained myofibres in Collins et al. (2007)). 
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Figure 7.6: Notchl and Notch2 expression in quiescent satellite cells on individual 
myofibres 
Murine EDL muscles were collagenase-digested to disaggregate the myofibres. 
Freshly-isolated individual fibres with their associated quiescent satellite cells were 
fixed, permeabilised and coimmunostained using an antibody to detect Pax7 with an 
antibody against the extracellular domain of Notch l (Notch l e)(a, b, c, d), the 
intracellular domain of Notch l (Notch l i)(e, f, g, h) or the intracellular domain of 
Notch2 (i, j, k, 1). Fibres were counterstained with DAPI. Quiescent satellite cells 
expressed Pax? (c, g, k: arrows). Membrane-bound Notch l (b: arrow; f: arrow) and 
Notch2 (j: arrow) were coexpressed with Pax7 at a very low level or were absent. (Bar: 
10 µM. ) 
At T24, Notch l expression was increased, but still confined to the plasma membrane of 
activated Pax7+ satellite cells, suggesting that Notch 1 remained inactive (Figure 7.7). 
Notch2 immunostaining showed the same expression as Notch i. implying that 
transmembrane Notch2 was also inactive. 
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Figure 7.7: Notchl and Notch2 expression in activated satellite cells on individual 
myofibres 
Murine EDL muscles were collagenase-digested to disaggregate the myofibres. Fibres 
were cultured in suspension in activation medium for 24 hours, to activate the 
associated satellite cells, and then were fixed, permeabilised and coimmunostained 
using an antibody to detect Pax7 with an antibody against the extracellular domain of 
Notch 1 (Notch l e)(a, b, c, d), the intracellular domain of Notch 1 (Notch 1 i)(e, f, g, h) or 
the intracellular domain of Notch2 (i, j, k, 1). Fibres were counterstained with DAPI. 
Activated satellite cells expressed Pax? (c, g, k: arrows) and coexpressed membrane- 
bound Notch1 (b: arrow; f: arrow) and Notch2 (j: arrows). (Bar: 1OuM. ) 
By 48 hours in culture, the majority of activated satellite cell progeny were 
proliferating, as demonstrated by the presence of myoblast doublets or clusters in Figure 
7.8. Notch 1 and Notch2 were expressed on the surface of activated, proliferating Pax? 
satellite cell progeny, at al)I)i oý. inu! Il', 
H 
1(, 
activation. Again, there was no evidence of nuclear localisation, suggesting that in 
activated, proliferating myoblasts Notch l and Notch- rem wný: . 
Figure 7.8: Notchl and Notch2 expression in proliferating satellite cell progeny on 
individual myofibres 
Murine EDL muscles were collagenase-digested to disaggregate the myofibres. Fibres 
were cultured in suspension in activation medium for 48 hours, to activate the 
associated satellite cells and allow them to proliferate. Fibres were fixed, permeabilised 
and coimmunostained using an antibody to detect Pax7 with an antibody against the 
extracellular domain of Notch 1 (Notch 1 e)(a, b, c, d), the intracellular domain of Notch 1 
(Notch 1 We, f, g, h) or the intracellular domain of Notch2 (i, j, k, 1). Fibres were 
counterstained with DAPI. Doublets and clusters of satellite cell progeny expressed 
Pax? (c, g, k: arrows). With Pax7, myoblasts coexpressed membrane-bound Notch 1 (h: 
arrows; f: arrows) and Notch2 (j: arrow). (Bar: 10µM. ) 
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Figure 7.9: Notchl and Notch2 expression in clusters of satellite cell progeny on 
individual myofibres 
Murine EDL muscles were collagenase-digested to disaggregate the myofibres. Fibres 
were cultured in suspension in activation medium for 72 hours, to activate the 
associated satellite cells, allowing them to proliferate and form clusters. Fibres were 
fixed, permeabilised and coimmunostained using an antibody to detect Pax7 expression 
with an antibody against the extracellular domain of Notch l (Notch l e)(a, b, c, d), the 
intracellular domain of Notch l (Notch l i)(e, f, g, h) or the intracellular domain of 
Notch2 (i, j, k, 1). Fibres were counterstained with DAPI. Some of the activated 
satellite cell progeny in clusters expressed Pax? (c (red nuclei), g and k (green 
nuclei))(white arrows), while some had downregulated their Pax7 expression (yellow 
arrows). Some progeny expressed membrane-bound Notch l without Pax? (a, b, c, d; 
yellow arrow) or with weak Pax? (e, f, g, h; yellow arrow) and some expressed 
membrane-bound Notch2 without Pax? (i, j, k, 1; yellow arrow). The remaining 
progeny coexpressed Pax7 with membrane-bound Notch 1 or Notch2. Notch 1 and 
Notch2 were present on the surface of most cells within clusters, and expression was 
higher at points of cell-cell contact (f). (Bar: 10µM. ) 
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By 72 hours in culture, the activated satellite cells had given rise to large cluster 
(Figure 7.9). Some myoblasts in these clusters downregulated their Patz. whilst other, 
maintained expression. Notch 1 and Notch2 were detected on the surface of some (but 
not all) cells within the clusters, suggesting that they were inactive in those mvoblast'. 
and were found on both Pax7+ and PaxT cells (or cells with low Pax7. presumably in 
the process of downregulating expression). Notch receptor expression was focused at 
points of cell-cell adhesion within the clusters. 
7.4 Discussion 
Previous studies of satellite cell behaviour on isolated fibres have shown that satellite 
cell progeny can adopt alternate fates: the majority lose expression of Pax7 and 
differentiate, whilst a minority maintain Pax7, withdraw from the cell cycle and return 
to an undifferentiated quiescence-like state (Zammit et al., 2004). 
Since heterogeneity occurs within clusters of satellite cell progeny, it is feasible that 
cell-cell or cell-myofibre signalling may influence satellite cell fate, possibly by Notch 
signalling. Comparable heterogeneity is also observed during C2C 12 cell myogenesis 
when differentiation is induced, whereby the majority of cells form differentiated 
myotubes, while a subpopulation are maintained as undifferentiated quiescent reserve 
cells (Yoshida et al., 1998). Results presented in previous chapters implicate Notch 
signalling in the fate choices made in C202 cultures. RT-PCR and immunostaining of 
isolated myofibres was, therefore, carried out to characterise the expression of Notch 
signalling components in quiescent and activated satellite cells. 
RT-PCR revealed that Notchl, Notch2 and Notch3 transcripts were expressed in 
freshly-isolated myofibre preparations and those cultured for 24 or 4S hour,,. The 
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pattern of transcript expression was the same for all three. Expression wti-a,, ohý, crved in 
freshly-isolated fibre preparations. After 24 hours the number of preparations 
containing transcripts declined and in addition, the quantity of transcript in each 
preparation appeared to decrease (although nested RT-PCR is not quantitative). After 
48 hours in culture, the number of preparations containing mRNA increased and the 
quantity of transcript in each preparation was upregulated. The number of fibre 
preparations containing transcripts varied between the receptors, how ever. At TO and 
T24, Notch l mRNA was expressed in the least number of preparations, followed by 
Notch3, then Notch2, but by T48 Notchl mRNA was present in all preparations, while 
Notch2 and Notch3 were present in approximately 80%. Preparations may be positive 
if receptor transcript is expressed in the fibre, the satellite cells or both. Even if the 
receptor is expressed in just one or two of many satellite cells, the preparation may be 
positive. It may be interesting to analyse myofibre preparations from Pax7 null mice by 
RT-PCR, to investigate the effect that loss of Pax7 has on Notch receptor expression. 
Sufficient numbers of positively-and negatively-stained satellite cells and their progeny 
would need to be counted to identify statistically significant trends in Notch receptor 
expression. However, initial immunostaining studies revealed that Notch 1 and Notch2 
are both expressed in quiescent satellite cells (albeit at very low levels), upregulated 
when activation is induced and are then expressed throughout proliferation and cluster 
formation, when alternate fate decisions are made. The two receptors were detected on 
the surface of the satellite cells throughout myogenesis, suggesting that they remained 
inactive i. e. the ICD was not cleaved and translocated to the nucleus. Howw ev er. it is 
possible that the antibodies used were unable to detect nuclear Notch receptors. 
In 
1998, Struhl and Adachi demonstrated for the first time that the Notch ICD enters the 
nucleus in response to ligand activation, via utilisation of a reporter gene mechanism. 
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This method was used because all intracellular epitope-specific Notch antibodies failed 
to demonstrate the nuclear localisation of active Notch. It is unknown why antibodies 
are unable to detect intracellular Notch, but this could explain why active Notch 
receptors were not observed throughout satellite cell myogenesis. Therefore, it remains 
possible, as suggested by RT-PCR analysis of single fibre preparations. that Notch I and 
Notch2 (and perhaps Notch3) may be expressed and active in quiescent satellite cells 
(possibly to retain them in an undifferentiated state), and upon activation the level of 
each receptor increases to instigate the proliferation of satellite cell progeny. 
Immunostaining using a Notchl antibody against the ECD shows that Notchl is 
expressed at the surface of most, but not all, cells within clusters. Its absence from the 
surface of a minority of progeny (Figure 7.9) could suggest that Notch 1 is active and 
hence nuclear in this population. However, antibodies against Notch 1 and Notch2 ICDs 
suggest surface expression in all progeny. This discrepancy between ECD- and ICD- 
specific antibodies may be due to technical limitations, as some antibodies that work 
well in isolated cells cannot be used with myofibre preparations (Zammit et al., 2002). 
(This may explain why nuclear Notch 1 and Notch2 were detected in immunostained 
C2C 12 cell cultures (sections 3.3 and 3.5), but were not detected in satellite cells. ) 
Therefore, (i) the ICD-specific antibodies may not be functional, or (ii) the staining 
pattern may be correct and Notch is expressed on the surface of all progeny, but is only 
active and nuclear in a subset, which the antibodies are incapable of detecting (Struhl 
and Adachi, 1998). It therefore remains possible that in myoblasts that are negative for 
cell surface Notchl, the receptor may be active and nuclear, although this was not 
confirmed by staining with the ICD-specific antibodies. Furthermore. it is possible that 
cells expressing Notchl on their surface may additionally contain active nuclear 
Notch 1, while the progeny in which membrane-bound Notch 1 is absent may contain no 
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Notch I receptor protein at all. An effective ICD-specific antibody would be required to 
confirm which hypothesis is correct. 
Within clusters where the receptor is potentially inactive, activation may be inhibited iii 
one of the following ways. O-fucosyltransferases and Fringe molecules can inhibit 
ligand binding and subsequent receptor activation (Bruckner et al., 2000; Okajima et al.. 
2003). Alternatively, the Numb isoforms, Itch or SellO could inhibit Notch function by 
promoting ubiquitination of the membrane-bound receptor. resulting in degradation of 
the ICD on activation (Wu et al., 2001; McGill and McGlade, 2003). 
The results presented here are similar to work reported previously, suggesting that 
Notchl is expressed by quiescent satellite cells and is activated during satellite cell 
activation, possibly promoting proliferation and inhibiting differentiation (Conboy and 
Rando, 2002). In the same studies, Numb expression was shown to increase in some 
progeny, leading to speculation that this may inhibit Notch 1 function, allowing those 
cells to differentiate (Conboy and Rando, 2002). As well as Numb, other modifying 
molecules (described above) may be expressed at different levels within progeny in 
clusters, controlling Notch signalling. Membrane-bound Notch appears to focus at 
points of cell-cell contact, suggesting that signalling may certainly be occurring 
between progeny within a cluster. 
RT-PCR showed that D114 and Jaggedl transcripts are expressed in freshly-isolated 
myofibre preparations and those cultured for 24 or 48 hours. However, the pattern of 
transcript expression is different for the two ligands. Jagged1 was expressed in every 
fibre preparation at each time point, although at T24 there appeared to be fewer 
transcripts per preparation than at TO and T48. D114 mRNA was expressed in most of 
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the freshly-isolated myofibre preparations, but the number of preparations containing 
transcripts became highly downregulated when activation was induced. 
D114 and Jaggedl transcripts were highly-expressed in freshly-isolated m` ofibres. 
Therefore, it is possible that D114 protein may be expressed on the surface of the fibres, 
signalling to adjacent satellite cells to activate Notch signalling in them, ensuring that 
they remain quiescent. This would be analogous with the model in C? C 12 cells (cc 
chapter 3, Figure 3.13), whereby monoubiquitinated D114 expressed on the surface of 
nascent myotubes is proposed to activate Notch signalling in adjacent reserve cells so 
that they remain quiescent. Jaggedl protein may be expressed on the surface of 
quiescent satellite cells, perhaps induced by active Notch receptors, which can 
autonomously upregulate Jaggedl expression (Ross and Kadesch, 2004). Again this 
would be analogous with observations made in C2C l2 cell cultures, whereby 
endogenous Jaggedl is highly coexpressed in quiescent reserve cells with active Notch 
receptors (section 3.5). 
When the fibres are cultured in activation medium the level of D114 transcript declines. 
During myofibre culture, degeneration (i. e. fibre death) is occurring, whereas C2C 12 
cell culture is a model of regeneration (i. e. fibre formation). Therefore, D114 may 
appear on forming fibres (i. e. on nascent myotubes forming in C2C 12 cultures, as 
described in sections 3.5 and 3.6), but may disappear during fibre degeneration (i. e. in 
cultured fibres) to release satellite cells from quiescence so that they can proliferate and 
mediate repair. 
In C2C12 cell cultures, Jaggedl promotes Notch signalling in proliferatingg myohlasts. 
Therefore, Jagged1 transcript expression may remain high throughout activation and 
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proliferation in fibre preparations, since the protein is expressed on the surface of 
satellite cells and is required to induce Notch signalling to maintain proliferation of 
satellite cell progeny. These hypotheses are speculative and could not be verified for 
the ligands, due to the lack of effective antibodies. 
The results presented in this chapter suggest that the Notch signalling pathway is 
involved in the regulation and maintenance of satellite cells, potentially following an 
analogous mode of signalling as observed during C2C12 cell myogenesis. To confirm 
whether this hypothesis is correct, the Notch signalling components characterised 
during satellite cell myogenesis were analysed by overexpression, described in chapter 
8. 
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CHAPTER 8: Overexpression analysis of Notch 1 and 3 in 
satellite cells 
8.1 Introduction 
Results presented in earlier chapters (3-6), implicate Notch signalling as a potentially 
important mechanism for maintaining proliferation of myoblasts and in determining 
alternate cell fates upon the induction of differentiation in C2C 12 cell cultures. Results 
presented in chapter 7 confirm that several Notch signalling pathway components are 
endogenously expressed in myofibres and/or satellite cells, suggesting that Notch 
signalling may play a role in satellite cell regulation. To investigate this, constitutively 
active Notch1 and Notch3 were retrovirally overexpressed in satellite cells maintained 
on myofibres. 
8.2 Notch receptor overexpression in clusters of satellite cell progeny 
on fibres 
Active Notchl and Notch3 were overexpressed in satellite cells maintained on 
myofibres using retroviral vectors. Notch3/mig contained Notch3 ICD cDNA, followed 
by an IRES and eGFP, while eGFP-NIC/puro encoded a fusion protein consisting of the 
Notch 1 ICD bound to eGFP (see Materials and Methods, sections 2.6.1.2 and 2.6.1.6). 
Freshly-isolated myofibres from murine EDL muscles were retrovirally-infected and 
cultured in suspension in activation medium for 72 hours (see Materials and Methods. 
section 2.6.4.2), which allowed satellite cells to activate, proliferate and form clusters of 
progeny. Myofibre preparations were fixed and immunostained (see Materials and 
Methods, section 2.9.3) using an anti-GFP antibody, to detect infected mvoh1asts. and 
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either (i) an anti-Pax7 antibody, to identify cells returning to quiescence, or (ii) an anti- 
MyoD antibody, to identify cells that had entered the differentiation path%k a} . 
Preparations were counterstained with DAPI. Approximately 21) infected and 
uninfected immunostained fibres were analysed (see Materials and Method,. section 
2.9.4). 
Numbers of GFP+, infected clusters (i. e. colonies that contained cells that were all 
GFP+) containing 1,2-3 or 4+ (i. e. 4 or more) cells were recorded and the mean 
percentages of cluster-types per fibre are shown in Figure 8.1. There were no 
statistically significant differences between the percentages of clusters containing 1,2-3 
or 4+ cells between control mig-infected fibre preparations and either eGFP-NIC/puro- 
or Notch3/mig-infected preparations. Since constitutively active Notch 1 and Notch3 
had no effect on the number of progeny within clusters, this suggests that 
overexpression did not affect proliferation. 
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Figure 8.1: Effect of active Notchl or Notch3 overexpression on proliferation of 
satellite cell progeny on isolated myofibres 
Murine EDL muscles were collagenase-digested to disaggregate myofibres. Fibres 
were retrovirally-infected with eGFP-NIC/puro, Notch3/mig or mig and cultured in 
suspension in activation medium for 72 hours. Approximately 20 fibres were fixed, 
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permeabilised and immunostained using an antibody to detect GFP . 
infected cells. Fibres were counterstained with DAPI. The number of cells (1,2-3 or 4---) \ý ithin each GFP+ cluster of satellite cell progeny on all fibres was counted. The mean percentage of 
each cluster-type per fibre is shown. Error bars represent the standard deviation. There 
were no statistically significant differences between the percentages of clusters 
containing 1,2-3 or 4+ cells between mig-infected fibres. eGFP-NIC puro- or Notch3/mig-infected fibres. Most infected clusters contained one GFP+ cell. followed by 2-3, then 4+ GFP+ cells. 
Ten randomly-chosen uninfected clusters (containing 4 or more progeny) were counted 
to determine the mean percentage of Pax7+ cells (Figure 8.2). As expected, there was 
no significant difference in the percentage of Pax7+ cells per uninfected cluster between 
untreated fibre preparations, or mig-, eGFP-NIC/puro-, or Notch3/mig-infected 
preparations. Therefore, any alteration in Pax7 expression in GFP+, infected cells could 
be attributed to overexpression of the gene of interest, rather than being a consequence 
of the infection process. 
There was a significant increase (p<0.001) in the mean percentage of Pax? * progeny in 
eGFP-NIC/puro-infected (99.29± 1.16) and Notch3/mig-infected (97.29±5.9) clusters, 
compared with mig-infected clusters (32.88±20.32)(Figure 8.2). However, there was no 
significant difference in Pax7 expression between eGFP-NIC/puro- and Notch3/mig- 
infected clusters, suggesting that constitutively active Notch l and Notch3 had an 
equivalent effect in clusters of satellite cell progeny, significantly increasing the number 
of myoblasts that expressed Pax7. 
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Figure 8.2: Effect of active tiotchl or Notch3 ov, erexpression on Pax7 expression in 
clusters of satellite cell progeny on isolated myofibres 
Murine EDL muscles were collagenase-digested to disagaregate myofibres. Fibres 
were retrovirally-infected with eGFP-NIC/puro, NotchImig or mi`, and cultured in 
suspension in activation medium for 72 hours. Approximately 20 fibres were fixed. 
permeabilised and immunostained using anti-GFP and anti-Pax7 antibodies. Fibres 
were counterstained with DAPI. Ten randomly-chosen uninfected clusters (-- 
progeny) were counted and the mean percentage of Pax7_ cells per uninfected cluster 
was calculated (a). Error bars represent the standard deviation. There was no 
significant difference in the percentage of Pax7_ cells per uninfected cluster between 
untreated fibres or mig-, eGFP-NIC/puro-, or Notch3/mig-infected fibres. The Pax7 
expression of each GFP+ cell was recorded and the mean percentage of Pax-"- cells per 
infected cluster per fibre was calculated (b). Error bars represent the standard deviation. 
*** (p<0.001) denotes that there was a significant increase in Pax7 expression in eGFP- 
NIC/puro-infected and Notch3/mig-infected satellite cell progeny compared with mig- 
infected myoblasts. There was no significant difference in Pax7 expression between 
eGFP-NIC/puro-infected and Notch3/mig-infected satellite cell progeny. Fluorescence 
microscopy images of representative clusters of satellite cell progeny resident on 
myofibres immunostained to detect Pax7/GFP/DAPI expression are shown (c-r). The 
cluster on the untreated fibre shown (c, d, e, f) contained both Pax7' and PaxT 
myoblasts. The mig-infected cluster shown (g, h, i, j) also contained both Pax7' and 
Pax7- myoblasts. The eGFP-NIC/puro-infected cluster (k, 1, m, n) and Notch3/mig- 
infected cluster (o, p, q, r) shown only contained Pax7+ cells. (Bar: 10pM. ) 
There was no significant difference in the percentage of MyoD+ cells per uninfected 
cluster between untreated or infected fibre preparations (Figure 8.3). There was a 
significant decrease (p<0.001) in the mean percentage of MyoD+ progeny in eGFP- 
NIC/puro-infected (28.67±29.21) and Notch3/mig-infected (0.91±2.87) clusters 
compared with mig-infected clusters (85.32± 13.34)(Figure 8.3), suggesting that 
constitutively active Notch 1 and Notch3 were both able to inhibit MyoD expression in 
clusters. However, active Notch3 appeared to inhibit MyoD more effectively, since 
MyoD expression in Notch3/mig-infected clusters (p<0.05) was significantly lower than 
in eGFP-NIC/puro-infected clusters. This is consistent with the effects of constitutively 
active Notch 1 and Notch3 on MyoD expression in proliferating C2C12 myoblasts (see 
sections 4.3.1 and 6.3) 
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Figure 8.3: Effect of active N'otchl or Notch3 overexpression on NIvoD expression 
in clusters of satellite cell progeny on isolated myofibres 
Murine EDL muscles were collagenase-digested to disaggregate myofibres. Fibres 
were retrovirally-infected with eGFP-NIC/puro, Notch31mig or mig and cultured in 
suspension in activation medium for 72 hours. Approximately 20 fibres were fixed. 
permeabilised and immunostained using anti-GFP and anti-MyoD antibodies. Fibres 
were counterstained with DAPI. Ten randomly-chosen uninfected clusters (-- 
progeny) were counted and the mean percentage of MyoD+ cells per uninfected cluster 
was calculated (a). Error bars represent the standard deviation. There was no 
significant difference in the percentage of MyoD cells per uninfected cluster between 
untreated fibres or mig-, eGFP-NIC/puro-, or Notch3/mig-infected fibres. The : \I v'oD 
expression of each GFP+ cell was recorded and the mean percentage of ti iyoD cells per 
infected cluster per fibre was calculated (b). Error bars represent the standard deviation. 
*** (p<0.001) denotes that there was a significant decrease in MyoD expression in 
eGFP-NIC/puro-infected and Notch3/mig-infected satellite cell progeny compared with 
mig-infected myoblasts. MyoD expression in Notch3/mig-infected myoblasts was 
significantly lower (* (p<0.05)) than in eGFP-NIC/puro-infected satellite cell progeny. 
Fluorescence microscopy images of representative clusters of satellite cell progeny 
resident on myofibres immunostained to detect MyoD/GFP/DAPI expression are shown 
(c-r). The cluster on the untreated fibre shown (c, d, e, f) contained both MyoD F and 
MyoDf myoblasts. The mig-infected GFP+ cluster shown (g, h, i, j) also contained both 
MyoD+ and MyoD- myoblasts. The eGFP-NIC/puro-infected cluster (k, 1, m, n) and the 
Notch3/mig-infected cluster (o, p, q, r) shown only contained MyoD- cells. (Bar: 
10 µM. ) 
8.3 Notch receptor overexpression in primary cultures 
Freshly-isolated myofibres were plated and infected with Notch3/mig or eGFP- 
NIC/puro (see Materials and Methods, section 2.6.4.1). Many of the satellite cells and 
their progeny migrated off the fibres onto the substrate and formed primary cultures, in 
which the myoblasts underwent proliferation, and eventual differentiation (i. e. 
formation of myotubes and reserve cells). 
Primary cultures were either BrdU-pulsed, fixed and immunostained using an anti-BrdU 
antibody (see Materials and Methods, section 2.10.2), to detect cycling cells, or 
fixed 
and immunostained using an anti-MyoD or anti-MHC antibody (section 2.9.2). to 
detect 
MyoD expression or differentiated cells respectively. Cultures N ere costained with an 
anti-GFP antibody, to identify infected cells, and counterstained with 
DAPI. 
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Figure 8.4 shows the mean percentages of infected and uninfected BrdL1+ nuclei in 
primary cultures propagated for 48 hours (T48). 72 hours (T72) or 96 hours (T96). As 
expected, the percentages of GFP- (uninfected)/BrdU+ nuclei were not statistically 
significantly different between any of the cultures at any time point. At T48, there wa: 
no significant difference in the percentage of GFP-/BrdU+ nuclei in any of the cultures. 
Levels of BrdU were high, suggesting that the majority of satellite cell progeny were 
proliferating and were unaffected by overexpression of constitutively active Notch I or 
Notch3. By T72, there was a significant decrease (p<0.05) in the mean percentage of 
Notch3/mig-infected cells (37.41±24.22) that incorporated BrdU, compared with mig- 
infected cells (70.05±8.5), suggesting that constitutively active Notch3 inhibited 
myoblast proliferation. There was no significant difference between the percentages of 
BrdU+ progeny infected with eGFP-NIC/puro (65.88±4.51) and mig, suggesting that 
constitutively active Notch l did not affect myoblast proliferation. There was no 
significant difference between the percentages of BrdU+ progeny infected with eGFP- 
NIC/puro and Notch3/mig, although BrdU incorporation in the Notch3/mig-infected 
cells was lower. The lack of statistical significance was probably due to the high 
standard deviation between the mean percentages of BrdU+ cells in Notch3/mig- 
infected cultures. By T96, there was still a significant decrease (p<0.05) in the mean 
percentage of progeny infected with Notch3/mig (30.6±7.43) that incorporated BrdU, 
compared with those infected with mig (44.41±2.43). Additionally, the mean 
percentage of GFP+/BrdU+ cells in Notch3/mig-infected cultures was significantly 
lower, compared with eGFP-NIC/puro-infected cultures (66.5±12.05). However, there 
was still no difference between eGFP-NIC/puro-infected cultures compared with mig- 
infected cultures. These results suggest that in primary cultures constituti\ e ly active 
Notch3 inhibits proliferation, but constitutively active Notch 1 has no effect. 
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Figure 8.4: Effect of active Notchl or Notch3 overexpression on proliferation of 
primary cultures 
Murine EDL muscles were collagenase-digested to disaggregate myofibres. Plated 
fibres were retrovirally-infected using eGFP-NIC/puro, Notch3/mig or mig and cultured 
for 48 (T48), 72 (T72) or 96 (T96) hours in activation medium, which allowed satellite 
cell progeny to activate, migrate off the fibres onto the substrate, proliferate and start to 
differentiate. Primary cultures were BrdU-pulsed, fixed and coimmunostained using 
anti-BrdU and anti-GFP antibodies. Cultures were counterstained with DAPI. For each 
culture (T48 (a), T72 (b) or T96 (c)), at least 100 cells per well in three individual wells 
were counted and the mean percentages of GFP+! BrdU+ (green bars) or GFP- BrdU 
(red bars) nuclei were calculated. Error bars represent the standard deviation. The 
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percentages of GFP-/BrdU+/ nuclei were not statistically significantly different between 
any of the cultures at any time point. At T48, there was no significant difference in the 
percentage of GFP+/BrdU+ nuclei in any of the cultures. and levels of BrdL' 
incorporation were over 90% in each culture. By T72. * (p<0.05) denotes that there 
was a significant decrease in BrdU incorporation in GFP+ cells in Notch3/mi`ý-infected 
cultures compared with mig-infected cultures, but there was no significant difference in 
the percentage of GFPT/BrdU+ cells between eGFP-NIC 'puro-infected cultures and mi`(- 
infected cultures. Also, there was no significant difference in BrdU incorporation 
between Notch3/mig-infected GFP- progeny and eGFP-NIC, puro-infected GFP 
progeny. By T96, * (p<0.05) denotes that there was still a significant decrease in BrdU 
incorporation in GFP+ cells in Notch3/mig-infected cultures compared with mw- 
infected cultures. Also, there was significantly less BrdU incorporation (* (p<0.05)) in 
GFP+ cells in Notch3/mig-infected cultures compared with eGFP-NIC/puro-infected 
cultures. However, there was still no significant difference in the mean percentage of 
GFP+/BrdU+ cells between eGFP-NIC/puro-infected cultures and mig-infected cultures. 
Figure 8.5 shows MyoD expression in infected primary cultures propagated for eight 
days. As expected, the percentages of uninfected MyoDY nuclei were not statistically 
significantly different between any of the cultures. Therefore, any alteration in MyoD 
expression in infected cells could be attributed to overexpression of the gene of interest, 
rather than the infection process. There was a significant decrease in the mean 
percentage of MyoD+ cells infected with eGFP-NIC/puro (40.08± 13.09; p<0.01) or 
Notch3/mig (0±0; p<0.001), compared with those infected with mig (92.59±12.83). In 
addition, MyoD expression in cells overexpressing constitutively active Notch3 was 
significantly lower (p<0.05) than in those overexpressing constitutively active Notch I. 
These results suggest that constitutively active Notch 1 and Notch3 both inhibit MyoD 
expression in primary cultures, but active Notch3 inhibits MyoD expression to a greater 
extent. 
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Figure 8.5: Effect of active Notchl or Notch3 overexpression on Nlyol) expression 
in primary cultures 
Murine EDL muscles were collagenase-digested to disaggregate m}yofibres. Plated 
myofibres were retrovirally-infected using eGFP-NIC/puro, Notch3 'mig or mi`g and 
cultured for a total of eight days, with one change of activation medium after 96 hours. 
which allowed satellite cell progeny to activate, migrate off the fibres onto the substrate 
and proliferate. Myoblasts fused and differentiated, forming myotubes. or remained 
undifferentiated reserve cells. Primary cultures were fixed and coimmunostained with 
anti-GFP and anti-MyoD antibodies. Cultures were counterstained with DAPI. For 
each culture, at least 100 cells per well in three individual wells were counted and the 
mean percentages of GFP+/MyoD4 (green bars) or GFP-/ MyoD+ (red bars) nuclei were 
calculated (a). Error bars represent the standard deviation. Percentages of GFP-/MyoD 
nuclei were not statistically significantly different between any of the cultures. There 
was a significant decrease in MyoD expression in GFP+ cells in eGFP-N IC/puro- 
infected cultures (** (p<0.01)) and Notch3/mig-infected cultures (* ** (p<0.001) ) 
compared with mig-infected cultures. In addition, the mean percentage of GFP'/ti, lyoD+ 
cells in Notch3/mig-infected cultures was significantly lower (* (p<0.05)) than in 
eGFP-NIC/puro-infected cultures. Fluorescence microscopy images of primary cultures 
immunostained to detect MyoD/GFP/DAPI expression are shown (b-q). Untreated 
cultures (b, c, d, e) contained both MyoD+ and MyoD- nuclei. mig-infected cultures (f, 
g, h, i) contained both infected and uninfected MyoD+ and MyoD- cells. eGFP- 
NIC/puro-infected cultures (j, k, 1, m) and Notch3/mig-infected cultures (n, o, p, q) 
contained both infected and uninfected cells. Uninfected cells were either MyoD+ or 
MyoD-, but infected cells in eGFP-NIC/puro-infected cultures were mainly MyoD-. In 
Notch3/mig-infected cultures MyoD was completely absent from infected cells. (Bar: 
20µM. ) 
The expression of MHC was investigated in retrovirally-infected primary cultures 
propagated for eight days (Figure 8.6). When examining MHC expression, nuclei were 
counted rather than cells, so each nucleus within an MHC+ multinucleated myotube was 
counted as an MHC+ `cell'. As expected, the percentages of uninfected MHC+ nuclei 
were not statistically significantly different between any of the cultures. There was a 
significant decrease in MHC expression (p<0.001) in cells infected with eGFP- 
NIC/puro or Notch3/mig compared with those infected with mig (87.08±10.4 1). MHC 
was completely absent from cells overexpressing constitutively active Notch l or 
Notch3, suggesting that both receptors inhibit differentiation in primary cultures. This 
is consistent with the effect of constitutively active Notch l and ti otch3 on 
differentiation in C2C12 cultures (sections 4.3.1 and 6.3). 
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Figure 8.6: Effect of active Notchl or Notch3 overexpression on differentiation of 
primary cultures 
Murine EDL muscles were collagenase-digested to disaggregate myofibres. Plated 
fibres were retrovirally-infected using eGFP-NIC 'puro. Notch3/mig or migand cultured 
for eight days, with one change of activation medium after 96 hours, which allowed 
satellite cell progeny to activate, migrate off the fibres onto the substrate and proliferate. 
Myoblasts fused and differentiated, forming myotubes. or remained undifferentiated 
reserve cells. Primary cultures were fixed and coimmunostained using anti-GFP and 
anti-MHC antibodies. Cultures were counterstained with DAPI. For each culture, at 
least 100 cells per well in three individual wells were counted and the mean percentages 
of GFP `/MHC+ (green bars) or GFP-/ MHC+ (red bars) cells were calculated (a). Error 
bars represent the standard deviation. The percentages of GFP-; MHC+ nuclei were not 
statistically significantly different between any of the cultures. *** (p<0.001) denotes 
that there was a significant decrease in MHC expression in GFP+ cells in eGFP- 
NIC/puro-infected cultures and Notch3/mig-infected cultures, compared with mig- 
infected cultures. There was no significant difference in the mean percentage of GFP+/ 
MHC+ cells between Notch3/mig-infected cultures and eGFP-NIC'euro-infected 
cultures. Fluorescence microscopy images of primary cultures immunostained to detect 
MHC/GFP/DAPI expression are shown (b-q). Untreated cultures (b, c, d, e) contained 
both differentiated and undifferentiated cells. mig-infected cultures (f, g. h, i) contained 
infected and uninfected cells, which were either differentiated or undifferentiated. 
eGFP-NIC/puro-infected cultures (j, k, 1, m) and Notch3/mig-infected cultures (n, o, p. 
q) contained both infected and uninfected cells. The uninfected cells were either 
differentiated or undifferentiated, while all infected cells remained undifferentiated. 
(Bar: 20µM. ) 
8.4 Discussion 
In earlier chapters, it was suggested that Notch l and Notch3 might play a role in 
maintaining proliferating myoblasts and in specifying undifferentiated reserve cells 
during C2C 12 cell differentiation. In chapter 7, it was established that both receptor 
transcripts were expressed in myofibre preparations and that Notch1 is expressed in 
satellite cells. Therefore, constitutively active Notch l and Notch3 were overexpressed 
in satellite cells, to investigate their effect on primary myogenic cell behaviour. 
Initially, clusters of satellite progeny that overexpressed the gene of interest were 
analysed. When cultured in suspension, satellite cells are retained underneath the basal 
lamina of their resident fibre, maintaining cell-cell contact and potential signalling 
between the myofibre and its associated satellite cells and within the clusters. Pax7 is 
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expressed in quiescent satellite cells and MyoD is switched on and coexpressed with 
Pax? following activation prior to proliferation and cluster formation. The majority of 
myoblasts in clusters then downregulate Pax7, maintain MyoD and go on to 
differentiate. However, a minority maintain their expression of Pax7 and downregulate 
MyoD. This Pax7+ population withdraws from the cell cycle and returns to an 
undifferentiated quiescence-like state, possibly facilitating self-renewal of the satellite 
cell population (Zammit et al., 2004). 
Constitutively active Notchl and Notch3 had no effect on the eventual number of cells 
within a cluster, suggesting that neither overexpressed receptor affected myoblast 
proliferation. Since both receptors are endogenously expressed (sections 7.1 and 7.3), 
and may be controlling proliferation (particularly Notchl), an effect may not be 
observed when the receptors are overexpressed because proliferation is already 
maximal. Both constitutively active receptors caused an increase in the number of 
Pax7+ cells and a decrease in the number of MyoD+ cells within clusters, although 
active Notch3 was more effective at inhibiting MyoD expression than Notch 1, which is 
analogous with observations made during C2C12 myogenesis. Therefore, constitutively 
active Notch l and Notch3 increase the number of cells within clusters that maintain 
their expression of Pax7, withdraw from cell cycle and become quiescent, and decrease 
the number of cells that express MyoD and differentiate. Thus endogenously active 
Notch1 and Notch3 may inhibit the differentiation of a subset of progeny within clusters 
by preventing MyoD expression, ensuring that they remain undifferentiated and 
quiescent and hence maintain their expression of Pax7. This is consistent with their 
effects during C2C 12 differentiation, where they inhibit differentiation and reduce 
MyoD expression. 
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Fibre preparations are difficult to maintain for a lon2 period in suspension culture. as 
they collapse after 120 hours. Therefore, to analyse proliferation and differentiation. the 
satellite cells need to move off the fibres into culture. Consequently fibres were plated 
and then retrovirally-infected, allowing infected satellite cells and their progeny to 
migrate off the fibres as primary cultures. Since myoblasts moved off the fibre onto an 
artificial substrate, cell-cell signalling between the myofibre and its associated satellite 
cells was lost and the myoblasts may have also been affected by mitogens present in the 
Matrigel TM substrate. It is important to note, therefore, that this is more comparable 
with C2C12 cell culture, and may not faithfully reflect Notch signalling as in satellite 
cells retained under a basal lamina, in contact with a fibre and other cells in a cluster. 
The number of cycling cells present in primary cultures was analysed and it was found 
that after only 48 hours in culture, neither constitutively active Notch l nor Notch3 
affected proliferation. At this early stage, overexpression of the receptors may have no 
effect on proliferation because the system is already saturated with active endogenous 
Notch receptors, which control proliferation and ensure that it is maximal. 
After 72 or 96 hours in culture, constitutively active Notch3 inhibited proliferation, 
while active Notch l had no effect, possibly because endogenous Notch l was still 
active. By this stage, myoblasts would have migrated away from the fibre and hence 
would be less affected by its signals. Interaction with the fibre may regulate myoblast 
proliferation, possibly by modulating and maintaining Notch3 activity, which may 
compete with endogenous Notch I. Therefore, as cells migrate away from the fibre, the 
inhibitory effects of Notch3 are maintained in Notch3/mig-infected cells. In C2C 12 
cells it was observed that in myoblasts at a low confluency, constitutively active Notch 
inhibited proliferation (see section 6.5), consistent with the results obtained with 
primary myoblasts. Notch3 may inhibit proliferation via upregulation of p27 expression 
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(see section 6.8), which induces cell cycle withdrawal into quiescence in e\ eral cell 
lines (Medema et al., 2000; Miskimins et al., 2001; Olashaww and Pledger. 2002). 
Primary cultures propagated for eight days formed a heterogeneous population of 
differentiated myotubes and undifferentiated reserve cells, comparable with 
differentiated C2C12 cell cultures. Overexpression of constitutively active Notch 1 or 
Notch3 prevented differentiation and resulted in downregulation of `1voD and \IHC. 
Active Notch3 had a more antagonistic effect on MyoD expression than active Notch 1. 
switching it off completely, which was also observed in C2C 12 cell cultures. This is 
consistent with the possibility that endogenously, the active Notchl and Notch 
receptors may inhibit differentiation in a subset of satellite cell progeny within clusters, 
and Notch3 ensures the return to quiescence of that subset. 
D114 and Jaggedl may facilitate activation of the Notch receptors in satellite cells, as 
suggested during C2C12 myogenesis (see chapter 3, Figure 3.13). Expression of the 
D114 and Jaggedl transcripts in single fibre preparations suggest that these ligands may 
be involved in satellite cell regulation. If the ligands do have the same effects in both 
systems, then Jagged1 may be responsible for activating Notch receptors in proliferating 
myoblasts to promote proliferation. Monoubiquitinated D114 expressed on the surface 
of myofibres, or in a subset of cells within clusters, may activate Notch signalling in 
adjacent cells within the clusters to ensure that they remain undifferentiated and return 
to quiescence facilitating self-renewal of the satellite cell pool. Jaggedl expression 
autonomously induced by Notch signalling may activate Notch receptors in adjacent 
naive cells within clusters, inhibiting their differentiation, thus specifying more 
` quiescent progeny. Attempts were made to retrovirally-overexpress D114 and Jagged I 
in satellite cells maintained on myofibres to investigate their function. without succc: s. 
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CHAPTER 9: Discussion 
Satellite cells are normally quiescent (Schultz et al., 1978), but are synchronously 
activated in response to growth signals or myotrauma to proliferate and produce 
myoblasts, which ultimately differentiate and fuse to repair existing myofibres or form 
new fibres (Grounds and McGeachie, 1987; Rantanen et al., 1995). Despite ongoing 
demands for growth and repair, the number of quiescent satellite cells remains relatively 
constant over time (reviewed in Seale and Rudnicki, 2000)(although there is an eventual 
decrease with age (Collins et al., 2007; Shefer et al., 2006)), demonstrating that renewal 
must occur. The source of new satellite cells remains controversial, although evidence 
suggests that satellite cells themselves are capable of self-renewal following activation 
(Collins et al., 2005; Zammit et al., 2004). When maintained on the surface of 
myofibres in vitro, satellite cells activate, proliferate and form clusters, which are 
heterogeneous as defined by the expression of Pax7. The majority of Pax7- cells 
differentiate, while some Pax7+ cells withdraw from cell cycle and return to an 
undifferentiated quiescence-like state (Zammit et al., 2004). Since heterogeneity occurs 
within clusters, it is possible that cell-cell or cell-myofibre signalling may influence 
satellite cell fate. Notch signalling is dependent upon cell-cell interactions, and has 
been previously shown to affect myogenesis, and in this thesis was investigated as a 
potential regulatory mechanism within clusters. 
The primary aim of this project was to investigate the role of Notch signalling 
in 
satellite cell regulation and maintenance. Two models were used: the 
first involý cý 
individual myofibres isolated from murine EDL muscles and maintained 
in suspension 
in vitro (Rosenblatt et al., 1995; Zammit et al., ? 004). Using this approach. the 
full 
complement of satellite cells associated with each myofibre 
is retained beneath the basal 
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lamina, maintaining cell-cell interactions. «hich are particularly important during Notch 
signalling. Studies were also carried out using primary satellite cell-deriN ed cultures 
). and the murine myogenic cell line C2C12 (Yaffe and Saxel, 1977; Blau et al.. 1 k-) 
s 'I 
which represents an accessible model of the early stages of myogenic differentiation. In 
the presence of a high concentration of serum, C2C 12 cells proliferate aý 
undifferentiated myoblasts, expressing MyoD and Myf5 (Yoshida et al., 1998). Serum 
depletion induces differentiation in 40-60% of cells: myogenin is expressed as cells 
withdraw from the cell cycle, fusion occurs and myotubes are formed (Yoshida et al.. 
1998). However, a proportion of myoblasts remain undifferentiated and mononucleated 
and are known as reserve cells. Similar reserve cell populations are also observed ývhen 
primary mouse (Kitzmann et al., 1998) and human myoblasts (Baroffio et al., 1996) are 
induced to differentiate. C2C12 reserve cells cycle very slowly, downregulate their 
expression of MyoD and Myf5 (Yoshida et al., 1998) and express CD34 (Beauchamp et 
al., 2000). Furthermore, reserve cells can be induced to proliferate by restimulation 
with high serum medium, and can again yield a heterogeneous population of 
differentiated and undifferentiated cells in the same proportions as originally observed 
(Yoshida et al., 1998). These characteristics make reserve cells a useful model of 
quiescent satellite cells. In fact, reserve cells are particularly useful as they model 
satellite cell sequestration in a regenerating (i. e. myotube-forming) environment, 
whereas single fibre culture is a model of satellite cell activation in a degenerating 
environment. Using the approaches described, the role of the Notch signalling pathway 
during myogenesis and satellite cell regulation was investigated. 
One of the main problems associated with this project was the lack of effective 
antibodies available for immunofluorescent detection and Western blot analysis of 
components of the Notch signalling pathway. For example, following cleavage at the 
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membrane and translocation of the acti\e ICD into the nucleus, nuclear botch wa> 
generally below the immunodetection threshold (Schroeter et al.. 191»y ). despite 
definitive evidence that this translocation exists (Struhl and . Adachi, 
1998). 
Furthermore, non-specific antibody binding to myotubes rendered some antibodies 
ineffectual, due to high levels of background staining; and some antibodies. which work 
well in isolated cells, could not be used to stain satellite cells and their progeny attached 
to myofibres, again due to background staining (Zammit et al., 2002). Despite these 
problems, various effective antibodies ensured that it was possible to examine the 
expression and function of several Notch pathway components. 
9.1 Characterisation of the expression and function of components of 
the Notch signalling pathway during C2C12 cell myogenesis 
Results presented in chapter 3 show that myogenic differentiation is accompanied by 
changes in the transcript and protein expression profiles of Notch components, 
consistent with a role for Notch signalling during myogenesis. These changes were 
often most striking after 24 to 48 hours, coincident with the onset of morphological 
differentiation. Thus Notch signalling components may change to specify cell fate 
within the population, ensuring that a subpopulation are maintained as undifferentiated 
reserve cells within a differentiated culture, thereby maintaining regenerative potential. 
Different receptor/ligand profiles are expressed in proliferating myoblasts, myotubes 
and reserve cells. This appears to result in distinct outcomes: regulating both the 
proliferation of muscle precursors through interaction with other myoblasts. and. 
through interaction with differentiated cells, the specification of undifferentiated reserve 
cells. 
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Of the four known Notch receptors, Notch4 is absent from CC 12 cell. whereas the 
active forms of Notchl, Notch2 and Notch3 were all expressed in proliferating 
myoblasts (although Notch3 is less abundant than the other two receptors). When 
differentiation is induced, expression is localised to undifferentiated reserve cells rather 
than differentiated myotubes. Thus active receptors may play a role in the maintenance 
of a proliferative state in myoblasts. In addition, active receptors may function in the 
specification of reserve cells, possibly by inhibiting their differentiation and or inducing 
cell cycle withdrawal. 
9.1.1 Notchl and Notch2 
To investigate receptor function, constitutively active ICDs were overexpressed in 
C2C 12 cells. Notch l and Notch2 have the highest homology of the four Notch 
receptors, since they are predominantly structurally conserved (Shimizu et al., 2002). 
This suggests that they may have similar functions, although evidence to support this is 
conflicting. It has been shown that the Notch1 ICD can functionally replace that of 
Notch2 (Kraman and McCright, 2005), but conversely, other data suggests divergent 
functions: Notchl and Notch2 differentially regulate expression of HES1 and HES5 
(Shimizu et al., 2002), and they have distinct functions during kidney development 
(reviewed in Weinmaster and Kopan, 2006). 
Overexpression of constitutively active Notchl in myoblasts had no effect on 
proliferation, but this could be because endogenous active Notch l was already 
maintaining proliferation at a maximal level. To investigate whether endogenous actin c 
Notch l maintains proliferation, its expression would need to be knocked down or out 
(perhaps using short hairpin RNA to silence gene expression). When 
differentiation is 
induced, the effect of exogenous active Notchl becomes apparent. suggcsting that 
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endogenous active Notch l may normally be downregulated upon the induction of 
differentiation, perhaps due to degradation by inhibitory molecules (e. g. Numb). 
Overexpression of constitutively active Notch1 increased the number of proliferating 
cells in cultures induced to differentiate, suggesting that active ti otch l normal l`" 
promotes proliferation. When differentiation was induced, constitutively active Notch I 
also significantly inhibited myogenic differentiation, which has been observed 
previously (Kopan et al., 1994; Nofziger et al., 1999; Shawber et al., 1996). The 
endogenous upregulation of active Notchl in reserve cells implies that its potential role 
in reserve cell specification is related to its ability to inhibit myogenic differentiation, 
hence maintaining those cells where it is localised in an undifferentiated state. In fact, 
since this project was started, it has been demonstrated that the activation of Notch I is 
important in maintaining reserve cells in an undifferentiated condition (Kitzmann et al., 
2006). Although active Notch l may inhibit differentiation in reserve cells, it may not 
be responsible for inducing their withdrawal from the cell cycle, if it also promotes 
proliferation. 
Constitutively active Notch 1 inhibited MyoD expression in myoblasts. Therefore, the 
mechanism by which constitutively active Notch1 inhibited myogenic differentiation 
was probably via MyoD downregulation. Active Notchl can antagonise myogenic 
C2C 12 cell differentiation either via RBP-JK-dependent direct inhibition of MyoD, 
possibly mediated by the transcriptional repressor HES 1, or by RBP-JK-independent 
inhibition of myogenesis at a target upstream of MyoD (Kopan et al., 1994; Kuroda et 
al., 1999; Nofziger et al., 1999; Shawber et al., 1996). Reserve cells are known to 
downregulate their expression of MyoD (Yoshida et al., 1998). Therefore, it is possible 
that upon the induction of differentiation, endogenous Notch 1 remains active in a subset 
of cells and signals via either the RBP-JK-dependent or -independent pathway to inhibit 
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myogenic differentiation, mediated by the downregulation of : MoD expression. to 
ensure that those cells remain undifferentiated. 
In this project, it was confirmed that the RBP-Jx-independent 'Notch signalling pathway 
was able to function in C2C12 cells, as previously suggested (Nofziger et al.. 1999: 
Shawber et al., 1996), since the overexpression of dominant negative RBP-Jx did not 
alter endogenous Notch signalling in proliferating myoblasts. When differentiation was 
induced, endogenous Notchl signalling (which normally promotes proliferation and 
inhibits differentiation) appeared to be slightly inhibited in cells that overexpressed 
dominant negative RBP-Jx. This suggests that, although endogenous Notch I signalling 
was mainly maintained by RBP-Jx-independent signalling, endogenous active Notch I 
may normally signal (partly at least) via the RBP-JK-dependent pathway in 
differentiated cultures. Whether overexpression of dominant negative RBP-JK 
definitely induces RBP-JK-independent signalling requires confirmation using a reporter 
construct (e. g. HEST promoter/luciferase) before the results presented can be believed 
and the role of RBP-JK-independent signalling in C2C 12 cells can be effectively 
deduced. Therefore, it remains unknown whether there is a preference for RBP-JK- 
independent signalling in normal C2C12 cultures, if the two pathways act cooperatively 
or independently, or if they have distinct functions during myogenesis. Investigating 
the role of RBP-JK-independent signalling is problematic, as the precise mechanism 
remains unclear; several molecules may activate Notch, which would make knock- 
down of the pathway, to determine its function, difficult. 
9.1.2 Notch3 
Notch3 and Notch4 are structurally diverged from Notchl and Notch-' (Lardelli ct al.. 
1994; Shimizu et al., 2002), and functional diversity between the receptors 
has been 
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demonstrated (Shimizu et al.. 2002). Therefore. although Notch -3 
is 1ucalked to 
proliferating myoblasts and reserve cells like Notch l and Notch 2. it may perform 
different functions. 
In chapter 6 it was shown that overexpression of constitutively active tiotch3 inhibited 
myogenic differentiation to an even greater extent than Notch 1. Active Notch l 
downregulates MyoD expression, suggesting that active Notch3 max' inhibit mvogcnic 
differentiation by downregulating MyoD, in the same way as Notch 1, presumably 
facilitated via either the RBP-JK-dependent or RBP-JK-independent pathway (Kopan et 
al., 1994; Kuroda et al., 1999; Nofziger et al., 1999; Shawber et al., 1996). This could 
be confirmed by overexpressing MyoD in Notch3/mig-infected cells, which should 
permit (i. e. rescue) differentiation if MyoD-downregulation is normally responsible for 
inhibiting differentiation. Notch3 signalling is much more effective at downregulating 
MyoD expression (switching it off entirely) and inhibiting myogenic differentiation 
than Notch 1, suggesting that in reserve cells where active Notch3 is highly expressed, it 
may act as the predominant receptor to inhibit myogenic differentiation. 
Unlike Notchl and Notch2, in addition to its role in inhibiting myogenic differentiation, 
Notch3 signalling may have other distinct functions and is potentially involved in cell 
cycle regulation. Cultures infected to overexpress constitutively active Notch3 
progressively lost expression during repeated subculture, possibly as a result of 
apoptosis of the cells containing a higher level of Notch3, allowing cells expressing less 
Notch3 to expand and eventually, after several passages, constitute the majorit}' of the 
culture. This hypothesis is supported by evidence that constitutively active Notch 
induced apoptosis, as demonstrated by FACS analysis. immunostaining and caspase 
expression. 
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Cells overexpressing active Notch3 may have undergone apoptosis due to alteration of 
the levels of the cdk inhibitors p2 l and p27. Constitutively acti% e Notch3 appeared to 
induce upregulation of p27 expression, so presumably. therefore. downregulation of p21 
(which would need to be confirmed by immunostaining and/or Western blot anal,, -,, I,, ). 
Upregulation of p21 and dephosphorylation of the retinoblastoma protein are critical 
regulatory components of both post-mitotic and apoptosis-resistant states, (\\'alsh and 
Perlman, 1997). Therefore, a predicted downregulation of p21 in cells overexpressing 
constitutively active Notch3 would reduce resistance to apoptosis. resulting in the 
observed upregulation of the pro-apoptotic molecule caspase 8. 
Overexpressed constitutively active Notch3 had an unusual effect on C2C l2 cell 
proliferation. Intriguingly, active Notch3 inhibited myoblast proliferation, but enhanced 
proliferation once differentiation was induced. However, the effect on myoblast 
proliferation was density-dependent, since proliferation of cultures seeded at a low 
density was inhibited, while cultures seeded at a high density showed more normal 
proliferation. A similar biphasic pattern of growth has been observed in VSMC. 
whereby constitutively active Notch3 induced retarded proliferation during the 
subconfluent phase but failed to decelerate post-confluence (Campos et al., 2002). This 
suggests that confluency can affect Notch3 signalling in VSMC and, it appears that the 
regulation of proliferation via Notch3 signalling is also determined by the confluency of 
the culture i. e. cell-cell contacts, and is independent on the presence or absence of 
mitogens (Campos et al., 2002). In C2C12 cultures seeded at low-density. 
overexpressing active Notch3, proliferation increased, reaching a peak when the culture 
presumably reached its threshold density, after which proliferation began to slowly 
decrease again, presumably as cells withdrew from the cell cycle. The Notch" mig- 
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infected cultures seeded at a higher density reached this threshold density sooner. before 
differentiation was induced (so the effect was mitogen-independent). and the rate of 
synthesis slowly decreased with time, as cells became more confluent. 
It is possible to speculate on the mechanism involved in Notch3 signalling. In low- 
density cultures, where there are few cell-cell contacts, constitutiv el`' active N otch3 is 
the predominant effector of Notch signalling and imposes a lower rate of proliferation. 
This is consistent with induction of high-level expression of the cdk inhibitor p27 
observed in Notch3-expressing cells, which should induce cells to enter GO phase. In 
cultures that are initially seeded at a higher density, and as the confluency of the culture 
increases with time, more cell-cell contacts are made, facilitating activation of the other 
Notch receptors (Notchl and Notch2), which competitively inhibit Notch3 signalling 
and consequently p27 expression, leading to an increased rate of prolit'eration. 
However, once a specific level of confluency has been reached, when the number of 
cell-cell contacts is above the threshold, Notch signalling again decreases proliferation, 
perhaps because Notch3 predominates and, via p27 expression, induces quiescence. 
Therefore, in myoblasts endogenous Notch1 and Notch2 signalling must predominate 
over Notch3 so that the cells can proliferate. When differentiation is induced. Notch I 
and Notch2 continue to predominate until cells have reached a threshold level of 
confluency at which Notch3 is activated in specific cells, possibly by D114 signalling 
from adjacent nascent myotubes, ensuring that those cells remain undifferentiated 
quiescent reserve cells through upregulation of p27. 
This model predicts that quantitative propidium iodide staining of myoblasts 
overexpressing active Notch3 would show a greater number of cells 
in GO, due to high 
p27 expression. However, this was not the case. This is possibly 
because for FAC ) 
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analysis the cells were seeded at a higher density than normal, thus increaing cell-ccIl 
contacts, which upregulated Notch signalling via the other receptor:. Inducing 
proliferation. 
Overall, the quantity of DNA in Notch3-infected cells was slightly higher than in 
control cells, suggesting an increase in the number or size of chromosomes. rather than 
an increase in ploidy. C2C12 cells are normally aneuploid, so can accommodate extra 
chromosomes (Anastasia et al., 2006). Indeed, Notch signalling plays a multifaceted 
role in cancer (Roy et al., 2007), which may result when aneuploid cells arise and are 
not destroyed. 
As well as affecting proliferation, expression of constitutively active Notch3 increased 
the size of C2C12 myoblasts. In VSMC, constitutively active Notch3 has a similar 
effect, so cells are larger and rounder than control cells. This is because active Notch3 
alters the actin cytoskeletal dynamics in VSMC, so there is an increase in actin fibres 
and an increase in steady-state levels of polymerised actin (Domenga et al., 2004). 
Therefore, in C2C 12 cells Notch3 overexpression may also increase cell-size by altering 
actin dynamics. The increase in actin fibres may enhance cell motility and migration 
(Chakravarti et al., 2005) of myoblasts to promote cell-cell contact and hence Notch 
signalling. 
9.1.3 Interaction between the Notch receptors during C2C12 cell myogenesis 
Active Notch3 is thought to perform functions distinct from Notch l and Notch2, and 
although the active Notch3 ICD can bind to RBP-Jx, unlike the other two receptors, it is 
a poor transcriptional activator (Kadesch, 2000). Indeed it acts as a transcriptional 
repressor by competing with the Notch 1 ICD for binding to both RBP-JK and a common 
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coactivator (Beatus et al., 1999). The Notch3 ICD may also compete with the Notch-2 
ICD (Beres et al., 2006) to antagonise its signalling, and. conversely the Notch' ICD 
may have negative regulatory effects upon Notch l and Notch3 (Shimizu et al.. O2). 
Therefore, in proliferating myoblasts and reserve cells. where all three receptors are 
expressed, slight differences in the quantity of each active receptor may alter these 
interactions and the competition between them, potentially resulting in different 
receptors predominating. Notch receptors may transactivate different sets of target 
genes, so predominance of one receptor may define phenotype. 
As well as direct competition between the ICDs for binding to RBP-JK and subsequent 
activation or repression of target genes, Notch receptors are differentially targeted by 
the various Numb isoforms for ubiquitination and degradation. Notch l is targeted by 
all four Numb isoforms while Notch3 is not a target of any Numb protein (Beres et al., 
2006). These data represent an additional mechanism by which Notch I (and Notch2) or 
Notch3 may functionally predominate in specific cell-types. 
The effect of direct interaction between the Notch I and Notch3 ICDs during C2C 12 cell 
myogenesis was investigated in co-infection experiments. In proliferating myoblasts, 
coexpression of active Notch 1 and Notch3 had no effect on proliferation. Earlier it was 
suggested that if another Notch receptor is active in C2C 12 cells in addition to Notch3 
(activated by cell-cell contact and subsequent ligand-Notch receptor interaction), the 
decrease in proliferation caused by Notch3 would be overridden, increasing 
proliferation until a threshold density is reached. Thus, when Notch 
l and Notch3 are 
both active, Notchl signalling controls myoblast proliferation. This 
is supported h` the 
observation that when differentiation was induced in cells coexpressing 
both receptors, 
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constitutively active Notch l appeared to control proliferation, further suggesting that 
Notch 1 may regulate proliferation. 
In differentiated cells that coexpressed constitutively active Notch l and Notch-)'. both 
receptors appeared to be functional, since Notchl signalling controlled proliferation. 
while Notchl and Notch3 cooperatively downregulated MyoD expression and inhibited 
myogenic differentiation. Coexpression studies suggested that Notch3 inhibits 
differentiation more effectively than Notch1. Since constitutively active Notch3 also 
highly upregulates p27, which induces cells to enter a quiescent state, it is likely that 
endogenous Notch3 expression predominates in reserve cells, inhibiting their 
differentiation and ensuring that the cells become quiescent. 
In summary, active Notchl may predominate in proliferating myoblasts, via 
competition between the Notch 1 and Notch3 ICDs for binding to RBP-JK or a common 
coactivator, where it maintains proliferation but causes downregulation of MyoD 
expression. In reserve cells, Notch 1 and Notch3 are both active. However, competition 
between the Notchl and Notch3 ICDs for binding to RBP-Jx or a common coactivator, 
in addition to expression of Numb isoforms that may cause degradation of Notch 1 but 
not Notch3 (Beres et al., 2006), may facilitate dominant Notch3 signalling. High levels 
of active Notch3 in reserve cells may cause downregulation of MyoD expression and 
inhibition of differentiation as well as upregulation of p27 expression, which causes the 
cells to reversibly withdraw from the cell cycle and become quiescent. 
9.1.4 DSL ligands 
Activation of Notch receptors in proliferating myoblasts and reserve cells requires 
interaction with DSL ligands on the surface of adjacent cells to facilitate CXL- 
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dependent Notch signalling, or autonomous activation by Dtx proteins. which potentiate 
CSL-independent signalling. The DSL ligands are classified into two structurally-- 
related groups: Delta-like ligands and Serrate-like ligands (reviewed in Harper et al.. 
2003). Differences in domain sizes and/or domain composition between the two groups 
may confer slightly divergent activities (Fleming, 1998). 
In chapter 3, Jaggedl and D114 were identified as playing a potential role in the 
maintenance of proliferating myoblasts and in determining alternate cell fates upon the 
induction of differentiation respectively. The function of the other DSL ligands was not 
as easy to establish, due to the absence of effective antibodies. However, expression of 
Jagged2 appears similar to Jagged l and may function in the same way. During 
myogenesis, the expression of the Delta-like ligand transcripts, Dill and D114, vas also 
similar. However, D111 transcript was expressed in both myotubes and reserve cells, 
while D114, unlike the other DSL ligands analysed, was localised to myotubes, 
suggesting that D114 may play a distinct role. 
Jagged l was found to be highly expressed in proliferating myoblasts and may, 
therefore, activate Notch 1, Notch2 and Notch3 receptors in adjacent myoblasts, 
maintaining them in a proliferative state. When differentiation is induced, D114 is 
expressed on the surface of both myotubes and reserve cells, but is monoubiquitinated 
in myotubes. Monoubiquitination promotes endocytosis, which may enhance the ability 
of the ligand to activate Notch receptors in adjacent cells (Parks et al., 2000). 
Therefore, monoubiquitinated D114 on the surface of nascent myotubes might activate 
Notch receptors in adjacent cells, inhibiting differentiation and maintaining them as 
undifferentiated reserve cells. When differentiation is induced, Jagged1 
is expressed on 
the surface of reserve cells. It is possible that in reserve cells, Notch receptors activated 
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by D114 may autonomously activate Jaggedl (Ross and Kadesch. 2004 º. Jaggedl may 
activate Notch receptors in adjacent naive cells. hence inhibiting their differentiation 
and thus recruiting more cells to the reserve cell compartment. Alternatively. Jagged l 
may activate Notch signalling in adjacent myotubes, affecting their growth or apoptosis 
(reviewed in Artavanis-Tsakonas et al., 1999). 
Overexpression of D114 or Jaggedl in proliferating myoblasts had no effect on 
proliferation but caused a decrease in MyoD expression, consistent with activation of 
Notch signalling in adjacent cells, resulting in MyoD downregulation. Although D11-ß 
can activate the Notch receptors in proliferating myoblasts, this is unlikely since D114 is 
endogenously expressed at a very low level in myoblasts. In contrast. Ja`i ged l is 
abundant in proliferating myoblasts and may, therefore, activate Notch signalling and 
maintain the proliferation of adjacent cells. When differentiation was induced, 
overexpressed D114 or Jaggedl appeared to inhibit differentiation, presumably by 
enhanced Notch activation. Therefore, in agreement with the hypothesis, 
monoubiquitinated D114 expressed on the surface of nascent myotubes and Jagged l on 
the surface of reserve cells may indeed activate Notch signalling in adjacent cells and 
inhibit differentiation to specify them as reserve cells. 
Coculture experiments were carried out to determine the effect of membrane-bound 
D114 and JaggedI on activating Notch in adjacent uninfected C2C 12 cells. The results 
imply that cells make the decision within the first 24 hours after differentiation 
is 
induced to differentiate or not, as during this period cells may be affected by expotiurc 
to D114 or Jagged 1. 
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Coculture was also carried out to determine the effect of the ligands on maintaining 
Notch signalling in reserve cells. Cells overexpressing D114 or Ja{g`ged l were mied 
with reserve cells and the cocultures were transferred to growth medium. which should 
induce MyoD expression and re-entry into the cell cycle of the resew e cell. 
Expression of D114 inhibited reserve cells from re-entering the cell cycle, and 
maintained their ability to bind lysenin. This suggests that D114 can maintain the 
balance of Notch signalling in the reserve cells, as in `differentiated' cultures. 
Significantly, Jaggedl did not maintain reserve cell status. This is consistent with 
Jaggedl regulating Notch signalling in proliferating myoblasts. such that exposure to 
this ligand alters Notch signalling in reserve cells, facilitating the transition to a 
proliferative state. These results support the hypothesis that endogenous Jagged l 
controls Notch signalling in proliferating myoblasts, but when differentiation is induced 
D114 is upregulated and is responsible for activating the Notch receptors in reserve cells 
to specify and maintain them in an undifferentiated state. Once D114-induced Notch 
signalling specifies reserve cells, Jaggedl may be autonomously expressed with the 
active Notch receptors, and may subsequently activate Notch signalling in adjacent 
naive cells. 
D114 and Jaggedl can both activate Notch signalling in adjacent cells. However. since 
Notch signalling induced by different ligands results in distinct outcomes, it is likely 
that the ligands differentially activate the three Notch receptors. Therefore, one 
receptor may predominate in a specific cell-type, as a result of both differential ligand 
activation and competition between the receptor ICDs, causing myogenic differentiation 
to be inhibited and the cells to either proliferate or become quiescent. Indeed, evidence 
from other systems indicates preferential ligand-receptor activation combinations. 
Human myeloid progenitors in contact with Jaggedl upregulate Notch 1, while those 
in 
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contact with D111 upregulate Notch3 expression (Neves et al.. 2006). Therefore, it i' 
possible that Jagged1 may upregulate Notch1 to a greater extent than the other receptors 
in proliferating myoblasts. allowing it to predominate and inhibit myo`genic 
differentiation, while D114 may induce Notch3 activation so it predominates in reserve 
cells, inhibiting their differentiation and upregulating p27 expression, which induces 
quiescence. 
Although the localisation of Dill expression was not fully elucidated, its effects were 
investigated by overexpression. Overexpression of Dill revealed that, as with D114 and 
Jaggedl, this ligand inhibits myogenic differentiation and causes NlyoD 
downregulation. As for D114, endogenous expression patterns suggest that Dill is not 
active in proliferating myoblasts. When differentiation is induced, however, expression 
is upregulated, but unlike D114, D111 is expressed in both myotubes and reserve cells, so 
its precise role in Notch receptor activation during myogenic differentiation remains 
unclear. In myotubes, D111 may cooperate with D114 to inhibit differentiation in 
adjacent cells and hence maintain a population of undifferentiated reserve cells. 
Alternatively, or additionally, it may be expressed in reserve cells, activating Notch 
signalling in adjacent myotubes, possibly regulating growth or apoptosis. 
Dill appears to play an important role during prenatal and postnatal myogenesis. 
suggesting that its function should be examined further (perhaps by coculture 
experiments similar to those described for D114 and Jagged l ). Postnatally, upon 
satellite cell activation in vitro D111 is upregulated in both satellite cells and adjacent 
myofibres and is proposed to activate Notch l signalling in satellite cells, promoting 
their proliferation and inhibiting differentiation (Conboy and 
Rando, 2002). The 
regenerative potential of muscle declines with age, and 
in mice. it has been Su`ggested 
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that this is partly due to the aged systemic environment. which causes diminished Dill- 
upregulation following injury and hence decreased tiotchl activation in satellite ce11 
(Conboy et al., 2003; Conboy et al., 2005). Prenatally, a null mutation of Dill result,, in 
lethality with defects in somitogenesis (Hrabe de Angelis et al.. 1997). A hvpomorphic 
mutation allows mice to survive until birth, but E 18.5 foetuses are motionless and have 
severe muscle hypotrophy because D111 controls both differentiation of early myoblasts 
and maintenance of myogenic progenitors in the embryo (Schuster-Gossler et al., 2007). 
9.1.5 Deltex molecules 
In addition to ligand-induced CSL-dependent Notch signalling, CSL-independent Notch 
signalling may be mediated autonomously via Dtx molecules. CSL-independent 
signalling does occur in C2C12 cells, and has been demonstrated in this project and in 
previously published work (Nofziger et al., 1999; Shawber et al., 1996). Dtx 1, Dtx2 
and Dtx3 transcripts were all expressed in proliferating myoblasts and in reserve cells 
(Dtx2 expression was the most abundant in reserve cells), and so may potentially 
autonomously activate Notch signalling. 
Overexpression of Dtxl led to a subtle increase in MyoD expression and slightly 
enhanced differentiation, suggesting that Dtxl may actually antagonise 
'notch 
signalling. Although most published data suggests that the Dtx molecules positively 
regulate Notch signalling (Kishi et al., 2001; Matsuno et al., 
1995). the result presented 
here is consistent with the observed antagonism of Notch 1 signalling caused 
by Dtx I 
overexpression in haematopoietic progenitors, whereby 
Dtxl inhibits coactivator 
recruitment (Izon et al., 2002). Therefore, Dtxl may play a role 
in antagonising each of 
the Notch receptors to control the levels of signalling 
in proliferating myoblasts and 
reserve cells. 
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Dtx3 overexpression did not alter mvoblast proliferation. MvoD expre-, siOn or 
myogenic differentiation, possibly due to endogenous Dtx3 expression alread\ having a 
maximal effect. This could be confirmed by Dtx3 inhibition. When differentiation is 
induced, overexpression of Dtx3 induced a slight decrease in the number of c% clin, -, 
cells. Endogenous Dtx3 may have decreased when differentiation was induced (perhaps 
due to Itch upregulation). as the effect of ectopic Dtx3 became apparent: it may pre,, ent 
proliferation, perhaps by antagonising Notchl. Alternatively. Dtx3 may function 
independently from Notch signalling. since it is structurally divergent from Dtx 1 and 
Dtx2 (Kishi et al., 2001), and could perhaps play a role in cell cycle withdrawal during, 
myogenic differentiation. 
To further characterise Dtx/Notch signalling during myogenesis. it would be necessary 
to overexpress Dtx2. This was not possible in this project. due to difficulty in 
producing full-length Dtx2 cDNA. However, it is possible that Dtx2 may activate 
autonomous Notch signalling and suppress myogenic differentiation in proliferating 
myoblasts and reserve cells, as it has been reported that Dtx2 overexpression in C2C 12 
cells suppresses myogenin expression (Kishi et al., 2001). However, these results are 
controversial, as Dtx2 overexpression did not affect morphological differentiation (i. e. 
myotube formation)(Kishi et al., 2001). 
9.1.6 Modifying molecules 
Several molecules may inhibit or enhance Notch signalling, by modifying the receptors 
or ligands. Glycosylation, facilitated by Fringe proteins. is critical for normal Notch 
signalling (Okajima et al., 2003). Fringe proteins are evolutionarily conserved prote1n' 
that act in the Golgi apparatus and catalyse the addition of , V-acetyt`glucosamine to 
0- 
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linked fucose residues in the EGF repeats of the Notch receptors. initiating their 
elongation (Bruckner et al., 2000; Moloney et al., 2000; Moran et al.. 1999). which 
either enhances or inhibits ligand-binding and subsequent signalling. In proliferating 
myoblasts, LFng and RFng transcripts were expressed and may. therefore. enhance or 
inhibit ligand-receptor signalling, possibly enhancing Jaggedly\'otchl signalling. 
LFng, RFng and MFng transcripts were expressed throughout myo`7enic differentiation. 
LFng and MFng transcripts were relatively abundant in reserve cells, while RFng was 
high in myotubes. Overexpression of the Fringe molecules may give an indication of 
their function and coculture with D114- or Jagged I-overexpressing cells would reveal 
their ability to enhance or inhibit Notch signalling induced by those ligands. 
Two Notch signalling inhibitory molecules, Numb and Itch, were investigated in this 
project. Numb binds to the ICD of the membrane-bound Notch 1 receptor and is 
thought to recruit components of the ubiquitination machinery (i. e. E3 ubiquitin ligasec 
such as Itch, SellO (McGill and McGlade, 2003) or LNX (Nie et al., 2002)), hence 
promoting Notch1 ubiquitination at the membrane. This facilitates degradation of the 
ICD following activation, preventing its transcription of target genes (McGill and 
McGlade, 2003). There are four mammalian Numb isoforms (Dho et al., 1999), which 
differentially target the Notch receptors (Beres et al., 2006). The antibody used for 
Western blot analysis detected all isoforms, but the similar sizes prevented 
identification by SDS-PAGE. However, Notch l is targeted by all four Numb isoforms. 
Notch2 (which was not studied) is variably repressed and Notch3 is not a target of any 
isoform (Beres et al., 2006), making resolution of individual isoforms less important. 
Itch can interact cooperatively with Numb to promote ubiquitination of membrane- 
bound Notchl (McGill and McGlade, ? 003) or it can independently ubiquitinate 
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Notchl, facilitating its subsequent degradation (Qiu et al.. 200(x: reviewed in 
Schweisguth, 2004). In addition, Itch can ubiquitinate Dtx molecules and cause their 
degradation, which may prevent positive regulation of Notch signalling, by Dtx 
(Chastagner et al., 2006). 
Numb and Itch were coexpressed in proliferating myoblasts and when differentiation 
was induced, were both upregulated in reserve cells. Since the membrane-bound form 
of each Notch receptor was detected in myoblasts and reserve cells, a large amount of 
each receptor expressed could be activated by contact with transmembrane ligands on 
adjacent cells. However, Numb and Itch (as well as other inhibitory molecules) may 
control the quantity of membrane-bound Notch receptors that become activated or are 
ubiquitinated and degraded, thus regulating the levels of Notch activation and signalling 
(reviewed in Kanwar and Fortini, 2004; Sakata et al., 2004; Wilkin et al., 2004). In 
addition, Itch may target Dtx molecules for ubiquitination and degradation (Chastagner 
et al., 2006) and hence regulate levels of CSL-independent Notch signalling. Therefore, 
these negative regulators may specify which receptor predominates in each cell type, 
ensuring that Notchl predominates in proliferating myoblasts, while Notch3 
predominates in reserve cells, since the various Numb isoforms inhibit Notch I but not 
Notch3 (Beres et al., 2006). 
Overexpression experiments demonstrated that Numb is indeed effective in inhibiting 
Notch signalling in myoblasts and reserve cells. In myoblasts overexpression of Numb 
had no effect on proliferation, but increased MyoD expression, consistent with inhibited 
Notch signalling (via Notch l and/or Notch2). However, when differentiation was 
induced, Numb overexpression had no effect. This result conflicts with that of 
Kitzmann et al. (2006), who reported that overexpression of Numb led to an increase in 
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differentiation in C2.7 mouse myoblasts and primary human myoblasts. It iý, pt ib1e 
that C2.7 myoblasts and human myoblasts normally differentiate less effectively than 
C2C12 cells, which would make their enhanced differentiation easier to observe. It is 
also feasible that the level of Numb achieved was insufficient to produce an observable 
effect in C2C 12 cells. In addition, Numb expression may have been repressed h` the 
high levels of Notch receptors, since reciprocal negative regulation between Notch and 
Numb has been observed in C2C12 cells (Chapman et al.. 2006). Alternatively. C'. 
mouse myoblasts and primary human myoblasts may express less receptor, such that 
Numb overexpression can effectively inhibit signalling. 
In addition to Numb and Itch, other inhibitory factors, including Sell0 and molecules 
from pathways that cross-talk with the Notch signalling pathway (e. g. Dishevelled from 
the Wingless signalling pathway), may regulate the levels of Notch signalling in 
myoblasts and reserve cells, and may cause degradation of the Notch receptors in 
myotubes too. This could be confirmed via characterisation of the expression of these 
inhibitory molecules during C2C l2 cell myogenesis and their ability to antagonise 
Notch signalling could be determined by overexpression. 
9.2 Characterisation of the expression and function of components of 
the Notch signalling pathway during satellite cell regulation and 
maintenance 
C2C 12 cell differentiation was used as an in vitro model of myogenesis and 
in 
particular, reserve cells were studied as a model of satellite cell specification and 
regulation. Endogenous expression of Notch signalling components «, aý also 
investigated in quiescent and activated satellite cells on the surface of 
isolated 
myofibres. 
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9.2.1 The Notch receptors 
Notchl, Notch2 and Notch3 transcripts were expressed in freshly-isolated myofibrc 
preparations. After 24 hours in culture, the number of preparations containing 
transcripts declined and in addition, the quantity of transcript in each preparation 
appeared to decrease. After 48 hours in culture, the number of preparations containing, 
mRNA increased and the quantity of transcript in each preparation appeared to be 
upregulated. The number of fibre preparations containing transcripts varied between 
the receptors. At TO and T24, Notch l mRNA was expressed in the least number of 
preparations, followed by Notch3, then Notch2, but by T48 Notch 1 mRNA was present 
in all preparations, while Notch2 and Notch3 were present in approximately 80"o. 
Preparations may be positive even if only one or two satellite cells on the myofibre 
express receptor transcript. 
Immunostaining revealed that Notchl and Notch2 are both expressed in quiescent 
satellite cells, upregulated when activation is induced and are then present throughout 
proliferation and cluster formation, when alternate fate decisions are made. In clusters, 
immunostaining using an antibody that detects the Notch 1 ECD showed that Notch I is 
expressed at the surface of most, but not all, progeny. Its absence from the surface of a 
minority suggests that Notchl could be active and hence nuclear in this population. 
However, antibodies against the Notchl and Notch2 ICDs also reported cell surface 
expression in all progeny, suggesting that the receptors are inactive. This may be 
because the antibodies used were unable to detect nuclear Notch (Struhl and Adachi. 
1998). It, therefore, remains possible that in clusters, Notch 1 and 2 may be expressed 
on the surface of all progeny, but may be active and nuclear in a subset. An effective 
ICD-specific antibody would be required to confirm which hypothesis is correct. 
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The results presented here are consistent with previous data. suggesting that botch I i' 
expressed by quiescent satellite cells and is activated during satellite cell activation. 
possibly promoting proliferation and inhibiting differentiation (Conbov and Rando, 
2002). In the same studies, Numb expression was shown to increase in some progeny. 
leading to speculation that this may inhibit Notchl, allowing those cells to differentiate 
(Conboy and Rando, 2002). Additional modifying molecules (e. g. Itch, Sell0 etc. ) 
could also be expressed at different levels within progeny in clusters, regulating 'botch 
signalling. 
Although the expression and activation status of Notch receptors on satellite cells 
remains unclear, overexpression of either active Notch l or Notch3 was carried out in 
the same system. Initially, clusters of satellite progeny that overexpressed the gene of 
interest were analysed. Since myofibres were cultured in suspension, satellite cells were 
retained underneath the basal lamina of their resident fibre, which ensured that cell-cell 
signalling between the myofibre and its associated satellite cells was maintained, in 
addition to potential cell-cell signalling within the clusters. According to Zammit et al. 
(2004), Pax7 is expressed in quiescent satellite cells. When the cells are activated. 
MyoD is switched on and is coexpressed with Pax7 and the cells then proliferate, 
forming clusters. The majority of myoblasts in clusters then downregulate their Pax? 
expression but maintain MyoD, and go on to differentiate. However. a minority of the 
progeny maintain their expression of Pax7 and downregulate MyoD. This Pax? 
population withdraws from cell cycle and return to an undifferentiated quiescence-like 
state, facilitating possible self-renewal of the satellite cell population. 
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Constitutively active Notch l and Notch3 appeared to have no effect on m obla`t 
proliferation (i. e. the number of cells within clusters). However. since both receptor-, 
are endogenously expressed, and may be controlling proliferation (particularly Notch I ). 
an effect on proliferation may not be observed when the receptors are overexpressed 
because it is already maximal. To determine whether the receptors do affect 
proliferation, their expression would need to be knocked down or out. Both 
constitutively active Notch1 and Notch3 increase the proportion of cells within clusters 
that maintain their expression of Pax? (and presumably withdraw from cell cycle and 
become quiescent) and reduce the proportion that express MyoD. Active Notch 1 and 
Notch3 may, therefore, inhibit the differentiation of a subset of progeny within clusters 
by antagonising MyoD expression, ensuring that they remain undifferentiated and 
quiescent and hence maintain their expression of Pax7. This is consistent ww ith their 
effect on C2C 12 differentiation, where they inhibit differentiation and are expressed by 
reserve cells. 
Primary cultures of satellite progeny that overexpressed active Notch 1 or Notch3 were 
also analysed. This is more comparable with C2C 12 cell culture, and may not be as 
representative of Notch signalling in satellite cells retained under the basal lamina. 
After 48 hours in culture, neither constitutively active Notch1 nor Notch3 affected 
proliferation, but this may be because the system is already saturated with acti% e 
endogenous Notch receptors, which control proliferation and ensure that it is maximal. 
After 72 or 96 hours in culture, constitutively active Notch3 inhibited proliferation, 
while active Notchl had no effect, possibly because endogenous Notchl was still 
active. Interaction with the fibre may regulate myoblast proliferation, possibly 
by 
modulating and maintaining Notch3 activity, which may compete with cndogenou,, 
365 
Notchl. Therefore, as cells migrate away from the fibre, the inhibitory effect. of 
Notch3 appear to be maintained in Notch3 mig-infected cells. In C2C12 cells it was 
observed that in myoblasts at a low confluency. constitutively active Notch3 inhibited 
proliferation, consistent with the results obtained with primary myoblasts. \ otch 3 may 
inhibit proliferation via upregulation of p27 expression, which can induce cell c% cle 
withdrawal into quiescence (Medema et al., 2000; Miskimins et al., 2001; Olashaw and 
Pledger, 2002). 
Primary cultures propagated for eight days formed a heterogeneous population of 
differentiated myotubes and undifferentiated reserve cells, comparable with 
differentiated C2C 12 cell cultures. Overexpression of constitutively active Notch ! or 
Notch3 prevented differentiation and resulted in downregulation of vlyoD. similar to 
their effects in C2C 12 cell cultures. Endogenously, active Notch l and Notch3 may 
inhibit differentiation in a subset of satellite cell progeny within clusters, and Notch3 
may ensure the return to quiescence of that subset. 
9.2.2 D114 and Jaggedl 
D114 and Jagged1 transcripts are differentially expressed in freshly-isolated myofibre 
preparations and those cultured for 24 or 48 hours. Jaggedl was expressed in every 
fibre preparation at each time point. D114 mRNA was also expressed in most of the 
freshly-isolated myofibre preparations, but the number of preparations containing 
transcripts became highly downregulated following activation. 
D114 transcripts were highly-expressed in freshly-isolated myofibre preparations. 
Therefore, it is possible that D114 protein may be expressed on the surface of the 
fibres, 
signalling to adjacent satellite cells to activate Notch signalling 
in them. ensuring that 
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they remain quiescent. This would be analogous with the model in C2C 1' ce11. (ice 
chapter 3, Figure 3.13), whereby monoubiquitinated D114 expressed on the surface of 
myotubes is proposed to activate Notch signalling in adjacent reserve cells so that they 
remain quiescent. However, embyronic in situ analysis, where D114 was replaced with a 
ß-galactosidase reporter gene, suggests that D114 is expressed on the , asculature (Gale 
et al., 2004), rather than myofibres. If D114 is absent from mature fibres, it may only' be 
involved in specifying rather than maintaining satellite (or reserve) cells. How e\ er. 
expression of D114 at points of myofibre/satellite cell contact, which would suggest a 
role in satellite cell maintenance, may not have been noticed in previous studies because 
it would appear similar to staining of the capillary bed (which is D114 (Gale et al., 
2004)). 
When the fibres are cultured in activation medium the level of D114 transcript declines. 
During myofibre culture, degeneration (i. e. fibre death) is occurring, whereas C2C 12 
cell culture is a model of regeneration (i. e. fibre formation). Therefore, D114 may 
appear on forming fibres (i. e. on nascent myotubes forming in C2C 12 cultures), but 
may disappear during fibre degeneration (i. e. in cultured fibres) to release satellite cells 
from quiescence so that they can mediate repair. 
Jagged l transcripts were highly-expressed in freshly-isolated myofibre preparations. 
Therefore, Jaggedl protein may be expressed on the surface of quiescent satellite cells. 
perhaps induced by active Notch receptors, which can autonomously upregulate 
Jagged]. expression (Ross and Kadesch, 2004). Again this would be analogous with 
observations made in C2C 12 cell cultures, whereby endogenous Jagged 
l is highly' 
coexpressed in quiescent reserve cells with active Notch receptors. 
In CC 1_' cell 
cultures, Jaggedl promotes Notch signalling in proliferating myoblasts. 
Therefore. 
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Jaggedl transcript expression may remain high throughout activation and proliferation 
in fibre preparations, since the protein is expressed on the surface of satellite cells and is 
required to induce Notch signalling to maintain proliferation of satellite cell progeny. 
9.3 Concluding remarks 
In conclusion, the results presented suggest that the Notch signalling pathway is 
involved in the regulation and maintenance of satellite cells. probably in similar ways to 
those observed in the C2C 12 model. Therefore, activation of Notch receptors in 
satellite cells may be facilitated by D114 and Jaggedl. Expression of the D114 and 
Jagged1 transcripts in single fibre preparations certainly suggest that the ligands are 
available for satellite cell regulation. However, the function of these ligands would 
need to be investigated by overexpression in satellite cells. If the ligands do have 
similar functions in both systems, then Jagged l may be responsible for activating the 
Notch receptors (predominantly Notchl) in proliferating myoblasts to maintain 
proliferation. Monoubiquitinated D114 expressed on the surface of myofibres, and/or in 
a subset of cells within clusters, may activate Notch signalling (predominantly Notch3) 
in adjacent cells within the clusters to ensure that they remain undifferentiated and 
return to quiescence (via p27 upregulation), facilitating self-renewal of the satellite cell 
pool. Jagged l expression autonomously induced by Notch signalling may activate 
Notch receptors in adjacent naive cells within clusters, inhibiting their differentiation, 
thus specifying more quiescent progeny. Loss-of-function of the receptors and ligands 
specified in this model (via knock-down experiments using shRNA for example) may 
indicate whether they function as hypothesised. 
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Table 9.1: Summary of published literature versus thesis conclusions 
Paper Main Findings Agree Comments 
(; X ) 
Kopan et Constitutively active Notchl localises to Notchl and 3 inhibit 
al., 1994 the nucleus and inhibits C2 myoblast  C2C12 differentiation 
differentiation. MyoD is the target for and induce \lyoD 
inactivation by Notch I. downregulation. 
Shawber Notch1 can inhibit C2C12 differentiation dnRBP-Jx did not alter 
et al., via a CBF1-independent pathway. HES1 C2C12 myogenesis. 
1996; is not upregulated endogenously when CBF 1-independent 
Nofziger differentiation is inhibited. Ectopic HES 1 signalling mal have 
et al., expression does not block myogenesis.  /X been functional. 
1999 Despite inhibiting myogenesis, CBF 1- Reporter constructs 
independent Notch signalling does not would be required to 
antagonise MyoD, suggesting that it determine this and also 
causes a general block in differentiation. to investigate HES 1. 
Jarriault et Jaggedl, Jagged2 and Dill suppress Jagged l, Dill and D114 
al., 1998 myogenic differentiation of C2 myoblasts  suppress C2C 12 
and u re late HES 1 expression. differentiation. 
Beatus et Notch 1 and Notch3 have distinct Notch l and Notch 3 nun 
al., 1999; functions. Unlike the other receptors, compete to result in the 
Beatus et Notch3 is a poor trans activator. It acts as predominance of one 
al., 2001 a repressor by blocking Notch 1 ICD receptor-type in 
transactivation. Notch3 and Notchl myoblasts or reserve 
ICDs compete with each other for access cells. The receptors 
to RBP-Jx: they can both bind to SKIP  /X both inhibit myogenic 
and displace the corepressor SMRT from differentiation and 
RBP-JK on the HES promoter. They also downregulate MyoD. 
compete for binding to a common However, Notch l may 
coactivator (PCAF). Notch 1-mediated play a more important 
transactivation and Notch3-mediated role in proliferation, 
repression is caused by differences in while Notch3 may 
their ANK and RE/AC regions. induce quiescence. 
Kitzmann Inhibition of Notch induces myotube Numb overexpression 
et al., hypertrophy in murine and human did not induce C2C 12 
2006 myoblasts and zebrafish embryos. myotube hypertrophy. 
Notch l activation is important in  /X Notch l. 2 and 3 were 
maintaining CD34- reserve cells in an localised to reserve cells 
undifferentiated state. and ectopic expression 
of active Notch I or 3 
inhibited differentiation. 
Conboy Notch 1 is activated upon satellite cell Notch 1 and 2 are 
and activation (by Dill) and promotes expressed in satellite 
Rando, proliferation of Pax3+ myogenic cells. Notch 1 or 3 
2002 precursor cells. Numb expression 
 overexpression 
increases and localises asymmetrically in inhibited satellite cell 
dividing progeny. Numb attenuates differentiation and 
Notch signalling, leading to commitment downre`gulated %1voD. 
to the myoblast cell fate (desmin+/Pax7+). Notch 
l may promote 
proliferation. 
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APPENDIX: 
Gene expression differences between proliferating my oblasts. 
myotubes and reserve cells, determined using the SuperArrav 
Mouse Notch Signaling Pathway Oligo GEArrav® (01111- 
059)(see section 3.7) 
Gene expression increases greater than 1.5-fold in proliferating my oblasts 
compared with myotubes (i. e. also decreases in myotubes compared s%ith 
myoblasts) 
Gene (and description) Expression change 
Adam] 7 (A disintegrin and metalloprotease domain 17) 1.594103149 
Ccndl (Cyclin D) 2.049725532 
Ccnel (Cyclin El) 11.74534282 
Cd44 (CD44 antigen) 3.29182143 
Fosll (Fos-like antigen 1) 3.147650323 
Fzdl (Frizzled homologue 1 (Drosophila)) 1.556839589 
Fzd6 (Frizzled homologue 6 (Drosophila)) 8.028122157 
Gli2 (GLI-Kruppel family member GLI2) 1.798138957 
Krtl-14 (Keratin complex 1, acidic, gene 14) 14.66348603 
Njkbl (Ubiquitin-conjugating enzyme E2D 3) 1.752914021 
Pparg (Peroxisome proliferator activated receptor gamma) 2.774102004 
Smo (Smoothened homologue (Drosophila)) 2.214854839 
Wisp] (WNTJ inducible signalling pathway protein 1) 2.874733795 
401 
Gene expression decreases greater than 1.5-fold in proliferating mý obla%t% 
compared with myotubes (i. e. increases in myotubes compared with m\ obla,, t' ) 
Gene Expression change 
Aes (Amino-terminal enhancer of split) 1.669 61124 
Aphl a (Anterior pharynx defective ]a homologue (C. elegans)) 1.84 961714 
Cdknla (Cyclin-dependent kinase inhibitor IA (p21)) 1.914632774 
Dtx2 (Deltex2 homologue (Drosophila)) 1.752965 21 
Ep300 (EIA binding protein p300) 1.5 - 2943014 
Fzd9 (Frizzled homologue 9 (Drosophila)) (1 2( ,11 822 
Il6st (Interleukin 6 signal transducer) . 
047 32>; 2 
Mtaplb (Microtubule-associated protein I B) 1.53-500185 ' 
Pofutl (Protein 0-fucosyltransferase 1) 2.069840 304 
Psenl (Presenilin 1) 2.1794 858 
Psen2 (Presenilin 2) 2.466341936 
Psenen (Presenilin enhancer 2 homologue (C. elegans)) 1.5809O213 4 
Ptcra (Pre T-cell antigen receptor alpha) 1.704701176 
Rbpsuh (Recombining binding protein suppressor of hairless) 1.94224135 
Runxl (Runt related transcription factor 1) 1.019422891 3 
Sellh (Sell (suppressor of lin12) 1 homologue (C. elegans)) 2.512739275 
Skiip (SKI interacting protein) 1.9414515 7 
Sufu (RIKENcDNA 9430020M11 gene) 2.975354545 
Supt6h (Suppressor of Ty 6 homologue (S. cerevisiae)) 1.985722879 
Wdr12 (WD repeat domain 12) 1.90847937 
Gene expression increases greater than 1.5-fold in proliferating myoblasts 
compared with reserve cells (i. e. decreases in reserve cells compared with 
myoblasts) 
Gene 
Adam10 (A disintegrin and metalloprotease domain 10) 
Fzd6 (. 
Krtl-1O 
Krtl-14 
Expression change 
1.8724454 
3.42519357 
7.250022535 
1.570510419 
3.764327287 
1.64863752 
, 12.24367 
S . 
8930456 35 
Ccndl (Cyclin DI) 
Ccnel (Cyclin EI) 
Cd44 (CD44 antigen 
'rizzled homologue 6 (U 
eratin 
eratin cot 
lex 1, acidic, g( 
lex 1, acidic, 
)r activated rec 
, unting locus) 
e10 
e14 
tor gamma 
eroxisome procifer 
Sil (Tall int 
402 
Gene expression decreases greater than 1.5-fold in proliferating mý ()hlast. 
compared with reserve cells (i. e. increases in reserve cells compared i%ith 
myoblasts) 
Gene Expression chan(, c Aes (Amino-terminal enhancer of split) 3600: 
Cdknla (Cyclin-dependent kinase inhibitor 1.4 (p21)) 1., S-4 14 
Dtxl (Deltexl homologue (Drosophila)) 2.1 p; '65-1-14 
Fos (FBJ osteosarcoma related oncogene) 5.491 146612 
Il6st (Interleukin 6 signal transducer) _ 2.1-06244-4 
Jag] (Jagged]) -. 441 84 
Notch3 (Notch gene homologue 3 (Drosophila)) 1 
. 
640205-1 -' 
Po utl (Protein O fucos ltrans erase 1) 1.89811061-1 
Rbpsuh (Recombining binding protein suppressor of hairless) 2.2 8-06' 2 Sellh (Sell (suppressor of lin12) 1 homologue (C. elegans)) 1.721)21)l_)45 77 
Wdr12 (WD repeat domain 12) 1.89 39 ý_ý24 
Gene expression increases greater than 1.5-fold in myotubes compared with 
reserve cells (i. e. decreases in reserve cells compared with myotubes) 
Gene Expression change 
Ccndl (CyclinDl) 1.671049863 
Dtx2 (Deltex2 homologue (Drosophila)) 2.602 845 X65 
Ep300 (EIA binding protein 300) 2.03977029 
Fzd9 (Frizzled 9 homologue (Drosophila)) 5.10109715 3 
Krt2-1 (Keratin complex 2, basic, gene 1) 
Mectl (Mucoepidermoid carcinoma translocated 1) 
1.611026667 
1.671896471 
Mtaplb (Microtubule-associated protein IB) 2.910936394 
Notch] (Notch gene homologue 1 (Drosophila)) 1.6071115 14 
Numb (Numb gene homologue (Drosophila)) 1.556958446 
Psen2 (Presenilin 2) 1.98652909 
Runxl (Runt related transcription actor 1) 3.655 915 
3 
Sufu (RIKEN cDNA 9430020M11 gene) 
Supt6h (Suppressor of Ty 6 homolo ue (S. cerevisiae)) . ..... - 
Zic2 (Zic amily member 2 (odd paired homologue, Drosophila)) 
2.407282919 
1.9.498.7-6 
1.50199141 r 
403 
Gene expression decreases greater than 1.5-fold in myotubes compared with 
reserve cells (i. e. increases in reserve cells compared with myotubes) 
Gene Ez ression chan e 
Ccnel (C clip E1) 1.62004225 
Cd44 (CD44 antigen) 2.096020116 
Dtxl (Deltexl homologue (Drosophila)) 1.578856047 
Dtx3 (Deltex3 homologue (Drosophila)) 1.75364949 
Fos (FBJ osteosarcoma related oncogene) 7.065867331 
Fosll (Fos-like antigen 1) 3.2477311 
Gli2 (GLI-Kruppel family member GLI2) 1.672682154 
Gli3 (GLI-Kru el amil member GLI3) 1.664502329 
Hesl (Hairy and enhancer of split 1(Drosophila)) 2.481890045 
Jag] (Jagged]) 2.71072794 
Smo (Smoothened homologue (Drosophila)) 3.288249122 
Wisp] (WNTI inducible signalling pathway protein 1) 3.61927761 
U16 
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